cell_id,bao_format,assay_subcellular_fraction,assay_test_type,doc_id,variant_id,tissue_id,assay_strain,assay_cell_type,confidence_score,assay_id,assay_category,description,curated_by,assay_organism,src_id,assay_tax_id,src_assay_id,assay_tissue,tid,assay_type,relationship_type,chembl_id
,BAO_0000218,,In vivo,9866,,2113.0,,,1,7524,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL618647
,BAO_0000218,,In vivo,9866,,2113.0,,,1,7525,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL618648
,BAO_0000218,,In vivo,9866,,2113.0,,,1,7526,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL618649
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7527,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL618650
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7528,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL618651
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7529,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL876497
,BAO_0000218,,In vivo,9866,,2048.0,,,1,7530,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL618652
,BAO_0000218,,In vivo,9866,,2048.0,,,1,7531,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL618653
,BAO_0000218,,In vivo,9866,,2048.0,,,1,7532,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL618654
,BAO_0000218,,,6351,,,,,1,7533,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618655
,BAO_0000218,,,1465,,,,,1,7534,,Compound was tested for solubility in water,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618656
,BAO_0000100,,,5182,,,,,0,7535,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),Intermediate,,1,,,,22229,P,U,CHEMBL618657
,BAO_0000218,,,17847,,,,,1,7536,,Solubility was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618658
,BAO_0000218,,,15339,,,,,1,7537,,solubility in water (ug/mL) at 37 degree C.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618659
,BAO_0000218,,,5202,,,,,1,7538,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618660
,BAO_0000218,,,1088,,,,,1,7539,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618661
,BAO_0000218,,,3169,,,,,1,7540,,Half life in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL873807
,BAO_0000218,,,5353,,,,,1,7541,,Half life in Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618662
,BAO_0000218,,In vivo,2864,,,,,1,7542,,Half life period after 3 mg/kg iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618663
,BAO_0000218,,In vivo,2864,,,,,1,7543,,Half life period after 3 mg/kg iv administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618664
,BAO_0000218,,In vivo,2864,,,,,1,7544,,Half life period after 3 mg/kg iv administration in the rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618665
,BAO_0000218,,,6362,,,,,1,7545,,Half life period in female Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876498
,BAO_0000218,,,6249,,,,,1,7546,,Half life period in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618666
,BAO_0000218,,,3169,,,,,1,7547,,Half-life in rats was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620440
,BAO_0000218,,,3169,,,,,1,7548,,Half-life in rats with metabolic oxidation,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620441
,BAO_0000218,,,3169,,,,,1,7549,,Half-life in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620442
,BAO_0000218,,In vivo,17260,,,,,1,7550,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620443
,BAO_0000218,,In vivo,17260,,,,,1,7551,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620444
,BAO_0000218,,In vivo,17260,,,,,1,7552,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620445
,BAO_0000218,,In vivo,17260,,,,,1,7553,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620446
,BAO_0000218,,,2879,,1969.0,,,1,7554,,Biological half-life measured in plasma of rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL620447
,BAO_0000218,,,2879,,1969.0,,,1,7555,,Biological half-life measured in plasma of rat; 22-25,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621129
,BAO_0000218,,,2879,,1969.0,,,1,7556,,Biological half-life measured in plasma of rat; 9-16,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621130
,BAO_0000218,,In vivo,3184,,,,,1,7557,,Compound was evaluated for its half life when administered intravenously in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL873808
,BAO_0000218,,In vivo,4891,,,,,1,7558,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876598
,BAO_0000218,,In vivo,429,,,,,1,7559,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621131
,BAO_0000218,,In vivo,5656,,,,,1,7560,,Half life (T1/2) after oral administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621132
,BAO_0000218,,In vivo,4413,,,,,1,7561,,Half life of compound after iv administration of 20 mg/kg dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621133
,BAO_0000218,,In vivo,3598,,,,,1,7562,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621312
,BAO_0000218,,,17267,,,,,1,7563,,Half life of compound was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621313
,BAO_0000218,,,4727,,178.0,,,1,7564,,Half life of compound was determined in rat blood,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL621314
,BAO_0000218,,In vivo,17651,,,,,1,7565,,Half life at 1 mg/kg was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621315
,BAO_0000218,,In vivo,17651,,,,,1,7566,,Half life at 10 mg/kg was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621316
,BAO_0000218,,,401,,,,,1,7567,,Half life in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621317
,BAO_0000218,,,4942,,,,,1,7568,,Half life in rats in hours,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621318
,BAO_0000218,,In vivo,17735,,,,,1,7569,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621319
,BAO_0000218,,In vivo,6056,,,,,1,7570,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621377
,BAO_0000218,,,5213,,,,,1,7571,,Half life was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621378
,BAO_0000218,,In vivo,6616,,,,,1,7572,,Half life after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876599
,BAO_0000218,,In vivo,5937,,,,,1,7573,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621379
,BAO_0000218,,,5819,,1969.0,,,1,7574,,Half life in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621380
,BAO_0000218,,,5819,,1969.0,,,1,7575,,Half life in rat plasma; Not detected,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621381
,BAO_0000218,,,6803,,,,,1,7576,,Half life in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618515
,BAO_0000218,,In vivo,17804,,,,,1,7577,,Half life period of compound was determined after peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618516
,BAO_0000218,,In vivo,17804,,,,,1,7578,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618517
,BAO_0000218,,,5948,,,,,1,7579,,Half life period in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618518
,BAO_0000218,,In vivo,1916,,,,,1,7580,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618519
,BAO_0000218,,In vivo,1916,,,,,1,7581,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618698
,BAO_0000218,,In vivo,1916,,,,,1,7582,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618862
,BAO_0000218,,In vivo,4890,,,,,1,7583,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618863
,BAO_0000218,,In vivo,17764,,,,,1,7584,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618864
,BAO_0000218,,In vivo,4727,,,,,1,7585,,Half life time in rat the dose of 2 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618865
,BAO_0000218,,In vivo,17509,,,,,1,7586,,Half-life 24 hr after 10 mg/kg iv administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618866
,BAO_0000218,,In vivo,17509,,,,,1,7587,,Half-life 24 hr after 2 mg/kg iv administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618867
,BAO_0000218,,,6597,,,,,1,7588,,Half-life consistent with the observed metabolic steady state in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875828
,BAO_0000218,,In vivo,17735,,,,,1,7589,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618868
,BAO_0000218,,,6597,,,,,1,7590,,Half-life for oxidative metabolic stability was determined using male human,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618869
,BAO_0000218,,In vivo,17670,,,,,1,7591,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618870
,BAO_0000218,,,1696,,1969.0,,,1,7592,,Half-life in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL618871
,BAO_0000218,,,1742,,1969.0,,,1,7593,,Half-life in rat plasma was determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL618872
,BAO_0000218,,,17800,,,,,1,7594,,Half-life in rats was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL873816
,BAO_0000218,,,12923,,,,,0,7595,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,Autocuration,,1,,,,22224,A,U,CHEMBL618873
,BAO_0000019,,,11954,,,,,0,7596,,Area under curve after oral dose of 0.1 mg//kg,Autocuration,,1,,,,22224,A,U,CHEMBL621602
,BAO_0000218,,,11954,,,,,0,7597,,Area under curve after oral dose of 0.3 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL621603
,BAO_0000218,,,11954,,,,,0,7598,,Area under curve after oral dose of 1 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL621604
,BAO_0000218,,,11954,,,,,0,7599,,Area under curve after oral dose of 10 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL621605
,BAO_0000218,,,11954,,,,,0,7600,,Area under curve after oral dose of 23.4 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL621606
,BAO_0000218,,,11954,,,,,0,7601,,Area under curve after oral dose of 3 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL621607
,BAO_0000218,,,11954,,,,,0,7602,,Area under curve after oral dose of 3.87 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL621608
,BAO_0000019,,,5237,,,,,0,7603,,Area under curve was determined,Autocuration,,1,,,,22224,A,U,CHEMBL621609
,BAO_0000218,,,4026,,,,,0,7604,,Area under curve at a dose of 10 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL621610
,BAO_0000218,,,5237,,,,,1,7605,,Area under curve was determined; ND=No data,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621611
,BAO_0000218,,,14793,,,,,1,7606,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621612
,BAO_0000218,,,14793,,,,,1,7607,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622308
,BAO_0000218,,,14793,,,,,1,7608,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622309
,BAO_0000218,,,14793,,,,,1,7609,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622310
,BAO_0000218,,,14793,,,,,1,7610,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622311
,BAO_0000218,,,14793,,,,,1,7611,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622312
,BAO_0000218,,,14793,,,,,1,7612,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622931
,BAO_0000218,,,14793,,,,,1,7613,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622932
,BAO_0000218,,,14793,,1969.0,,,1,7614,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622736
,BAO_0000218,,,14793,,1969.0,,,1,7615,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622737
,BAO_0000218,,,14793,,1969.0,,,1,7616,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622738
,BAO_0000218,,,14793,,1969.0,,,1,7617,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622739
,BAO_0000218,,,14793,,1969.0,,,1,7618,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622740
,BAO_0000218,,,14793,,1969.0,,,1,7619,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622741
,BAO_0000218,,,14793,,1969.0,,,1,7620,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622742
,BAO_0000218,,,14793,,1969.0,,,1,7621,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622743
,BAO_0000218,,,11637,,1969.0,,,1,7622,,AUC in mice,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL622744
,BAO_0000019,,,11149,,,,,0,7623,,Area under curve was measured from the graph obtained from concentration Vs time,Autocuration,,1,,,,22224,A,U,CHEMBL624134
,BAO_0000019,,,10016,,,,,0,7624,,Area under curve value of compound per hour after oral administration,Autocuration,,1,,,,22224,A,U,CHEMBL624135
,BAO_0000218,,,17796,,,,,1,7625,,Area under curve was determined after oral administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624136
,BAO_0000218,,,17796,,,,,1,7626,,Area under curve was determined after oral administration in rats; No data,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624137
,BAO_0000218,,,17796,,,,,1,7627,,Area under curve was determined after oral administration in rats;No data,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624320
,BAO_0000218,,,12923,,,,,1,7628,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624321
,BAO_0000218,,,15372,,,,,1,7629,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624322
,BAO_0000218,,,15372,,,,,1,7630,,Area under curve was determined for the compound after iv dose of 5.06 in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624323
,BAO_0000218,,,15372,,,,,1,7631,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624324
,BAO_0000218,,,15372,,,,,1,7632,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624325
,BAO_0000218,,,15372,,,,,1,7633,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624326
,BAO_0000218,,,15372,,,,,1,7634,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624327
,BAO_0000218,,,15372,,,,,1,7635,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624328
,BAO_0000218,,,14169,,,,,1,7636,,Area under curve was determined in Dogs after peroral administration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL627848
,BAO_0000218,,,14169,,,,,1,7637,,Area under curve was determined in Rats after peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627849
,BAO_0000218,,,14258,,,,,1,7638,,Area under curve was determined in carotid blood of rat when administered intradermally,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627850
,BAO_0000218,,,14258,,,,,1,7639,,Area under curve was determined in portal blood of rat when administered intradermally,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627851
,BAO_0000218,,,15011,,,,,1,7640,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627852
,BAO_0000218,,,15011,,,,,1,7641,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627853
,BAO_0000218,,,15011,,,,,1,7642,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627854
,BAO_0000218,,,15011,,,,,1,7643,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627855
,BAO_0000218,,,15011,,,,,1,7644,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627856
,BAO_0000218,,,15011,,,,,1,7645,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL875339
,BAO_0000218,,,15011,,,,,1,7646,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627857
,BAO_0000218,,In vivo,11195,,2106.0,,,1,7647,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL627858
,BAO_0000218,,,10130,,178.0,,,1,7648,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627859
,BAO_0000218,,,10130,,955.0,,,1,7649,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL627860
,BAO_0000218,,,10130,,948.0,,,1,7650,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL627019
,BAO_0000218,,,10130,,2107.0,,,1,7651,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627020
,BAO_0000218,,,10130,,2048.0,,,1,7652,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627021
,BAO_0000218,,,10130,,2385.0,,,1,7653,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627022
,BAO_0000218,,,10130,,,,,1,7654,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627023
,BAO_0000218,,,10130,,2106.0,,,1,7655,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL627024
,BAO_0000218,,,10130,,2046.0,,,1,7656,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL627025
,BAO_0000218,,,10130,,2113.0,,,1,7657,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627026
,BAO_0000218,,,10130,,178.0,,,1,7658,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627027
,BAO_0000218,,,10130,,955.0,,,1,7659,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL627028
,BAO_0000218,,,10130,,948.0,,,1,7660,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL627029
,BAO_0000218,,,10130,,2113.0,,,1,7661,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627030
,BAO_0000218,,,10130,,2107.0,,,1,7662,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627031
,BAO_0000218,,,10130,,2048.0,,,1,7663,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627032
,BAO_0000218,,,10130,,2385.0,,,1,7664,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627033
,BAO_0000218,,,10130,,,,,1,7665,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627034
,BAO_0000218,,,10130,,2106.0,,,1,7666,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL627035
,BAO_0000218,,,10130,,2046.0,,,1,7667,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL627036
,BAO_0000218,,,10130,,178.0,,,1,7668,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL875340
,BAO_0000218,,,10130,,948.0,,,1,7669,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL627037
,BAO_0000218,,,10130,,2113.0,,,1,7670,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627038
,BAO_0000218,,,10130,,2107.0,,,1,7671,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627039
,BAO_0000218,,,10130,,2385.0,,,1,7672,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627040
,BAO_0000218,,,10130,,2106.0,,,1,7673,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL624663
,BAO_0000218,,,10130,,2046.0,,,1,7674,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL625963
,BAO_0000218,,,10130,,955.0,,,1,7675,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL876799
,BAO_0000218,,,10130,,2048.0,,,1,7676,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626133
,BAO_0000218,,,10130,,,,,1,7677,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626134
,BAO_0000218,,,6295,,,,,1,7678,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626135
,BAO_0000218,,,6296,,,,,1,7679,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626136
,BAO_0000218,,,6296,,,,,1,7680,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626137
,BAO_0000218,,,6295,,,,,1,7681,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626138
,BAO_0000218,,,6296,,,,,1,7682,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626139
,BAO_0000218,,In vivo,17260,,,,,1,7683,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626140
,BAO_0000218,,In vivo,17260,,,,,1,7684,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626141
,BAO_0000218,,,17686,,,,,1,7685,,C24h in rat p.o. at 20 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626142
,BAO_0000218,,In vivo,9866,,2385.0,,,1,7686,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627930
,BAO_0000218,,In vivo,9866,,2385.0,,,1,7687,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627931
,BAO_0000218,,In vivo,9866,,2385.0,,,1,7688,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627932
,BAO_0000218,,In vivo,9866,,2106.0,,,1,7689,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL627933
,BAO_0000218,,In vivo,9866,,2106.0,,,1,7690,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL627934
,BAO_0000218,,In vivo,9866,,2106.0,,,1,7691,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL627935
,BAO_0000218,,In vivo,9866,,178.0,,,1,7692,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627936
,BAO_0000218,,In vivo,9866,,178.0,,,1,7693,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627937
,BAO_0000218,,In vivo,9866,,178.0,,,1,7694,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627938
,BAO_0000218,,In vivo,9866,,178.0,,,1,7695,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627939
,BAO_0000218,,In vivo,9866,,178.0,,,1,7696,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627940
,BAO_0000218,,In vivo,9866,,178.0,,,1,7697,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627941
,BAO_0000218,,In vivo,9866,,178.0,,,1,7698,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL876800
,BAO_0000218,,In vivo,9866,,178.0,,,1,7699,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627942
,BAO_0000218,,In vivo,9866,,178.0,,,1,7700,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627943
,BAO_0000218,,In vivo,9866,,178.0,,,1,7701,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627944
,BAO_0000218,,In vivo,9866,,178.0,,,1,7702,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627945
,BAO_0000218,,In vivo,9866,,178.0,,,1,7703,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628584
,BAO_0000218,,In vivo,9866,,178.0,,,1,7704,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628585
,BAO_0000218,,In vivo,9866,,178.0,,,1,7705,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628586
,BAO_0000218,,In vivo,9866,,178.0,,,1,7706,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628587
,BAO_0000218,,In vivo,9866,,178.0,,,1,7707,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628588
,BAO_0000218,,In vivo,9866,,178.0,,,1,7708,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628589
,BAO_0000218,,In vivo,9866,,178.0,,,1,7709,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625304
,BAO_0000218,,In vivo,9866,,178.0,,,1,7710,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625305
,BAO_0000218,,In vivo,9866,,178.0,,,1,7711,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625306
,BAO_0000218,,In vivo,9866,,178.0,,,1,7712,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625307
,BAO_0000218,,In vivo,9866,,178.0,,,1,7713,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625308
,BAO_0000218,,In vivo,9866,,178.0,,,1,7714,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627740
,BAO_0000218,,In vivo,9866,,178.0,,,1,7715,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627741
,BAO_0000218,,In vivo,9866,,178.0,,,1,7716,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627742
,BAO_0000218,,In vivo,9866,,178.0,,,1,7717,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627743
,BAO_0000218,,In vivo,9866,,178.0,,,1,7718,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627744
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7719,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL627745
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7720,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL627746
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7721,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL627747
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7722,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL876810
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7723,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL627748
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7724,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL627749
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7725,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL627750
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7726,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618728
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7727,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618729
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7728,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618730
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7729,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618731
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7730,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618732
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7731,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618733
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7732,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618734
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7733,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618735
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7734,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL876602
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7735,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618736
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7736,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618737
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7737,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618738
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7738,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618739
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7739,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618740
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7740,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618741
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7741,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618742
,BAO_0000218,,In vivo,9866,,10000001.0,,,1,7742,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL618743
,BAO_0000218,,In vivo,17752,,1969.0,,,1,7743,,Half-life from rat plasma at a single oral dose of 25 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL618744
,BAO_0000218,,,5610,,,,,1,7744,,Half-life in male rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618745
,BAO_0000218,,In vivo,5939,,,,,1,7745,,Half-life in rat after peroral administration at 10 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620479
,BAO_0000218,,In vivo,5939,,,,,1,7746,,Half-life in rat after peroral administration at 5 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620480
,BAO_0000218,,In vivo,17771,,,,,1,7747,,Half-life in rat at a dose of 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620481
,BAO_0000218,,,1974,,,,,1,7748,,Half-life was evaluated in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620482
,BAO_0000218,,,4239,,,,,1,7749,,Half-life was measured in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876603
,BAO_0000218,,In vivo,6681,,,,,1,7750,,Half-life period for the compound was determined in rats at 50 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620483
,BAO_0000218,,In vivo,17752,,,,,1,7751,,Half-life period in rats after intravenous administration at 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620484
,BAO_0000218,,In vivo,6046,,,,,1,7752,,Half-life period in rat at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620485
,BAO_0000218,,In vivo,6685,,,,,1,7753,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620486
,BAO_0000218,,In vivo,6685,,,,,1,7754,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620487
,BAO_0000218,,In vivo,6685,,,,,1,7755,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620488
,BAO_0000218,,In vivo,4727,,,,,1,7756,,Half-life time in rat the dose of 2 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620489
,BAO_0000218,,In vivo,1088,,,,,1,7757,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620490
,BAO_0000218,,In vivo,5610,,,,,1,7758,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620491
,BAO_0000218,,In vivo,3032,,1969.0,,,1,7759,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL876604
,BAO_0000218,,In vivo,5199,,,,,1,7760,,Oral half life was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620492
,BAO_0000218,,In vivo,14941,,,,,1,7761,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620493
,BAO_0000218,,In vivo,4408,,,,,1,7762,,Pharmacokinetic property (t1/2) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620494
,BAO_0000218,,,2552,,1969.0,,,1,7763,,Plasma elimination half-life was determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL620495
,BAO_0000218,,In vivo,5199,,1969.0,,,1,7764,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL620496
,BAO_0000218,,In vivo,15662,,1969.0,,,1,7765,,Plasma half life was observed after intravenous administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL620497
,BAO_0000218,,,1465,,1969.0,,,1,7766,,Plasma half-life was determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL620498
,BAO_0000218,,In vivo,1446,,1969.0,,,1,7767,,Plasma half-life following oral administration in Fisher rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL620499
,BAO_0000218,,,6824,,1969.0,,,1,7768,,Plasma half-life in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL620500
,BAO_0000218,,In vivo,17533,,1969.0,,,1,7769,,Plasmatic Half-life after intravenous administration to rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL873809
,BAO_0000218,,In vivo,5979,,,,,1,7770,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620501
,BAO_0000218,,In vivo,4689,,,,,1,7771,,Terminal half life after intravenous administration (1 mg/kg) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620502
,BAO_0000218,,In vivo,4689,,,,,1,7772,,Terminal half life in Rat at a oral dose of 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620503
,BAO_0000218,,In vivo,2463,,,,,1,7773,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620504
,BAO_0000218,,In vivo,4883,,,,,1,7774,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876605
,BAO_0000218,,In vivo,4883,,,,,1,7775,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620505
,BAO_0000218,,In vivo,15662,,1969.0,,,1,7776,,plasma half life was observed after intravenous administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL873811
,BAO_0000218,,In vivo,3598,,,,,1,7777,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624016
,BAO_0000218,,,4576,,,,,1,7778,,Half life of compound determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624017
,BAO_0000218,,,4576,,,,,1,7779,,Mean residence time determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624018
,BAO_0000218,,,4576,,,,,1,7780,,Plasma half life determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624019
,BAO_0000218,,In vivo,4910,,955.0,,,1,7781,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL624020
,BAO_0000218,,In vivo,4891,,,,,1,7782,,Compound was evaluated for pharmacokinetic parameter maximum time period,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624201
,BAO_0000218,,In vivo,429,,,,,1,7783,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL872528
,BAO_0000218,,In vivo,5974,,,,,1,7784,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624202
,BAO_0000218,,In vivo,5974,,,,,1,7785,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624203
,BAO_0000218,,In vivo,5974,,,,,1,7786,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624350
,BAO_0000218,,In vivo,5974,,,,,1,7787,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621320
,BAO_0000218,,In vivo,17582,,,,,1,7788,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621321
,BAO_0000218,,,4026,,,,,1,7789,,Maximum time (Tmax) required to reach Cmax in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621322
,BAO_0000218,,In vivo,4890,,,,,1,7790,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621323
,BAO_0000218,,In vivo,6571,,,,,1,7791,,Maximum time of clearance of compound in rats after peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621324
,BAO_0000218,,,4727,,,,,1,7792,,Maximum time at the dose of 2 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621325
,BAO_0000218,,In vivo,17651,,1969.0,,,1,7793,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL875837
,BAO_0000218,,In vivo,17651,,1969.0,,,1,7794,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621326
,BAO_0000218,,In vivo,14465,,,,,1,7795,,Tmax in Guinea pig (PO dose),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621327
,BAO_0000218,,In vivo,14941,,,,,1,7796,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621328
,BAO_0000218,,In vivo,5960,,,,,1,7797,,Pharmacokinetic parameter (Tmax) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621329
,BAO_0000218,,In vivo,5022,,,,,1,7798,,Pharmacokinetic parameter (Tmax) was estimated,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621330
,BAO_0000218,,In vivo,4408,,,,,1,7799,,Pharmacokinetic property (Tmax) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621331
,BAO_0000218,,In vivo,5983,,,,,1,7800,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621332
,BAO_0000218,,In vivo,4689,,,,,1,7801,,T max in Rat at a oral dose of 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621333
,BAO_0000218,,In vivo,2792,,,,,1,7802,,T max was determined at 10 mg/kg po dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621334
,BAO_0000218,,,15011,,,,,1,7803,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL621335
,BAO_0000218,,,14180,,,,,1,7804,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL621336
,BAO_0000218,,,14180,,,,,1,7805,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621337
,BAO_0000218,,,14599,,,,,1,7806,,Area under curve was measured after i.v. administration into Beagle dog.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL621338
,BAO_0000218,,,14599,,,,,1,7807,,Area under curve was measured after iv administration into Beagle dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL875838
,BAO_0000218,,,14599,,,,,1,7808,,Area under curve was measured after po administration into Beagle dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL621339
,BAO_0000218,,,14599,,,,,1,7809,,Area under curve was measured after po administration into Beagle dog.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL621340
,BAO_0000218,,,15675,,,,,0,7810,,Area under curve was measured at peroral dose of 3 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL621341
,BAO_0000019,,,12706,,,,,0,7811,,Area under curve was measured by using concentration Vs time,Autocuration,,1,,,,22224,A,U,CHEMBL621342
,BAO_0000019,,,12706,,,,,0,7812,,Area under curve was measured by using concentration Vs time; not tested,Autocuration,,1,,,,22224,A,U,CHEMBL621343
,BAO_0000218,,,9750,,,,,1,7813,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL621344
,BAO_0000218,,,9750,,,,,1,7814,,Area under curve(AUC) was measured in mice after oral administration.,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL621345
,BAO_0000019,,,14691,,,,,0,7815,,Area under curve(AUC) value of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL621346
,BAO_0000218,,,14691,,,,,0,7816,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,Autocuration,,1,,,,22224,A,U,CHEMBL621347
,BAO_0000218,,,14691,,,,,1,7817,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL621348
,BAO_0000019,,,2939,,178.0,,,0,7818,,Area under curve(carotid artery) was determined by the availability in blood,Autocuration,,1,,,Blood,22224,A,U,CHEMBL621349
,BAO_0000019,,,2939,,178.0,,,0,7819,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,Autocuration,,1,,,Blood,22224,A,U,CHEMBL621350
,BAO_0000019,,,2939,,178.0,,,0,7820,,Area under curve(carotid artery) was determined by the availability in blood; No data,Autocuration,,1,,,Blood,22224,A,U,CHEMBL875839
,BAO_0000019,,,2939,,178.0,,,0,7821,,Area under curve(portal vein) was determined by the availability in blood,Autocuration,,1,,,Blood,22224,A,U,CHEMBL620211
,BAO_0000019,,,2939,,178.0,,,0,7822,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,Autocuration,,1,,,Blood,22224,A,U,CHEMBL620212
,BAO_0000019,,,2939,,178.0,,,0,7823,,Area under curve(portal vein) was determined by the availability in blood; No data,Autocuration,,1,,,Blood,22224,A,U,CHEMBL620213
,BAO_0000218,,,9552,,1969.0,,,1,7824,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Intermediate,Macaca mulatta,1,9544.0,,Plasma,50797,A,N,CHEMBL620214
,BAO_0000218,,,9552,,1969.0,,,1,7825,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Intermediate,Macaca mulatta,1,9544.0,,Plasma,50797,A,N,CHEMBL620215
,BAO_0000218,,,9552,,1969.0,,,1,7826,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,Intermediate,Macaca mulatta,1,9544.0,,Plasma,50797,A,N,CHEMBL620216
,BAO_0000218,,,9552,,1969.0,,,1,7827,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL620888
,BAO_0000218,,,9552,,1969.0,,,1,7828,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL620889
,BAO_0000019,,,9552,,1969.0,,,0,7829,,Area under plasma concentration vs time curve observed in rats for 0-3 h,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL620890
,BAO_0000218,,,11911,,1969.0,,,1,7830,,Area under plasma time curve determined in male rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL620891
,BAO_0000019,,,16618,,,,,0,7831,,Area under the MAP curve measured over 5 min.,Autocuration,,1,,,,22224,A,U,CHEMBL620892
,BAO_0000218,,,14387,,,,,1,7832,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL621079
,BAO_0000218,,,14387,,,,,1,7833,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL621080
,BAO_0000218,,,12836,,,,,1,7834,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL621081
,BAO_0000218,,,12836,,,,,1,7835,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,Intermediate,Cricetinae,1,10026.0,,,100712,A,N,CHEMBL621082
,BAO_0000218,,,12836,,,,,1,7836,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621083
,BAO_0000218,,,14339,,,,,1,7837,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL621084
,BAO_0000218,,,14339,,,,,1,7838,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL621085
,BAO_0000218,,,14339,,,,,1,7839,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL621086
,BAO_0000218,,,10524,,,,,1,7840,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL621087
,BAO_0000218,,,9994,,,,,1,7841,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL622607
,BAO_0000218,,,11325,,,,,1,7842,,Serum AUC in marmosets (IV dose),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL622608
,BAO_0000019,,,12536,,,,,0,7843,,Area under the curve after intravenous administration at a dose of 10 umol/kg,Autocuration,,1,,,,22224,A,U,CHEMBL624481
,BAO_0000019,,,12536,,,,,0,7844,,Area under the curve after intravenous administration at a dose of 2 umol/kg,Autocuration,,1,,,,22224,A,U,CHEMBL624482
,BAO_0000019,,,12536,,,,,0,7845,,Area under the curve after intravenous administration at a dose of 4 umol/kg,Autocuration,,1,,,,22224,A,U,CHEMBL624483
,BAO_0000019,,,12536,,,,,0,7846,,Area under the curve after intravenous administration at a dose of 40 umol/kg,Autocuration,,1,,,,22224,A,U,CHEMBL624484
,BAO_0000019,,,12536,,,,,0,7847,,Area under the curve after intravenous administration at a dose of 5 umol/kg,Autocuration,,1,,,,22224,A,U,CHEMBL624485
,BAO_0000218,,,15556,,,,,1,7848,,Area under the curve for fumarate salt was evaluated in F344 Rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624486
,BAO_0000019,,,2809,,,,,0,7849,,Area under the curve for the compound was calculated.,Autocuration,,1,,,,22224,A,U,CHEMBL624487
,BAO_0000019,,,9511,,,,,0,7850,,Area under the curve in concentration/ time,Autocuration,,1,,,,22224,A,U,CHEMBL624488
,BAO_0000218,,,12818,,,,,1,7851,,Area under the curve administered intraintestinal in rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624489
,BAO_0000218,,,12818,,,,,1,7852,,Area under the curve administered intravenously in rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625184
,BAO_0000019,,,15118,,,,,0,7853,,Area under the curve during intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL625185
,BAO_0000019,,,15118,,,,,0,7854,,Area under the curve during intravenous administration; Not determined,Autocuration,,1,,,,22224,A,U,CHEMBL875954
,BAO_0000019,,,15118,,,,,0,7855,,Area under the curve during systemic administration,Autocuration,,1,,,,22224,A,U,CHEMBL625186
,BAO_0000019,,,15118,,,,,0,7856,,Area under the curve during systemic administration; Not determined,Autocuration,,1,,,,22224,A,U,CHEMBL625187
,BAO_0000019,,,2632,,,,,0,7857,,Area under the curve was calculated for the compound.,Autocuration,,1,,,,22224,A,U,CHEMBL625188
,BAO_0000218,,,14346,,,,,1,7858,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625189
,BAO_0000218,,,14346,,,,,1,7859,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625190
,BAO_0000218,,,14346,,,,,1,7860,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621733
,BAO_0000218,,,14346,,,,,1,7861,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621734
,BAO_0000218,,,11149,,,,,1,7862,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621735
,BAO_0000218,,,17796,,1969.0,,,1,7863,,Clearance of the drug was measured in the plasma of rat; No data,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621736
,BAO_0000218,,,5247,,1969.0,,,1,7864,,The pharmacokinetic parameter plasma clearance in vivo in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621737
,BAO_0000218,,,4727,,,,,1,7865,,Plasma clearance at the dose of 2 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621738
,BAO_0000218,,In vivo,5654,,,,,1,7866,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622806
,BAO_0000218,,In vivo,5654,,,,,1,7867,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623519
,BAO_0000218,,In vivo,17260,,,,,1,7868,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623520
,BAO_0000218,,In vivo,17065,,,,,1,7869,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623521
,BAO_0000218,,In vivo,17671,,,,,1,7870,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623522
,BAO_0000218,,In vivo,6672,,,,,1,7871,,Clearance rate in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623523
,BAO_0000218,,In vivo,6673,,,,,1,7872,,Clearance rate in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623690
,BAO_0000218,,In vivo,5978,,,,,1,7873,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623691
,BAO_0000218,,In vivo,5978,,,,,1,7874,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623692
,BAO_0000218,,In vivo,5978,,,,,1,7875,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623693
,BAO_0000218,,In vivo,5978,,,,,1,7876,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623694
,BAO_0000218,,In vivo,4413,,,,,1,7877,,Clearance of compound after iv administration of 20 mg/kg dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623695
,BAO_0000218,,In vivo,2661,,,,,1,7878,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623696
,BAO_0000218,,In vivo,2661,,,,,1,7879,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623697
,BAO_0000218,,In vivo,5005,,1969.0,,,0,7880,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Intermediate,Macaca mulatta,1,9544.0,,Plasma,22224,A,U,CHEMBL623698
,BAO_0000218,,In vivo,5005,,1969.0,,,0,7881,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,22224,A,U,CHEMBL623699
,BAO_0000218,,In vivo,15765,,,,,1,7882,,Mean (%CV) PK parameters for CL(mL/min/kg).,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623700
,BAO_0000218,,In vivo,3747,,,,,1,7883,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623701
,BAO_0000218,,In vivo,16366,,1969.0,,,1,7884,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623702
,BAO_0000218,,In vivo,4199,,,,,1,7885,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623703
,BAO_0000218,,In vivo,17267,,,,,1,7886,,Plasma clearance in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623704
,BAO_0000218,,In vivo,6535,,,,,1,7887,,Plasma clearance in rat after administration of 2 mg/kg iv,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623705
,BAO_0000218,,In vivo,6535,,,,,1,7888,,Plasma clearance in rat after administration of 2 mg/kg iv,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623706
,BAO_0000218,,In vivo,5041,,,,,1,7889,,Plasma clearance was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623707
,BAO_0000218,,In vivo,5960,,,,,1,7890,,Plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623708
,BAO_0000218,,In vivo,5937,,,,,1,7891,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623709
,BAO_0000218,,In vivo,5871,,,,,1,7892,,Plasma clearance in rat by iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623710
,BAO_0000218,,In vivo,5874,,,,,1,7893,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623711
,BAO_0000218,,In vivo,6504,,,,,1,7894,,Plasma clearance in rat p.o.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623712
,BAO_0000218,,In vivo,6803,,,,,1,7895,,Plasma clearance in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623713
,BAO_0000218,,In vivo,5041,,,,,1,7896,,Plasma clearance was determined; ND denotes no data,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623714
,BAO_0000218,,In vivo,5041,,,,,1,7897,,Plasma clearance was determined; ND denotes not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623715
,BAO_0000218,,In vivo,1916,,,,,1,7898,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623716
,BAO_0000218,,In vivo,5199,,,,,1,7899,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622980
,BAO_0000218,,In vivo,16367,,,,,1,7900,,Plasma administration to rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622981
,BAO_0000218,,In vivo,6362,,,,,1,7901,,Plasma clearance of the compound in female Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622982
,BAO_0000218,,In vivo,15662,,,,,1,7902,,Plasma clearance was observed after intravenous administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622983
,BAO_0000218,,In vivo,6215,,,,,1,7903,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622984
,BAO_0000218,,In vivo,1466,,,,,1,7904,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622985
,BAO_0000218,,In vivo,15662,,1969.0,,,1,7905,,plasma clearance was observed after intravenous administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623631
,BAO_0000218,,In vivo,4723,,,,,1,7906,,In vivo CL/F determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623632
,BAO_0000218,,In vivo,2792,,1969.0,,,1,7907,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623633
,BAO_0000218,,In vivo,2792,,1969.0,,,1,7908,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623634
,BAO_0000218,,In vivo,5213,,,,,1,7909,,Compound was tested for the lower blood clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623635
,BAO_0000218,,In vivo,4687,,,,,1,7910,,Evaluated for the low clearance in rat (in vivo),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621195
,BAO_0000218,,In vivo,3371,,,,,1,7911,,Pharmacokinetic property (CLb)of the compound was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621196
,BAO_0000218,,In vivo,4690,,,,,1,7912,,Rapid clearance after intravenous administration in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875287
,BAO_0000218,,In vivo,5702,,,,,1,7913,,Clearance measured in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621197
,BAO_0000218,,In vivo,740,,1969.0,,,1,7914,,Compound was evaluated for plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621198
,BAO_0000218,,In vivo,4853,,1969.0,,,1,7915,,Low plasma clearance was calculated in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621199
,BAO_0000218,,In vivo,5789,,,,,1,7916,,Pharmacokinetic property (Clp) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621200
,BAO_0000218,,In vivo,4527,,,,,1,7917,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621201
,BAO_0000218,,In vivo,4527,,,,,1,7918,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621202
,BAO_0000218,,In vivo,6518,,,,,1,7919,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621203
,BAO_0000218,,In vivo,6518,,,,,1,7920,,Plasma clearance after IV dosing at 1 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621204
,BAO_0000218,,In vivo,9866,,948.0,,,1,7921,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621205
,BAO_0000218,,In vivo,9866,,948.0,,,1,7922,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621206
,BAO_0000218,,In vivo,9866,,948.0,,,1,7923,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621207
,BAO_0000218,,In vivo,9866,,948.0,,,1,7924,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621208
,BAO_0000218,,In vivo,9866,,948.0,,,1,7925,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621209
,BAO_0000218,,In vivo,9866,,948.0,,,1,7926,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL876484
,BAO_0000218,,In vivo,9866,,948.0,,,1,7927,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621210
,BAO_0000218,,In vivo,9866,,948.0,,,1,7928,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621211
,BAO_0000218,,In vivo,9866,,948.0,,,1,7929,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621212
,BAO_0000218,,In vivo,9866,,948.0,,,1,7930,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621213
,BAO_0000218,,In vivo,9866,,948.0,,,1,7931,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621214
,BAO_0000218,,In vivo,9866,,948.0,,,1,7932,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621215
,BAO_0000218,,In vivo,9866,,948.0,,,1,7933,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621216
,BAO_0000218,,In vivo,9866,,948.0,,,1,7934,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621217
,BAO_0000218,,In vivo,9866,,948.0,,,1,7935,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621218
,BAO_0000218,,In vivo,9866,,948.0,,,1,7936,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621219
,BAO_0000218,,In vivo,9866,,948.0,,,1,7937,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621220
,BAO_0000218,,In vivo,9866,,948.0,,,1,7938,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621221
,BAO_0000218,,In vivo,9866,,948.0,,,1,7939,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621222
,BAO_0000218,,In vivo,9866,,948.0,,,1,7940,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621223
,BAO_0000218,,In vivo,9866,,948.0,,,1,7941,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL876485
,BAO_0000218,,In vivo,9866,,948.0,,,1,7942,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621224
,BAO_0000218,,In vivo,9866,,948.0,,,1,7943,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621225
,BAO_0000218,,In vivo,9866,,948.0,,,1,7944,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621226
,BAO_0000218,,In vivo,9866,,2113.0,,,1,7945,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621227
,BAO_0000218,,In vivo,9866,,2113.0,,,1,7946,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621228
,BAO_0000218,,In vivo,9866,,2113.0,,,1,7947,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621229
,BAO_0000218,,In vivo,9866,,2113.0,,,1,7948,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621230
,BAO_0000218,,In vivo,9866,,2113.0,,,1,7949,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621231
,BAO_0000218,,In vivo,9866,,2113.0,,,1,7950,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621232
,BAO_0000218,,In vivo,9866,,2113.0,,,1,7951,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621233
,BAO_0000218,,In vivo,9866,,2113.0,,,1,7952,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621234
,BAO_0000218,,In vivo,9866,,2113.0,,,1,7953,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621235
,BAO_0000218,,In vivo,9866,,2113.0,,,1,7954,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621236
,BAO_0000218,,In vivo,9866,,2113.0,,,1,7955,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621237
,BAO_0000218,,In vivo,9866,,2113.0,,,1,7956,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL876486
,BAO_0000218,,In vivo,9866,,160.0,,,1,7957,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL622436
,BAO_0000218,,In vivo,9866,,160.0,,,1,7958,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL622437
,BAO_0000218,,In vivo,9866,,160.0,,,1,7959,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL622438
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7960,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622439
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7961,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622440
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7962,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622441
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7963,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622442
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7964,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622443
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7965,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622444
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7966,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622445
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7967,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622446
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7968,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622447
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7969,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622448
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7970,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622449
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7971,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622450
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7972,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622451
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7973,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622452
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7974,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622453
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7975,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622454
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7976,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622455
,BAO_0000218,,In vivo,9866,,2107.0,,,1,7977,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL876024
,BAO_0000218,,In vivo,2792,,,,,1,7978,,T max was determined at 3 mg/kg po dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622456
,BAO_0000218,,In vivo,15078,,,,,1,7979,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622457
,BAO_0000218,,In vivo,15078,,,,,1,7980,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622458
,BAO_0000218,,,15022,,,,,1,7981,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622459
,BAO_0000218,,,15022,,,,,1,7982,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL873343
,BAO_0000218,,,15022,,,,,1,7983,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622460
,BAO_0000218,,,4576,,1969.0,,,1,7984,,Time for maximum plasma concentration determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622461
,BAO_0000218,,In vivo,6681,,1969.0,,,1,7985,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622462
,BAO_0000218,,In vivo,16365,,,,,1,7986,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622463
,BAO_0000218,,In vivo,16365,,,,,1,7987,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622464
,BAO_0000218,,In vivo,16365,,,,,1,7988,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622465
,BAO_0000218,,In vivo,16365,,,,,1,7989,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622466
,BAO_0000218,,In vivo,16365,,,,,1,7990,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622467
,BAO_0000218,,,6824,,1969.0,,,1,7991,,Time of maximum plasma concentration in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622468
,BAO_0000218,,,6685,,1969.0,,,1,7992,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL876025
,BAO_0000218,,,6685,,1969.0,,,1,7993,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622469
,BAO_0000218,,,6685,,1969.0,,,1,7994,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622470
,BAO_0000218,,In vivo,15662,,,,,1,7995,,Time required to reach maximum concentration (Cmax) after oral administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622471
,BAO_0000218,,,1742,,1969.0,,,1,7996,,Time required to reach maximum concentration in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622472
,BAO_0000218,,In vivo,2774,,1969.0,,,1,7997,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622473
,BAO_0000218,,In vivo,5199,,1969.0,,,1,7998,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL624282
,BAO_0000218,,In vivo,12873,,1969.0,,,1,7999,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL624283
,BAO_0000218,,In vivo,12873,,1969.0,,,1,8000,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL624284
,BAO_0000218,,In vivo,1916,,1969.0,,,1,8001,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL624285
,BAO_0000218,,In vivo,16367,,,,,1,8002,,Time to reach Cmax after oral administration to rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624286
,BAO_0000218,,In vivo,16366,,,,,1,8003,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624287
,BAO_0000218,,,216,,,,,1,8004,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624288
,BAO_0000218,,In vivo,6410,,1969.0,,,1,8005,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL624289
,BAO_0000218,,In vivo,6410,,1969.0,,,1,8006,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL873344
,BAO_0000218,,In vivo,6215,,,,,1,8007,,Tmax after peroral administration (10 mg/kg) was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL619623
,BAO_0000218,,In vivo,3598,,,,,1,8008,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621399
,BAO_0000218,,In vivo,4527,,,,,1,8009,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621400
,BAO_0000218,,In vivo,17670,,,,,1,8010,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621401
,BAO_0000218,,,1465,,,,,1,8011,,Tmax was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621402
,BAO_0000218,,,2552,,,,,1,8012,,Tmax was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621403
,BAO_0000218,,In vivo,5656,,,,,1,8013,,Tmax after oral administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621121
,BAO_0000218,,In vivo,17764,,,,,1,8014,,Tmax after peroral administration in rats at 2.4 uM/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL872525
,BAO_0000218,,,5610,,,,,1,8015,,Tmax in male rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621122
,BAO_0000218,,In vivo,6046,,,,,1,8016,,Tmax in rat at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621123
,BAO_0000218,,In vivo,5874,,,,,1,8017,,Tmax in rat by po administration at a dose of 40 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621124
,BAO_0000218,,,17596,,,,,1,8018,,Tmax in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621125
,BAO_0000218,,In vivo,17804,,,,,1,8019,,Tmax was measured in rats after peroral administration at 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621126
,BAO_0000218,,In vivo,1908,,,,,1,8020,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621127
,BAO_0000218,,In vivo,2959,,,,,1,8021,,Tmax value after administration of 20 mg/Kg oral dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621128
,BAO_0000218,,In vivo,6757,,,,,1,8022,,Tmax value at a dose of 10 mg/kg in male SD rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618263
,BAO_0000218,,In vivo,6757,,,,,1,8023,,Tmax value at a dose of 100 mg/kg in male SD rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618264
,BAO_0000218,,In vivo,6757,,,,,1,8024,,Tmax value at a dose of 50 mg/kg in male SD rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618265
,BAO_0000218,,In vivo,4186,,1969.0,,,1,8025,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL618266
,BAO_0000218,,In vivo,15662,,,,,1,8026,,time required to reach maximum concentration (Cmax) after oral administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618267
,BAO_0000218,,,429,,1088.0,,,1,8027,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL618450
,BAO_0000218,,,429,,1088.0,,,1,8028,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL618451
,BAO_0000218,,,5546,,,,,1,8029,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618452
,BAO_0000218,,,3173,,1088.0,,,1,8030,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL618453
,BAO_0000218,,,3173,,1088.0,,,1,8031,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL618454
,BAO_0000218,,,3173,,1088.0,,,1,8032,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL618455
,BAO_0000218,,In vivo,4257,,,,,1,8033,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618456
,BAO_0000218,,In vivo,6011,,,,,1,8034,,Compound distribution in rat tissues was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618457
,BAO_0000218,,In vivo,5472,,,,,1,8035,,Volume of distribution was evaluated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618458
,BAO_0000218,,,14346,,,,,1,8036,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618459
,BAO_0000218,,,14346,,,,,1,8037,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876733
,BAO_0000218,,,14346,,,,,1,8038,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL618460
,BAO_0000218,,,14346,,,,,1,8039,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618461
,BAO_0000019,,,15469,,,,,0,8040,,Area under the curve was determined after oral administration (300 uM/Kg),Autocuration,,1,,,,22224,A,U,CHEMBL618462
,BAO_0000218,,,14346,,,,,1,8041,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618463
,BAO_0000218,,,14346,,,,,1,8042,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618464
,BAO_0000218,,,14346,,,,,1,8043,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618465
,BAO_0000218,,,14346,,,,,1,8044,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618466
,BAO_0000218,,,14346,,,,,1,8045,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618467
,BAO_0000218,,,15372,,,,,1,8046,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618468
,BAO_0000218,,,12935,,1969.0,,,1,8047,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL618469
,BAO_0000218,,,12935,,1969.0,,,1,8048,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL618470
,BAO_0000218,,,14813,,,,,0,8049,,Plasma drug AUC in rat (PO dose),Autocuration,,1,,,,22224,A,U,CHEMBL618471
,BAO_0000218,,,15792,,,,,1,8050,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL618472
,BAO_0000218,,,3579,,,,,0,8051,,Area under was determined at a dose of 30 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL618473
,BAO_0000218,,,12487,,,,,1,8052,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,Intermediate,Mustela putorius furo,1,9669.0,,,50506,A,N,CHEMBL621699
,BAO_0000218,,,12487,,,,,1,8053,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621700
,BAO_0000218,,,12487,,,,,1,8054,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621701
,BAO_0000218,,,12487,,,,,1,8055,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,Intermediate,Mustela putorius furo,1,9669.0,,,50506,A,N,CHEMBL621702
,BAO_0000218,,,12487,,,,,1,8056,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL621703
,BAO_0000218,,,12487,,,,,1,8057,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL621704
,BAO_0000218,,,12902,,,,,1,8058,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624259
,BAO_0000218,,,12902,,,,,1,8059,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624260
,BAO_0000218,,,12902,,,,,1,8060,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624430
,BAO_0000218,,,12902,,,,,1,8061,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624431
,BAO_0000218,,,12902,,,,,1,8062,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624432
,BAO_0000218,,,12902,,,,,1,8063,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624433
,BAO_0000218,,,12902,,,,,1,8064,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624434
,BAO_0000218,,,12902,,,,,1,8065,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624435
,BAO_0000218,,,12745,,,,,1,8066,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL618570
,BAO_0000218,,,12745,,,,,1,8067,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL618571
,BAO_0000218,,,12745,,,,,1,8068,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL618572
,BAO_0000218,,,12745,,,,,1,8069,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL618573
,BAO_0000218,,,12745,,,,,1,8070,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL619267
,BAO_0000218,,,12745,,,,,1,8071,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL619431
,BAO_0000218,,,12745,,,,,1,8072,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL619432
,BAO_0000218,,,12745,,,,,1,8073,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL619433
,BAO_0000218,,,13298,,1969.0,,,0,8074,,AUC in mice after oral dose (50 mg/kg),Autocuration,,1,,,Plasma,22224,A,U,CHEMBL619434
,BAO_0000218,,,12226,,1977.0,,,1,8075,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,Intermediate,Mus musculus,1,10090.0,,Serum,50594,A,N,CHEMBL619435
,BAO_0000019,,,12634,,1969.0,,,0,8076,,AUC (0-4 hr) ug/ml/h,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL619436
,BAO_0000218,,,14810,,,,,1,8077,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL619437
,BAO_0000218,,,13889,,,,,0,8078,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,Autocuration,,1,,,,22224,A,U,CHEMBL619438
,BAO_0000218,,,10018,,,,,1,8079,,Compound was evaluated for Area under curve in mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL619439
,BAO_0000218,,,8758,,,,,1,8080,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL619440
,BAO_0000218,,,8758,,,,,0,8081,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Autocuration,,1,,,,22224,F,U,CHEMBL619441
,BAO_0000218,,,8758,,,,,1,8082,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL619442
,BAO_0000019,,,2249,,,,,0,8083,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,Autocuration,,1,,,,22224,A,U,CHEMBL875156
,BAO_0000019,,,2249,,,,,0,8084,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,Autocuration,,1,,,,22224,A,U,CHEMBL619443
,BAO_0000019,,,2249,,,,,0,8085,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,Autocuration,,1,,,,22224,A,U,CHEMBL619444
,BAO_0000019,,,2249,,,,,0,8086,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,Autocuration,,1,,,,22224,A,U,CHEMBL623464
,BAO_0000218,,,15115,,,,,1,8087,,Compound was evaluated for area under curve when administered through oral route in mouse,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623465
,BAO_0000218,,In vivo,6518,,,,,1,8088,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623466
,BAO_0000218,,In vivo,6518,,,,,1,8089,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623467
,BAO_0000218,,In vivo,6249,,,,,1,8090,,Plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623468
,BAO_0000218,,In vivo,2463,,,,,1,8091,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622660
,BAO_0000218,,In vivo,4969,,,,,1,8092,,Plasma clearance rate in Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622661
,BAO_0000218,,In vivo,17720,,,,,1,8093,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL622662
,BAO_0000218,,In vivo,3457,,,,,1,8094,,Pharmacokinetic property (total body clearance) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622663
,BAO_0000218,,In vivo,5983,,,,,1,8095,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622664
,BAO_0000218,,,6295,,,,,1,8096,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622665
,BAO_0000218,,,6296,,,,,1,8097,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622666
,BAO_0000218,,In vivo,17686,,,,,1,8098,,Cl in rat i.v. at 2 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621615
,BAO_0000218,,In vivo,17764,,,,,1,8099,,Clearance of compound after intravenous administration in rats at 24 uM/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621616
,BAO_0000218,,In vivo,5503,,,,,1,8100,,Clearance was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621617
,BAO_0000218,,In vivo,4368,,,,,1,8101,,Clearance by intravenous administration of 3.4 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621618
,BAO_0000218,,In vivo,6005,,,,,1,8102,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621619
,BAO_0000218,,In vivo,5031,,,,,1,8103,,Clearance rate after i.v. administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621620
,BAO_0000218,,In vivo,4890,,,,,1,8104,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621786
,BAO_0000218,,In vivo,5182,,,,,1,8105,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621787
,BAO_0000218,,In vivo,5979,,,,,1,8106,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621788
,BAO_0000218,,In vivo,5656,,,,,1,8107,,Clearance (Cl) after oral administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621789
,BAO_0000218,,In vivo,17804,,,,,1,8108,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621790
,BAO_0000218,,In vivo,4839,,1969.0,,,1,8109,,Compound was tested for plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621791
,BAO_0000218,Microsomes,In vitro,5041,,,,,1,8110,,In vitro microsome metabolism clearance in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621792
,BAO_0000218,Microsomes,In vitro,5041,,,,,1,8111,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621793
,BAO_0000218,,In vivo,5974,,,,,1,8112,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621794
,BAO_0000218,,In vivo,5496,,1969.0,,,1,8113,,In vivo plasma clearance was determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621795
,BAO_0000218,,In vivo,5739,,,,,1,8114,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621796
401.0,BAO_0000218,,In vivo,5676,,2107.0,,Hepatocyte,1,8115,,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621797
,BAO_0000218,,In vivo,4239,,,,,1,8116,,Pharmacokinetic property (Plasma clearance) was measured in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621798
,BAO_0000218,,In vivo,5676,,,,,1,8117,,Pharmacokinetic property (clearance) in rat i.v.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621799
,BAO_0000218,,In vivo,1918,,,,,1,8118,,"Plasma Clearance was evaluated in rats, iv",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621800
,BAO_0000218,,In vivo,17800,,,,,1,8119,,Plasma clearance (in vivo) in rats was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621801
,BAO_0000218,,In vivo,6056,,,,,1,8120,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621802
,BAO_0000218,,In vivo,5496,,,,,1,8121,,Plasma clearance was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618596
,BAO_0000218,,In vivo,5939,,,,,1,8122,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618597
,BAO_0000218,,In vivo,5939,,,,,1,8123,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618598
,BAO_0000218,,In vivo,17752,,,,,1,8124,,Plasma clearance in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618599
,BAO_0000218,,In vivo,4576,,,,,1,8125,,Plasma clearance rate determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618600
,BAO_0000218,,In vivo,6011,,,,,1,8126,,Plasma clearance was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618601
,BAO_0000218,,In vivo,5510,,,,,1,8127,,Plasma clearance was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618602
,BAO_0000218,,In vivo,5948,,,,,1,8128,,Plasma clearance value in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618603
,BAO_0000218,,Ex vivo,6125,,2107.0,,,1,8129,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL618604
,BAO_0000218,,In vivo,4839,,,,,1,8130,,Clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618605
,BAO_0000218,,In vivo,17686,,,,,1,8131,,Total body clearance in rat i.v. at 2 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618606
,BAO_0000218,,In vivo,6571,,,,,1,8132,,Clearance of compound in rats after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618607
,BAO_0000218,,In vivo,3364,,,,,1,8133,,Clearance after iv administration to rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618608
,BAO_0000218,,In vivo,13569,,,,,1,8134,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618609
,BAO_0000218,,In vivo,13569,,,,,1,8135,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618610
,BAO_0000218,,In vivo,13569,,,,,1,8136,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618611
,BAO_0000218,,In vivo,13569,,,,,1,8137,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618612
,BAO_0000218,,In vivo,13569,,,,,1,8138,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618613
,BAO_0000218,,In vivo,13569,,,,,1,8139,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621076
,BAO_0000218,,In vivo,13569,,,,,1,8140,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621077
,BAO_0000218,,In vivo,17670,,,,,1,8141,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621078
,BAO_0000218,,In vivo,5970,,,,,1,8142,,Clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621251
,BAO_0000218,,In vivo,6495,,,,,1,8143,,Clearance in rat after oral administration at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621252
,BAO_0000218,,In vivo,4590,,,,,1,8144,,Clearance in rat.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621253
,BAO_0000218,,In vivo,6193,,,,,1,8145,,Clearance rate following an oral dose of 20 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621254
,BAO_0000218,,In vivo,2832,,,,,1,8146,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621255
,BAO_0000218,,In vivo,1052,,1969.0,,,1,8147,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621256
,BAO_0000218,,In vivo,9866,,2107.0,,,1,8148,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621257
,BAO_0000218,,In vivo,9866,,2107.0,,,1,8149,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621258
,BAO_0000218,,In vivo,9866,,2107.0,,,1,8150,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621259
,BAO_0000218,,In vivo,9866,,2107.0,,,1,8151,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621260
,BAO_0000218,,In vivo,9866,,2107.0,,,1,8152,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL876494
,BAO_0000218,,In vivo,9866,,2107.0,,,1,8153,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621261
,BAO_0000218,,In vivo,9866,,2107.0,,,1,8154,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621262
,BAO_0000218,,In vivo,9866,,2107.0,,,1,8155,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621263
,BAO_0000218,,In vivo,9866,,2107.0,,,1,8156,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621264
,BAO_0000218,,In vivo,9866,,2385.0,,,1,8157,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL621265
,BAO_0000218,,In vivo,9866,,2385.0,,,1,8158,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL621266
,BAO_0000218,,In vivo,9866,,2385.0,,,1,8159,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL621267
,BAO_0000218,,In vivo,9866,,2385.0,,,1,8160,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL621268
,BAO_0000218,,In vivo,9866,,2385.0,,,1,8161,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL621269
,BAO_0000218,,In vivo,9866,,2385.0,,,1,8162,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL621270
,BAO_0000218,,In vivo,9866,,2385.0,,,1,8163,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL621271
,BAO_0000218,,In vivo,9866,,2385.0,,,1,8164,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL621272
,BAO_0000218,,In vivo,9866,,2385.0,,,1,8165,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL621273
,BAO_0000218,,In vivo,9866,,2385.0,,,1,8166,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL621274
,BAO_0000218,,In vivo,9866,,2385.0,,,1,8167,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL876495
,BAO_0000218,,In vivo,9866,,2385.0,,,1,8168,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL621275
,BAO_0000218,,In vivo,9866,,2385.0,,,1,8169,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL621276
,BAO_0000218,,In vivo,9866,,2385.0,,,1,8170,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL621277
,BAO_0000218,,In vivo,9866,,160.0,,,1,8171,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL621278
,BAO_0000218,,In vivo,9866,,160.0,,,1,8172,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL621279
,BAO_0000218,,In vivo,9866,,160.0,,,1,8173,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL621280
,BAO_0000218,,In vivo,9866,,2106.0,,,1,8174,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621281
,BAO_0000218,,In vivo,9866,,2106.0,,,1,8175,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621282
,BAO_0000218,,In vivo,9866,,2106.0,,,1,8176,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621283
,BAO_0000218,,In vivo,9866,,2106.0,,,1,8177,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621284
,BAO_0000218,,In vivo,9866,,2106.0,,,1,8178,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621285
,BAO_0000218,,In vivo,9866,,2106.0,,,1,8179,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621286
,BAO_0000218,,In vivo,9866,,2106.0,,,1,8180,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL623220
,BAO_0000218,,In vivo,9866,,2106.0,,,1,8181,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL623221
,BAO_0000218,,In vivo,9866,,2106.0,,,1,8182,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL876029
,BAO_0000218,,In vivo,9866,,945.0,,,1,8183,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL623222
,BAO_0000218,,In vivo,9866,,945.0,,,1,8184,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL623223
,BAO_0000218,,In vivo,9866,,945.0,,,1,8185,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL621445
,BAO_0000218,,In vivo,13950,,178.0,,,1,8186,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL621446
,BAO_0000218,,In vivo,13950,,178.0,,,1,8187,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL621447
,BAO_0000218,,In vivo,13950,,178.0,,,1,8188,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL619681
,BAO_0000218,,In vivo,13950,,178.0,,,1,8189,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL619682
,BAO_0000218,,In vivo,13950,,178.0,,,1,8190,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL619683
,BAO_0000218,,In vivo,13950,,955.0,,,1,8191,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL619684
,BAO_0000218,,In vivo,13950,,955.0,,,1,8192,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL619685
,BAO_0000218,,In vivo,13950,,955.0,,,1,8193,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL619686
,BAO_0000218,,In vivo,13950,,955.0,,,1,8194,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL619687
,BAO_0000218,,In vivo,13950,,955.0,,,1,8195,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL619688
,BAO_0000218,,In vivo,13950,,948.0,,,1,8196,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL619689
,BAO_0000218,,In vivo,13950,,948.0,,,1,8197,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL619690
,BAO_0000218,,In vivo,13950,,948.0,,,1,8198,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL619691
,BAO_0000218,,In vivo,6062,,,,,1,8199,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL619692
,BAO_0000218,,,3598,,,,,1,8200,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL619693
,BAO_0000218,,In vivo,1908,,,,,1,8201,,Vc value after IV dose at a dose of 5 mg/kg in rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL619694
,BAO_0000218,,In vivo,17596,,,,,1,8202,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL619695
,BAO_0000218,,In vivo,4891,,,,,1,8203,,Compound was evaluated for pharmacokinetic parameter volume of distribution,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL619696
,BAO_0000218,,In vivo,740,,,,,1,8204,,Compound was evaluated for volume of distribution in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL619697
,BAO_0000218,,In vivo,16366,,,,,1,8205,,Steady state volume distribution was determined; steady state(ss),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL619698
,BAO_0000218,,In vivo,3364,,,,,1,8206,,Steady state volume of distribution after iv administration to rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL619699
,BAO_0000218,,In vivo,2552,,,,,1,8207,,Steady state volume of distribution dosing at 3 mg/kg iv,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL619700
,BAO_0000218,,In vivo,406,,,,,1,8208,,The compound was evaluated for volume of distribution in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL619701
,BAO_0000218,,In vivo,12500,,,,,1,8209,,The compound was tested for volume of distribution in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL619702
,BAO_0000218,,In vivo,12500,,,,,1,8210,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620335
,BAO_0000218,,In vivo,5656,,,,,1,8211,,Volume distribution (VD) after oral administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620336
,BAO_0000218,,In vivo,17671,,,,,1,8212,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620337
,BAO_0000218,,In vivo,1094,,,,,1,8213,,Volume distribution in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620520
,BAO_0000218,,In vivo,5833,,,,,1,8214,,Volume distribution in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620521
,BAO_0000218,,In vivo,5939,,,,,1,8215,,Volume distribution in rat after peroral administration at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875825
,BAO_0000218,,In vivo,5939,,,,,1,8216,,Volume distribution in rat after peroral administration at 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620522
,BAO_0000218,,In vivo,6005,,,,,1,8217,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620523
,BAO_0000218,,In vivo,1696,,,,,1,8218,,Volume of distribution in rat.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620524
,BAO_0000218,,In vivo,6672,,,,,1,8219,,Volume of distribution in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620525
,BAO_0000218,,In vivo,6673,,,,,1,8220,,Volume of distribution in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620526
,BAO_0000218,,In vivo,5871,,,,,1,8221,,Volume of distribution in rat by iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620527
,BAO_0000218,,In vivo,6803,,,,,1,8222,,Volume of distribution in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620528
,BAO_0000218,,In vivo,5199,,,,,1,8223,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620529
,BAO_0000218,,,4727,,,,,1,8224,,Volume distribution at the dose of 2 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620530
,BAO_0000218,,In vivo,16367,,,,,1,8225,,Steady state volume of distribution was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620531
,BAO_0000218,,In vivo,5005,,,,,0,8226,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Intermediate,Macaca mulatta,1,9544.0,,,22224,A,U,CHEMBL620532
,BAO_0000218,,In vivo,5005,,,,,0,8227,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL620533
,BAO_0000218,,In vivo,5005,,,,,0,8228,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,Intermediate,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL620534
,BAO_0000218,,In vivo,15765,,,,,1,8229,,Mean (%CV) PK parameters for Vdss(mL/kg).,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620535
,BAO_0000218,,In vivo,2792,,,,,1,8230,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875826
,BAO_0000218,,In vivo,2792,,,,,1,8231,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620536
,BAO_0000218,,In vivo,5334,,,,,1,8232,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620537
,BAO_0000218,,In vivo,5334,,,,,1,8233,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618526
,BAO_0000218,,In vivo,5739,,,,,1,8234,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618527
,BAO_0000218,,In vivo,5789,,,,,1,8235,,Pharmacokinetic property (Vdss) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618528
,BAO_0000218,,In vivo,4239,,,,,1,8236,,Pharmacokinetic property (vdss) was measured in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618529
,BAO_0000218,,In vivo,4709,,,,,1,8237,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618530
,BAO_0000218,,In vivo,6642,,,,,1,8238,,Volume of distribution in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618531
,BAO_0000218,,In vivo,5247,,,,,1,8239,,The pharmacokinetic parameter volume of distribution in vivo in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618532
,BAO_0000218,,In vivo,17720,,,,,1,8240,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL618533
,BAO_0000218,,In vivo,17686,,,,,1,8241,,Vdss in rat i.v. at 2 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618534
,BAO_0000218,,In vivo,4689,,,,,1,8242,,Volume distribution after intravenous administration (1 mg/kg) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618535
,BAO_0000218,,In vivo,5654,,,,,1,8243,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618536
,BAO_0000218,,In vivo,5654,,,,,1,8244,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618537
,BAO_0000218,,In vivo,4527,,,,,1,8245,,Volume distribution at a dose of 10 uM/kg in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618538
,BAO_0000218,,In vivo,4521,,,,,1,8246,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618539
,BAO_0000218,,In vivo,6057,,,,,1,8247,,Volume distribution was calculated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618540
,BAO_0000218,,In vivo,5510,,,,,1,8248,,Volume distribution was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618541
,BAO_0000218,,In vivo,2938,,,,,1,8249,,Volume of distribution after intravenous administration was evaluated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618542
,BAO_0000218,,In vivo,6679,,,,,1,8250,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622544
,BAO_0000218,,In vivo,6685,,,,,1,8251,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622545
,BAO_0000218,,In vivo,6685,,,,,1,8252,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622546
,BAO_0000218,,In vivo,6685,,,,,1,8253,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622547
,BAO_0000218,,In vivo,5145,,,,,1,8254,,Volume of distribution in steady state was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622548
,BAO_0000218,,In vivo,6467,,,,,1,8255,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622549
,BAO_0000218,,In vivo,6467,,,,,1,8256,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622550
,BAO_0000218,,,15115,,,,,1,8257,,Compound was evaluated for area under curve when administered through oral route to mouse,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL622551
,BAO_0000218,,,8758,,,,,1,8258,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622552
,BAO_0000218,,,8758,,,,,1,8259,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622553
,BAO_0000218,,In vivo,8267,,,,,0,8260,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,Autocuration,,1,,,,22224,F,U,CHEMBL622554
,BAO_0000218,,,8267,,,,,1,8261,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL622555
,BAO_0000218,,,14239,,,,,1,8262,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL622556
,BAO_0000218,,,14239,,,,,1,8263,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL622557
,BAO_0000218,,,10754,,178.0,,,1,8264,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL622558
,BAO_0000218,,,10754,,178.0,,,1,8265,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL622559
,BAO_0000218,,,10754,,,,,1,8266,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL622560
,BAO_0000218,,,14681,,,,,1,8267,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622561
,BAO_0000218,,,14681,,,,,1,8268,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622562
,BAO_0000218,,,14681,,,,,1,8269,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622563
,BAO_0000019,,,13118,,,,,0,8270,,Concentration of compound in Central nervous system,Autocuration,,1,,,,22224,A,U,CHEMBL622564
,BAO_0000019,,,13118,,,,,0,8271,,Concentration of compound in Central nervous system; Not detectable,Autocuration,,1,,,,22224,A,U,CHEMBL622565
,BAO_0000218,,,13318,,,,,1,8272,,"Concentration of diester in the blood, following oral administration in mice",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL622566
,BAO_0000218,,,13318,,,,,1,8273,,"Concentration of monoester in the blood, following oral administration in mice",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL624515
,BAO_0000218,,,13318,,,,,1,8274,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL624516
,BAO_0000019,,,15692,,,,,0,8275,,Evaluated for Pharmacokinetic property: Area under the curve,Autocuration,,1,,,,22224,A,U,CHEMBL624517
,BAO_0000218,,,14839,,,,,1,8276,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL624518
,BAO_0000218,,,14839,,,,,1,8277,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL624519
,BAO_0000218,,,14839,,,,,1,8278,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL624520
,BAO_0000218,,,14839,,,,,1,8279,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL624521
,BAO_0000218,,,14839,,,,,1,8280,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL624522
,BAO_0000218,,,14839,,,,,1,8281,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL624523
,BAO_0000218,,,14839,,,,,1,8282,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL624409
,BAO_0000218,,,14839,,,,,1,8283,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL624410
,BAO_0000218,,,14839,,,,,1,8284,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL624411
,BAO_0000218,,,14839,,,,,1,8285,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL623531
,BAO_0000218,,,14839,,,,,1,8286,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL623532
,BAO_0000218,,,14839,,,,,1,8287,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL623533
,BAO_0000218,,,14839,,,,,1,8288,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL623534
,BAO_0000218,,,14839,,,,,1,8289,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623535
,BAO_0000218,,,14839,,,,,1,8290,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623536
,BAO_0000218,,,14839,,,,,1,8291,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623537
,BAO_0000218,,,14839,,,,,1,8292,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623538
,BAO_0000218,,,14839,,,,,1,8293,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623539
,BAO_0000218,,,14839,,,,,1,8294,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623540
,BAO_0000218,,,14839,,,,,1,8295,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623541
,BAO_0000218,,,14839,,,,,1,8296,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623542
,BAO_0000218,,,14839,,,,,1,8297,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623543
,BAO_0000218,,,14839,,,,,1,8298,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623544
,BAO_0000218,,,14839,,,,,1,8299,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623545
,BAO_0000218,,,14839,,,,,1,8300,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623546
,BAO_0000218,,In vivo,5408,,1969.0,,,1,8301,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623547
,BAO_0000218,,In vivo,6827,,,,,1,8302,,High i.v. clearance in Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623548
,BAO_0000218,Microsomes,In vitro,17538,,2107.0,,,1,8303,,In vitro clearance in rat liver microsomes,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL623549
,BAO_0000218,Microsomes,In vitro,6331,,2107.0,,,1,8304,,Intrinsic clearance in rat liver microsomes was determined,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL623550
401.0,BAO_0000218,,In vitro,5948,,2107.0,,Hepatocyte,1,8305,,Intrinsic clearance in rat hepatocytes was determined,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL875276
,BAO_0000218,,In vivo,4026,,,,,1,8306,,Plasma Clearance was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621872
,BAO_0000218,,In vivo,6647,,,,,1,8307,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621873
,BAO_0000218,,In vivo,1696,,,,,1,8308,,Plasma clearance in rat.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621874
,BAO_0000218,,In vivo,6597,,,,,1,8309,,Plasma clearance in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621875
,BAO_0000218,,In vivo,347,,,,,1,8310,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621876
,BAO_0000218,,In vivo,16423,,,,,1,8311,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621877
,BAO_0000218,,In vivo,2879,,,,,1,8312,,Plasma clearance was measured in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621878
,BAO_0000218,,In vivo,4883,,,,,1,8313,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621879
,BAO_0000218,,In vivo,5328,,1969.0,,,1,8314,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621880
,BAO_0000218,,In vivo,5160,,,,,1,8315,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621881
,BAO_0000218,,In vivo,17582,,,,,1,8316,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621882
,BAO_0000218,,In vivo,17651,,,,,1,8317,,Total clearance at 1 mg/kg was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875283
,BAO_0000218,,In vivo,17651,,,,,1,8318,,Total clearance at 10 mg/kg was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621883
,BAO_0000218,,In vivo,6596,,,,,1,8319,,Clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621884
,BAO_0000218,,In vivo,4796,,,,,1,8320,,Plasma clearance rate determined in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621885
,BAO_0000218,,In vivo,6850,,,,,1,8321,,Clearance of compound in rat was evaluated,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621886
,BAO_0000218,,In vivo,5932,,1969.0,,,1,8322,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621887
,BAO_0000218,,In vivo,3371,,,,,1,8323,,Pharmacokinetic property (blood clearance) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621888
,BAO_0000218,,In vivo,2083,,,,,1,8324,,Plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621889
,BAO_0000218,,In vivo,4942,,,,,1,8325,,Plasma clearance in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621890
,BAO_0000218,Microsomes,In vitro,6838,,2107.0,,,1,8326,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621891
,BAO_0000218,,In vivo,5353,,,,,1,8327,,Clearance in Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621892
,BAO_0000218,,In vivo,6641,,,,,1,8328,,Clearance rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621893
,BAO_0000218,,In vivo,6641,,,,,1,8329,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621894
,BAO_0000218,,In vivo,6641,,,,,1,8330,,Clearance rat; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621895
,BAO_0000218,,In vivo,6444,,,,,1,8331,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875284
,BAO_0000218,,In vivo,6444,,,,,1,8332,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618699
,BAO_0000218,,In vivo,6444,,,,,1,8333,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618700
,BAO_0000218,,In vivo,6211,,,,,1,8334,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618701
,BAO_0000218,,In vivo,12873,,1969.0,,,1,8335,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL876600
,BAO_0000218,,In vivo,6570,,,,,1,8336,,Clearance of compound in rat after 1 mg/kg i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618702
,BAO_0000218,,In vivo,3341,,,,,1,8337,,Compound was evaluated for Hepatic clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618703
,BAO_0000218,,In vivo,4891,,,,,1,8338,,In vivo clearance after 5 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618704
,BAO_0000218,,In vivo,1094,,1969.0,,,1,8339,,Compound was tested for plasma clearance in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL618705
,BAO_0000218,,In vivo,2938,,,,,1,8340,,Hepatic clearance after intravenous administration was evaluated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618706
,BAO_0000218,,In vivo,17853,,,,,1,8341,,Lower clearance in rat (i.v.) at 0.5 mpk,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618707
,BAO_0000218,,In vivo,6049,,1969.0,,,1,8342,,Pharmacokinetic parameter expressed as plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL618708
,BAO_0000218,,In vivo,5789,,,,,1,8343,,Pharmacokinetic property (Clp) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618709
,BAO_0000218,,In vivo,4514,,,,,1,8344,,Plasma clearance in Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618710
,BAO_0000218,,In vivo,6448,,,,,1,8345,,Plasma clearance (Clp) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618711
,BAO_0000218,,In vivo,6062,,,,,1,8346,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618712
,BAO_0000218,,In vivo,5710,,,,,1,8347,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618713
,BAO_0000218,,In vivo,4709,,,,,1,8348,,Plasma clearance after intravenous administration of 1 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618714
,BAO_0000218,,In vivo,4521,,,,,1,8349,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618715
,BAO_0000218,,In vivo,1742,,,,,1,8350,,Plasma clearance in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618716
,BAO_0000218,,In vivo,6057,,,,,1,8351,,Plasma clearance measured in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876601
,BAO_0000218,,In vivo,6057,,,,,1,8352,,Plasma clearance was calculated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618717
,BAO_0000218,,In vivo,5145,,,,,1,8353,,Plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618718
,BAO_0000218,,In vivo,5833,,,,,1,8354,,Plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618719
,BAO_0000218,,In vivo,6453,,,,,1,8355,,Plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618720
,BAO_0000218,,In vivo,6640,,,,,1,8356,,Plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618721
,BAO_0000218,,In vivo,6305,,,,,1,8357,,Plasma clearance in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621477
,BAO_0000218,,In vivo,6642,,,,,1,8358,,Plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621478
,BAO_0000218,,In vivo,5472,,,,,1,8359,,Plasma clearance was evaluated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621479
,BAO_0000218,,In vivo,5472,,,,,1,8360,,Plasma clearance was evaluated in rat; Not tested,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621480
,BAO_0000218,,In vivo,5144,,,,,1,8361,,Plasma clearance rate was determined for the compound in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621481
,BAO_0000218,,In vivo,6685,,,,,1,8362,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621482
,BAO_0000218,,In vivo,6685,,,,,1,8363,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621483
,BAO_0000218,,In vivo,6685,,,,,1,8364,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621484
,BAO_0000218,,In vivo,13950,,948.0,,,1,8365,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621485
,BAO_0000218,,In vivo,13950,,948.0,,,1,8366,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL621486
,BAO_0000218,,In vivo,13950,,160.0,,,1,8367,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL621487
,BAO_0000218,,In vivo,13950,,160.0,,,1,8368,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL621488
,BAO_0000218,,In vivo,13950,,160.0,,,1,8369,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL621489
,BAO_0000218,,In vivo,13950,,160.0,,,1,8370,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL621490
,BAO_0000218,,In vivo,13950,,160.0,,,1,8371,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL621491
,BAO_0000218,,In vivo,13950,,2113.0,,,1,8372,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621492
,BAO_0000218,,In vivo,13950,,2113.0,,,1,8373,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621493
,BAO_0000218,,In vivo,13950,,2113.0,,,1,8374,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621494
,BAO_0000218,,In vivo,13950,,2113.0,,,1,8375,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621495
,BAO_0000218,,In vivo,13950,,2113.0,,,1,8376,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621496
,BAO_0000218,,In vivo,13950,,2107.0,,,1,8377,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621497
,BAO_0000218,,In vivo,13950,,2107.0,,,1,8378,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621498
,BAO_0000218,,In vivo,13950,,2107.0,,,1,8379,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621499
,BAO_0000218,,In vivo,13950,,2107.0,,,1,8380,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL618634
,BAO_0000218,,In vivo,13950,,2107.0,,,1,8381,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL618635
,BAO_0000218,,In vivo,13950,,2048.0,,,1,8382,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL618636
,BAO_0000218,,In vivo,13950,,2048.0,,,1,8383,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL619737
,BAO_0000218,,In vivo,13950,,2048.0,,,1,8384,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL619738
,BAO_0000218,,In vivo,13950,,2048.0,,,1,8385,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624329
,BAO_0000218,,In vivo,13950,,2048.0,,,1,8386,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624330
,BAO_0000218,,In vivo,13950,,2385.0,,,1,8387,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624331
,BAO_0000218,,In vivo,13950,,2385.0,,,1,8388,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624332
,BAO_0000218,,In vivo,13950,,2385.0,,,1,8389,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624333
,BAO_0000218,,In vivo,13950,,2385.0,,,1,8390,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624334
,BAO_0000218,,In vivo,13950,,2385.0,,,1,8391,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624335
,BAO_0000218,,In vivo,13950,,2106.0,,,1,8392,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL620016
,BAO_0000218,,In vivo,13950,,2106.0,,,1,8393,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL620169
,BAO_0000218,,In vivo,13950,,2106.0,,,1,8394,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL620170
,BAO_0000218,,In vivo,13950,,2106.0,,,1,8395,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL620171
,BAO_0000218,,In vivo,13950,,2106.0,,,1,8396,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL620172
,BAO_0000218,,In vivo,13950,,945.0,,,1,8397,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL620173
,BAO_0000218,,In vivo,13950,,945.0,,,1,8398,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL620174
,BAO_0000218,,In vivo,13950,,945.0,,,1,8399,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL620175
,BAO_0000218,,In vivo,13950,,945.0,,,1,8400,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL620176
,BAO_0000218,,In vivo,13950,,945.0,,,1,8401,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL620177
,BAO_0000218,,,13950,,2037.0,,,1,8402,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL620178
,BAO_0000218,,,13950,,2037.0,,,1,8403,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL620179
,BAO_0000218,,,13950,,,,,1,8404,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620180
,BAO_0000218,,In vivo,6570,,,,,1,8405,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620181
,BAO_0000218,,In vivo,6571,,,,,1,8406,,Volume of distribution of compound in rats after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620182
,BAO_0000218,,In vivo,6453,,,,,1,8407,,Volume of distribution in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620183
,BAO_0000218,,In vivo,6444,,,,,1,8408,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620184
,BAO_0000218,,In vivo,6444,,,,,1,8409,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620185
,BAO_0000218,,In vivo,6444,,,,,1,8410,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620186
,BAO_0000218,,In vivo,5353,,,,,1,8411,,Volume of distribution was determined in Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620187
,BAO_0000218,,In vivo,5334,,,,,1,8412,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620188
,BAO_0000218,,In vivo,5334,,,,,1,8413,,Volume of distribution was reported in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620189
,BAO_0000218,,In vivo,6641,,,,,1,8414,,Volumes of distribution in rat after peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620190
,BAO_0000218,,In vivo,6641,,,,,1,8415,,Volumes of distribution in rat after po administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620191
,BAO_0000218,,In vivo,6641,,,,,1,8416,,Volumes of distribution in rat after po administration; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620192
,BAO_0000218,,In vivo,5676,,,,,1,8417,,Pharmacokinetic property (Volume) in rat i.v.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620193
,BAO_0000218,,In vivo,6410,,,,,1,8418,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620194
,BAO_0000218,,In vivo,17670,,,,,1,8419,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876730
,BAO_0000218,,In vivo,6495,,,,,1,8420,,Volume distribution in rat after oral administration at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620195
,BAO_0000218,,In vivo,5408,,,,,1,8421,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620196
,BAO_0000218,,In vivo,4883,,,,,1,8422,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620197
,BAO_0000218,,In vivo,6647,,,,,1,8423,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620198
,BAO_0000218,,In vivo,6495,,,,,1,8424,,Volume of distribution in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620199
,BAO_0000218,,In vivo,2661,,,,,1,8425,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620200
,BAO_0000218,,In vivo,2661,,,,,1,8426,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620201
,BAO_0000218,,In vivo,5974,,,,,1,8427,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620202
,BAO_0000218,,In vivo,5974,,,,,1,8428,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620203
,BAO_0000218,,In vivo,5974,,,,,1,8429,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620204
,BAO_0000218,,In vivo,5974,,,,,1,8430,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620205
,BAO_0000218,,In vivo,5960,,,,,1,8431,,Pharmacokinetic parameter (Vss) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624664
,BAO_0000218,,In vivo,5676,,,,,1,8432,,Pharmacokinetic property (Volume) in rat i.v.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624665
,BAO_0000218,,,5948,,,,,1,8433,,Pharmacokinetic property (Vss) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624666
,BAO_0000218,,In vivo,5979,,,,,1,8434,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624667
,BAO_0000218,,In vivo,5978,,,,,1,8435,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624668
,BAO_0000218,,In vivo,5978,,,,,1,8436,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624669
,BAO_0000218,,In vivo,5978,,,,,1,8437,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624670
,BAO_0000218,,In vivo,5978,,,,,1,8438,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624671
,BAO_0000218,,In vivo,6448,,,,,1,8439,,Steady state volume distribution in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624672
,BAO_0000218,,In vivo,12873,,1969.0,,,1,8440,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL624673
,BAO_0000218,,In vivo,4576,,,,,1,8441,,Steady state volume of distribution determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624674
,BAO_0000218,,In vivo,17582,,,,,1,8442,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624675
,BAO_0000218,,In vivo,1466,,,,,1,8443,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621728
,BAO_0000218,,,5182,,,,,1,8444,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621729
,BAO_0000218,,,5182,,,,,1,8445,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621730
,BAO_0000218,,In vivo,6535,,,,,1,8446,,Volume distribution in rat after administration of 2 mg/kg iv,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621731
,BAO_0000218,,In vivo,6535,,,,,1,8447,,Volume distribution in rat after administration of 2 mg/kg iv,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621732
,BAO_0000218,,In vivo,5041,,,,,1,8448,,Volume in steady state distribution value was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621908
,BAO_0000218,,In vivo,5041,,,,,1,8449,,Volume in steady state distribution value was determined; ND denotes no data,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875347
,BAO_0000218,,In vivo,5041,,,,,1,8450,,Volume in steady state distribution value was determined; ND denotes not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621909
,BAO_0000218,,In vivo,17065,,,,,1,8451,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621910
,BAO_0000218,,In vivo,6597,,,,,1,8452,,Volume of distribution at steady state was evaluated in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621911
,BAO_0000218,,In vivo,15662,,,,,1,8453,,Volume of distribution at steady state was observed after intravenous administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621912
,BAO_0000218,,In vivo,6485,,,,,1,8454,,Volume of distribution in steady state was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621913
,BAO_0000218,,In vivo,17655,,,,,1,8455,,Volume of distribution in steady state was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621914
,BAO_0000218,,In vivo,6616,,,,,1,8456,,Volume of distribution after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621915
,BAO_0000218,,In vivo,1916,,,,,1,8457,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621916
,BAO_0000218,,In vivo,16438,,2107.0,,,1,8458,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL621917
,BAO_0000218,,In vivo,16438,,2107.0,,,1,8459,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL621918
,BAO_0000218,,In vivo,16438,,2106.0,,,1,8460,,Biodistribution of compound (oxidized form) in spleen tissue,Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL621919
,BAO_0000218,,In vivo,16438,,2106.0,,,1,8461,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL621920
,BAO_0000218,,In vivo,16438,,2106.0,,,1,8462,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL621921
,BAO_0000218,,In vivo,16438,,2106.0,,,1,8463,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL622401
,BAO_0000218,,In vivo,16438,,2106.0,,,1,8464,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL875348
,BAO_0000218,,In vivo,16438,,2106.0,,,1,8465,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL622402
,BAO_0000218,,In vivo,16438,,178.0,,,1,8466,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL622403
,BAO_0000218,,In vivo,16438,,178.0,,,1,8467,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL622404
,BAO_0000218,,In vivo,16438,,955.0,,,1,8468,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL622405
,BAO_0000218,,In vivo,16438,,955.0,,,1,8469,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL622406
,BAO_0000218,,In vivo,16438,,955.0,,,1,8470,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL622407
,BAO_0000218,,In vivo,16438,,948.0,,,1,8471,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,Intermediate,Mus musculus,1,10090.0,,Heart,50594,A,N,CHEMBL622408
,BAO_0000218,,In vivo,16438,,948.0,,,1,8472,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Intermediate,Mus musculus,1,10090.0,,Heart,50594,A,N,CHEMBL622409
,BAO_0000218,,In vivo,16438,,948.0,,,1,8473,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,Mus musculus,1,10090.0,,Heart,50594,A,N,CHEMBL622410
,BAO_0000218,,In vivo,16438,,2113.0,,,1,8474,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL622411
,BAO_0000218,,In vivo,16438,,2113.0,,,1,8475,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL627864
,BAO_0000218,,In vivo,16438,,2113.0,,,1,8476,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL627865
,BAO_0000218,,In vivo,16438,,2107.0,,,1,8477,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL627866
,BAO_0000218,,In vivo,16438,,2107.0,,,1,8478,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL627751
,BAO_0000218,,In vivo,16438,,2106.0,,,1,8479,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL627752
,BAO_0000218,,In vivo,16438,,2106.0,,,1,8480,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL627753
,BAO_0000218,,In vivo,16438,,2106.0,,,1,8481,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL627754
,BAO_0000218,,,12467,,,,,1,8482,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627755
,BAO_0000218,,In vivo,17208,,955.0,,,1,8483,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL627756
,BAO_0000218,,In vivo,17208,,955.0,,,1,8484,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL627757
,BAO_0000218,,In vivo,17208,,955.0,,,1,8485,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL627758
,BAO_0000218,,In vivo,17208,,955.0,,,1,8486,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL627759
,BAO_0000218,,In vivo,17208,,955.0,,,1,8487,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL627760
,BAO_0000218,,In vivo,17208,,955.0,,,1,8488,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL627761
,BAO_0000218,,In vivo,17208,,948.0,,,1,8489,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Heart,50594,A,N,CHEMBL876811
,BAO_0000218,,In vivo,17208,,948.0,,,1,8490,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Heart,50594,A,N,CHEMBL627762
,BAO_0000218,,In vivo,17208,,948.0,,,1,8491,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Heart,50594,A,N,CHEMBL627763
,BAO_0000218,,In vivo,17208,,948.0,,,1,8492,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Heart,50594,A,N,CHEMBL627764
,BAO_0000218,,In vivo,17208,,948.0,,,1,8493,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Heart,50594,A,N,CHEMBL627765
,BAO_0000218,,In vivo,17208,,948.0,,,1,8494,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Heart,50594,A,N,CHEMBL627766
,BAO_0000218,,In vivo,17208,,2113.0,,,1,8495,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL627767
,BAO_0000218,,In vivo,17208,,2113.0,,,1,8496,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL627768
,BAO_0000218,,In vivo,17208,,2113.0,,,1,8497,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL628422
,BAO_0000218,,In vivo,17208,,2113.0,,,1,8498,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL628423
,BAO_0000218,,In vivo,5089,,,,,1,8499,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628424
,BAO_0000218,,In vivo,5089,,,,,1,8500,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628425
,BAO_0000218,,In vivo,4257,,,,,1,8501,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628426
,BAO_0000218,,In vivo,6679,,,,,1,8502,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628427
,BAO_0000218,,In vivo,5546,,,,,1,8503,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626938
,BAO_0000218,,In vivo,6141,,,,,1,8504,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626939
,BAO_0000218,,In vivo,5334,,,,,1,8505,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626940
,BAO_0000218,,In vivo,5334,,,,,1,8506,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626941
,BAO_0000218,,In vivo,5334,,,,,1,8507,,Plasma clearance was reported in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626942
,BAO_0000218,,In vivo,4689,,,,,1,8508,,Plasma clearance after intravenous administration (1 mg/kg) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876812
,BAO_0000218,,In vivo,6848,,,,,1,8509,,Plasma clearance of compound in rats was evaluated,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626943
,BAO_0000218,,In vivo,6848,,,,,1,8510,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626944
,BAO_0000218,,In vivo,6467,,,,,1,8511,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626945
,BAO_0000218,,In vivo,6467,,,,,1,8512,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626946
,BAO_0000218,,In vivo,4956,,,,,1,8513,,Plasma clearance rate in Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626856
,BAO_0000218,,In vivo,5529,,,,,1,8514,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626857
,BAO_0000218,,In vivo,406,,1969.0,,,1,8515,,The compound was evaluated for plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626858
,BAO_0000218,,In vivo,17655,,1969.0,,,1,8516,,Total plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627018
,BAO_0000218,,In vivo,3293,,178.0,,,1,8517,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625331
,BAO_0000218,,In vivo,4075,,178.0,,,1,8518,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625332
,BAO_0000218,,In vivo,2792,,,,,1,8519,,C max was determined at 10 mg/kg po dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877590
,BAO_0000218,,In vivo,2792,,,,,1,8520,,C max was determined at 3 mg/kg po dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625333
,BAO_0000218,,In vivo,17594,,,,,1,8521,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625334
,BAO_0000218,,In vivo,17594,,,,,1,8522,,Cmax after single intravenous bolus of 1 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625335
,BAO_0000218,,In vivo,4762,,,,,1,8523,,Cmax of compound at 5 mg/kg after po administration was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625336
,BAO_0000218,,In vivo,17509,,,,,1,8524,,Cmax 24 hr after 10 mg/kg oral administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625337
,BAO_0000218,,In vivo,17509,,,,,1,8525,,Cmax 24 hr after 2 mg/kg oral administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625338
,BAO_0000218,,In vivo,1466,,1969.0,,,1,8526,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625339
,BAO_0000218,,In vivo,6535,,,,,1,8527,,Cmax in rat after administration of 2 mg/kg iv,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625340
,BAO_0000218,,In vivo,6535,,,,,1,8528,,Cmax in rat after administration of 2 mg/kg iv,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625341
,BAO_0000218,,In vivo,3169,,,,,1,8529,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622687
,BAO_0000218,,In vivo,6515,,1969.0,,,1,8530,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622688
,BAO_0000218,,In vivo,11149,,178.0,,,1,8531,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622689
,BAO_0000218,,In vivo,11149,,178.0,,,1,8532,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL620295
,BAO_0000218,,In vivo,17858,,,,,1,8533,,Cmax after 10 mg/kg oral administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620296
,BAO_0000218,,In vivo,6518,,,,,1,8534,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620297
,BAO_0000218,,In vivo,6518,,,,,1,8535,,Cmax after IV dosing at 1 mg/kg in rat; no data,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620298
,BAO_0000218,,In vivo,4426,,,,,1,8536,,Cmax after oral administration at 20 mpk in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620299
,BAO_0000218,,In vivo,4426,,,,,1,8537,,Cmax after oral administration at 20 mpk in rats; Not performed.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620300
,BAO_0000218,,In vivo,4426,,,,,1,8538,,Cmax after oral administration at 20 mpk in rats d; Not performed.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620301
,BAO_0000218,,In vivo,5656,,,,,1,8539,,Cmax after oral administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620302
,BAO_0000218,,In vivo,6518,,,,,1,8540,,Cmax after oral administration at a dose of 2 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620303
,BAO_0000218,,In vivo,6518,,,,,1,8541,,Cmax after oral administration at a dose of 4 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620304
,BAO_0000218,,In vivo,6113,,,,,1,8542,,Cmax in rats after 20 mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620305
,BAO_0000218,,In vivo,17764,,,,,1,8543,,Cmax after peroral administration in rats at 2.4 uM/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620306
,BAO_0000218,,In vivo,4756,,,,,1,8544,,Cmax at the dose of 2 mg/Kg administered perorally in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620307
,BAO_0000218,,In vivo,4756,,,,,1,8545,,Cmax at the dose of 5 mg/Kg administered perorally in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620308
,BAO_0000218,,In vivo,6402,,,,,1,8546,,Cmax by administering at 20 mg/kg p.o. in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620309
,BAO_0000218,,In vivo,5610,,,,,1,8547,,Cmax in male rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620310
,BAO_0000218,,In vivo,5207,,,,,1,8548,,Cmax in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620311
,BAO_0000218,,In vivo,6011,,,,,1,8549,,Cmax in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620312
,BAO_0000218,,In vivo,6504,,,,,1,8550,,Cmax in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620313
,BAO_0000218,,In vivo,6046,,,,,1,8551,,Cmax in rat at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620314
,BAO_0000218,,In vivo,6504,,,,,1,8552,,Cmax in rat at the dose of 1 mg/kg i.v.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620315
,BAO_0000218,,In vivo,5874,,,,,1,8553,,Cmax in rat by po administration at a dose of 40 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620316
,BAO_0000218,,In vivo,17686,,,,,1,8554,,Cmax in rat p.o. at 20 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620317
,BAO_0000218,,In vivo,5836,,,,,1,8555,,Cmax in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620318
,BAO_0000218,,In vivo,17596,,,,,1,8556,,Cmax in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620319
,BAO_0000218,,In vivo,16423,,,,,1,8557,,Cmax was evaluated after 20 uM/kg of peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620320
,BAO_0000218,,In vivo,17804,,,,,1,8558,,Cmax was measured in rats after peroral administration at 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620321
,BAO_0000218,,In vivo,1908,,,,,1,8559,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620322
,BAO_0000218,,,13950,,,,,1,8560,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620323
,BAO_0000218,,,13950,,1870.0,,,1,8561,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Frontal cortex,50597,A,N,CHEMBL620324
,BAO_0000218,,,13950,,1870.0,,,1,8562,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Frontal cortex,50597,A,N,CHEMBL620325
,BAO_0000218,,,13950,,10000000.0,,,1,8563,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL620326
,BAO_0000218,,,13950,,10000000.0,,,1,8564,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL620327
,BAO_0000218,,,13950,,,,,1,8565,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620328
,BAO_0000218,,,13950,,,,,1,8566,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620329
,BAO_0000218,,,13950,,1891.0,,,1,8567,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Midbrain,50597,A,N,CHEMBL620330
,BAO_0000218,,,13950,,1891.0,,,1,8568,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Midbrain,50597,A,N,CHEMBL875286
,BAO_0000218,,,13950,,,,,1,8569,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620331
,BAO_0000218,,,13950,,,,,1,8570,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620332
,BAO_0000218,,,13950,,2435.0,,,1,8571,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL620333
,BAO_0000218,,,13950,,2435.0,,,1,8572,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL620334
,BAO_0000218,,,16434,,178.0,,,1,8573,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL621015
,BAO_0000218,,,16434,,178.0,,,1,8574,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL621016
,BAO_0000218,,,16434,,178.0,,,1,8575,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL621191
,BAO_0000218,,,16434,,178.0,,,1,8576,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL621192
,BAO_0000218,,,16434,,178.0,,,1,8577,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL621193
,BAO_0000218,,,16434,,178.0,,,1,8578,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL621194
,BAO_0000218,,,16434,,178.0,,,1,8579,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624204
,BAO_0000218,,,16434,,178.0,,,1,8580,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624205
,BAO_0000218,,,16435,,178.0,,,1,8581,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624206
,BAO_0000218,,,16435,,178.0,,,1,8582,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624207
,BAO_0000218,,,16435,,178.0,,,1,8583,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624208
,BAO_0000218,,,16435,,178.0,,,1,8584,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624209
,BAO_0000218,,,16435,,178.0,,,1,8585,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624210
,BAO_0000218,,,16435,,178.0,,,1,8586,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624211
,BAO_0000218,,,16435,,178.0,,,1,8587,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624212
,BAO_0000218,,,16435,,178.0,,,1,8588,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624213
,BAO_0000218,,,16434,,178.0,,,1,8589,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL876611
,BAO_0000218,,,16434,,178.0,,,1,8590,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624214
,BAO_0000218,,,16434,,178.0,,,1,8591,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624215
,BAO_0000218,,,16435,,178.0,,,1,8592,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624216
,BAO_0000218,,,16435,,178.0,,,1,8593,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624217
,BAO_0000218,,,16435,,178.0,,,1,8594,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624218
,BAO_0000218,,,16435,,178.0,,,1,8595,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624219
,BAO_0000218,,,16435,,178.0,,,1,8596,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624220
,BAO_0000218,,,16435,,178.0,,,1,8597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624221
,BAO_0000218,,,16434,,,,,1,8598,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624222
,BAO_0000218,,,16434,,,,,1,8599,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624223
,BAO_0000218,,,16434,,,,,1,8600,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624224
,BAO_0000218,,,16434,,,,,1,8601,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624225
,BAO_0000218,,In vivo,17764,,,,,1,8602,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622420
,BAO_0000218,,In vivo,5031,,,,,1,8603,,Volume of steady state distribution after i.v. administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622421
,BAO_0000218,,In vivo,6215,,,,,1,8604,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622422
,BAO_0000218,,In vivo,17671,,,,,1,8605,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622423
,BAO_0000218,,In vivo,17752,,,,,1,8606,,Vss was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622424
,BAO_0000218,,In vivo,6596,,,,,1,8607,,Vss in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622425
,BAO_0000218,,In vivo,16423,,,,,1,8608,,Vss was evaluated after 10 uM/kg of intra arterial administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876612
,BAO_0000218,,In vivo,15662,,,,,1,8609,,volume of distribution at steady state was observed after intravenous administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622426
,BAO_0000218,,In vivo,6062,,,,,1,8610,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622427
,BAO_0000218,,In vivo,5874,,,,,1,8611,,Pharmacokinetic (PK) parameter Vz in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622428
,BAO_0000218,,In vivo,4942,,,,,1,8612,,Volume distribution in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622429
,BAO_0000218,,In vivo,17796,,,,,1,8613,,Volume of distribution in rat; No data,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622430
,BAO_0000218,,In vivo,4890,,,,,1,8614,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622431
,BAO_0000218,,,15765,,2116.0,,,1,8615,,% absorption predicted from in vitro rat ileum transport studies,Intermediate,Rattus norvegicus,1,10116.0,,Ileum,50597,A,N,CHEMBL622432
,BAO_0000218,,In vivo,13569,,,,,1,8616,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622433
,BAO_0000218,,In vivo,13569,,,,,1,8617,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622434
,BAO_0000218,,In vivo,13569,,,,,1,8618,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622435
,BAO_0000218,,In vivo,13569,,,,,1,8619,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618748
,BAO_0000218,,In vivo,13569,,,,,1,8620,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618749
,BAO_0000218,,In vivo,13569,,,,,1,8621,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618750
,BAO_0000218,,In vivo,13569,,,,,1,8622,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618751
,BAO_0000218,,In vivo,13569,,,,,1,8623,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618752
,BAO_0000218,,In vivo,4576,,,,,1,8624,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618753
,BAO_0000218,,In vivo,750,,1969.0,,,1,8625,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL618754
,BAO_0000218,,In vivo,750,,,,,1,8626,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618755
,BAO_0000218,,In vivo,4590,,,,,1,8627,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618756
,BAO_0000218,,In vivo,1716,,,,,1,8628,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618757
,BAO_0000218,,In vivo,1974,,,,,1,8629,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618758
,BAO_0000218,,In vivo,4502,,,,,1,8630,,Oral bioavailability in rat (dose 30 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621088
,BAO_0000218,,,3371,,,,,1,8631,,Pharmacokinetic property (cLogP) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621089
,BAO_0000218,,,9099,,178.0,,,1,8632,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,F,N,CHEMBL621090
,BAO_0000218,,,9099,,178.0,,,1,8633,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,F,N,CHEMBL621091
,BAO_0000218,,In vivo,4590,,,,,1,8634,,Clearance in rat.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876731
,BAO_0000218,,In vivo,3184,,,,,1,8635,,Compound was evaluated for its clearance when administered intravenously in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621092
,BAO_0000218,,In vivo,16456,,,,,1,8636,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621093
,BAO_0000218,,,4199,,,,,1,8637,,Blood: Brain distribution ratio is determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621094
,BAO_0000218,,,4199,,,,,1,8638,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621095
,BAO_0000218,,,4199,,,,,1,8639,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621096
,BAO_0000218,,In vivo,8677,,2113.0,,,1,8640,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621097
,BAO_0000218,,,7449,,,,,1,8641,,Percent dose excreted in 0-48 hours administered ip to male rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL621098
,BAO_0000218,,,11977,,2037.0,,,1,8642,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL621099
,BAO_0000218,,,11977,,2037.0,,,1,8643,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL621100
,BAO_0000218,,,11977,,2037.0,,,1,8644,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL621101
,BAO_0000218,,,11977,,2037.0,,,1,8645,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL621102
,BAO_0000218,,,11977,,2037.0,,,1,8646,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL876732
,BAO_0000218,,,11977,,,,,1,8647,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621103
,BAO_0000218,,,11977,,,,,1,8648,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621104
,BAO_0000218,,,11977,,,,,1,8649,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621105
,BAO_0000218,,,11977,,,,,1,8650,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621106
,BAO_0000218,,,11977,,,,,1,8651,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621107
,BAO_0000218,,,11977,,,,,1,8652,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621108
,BAO_0000218,,,11977,,,,,1,8653,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621109
,BAO_0000218,,In vivo,17208,,2113.0,,,1,8654,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL621110
,BAO_0000218,,In vivo,17208,,2113.0,,,1,8655,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL621111
,BAO_0000218,,In vivo,17208,,2107.0,,,1,8656,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL622541
,BAO_0000218,,In vivo,17208,,2107.0,,,1,8657,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL622542
,BAO_0000218,,In vivo,17208,,2107.0,,,1,8658,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL622543
,BAO_0000218,,In vivo,17208,,2107.0,,,1,8659,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL624412
,BAO_0000218,,In vivo,17208,,2107.0,,,1,8660,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL624413
,BAO_0000218,,In vivo,17208,,2107.0,,,1,8661,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL624414
,BAO_0000218,,In vivo,17208,,2048.0,,,1,8662,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Lung,50594,A,N,CHEMBL624415
,BAO_0000218,,In vivo,17208,,2048.0,,,1,8663,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Lung,50594,A,N,CHEMBL624416
,BAO_0000218,,In vivo,17208,,2048.0,,,1,8664,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Lung,50594,A,N,CHEMBL624417
,BAO_0000218,,In vivo,17208,,2048.0,,,1,8665,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Lung,50594,A,N,CHEMBL624418
,BAO_0000218,,In vivo,17208,,2048.0,,,1,8666,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Lung,50594,A,N,CHEMBL624419
,BAO_0000218,,In vivo,17208,,2048.0,,,1,8667,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Lung,50594,A,N,CHEMBL624420
,BAO_0000218,,In vivo,17208,,2385.0,,,1,8668,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Muscle tissue,50594,A,N,CHEMBL624421
,BAO_0000218,,In vivo,17208,,2385.0,,,1,8669,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Muscle tissue,50594,A,N,CHEMBL624422
,BAO_0000218,,In vivo,17208,,2385.0,,,1,8670,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Muscle tissue,50594,A,N,CHEMBL624423
,BAO_0000218,,In vivo,17208,,2385.0,,,1,8671,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Muscle tissue,50594,A,N,CHEMBL625123
,BAO_0000218,,In vivo,17208,,2385.0,,,1,8672,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Muscle tissue,50594,A,N,CHEMBL625124
,BAO_0000218,,In vivo,17208,,2385.0,,,1,8673,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Muscle tissue,50594,A,N,CHEMBL625125
,BAO_0000218,,In vivo,17208,,14.0,,,1,8674,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Zone of skin,50594,A,N,CHEMBL625126
,BAO_0000218,,In vivo,17208,,14.0,,,1,8675,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Zone of skin,50594,A,N,CHEMBL626947
,BAO_0000218,,In vivo,17208,,14.0,,,1,8676,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Zone of skin,50594,A,N,CHEMBL626948
,BAO_0000218,,In vivo,17208,,14.0,,,1,8677,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Zone of skin,50594,A,N,CHEMBL626949
,BAO_0000218,,In vivo,17208,,14.0,,,1,8678,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Zone of skin,50594,A,N,CHEMBL626950
,BAO_0000218,,In vivo,17208,,14.0,,,1,8679,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Zone of skin,50594,A,N,CHEMBL626951
,BAO_0000218,,In vivo,17208,,2106.0,,,1,8680,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL626952
,BAO_0000218,,In vivo,17208,,2106.0,,,1,8681,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL626953
,BAO_0000218,,In vivo,17208,,2106.0,,,1,8682,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL626954
,BAO_0000218,,In vivo,17208,,2106.0,,,1,8683,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL626955
,BAO_0000218,,In vivo,17208,,2106.0,,,1,8684,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL626956
,BAO_0000218,,In vivo,17208,,2106.0,,,1,8685,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL626957
,BAO_0000218,,In vivo,17208,,178.0,,,1,8686,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL626958
,BAO_0000218,,In vivo,17208,,178.0,,,1,8687,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL626959
,BAO_0000218,,In vivo,17208,,178.0,,,1,8688,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL626960
,BAO_0000218,,In vivo,17208,,178.0,,,1,8689,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL626961
,BAO_0000218,,In vivo,17208,,178.0,,,1,8690,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL627589
,BAO_0000218,,In vivo,17208,,178.0,,,1,8691,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL627590
,BAO_0000218,,,3132,,,,,1,8692,,Time taken for EC90 was determined when tested in mouse,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627591
,BAO_0000218,,,3132,,,,,1,8693,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627592
,BAO_0000218,,In vivo,16597,,,,,1,8694,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627593
,BAO_0000218,,,5727,,,,,1,8695,,Half life in mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627594
,BAO_0000218,,In vivo,5302,,,,,1,8696,,Half life period in mouse after 10 mg/Kg dose,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL876813
,BAO_0000218,,In vivo,5302,,,,,1,8697,,Half life period in mouse after 10 mg/kg dose,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627595
,BAO_0000218,,In vivo,6348,,,,,1,8698,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627596
,BAO_0000218,,In vivo,5964,,,,,1,8699,,Cmax value at 5 mg/kg po was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627597
,BAO_0000218,,In vivo,6078,,,,,1,8700,,Cmax value evaluated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627598
,BAO_0000218,,In vivo,5206,,955.0,,,1,8701,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL627599
,BAO_0000218,,In vivo,2959,,,,,1,8702,,Cmax value after administration of 20 mg/Kg oral dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627600
,BAO_0000218,,In vivo,5964,,,,,1,8703,,Cmax value at 1 mg/kg po in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627601
,BAO_0000218,,In vivo,5964,,,,,1,8704,,Cmax value at 5 mg/kg po in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627776
,BAO_0000218,,In vivo,6757,,,,,1,8705,,Cmax value at a dose of 10 mg/kg in male SD rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627777
,BAO_0000218,,In vivo,6757,,,,,1,8706,,Cmax value at a dose of 100 mg/kg in male SD rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627778
,BAO_0000218,,In vivo,6757,,,,,1,8707,,Cmax value at a dose of 50 mg/kg in male SD rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627779
,BAO_0000218,,In vivo,17617,,,,,1,8708,,Cmax value in rats at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876814
,BAO_0000218,,In vivo,1445,,,,,1,8709,,Cmax value was evaluated in rats at a dose of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627780
,BAO_0000218,,In vivo,6082,,,,,1,8710,,Cmax value was determined after peroral administration of 20 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627781
,BAO_0000218,,In vivo,1446,,,,,1,8711,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627782
,BAO_0000218,,In vivo,5407,,1969.0,,,1,8712,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627783
,BAO_0000218,,In vivo,2690,,1969.0,,,1,8713,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627784
,BAO_0000218,,In vivo,2661,,,,,1,8714,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627785
,BAO_0000218,,In vivo,2661,,,,,1,8715,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627786
,BAO_0000218,,In vivo,4891,,1969.0,,,1,8716,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627787
,BAO_0000218,,In vivo,2807,,1969.0,,,1,8717,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627788
,BAO_0000218,,In vivo,2807,,1969.0,,,1,8718,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626579
,BAO_0000218,,In vivo,2807,,1969.0,,,1,8719,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626580
,BAO_0000218,,In vivo,3634,,,,,1,8720,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876815
,BAO_0000218,,In vivo,1881,,1969.0,,,1,8721,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626581
,BAO_0000218,,In vivo,1881,,1969.0,,,1,8722,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626582
,BAO_0000218,,In vivo,429,,,,,1,8723,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626583
,BAO_0000218,,In vivo,5974,,,,,1,8724,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626205
,BAO_0000218,,In vivo,5974,,,,,1,8725,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626206
,BAO_0000218,,In vivo,5974,,,,,1,8726,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626207
,BAO_0000218,,In vivo,5974,,,,,1,8727,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623882
,BAO_0000218,,In vivo,17582,,,,,1,8728,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623883
,BAO_0000218,,In vivo,17582,,,,,1,8729,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623884
,BAO_0000218,,In vivo,3032,,1969.0,,,1,8730,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623885
,BAO_0000218,,In vivo,6295,,1969.0,,,1,8731,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623886
,BAO_0000218,,In vivo,6619,,,,,1,8732,,Maximal concentration in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623887
,BAO_0000218,,In vivo,6616,,,,,1,8733,,Maximal concentration after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623888
,BAO_0000218,,In vivo,3249,,1969.0,,,1,8734,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623889
,BAO_0000218,,In vivo,17791,,1969.0,,,1,8735,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623890
,BAO_0000218,,In vivo,17791,,1969.0,,,1,8736,,Cmax in rat plasma after oral dose (50 mg/Kg),Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623891
,BAO_0000218,,In vivo,1360,,1969.0,,,1,8737,,Maximal plasma concentration was determined.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623892
,BAO_0000218,,In vivo,2552,,1969.0,,,1,8738,,Maximal plasma drug concentration was determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623893
,BAO_0000218,,In vivo,6571,,,,,1,8739,,Maximal concentration in rats after peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877616
,BAO_0000218,,In vivo,6570,,,,,1,8740,,Maximum concentration in rat after 2 mg/kg peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623894
,BAO_0000218,,In vivo,6567,,1969.0,,,1,8741,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623895
,BAO_0000218,,In vivo,3031,,,,,1,8742,,Maximum concentration of compound in rat was evaluated.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623896
,BAO_0000218,,In vivo,3436,,,,,1,8743,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623897
,BAO_0000218,,In vivo,3436,,,,,1,8744,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623898
,BAO_0000218,,In vivo,2083,,,,,1,8745,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623899
,BAO_0000218,,In vivo,3436,,,,,1,8746,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623900
,BAO_0000218,,In vivo,4527,,,,,1,8747,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623901
,BAO_0000218,,In vivo,1974,,,,,1,8748,,Maximum concentration was evaluated in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623902
,BAO_0000218,,In vivo,3307,,1359.0,,,1,8749,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,Cerebrospinal fluid,50597,A,N,CHEMBL623903
,BAO_0000218,,In vivo,3307,,1969.0,,,1,8750,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623904
,BAO_0000218,,In vivo,1916,,1969.0,,,1,8751,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL877617
,BAO_0000218,,In vivo,1500,,,,,1,8752,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623905
,BAO_0000218,,In vivo,1500,,,,,1,8753,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623906
,BAO_0000218,,In vivo,4186,,1969.0,,,1,8754,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623907
,BAO_0000218,,,16434,,,,,1,8755,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623908
,BAO_0000218,,,16434,,,,,1,8756,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623909
,BAO_0000218,,,16434,,,,,1,8757,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623910
,BAO_0000218,,,16434,,,,,1,8758,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623911
,BAO_0000218,,,16435,,,,,1,8759,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623912
,BAO_0000218,,,16435,,,,,1,8760,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624616
,BAO_0000218,,,16435,,,,,1,8761,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624617
,BAO_0000218,,,16435,,,,,1,8762,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624618
,BAO_0000218,,,16435,,,,,1,8763,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624619
,BAO_0000218,,,16435,,,,,1,8764,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624794
,BAO_0000218,,,16435,,,,,1,8765,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624795
,BAO_0000218,,,16435,,,,,1,8766,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623921
,BAO_0000218,,,16434,,,,,1,8767,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623922
,BAO_0000218,,,16434,,,,,1,8768,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623923
,BAO_0000218,,,16434,,,,,1,8769,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623924
,BAO_0000218,,,16435,,,,,1,8770,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623925
,BAO_0000218,,,16435,,,,,1,8771,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623926
,BAO_0000218,,,16435,,,,,1,8772,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623927
,BAO_0000218,,,16435,,,,,1,8773,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623928
,BAO_0000218,,,16435,,,,,1,8774,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623929
,BAO_0000218,,,16435,,,,,1,8775,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623930
,BAO_0000218,,,16434,,955.0,,,1,8776,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL623931
,BAO_0000218,,,16434,,955.0,,,1,8777,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622165
,BAO_0000218,,,16434,,955.0,,,1,8778,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL621249
,BAO_0000218,,,16434,,955.0,,,1,8779,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL621250
,BAO_0000218,,,16434,,955.0,,,1,8780,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL621448
,BAO_0000218,,,16434,,955.0,,,1,8781,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL621449
,BAO_0000218,,,16434,,955.0,,,1,8782,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL621450
,BAO_0000218,,,16434,,955.0,,,1,8783,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL621451
,BAO_0000218,,,16435,,955.0,,,1,8784,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL621452
,BAO_0000218,,,16435,,955.0,,,1,8785,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL621453
,BAO_0000218,,,16435,,955.0,,,1,8786,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL621454
,BAO_0000218,,,16435,,955.0,,,1,8787,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL621455
,BAO_0000218,,,16435,,955.0,,,1,8788,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL621456
,BAO_0000218,,,16435,,955.0,,,1,8789,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625145
,BAO_0000218,,,16435,,955.0,,,1,8790,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL875847
,BAO_0000218,,,16435,,955.0,,,1,8791,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625146
,BAO_0000218,,,16434,,955.0,,,1,8792,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625147
,BAO_0000218,,,16434,,955.0,,,1,8793,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625148
,BAO_0000218,,,16434,,955.0,,,1,8794,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625149
,BAO_0000218,,,16435,,955.0,,,1,8795,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625150
,BAO_0000218,,,16435,,955.0,,,1,8796,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625151
,BAO_0000218,,,16435,,955.0,,,1,8797,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625152
,BAO_0000218,,,16435,,955.0,,,1,8798,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625153
,BAO_0000218,,,16435,,955.0,,,1,8799,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625154
,BAO_0000218,,,16435,,955.0,,,1,8800,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625155
,BAO_0000218,,,11977,,,,,1,8801,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625156
,BAO_0000218,,,11977,,,,,1,8802,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624354
,BAO_0000218,,,11977,,10000000.0,,,1,8803,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL624355
,BAO_0000218,,,11977,,10000000.0,,,1,8804,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL624356
,BAO_0000218,,,11977,,10000000.0,,,1,8805,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL624357
,BAO_0000218,,,11977,,10000000.0,,,1,8806,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL624358
,BAO_0000218,,,11977,,2435.0,,,1,8807,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL624359
,BAO_0000218,,,11977,,2435.0,,,1,8808,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL624360
,BAO_0000218,,,11977,,2435.0,,,1,8809,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL624361
,BAO_0000218,,,11977,,2435.0,,,1,8810,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL624362
,BAO_0000218,,,11977,,2435.0,,,1,8811,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL624363
,BAO_0000218,,In vivo,11977,,178.0,,,1,8812,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624364
,BAO_0000218,,In vivo,11977,,178.0,,,1,8813,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624365
,BAO_0000218,,In vivo,11977,,178.0,,,1,8814,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624366
,BAO_0000218,,In vivo,11977,,178.0,,,1,8815,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624367
,BAO_0000218,,In vivo,11977,,955.0,,,1,8816,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL624368
,BAO_0000218,,In vivo,11977,,955.0,,,1,8817,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL624369
,BAO_0000218,,In vivo,11977,,955.0,,,1,8818,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL624370
,BAO_0000218,,In vivo,11977,,955.0,,,1,8819,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625069
,BAO_0000218,,In vivo,11977,,955.0,,,1,8820,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625070
,BAO_0000218,,In vivo,11977,,948.0,,,1,8821,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626051
,BAO_0000218,,In vivo,11977,,948.0,,,1,8822,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626052
,BAO_0000218,,In vivo,11977,,948.0,,,1,8823,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626053
,BAO_0000218,,In vivo,11977,,948.0,,,1,8824,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626054
,BAO_0000218,,In vivo,11977,,948.0,,,1,8825,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626055
,BAO_0000218,,In vivo,11977,,2113.0,,,1,8826,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626056
,BAO_0000218,,In vivo,11977,,2113.0,,,1,8827,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626057
,BAO_0000218,,In vivo,11977,,2113.0,,,1,8828,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625193
,BAO_0000218,,In vivo,11977,,2113.0,,,1,8829,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625194
,BAO_0000218,,In vivo,11977,,2107.0,,,1,8830,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625195
,BAO_0000218,,In vivo,11977,,2107.0,,,1,8831,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625196
,BAO_0000218,,In vivo,11977,,2107.0,,,1,8832,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625197
,BAO_0000218,,In vivo,11977,,2107.0,,,1,8833,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625198
,BAO_0000218,,In vivo,11977,,2107.0,,,1,8834,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627929
,BAO_0000218,,In vivo,11977,,2048.0,,,1,8835,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627074
,BAO_0000218,,In vivo,11977,,2048.0,,,1,8836,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627075
,BAO_0000218,,In vivo,11977,,2048.0,,,1,8837,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627076
,BAO_0000218,,In vivo,11977,,2048.0,,,1,8838,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627077
,BAO_0000218,,In vivo,11977,,2048.0,,,1,8839,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627078
,BAO_0000218,,In vivo,11977,,2385.0,,,1,8840,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627079
,BAO_0000218,,In vivo,4573,,,,,1,8841,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL873824
,BAO_0000218,,In vivo,3132,,1969.0,,,1,8842,,Half life in mouse plasma was determined at dose 25 mg/kg,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL627080
,BAO_0000218,,,17718,,,,,1,8843,,Half life was determined,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627081
,BAO_0000218,,In vivo,17728,,,,,1,8844,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627082
,BAO_0000218,,In vivo,5961,,,,,1,8845,,Half-life in male mice after 1 mg/kg intravenous dose,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627083
,BAO_0000218,,,17731,,1969.0,,,1,8847,,Half life in mice plasma,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL627085
,BAO_0000218,,,17592,,,,,1,8848,,Half life in mouse,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627086
,BAO_0000218,,In vivo,3132,,1969.0,,,1,8849,,Half life in mouse plasma at dose 25 mg/kg,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL627087
,BAO_0000218,,In vivo,17729,,,,,1,8850,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627088
,BAO_0000218,,In vivo,17729,,,,,1,8851,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627089
,BAO_0000218,,In vivo,17729,,,,,1,8852,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627090
,BAO_0000218,,In vivo,3277,,,,,1,8853,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627091
,BAO_0000218,,In vivo,3760,,,,,1,8854,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627092
,BAO_0000218,,In vivo,3760,,,,,1,8855,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL876785
,BAO_0000218,,In vivo,2862,,,,,1,8856,,Half-life by iv administration in mouse,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627093
,BAO_0000218,,In vivo,2862,,,,,1,8857,,Half-life by oral administration in mouse,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627094
,BAO_0000218,,,5980,,,,,1,8858,,Half-life in mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627095
,BAO_0000218,,,6159,,955.0,,,1,8859,,Half-life using mouse brain homogenate,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL627096
,BAO_0000218,,,6254,,,,,1,8860,,Half-life was measured in mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627097
,BAO_0000218,,In vivo,6062,,,,,1,8861,,Half-life was measured in mouse after an iv dose of 1 mg/kg,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627098
,BAO_0000218,,,1574,,178.0,,,1,8862,,Half-life period was determined in mouse blood,Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL627099
,BAO_0000218,,,56,,955.0,,,1,8863,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL627100
,BAO_0000218,,,993,,1969.0,,,1,8864,,Plasma half life in mouse,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL627101
,BAO_0000218,,,6652,,,,,1,8865,,Stability of the peptide in the presence of mouse serum,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627102
,BAO_0000218,,,17852,,,,,1,8866,,Terminal half life of compound was determined in mouse,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627103
,BAO_0000218,,In vivo,2675,,,,,1,8867,,Terminal half life was evaluated in mice after intravenous administration,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627104
,BAO_0000218,,In vivo,2675,,,,,1,8868,,Terminal half life was evaluated in mice after oral administration,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627105
,BAO_0000218,,,499,,,,,1,8869,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL876786
,BAO_0000218,,,499,,,,,1,8870,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL873825
,BAO_0000218,,,499,,,,,1,8871,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627106
,BAO_0000218,,In vivo,14239,,,,,1,8872,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626336
,BAO_0000218,,In vivo,5506,,,,,1,8873,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL877462
,BAO_0000218,,In vivo,5506,,,,,1,8874,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626337
,BAO_0000218,,,17734,,,,,1,8875,,Half life after intraperitoneal administration of 100 mg/kg in mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626338
,BAO_0000218,,In vivo,17728,,,,,1,8876,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626339
,BAO_0000218,,In vivo,17728,,,,,1,8877,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626340
,BAO_0000218,,In vivo,17728,,,,,1,8878,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625377
,BAO_0000218,,In vivo,17728,,,,,1,8879,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625378
,BAO_0000218,,In vivo,17728,,,,,1,8880,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625379
,BAO_0000251,Microsomes,,14294,,,,,0,8881,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),Autocuration,Sus scrofa,1,9823.0,,,22224,A,U,CHEMBL625380
,BAO_0000251,Microsomes,,14294,,,,,0,8882,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),Autocuration,Sus scrofa,1,9823.0,,,22224,A,U,CHEMBL625381
,BAO_0000019,,,6056,,,,,0,8883,,Stability to porcine renal DHP-I,Autocuration,Sus scrofa,1,9823.0,,,22224,A,U,CHEMBL625382
,BAO_0000218,,In vivo,1317,,,,,0,8884,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,Autocuration,Sus scrofa,1,9823.0,,,22224,A,U,CHEMBL873828
,BAO_0000218,,In vivo,1317,,,,,0,8885,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,Autocuration,Sus scrofa,1,9823.0,,,22224,A,U,CHEMBL625383
,BAO_0000019,,,5229,,,,,0,8886,,Half-life of the parent prodrug in porcine esterase solution,Autocuration,Sus scrofa,1,9823.0,,,22224,A,U,CHEMBL625384
,BAO_0000019,,,4231,,,,,0,8887,,"First order rate constant, k was determined in in pig liver Esterase",Autocuration,Sus scrofa,1,9823.0,,,22224,A,U,CHEMBL625385
,BAO_0000221,,,4231,,2107.0,,,0,8888,,Half life of the in pig liver Esterase,Autocuration,Sus scrofa,1,9823.0,,Liver,22224,A,U,CHEMBL625386
,BAO_0000221,,,5318,,2107.0,,,0,8889,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,Autocuration,Sus scrofa,1,9823.0,,Liver,22224,A,U,CHEMBL623571
,BAO_0000221,,,5318,,2107.0,,,0,8890,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,Autocuration,Sus scrofa,1,9823.0,,Liver,22224,A,U,CHEMBL623572
,BAO_0000221,,,5318,,2107.0,,,0,8891,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,Autocuration,Sus scrofa,1,9823.0,,Liver,22224,A,U,CHEMBL623573
,BAO_0000221,,,3305,,2107.0,,,0,8892,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,Autocuration,Sus scrofa,1,9823.0,,Liver,22224,A,U,CHEMBL623574
,BAO_0000221,,,3305,,2107.0,,,0,8893,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,Autocuration,Sus scrofa,1,9823.0,,Liver,22224,A,U,CHEMBL623575
,BAO_0000221,,,2842,,2107.0,,,0,8894,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,Autocuration,Sus scrofa,1,9823.0,,Liver,22224,A,U,CHEMBL623749
,BAO_0000221,,,2842,,2107.0,,,0,8895,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,Autocuration,Sus scrofa,1,9823.0,,Liver,22224,A,U,CHEMBL623750
,BAO_0000221,,In vitro,889,,2107.0,,,0,8896,,Half-life in vitro in pig liver,Autocuration,Sus scrofa,1,9823.0,,Liver,22224,A,U,CHEMBL623751
,BAO_0000221,,,1904,,2107.0,,,0,8897,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,Autocuration,Sus scrofa,1,9823.0,,Liver,22224,A,U,CHEMBL623752
,BAO_0000218,,In vivo,4186,,1969.0,,,1,8898,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623753
,BAO_0000218,,In vivo,2774,,1969.0,,,1,8899,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623754
,BAO_0000218,,In vivo,1742,,1969.0,,,1,8900,,Maximum concentration in rat plasma was determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623755
,BAO_0000218,,In vivo,3169,,,,,1,8901,,Maximum concentration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623756
,BAO_0000218,,In vivo,3169,,,,,1,8902,,Maximum concentration in rats at 1-2 hours,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623757
,BAO_0000218,,In vivo,2081,,,,,1,8903,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623758
,BAO_0000218,,In vivo,3307,,955.0,,,1,8904,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL623759
,BAO_0000218,,In vivo,4727,,,,,1,8905,,Maximum concentration at the dose of 2 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623760
,BAO_0000218,,In vivo,6597,,,,,1,8906,,Maximum concentration was evaluated in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623761
,BAO_0000218,,In vivo,16365,,1969.0,,,1,8907,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623762
,BAO_0000218,,In vivo,16365,,1969.0,,,1,8908,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL877594
,BAO_0000218,,In vivo,16365,,1969.0,,,1,8909,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623763
,BAO_0000218,,In vivo,16365,,1969.0,,,1,8910,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623764
,BAO_0000218,,In vivo,16365,,1969.0,,,1,8911,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623765
,BAO_0000218,,In vivo,2591,,178.0,,,1,8912,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL623766
,BAO_0000218,,In vivo,2591,,178.0,,,1,8913,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL623767
,BAO_0000218,,In vivo,2591,,178.0,,,1,8914,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL623768
,BAO_0000218,,In vivo,5978,,1969.0,,,1,8915,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623769
,BAO_0000218,,In vivo,5978,,1969.0,,,1,8916,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623770
,BAO_0000218,,In vivo,5978,,1969.0,,,1,8917,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623771
,BAO_0000218,,In vivo,5978,,1969.0,,,1,8918,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623772
,BAO_0000218,,In vivo,5978,,1969.0,,,1,8919,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623773
,BAO_0000218,,In vivo,5978,,1969.0,,,1,8920,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623774
,BAO_0000218,,In vivo,5978,,1969.0,,,1,8921,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623775
,BAO_0000218,,In vivo,14465,,,,,1,8922,,Cmax in rat (PO dose),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623776
,BAO_0000218,,In vivo,4723,,1969.0,,,1,8923,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622191
,BAO_0000218,,In vivo,4723,,1969.0,,,1,8924,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622192
,BAO_0000218,,In vivo,4576,,1969.0,,,1,8925,,Maximum plasma concentration determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622193
,BAO_0000218,,In vivo,12873,,1969.0,,,1,8926,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622194
,BAO_0000218,,In vivo,12873,,1969.0,,,1,8927,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622195
,BAO_0000218,,In vivo,6824,,1969.0,,,1,8928,,Maximum plasma concentration in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622196
,BAO_0000218,,In vivo,17065,,1969.0,,,1,8929,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622197
,BAO_0000218,,In vivo,2932,,1969.0,,,1,8930,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622198
,BAO_0000218,,In vivo,2932,,1969.0,,,1,8931,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622199
,BAO_0000218,,In vivo,2879,,1969.0,,,1,8932,,Maximum plasma concentration of compound was measured in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622200
,BAO_0000218,,In vivo,2864,,1969.0,,,1,8933,,Maximum plasma concentration after 20 mg/kg oral administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622201
,BAO_0000218,,In vivo,16367,,1969.0,,,1,8934,,Maximum plasma concentration after oral administration to rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623990
,BAO_0000218,,In vivo,17717,,1969.0,,,1,8935,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623991
,BAO_0000218,,In vivo,17717,,1969.0,,,1,8936,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623992
,BAO_0000218,,In vivo,17717,,1969.0,,,1,8937,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623993
,BAO_0000218,,In vivo,17717,,1969.0,,,1,8938,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623994
,BAO_0000218,,In vivo,17720,,1969.0,,,1,8939,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,F,N,CHEMBL623995
,BAO_0000218,,In vivo,17720,,1969.0,,,1,8940,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,F,N,CHEMBL623996
,BAO_0000218,,In vivo,17720,,1969.0,,,1,8941,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,F,N,CHEMBL623997
,BAO_0000218,,In vivo,4516,,1969.0,,,1,8942,,Maximum plasma concentration dosed orally in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623998
,BAO_0000218,,In vivo,4516,,1969.0,,,1,8943,,Maximum plasma concentration dosed orally in rats after 6 hours,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623999
,BAO_0000218,,In vivo,4516,,1969.0,,,1,8944,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL624000
,BAO_0000218,,In vivo,5199,,1969.0,,,1,8945,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL624001
,BAO_0000218,,In vivo,17538,,1969.0,,,1,8946,,Maximum plasma concentration in rat after po administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL624002
,BAO_0000218,,In vivo,6685,,1969.0,,,1,8947,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL624003
,BAO_0000218,,In vivo,6685,,1969.0,,,1,8948,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL624004
,BAO_0000218,,,16434,,948.0,,,1,8949,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624005
,BAO_0000218,,,16434,,948.0,,,1,8950,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624006
,BAO_0000218,,,16434,,948.0,,,1,8951,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624007
,BAO_0000218,,,16434,,948.0,,,1,8952,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624008
,BAO_0000218,,,16434,,948.0,,,1,8953,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624009
,BAO_0000218,,,16434,,948.0,,,1,8954,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL874387
,BAO_0000218,,,16434,,948.0,,,1,8955,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624010
,BAO_0000218,,,16434,,948.0,,,1,8956,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624011
,BAO_0000218,,,16435,,948.0,,,1,8957,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624012
,BAO_0000218,,,16435,,948.0,,,1,8958,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624013
,BAO_0000218,,,16435,,948.0,,,1,8959,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624736
,BAO_0000218,,,16435,,948.0,,,1,8960,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624737
,BAO_0000218,,,16434,,948.0,,,1,8961,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624738
,BAO_0000218,,,16434,,948.0,,,1,8962,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624739
,BAO_0000218,,,16434,,948.0,,,1,8963,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624740
,BAO_0000218,,,16435,,948.0,,,1,8964,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624896
,BAO_0000218,,,16435,,948.0,,,1,8965,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624897
,BAO_0000218,,,16435,,948.0,,,1,8966,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624108
,BAO_0000218,,,16435,,948.0,,,1,8967,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624109
,BAO_0000218,,,16435,,948.0,,,1,8968,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624110
,BAO_0000218,,,16435,,948.0,,,1,8969,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624111
,BAO_0000218,,,16435,,948.0,,,1,8970,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624112
,BAO_0000218,,,16435,,948.0,,,1,8971,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624113
,BAO_0000218,,,16435,,948.0,,,1,8972,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL619709
,BAO_0000218,,,16435,,948.0,,,1,8973,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL619710
,BAO_0000218,,,16434,,2113.0,,,1,8974,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619711
,BAO_0000218,,,16434,,2113.0,,,1,8975,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619712
,BAO_0000218,,,16434,,2113.0,,,1,8976,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619713
,BAO_0000218,,,16434,,2113.0,,,1,8977,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619714
,BAO_0000218,,,16434,,2113.0,,,1,8978,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619715
,BAO_0000218,,,16434,,2113.0,,,1,8979,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619716
,BAO_0000218,,,16434,,2113.0,,,1,8980,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619717
,BAO_0000218,,,16434,,2113.0,,,1,8981,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619718
,BAO_0000218,,,16435,,2113.0,,,1,8982,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619719
,BAO_0000218,,,16435,,2113.0,,,1,8983,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL875329
,BAO_0000218,,,16435,,2113.0,,,1,8984,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619720
,BAO_0000218,,,16435,,2113.0,,,1,8985,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619721
,BAO_0000218,,,16435,,2113.0,,,1,8986,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619722
,BAO_0000218,,,16435,,2113.0,,,1,8987,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619723
,BAO_0000218,,,16435,,2113.0,,,1,8988,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619724
,BAO_0000218,,,16435,,2113.0,,,1,8989,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619725
,BAO_0000218,,,16434,,2113.0,,,1,8990,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619726
,BAO_0000218,,,16434,,2113.0,,,1,8991,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619727
,BAO_0000218,,,16434,,2113.0,,,1,8992,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619728
,BAO_0000218,,,16435,,2113.0,,,1,8993,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL619729
,BAO_0000218,,In vivo,11977,,2385.0,,,1,8994,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL619730
,BAO_0000218,,In vivo,11977,,2385.0,,,1,8995,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL619731
,BAO_0000218,,In vivo,11977,,2385.0,,,1,8996,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL619732
,BAO_0000218,,In vivo,11977,,2385.0,,,1,8997,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL619733
,BAO_0000218,,In vivo,11977,,2385.0,,,1,8998,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL619734
,BAO_0000218,,In vivo,11977,,14.0,,,1,8999,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL619735
,BAO_0000218,,In vivo,11977,,14.0,,,1,9000,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL875330
,BAO_0000218,,In vivo,11977,,14.0,,,1,9001,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL628465
,BAO_0000218,,In vivo,11977,,14.0,,,1,9002,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL628466
,BAO_0000218,,In vivo,11977,,14.0,,,1,9003,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL628467
,BAO_0000218,,In vivo,11977,,2106.0,,,1,9004,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL628468
,BAO_0000218,,In vivo,11977,,2106.0,,,1,9005,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL628469
,BAO_0000218,,In vivo,11977,,2106.0,,,1,9006,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL628470
,BAO_0000218,,In vivo,11977,,2106.0,,,1,9007,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL628471
,BAO_0000218,,In vivo,11977,,2106.0,,,1,9008,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL628472
,BAO_0000218,,In vivo,11977,,2046.0,,,1,9009,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL625191
,BAO_0000218,,In vivo,11977,,2046.0,,,1,9010,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL625192
,BAO_0000218,,In vivo,11977,,2046.0,,,1,9011,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL875337
,BAO_0000218,,In vivo,11977,,2046.0,,,1,9012,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626341
,BAO_0000218,,In vivo,11977,,2046.0,,,1,9013,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626342
,BAO_0000218,,In vivo,11977,,2107.0,,,1,9014,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621943
,BAO_0000218,,,3748,,,,,1,9015,,Half life in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621944
,BAO_0000218,,,15765,,,,,1,9016,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621945
,BAO_0000218,,,4871,,,,,1,9017,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621946
,BAO_0000218,,,4871,,,,,1,9018,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621947
,BAO_0000218,,,4872,,,,,1,9019,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621948
,BAO_0000218,,,4872,,,,,1,9020,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621949
,BAO_0000218,,,5413,,,,,1,9021,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621950
,BAO_0000218,,,5413,,,,,1,9022,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621951
,BAO_0000218,,In vivo,15272,,178.0,,,1,9023,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL621952
,BAO_0000218,,,4689,,2107.0,,,1,9024,,Stability (%) in rat liver microsomes,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621953
,BAO_0000218,,,6057,,,,,1,9025,,Area under curve was calculated after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621954
,BAO_0000218,,,6057,,,,,1,9026,,Area under the curve was calculated after iv administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621955
,BAO_0000218,,,6057,,,,,1,9027,,Area under the curve was calculated in rat after peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621956
,BAO_0000218,,,6211,,,,,1,9028,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621957
,BAO_0000218,,,5710,,,,,1,9029,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621958
,BAO_0000218,,,5710,,,,,1,9030,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621959
,BAO_0000218,,,17853,,,,,1,9031,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621960
,BAO_0000218,,,17853,,,,,1,9032,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621961
,BAO_0000218,,,15765,,,,,1,9033,,p value of the compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621962
,BAO_0000218,,,15765,,,,,1,9034,,p value of the compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL876787
,BAO_0000218,,,15765,,,,,1,9035,,p value of the compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621963
,BAO_0000218,,,6175,,945.0,,,1,9036,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL622637
,BAO_0000218,,,6175,,945.0,,,1,9037,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL622638
,BAO_0000218,,,6175,,945.0,,,1,9038,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL626561
,BAO_0000019,,,7991,,,,,0,9039,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,F,U,CHEMBL626562
,BAO_0000218,,,429,,,,,0,9040,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL626563
,BAO_0000218,,,429,,,,,0,9041,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL626564
,BAO_0000218,,In vivo,6253,,,,,0,9042,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL626565
,BAO_0000218,,In vivo,6253,,,,,0,9043,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL626566
,BAO_0000218,,In vivo,3615,,,,,0,9044,,Clearance rate in rabbits,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL626567
,BAO_0000218,,In vivo,4059,,,,,0,9045,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL626568
,BAO_0000218,,In vivo,5124,,,,,0,9046,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL626569
,BAO_0000218,,In vivo,5124,,,,,0,9047,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL626570
,BAO_0000218,,In vivo,5124,,,,,0,9048,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL626571
,BAO_0000218,,In vivo,429,,,,,0,9049,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL626572
,BAO_0000218,,In vivo,4059,,1969.0,,,0,9050,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Autocuration,Oryctolagus cuniculus,1,9986.0,,Plasma,22224,A,U,CHEMBL626573
,BAO_0000251,Microsomes,,9659,,2107.0,,,0,9051,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Autocuration,Oryctolagus cuniculus,1,9986.0,,Liver,22224,A,U,CHEMBL626574
,BAO_0000251,Microsomes,,9659,,2107.0,,,0,9052,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Autocuration,Oryctolagus cuniculus,1,9986.0,,Liver,22224,A,U,CHEMBL626575
,BAO_0000218,,,3639,,,,,0,9053,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL626576
,BAO_0000218,,,3639,,,,,0,9054,,Dose at which bioavailability of perorally administered compound was tested in rabbit,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL626577
,BAO_0000218,,In vivo,3639,,,,,0,9055,,The compound was tested for its bioavailability in rabbit (by oral dosage).,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL626578
,BAO_0000218,,In vivo,5124,,,,,0,9056,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL625263
,BAO_0000218,,In vivo,5124,,,,,0,9057,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL625264
,BAO_0000218,,In vivo,5124,,,,,0,9058,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL625265
,BAO_0000251,Microsomes,,14294,,,,,0,9059,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL625266
,BAO_0000251,Microsomes,,14294,,,,,0,9060,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL876796
,BAO_0000218,,In vivo,429,,,,,0,9061,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL625267
,BAO_0000218,,In vivo,5124,,1969.0,,,0,9062,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Autocuration,Oryctolagus cuniculus,1,9986.0,,Plasma,22224,A,U,CHEMBL625268
,BAO_0000218,,In vivo,5124,,1969.0,,,0,9063,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Autocuration,Oryctolagus cuniculus,1,9986.0,,Plasma,22224,A,U,CHEMBL625269
,BAO_0000218,,In vivo,5124,,1969.0,,,0,9064,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Autocuration,Oryctolagus cuniculus,1,9986.0,,Plasma,22224,A,U,CHEMBL624689
,BAO_0000218,,In vivo,429,,,,,0,9065,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL624690
,BAO_0000218,,,429,,1088.0,,,0,9066,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),Autocuration,Oryctolagus cuniculus,1,9986.0,,Urine,22224,A,U,CHEMBL624691
,BAO_0000218,,,429,,1088.0,,,0,9067,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),Autocuration,Oryctolagus cuniculus,1,9986.0,,Urine,22224,A,U,CHEMBL624692
,BAO_0000218,,In vivo,4059,,,,,0,9068,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL624693
,BAO_0000218,,In vivo,4137,,,,,0,9069,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL624694
,BAO_0000221,,In vitro,11672,,,,,0,9070,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL877596
,BAO_0000019,,,12886,,,,,0,9071,,Time within which only 10% of the drug was degraded,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL624695
,BAO_0000221,,,3853,,2107.0,,,0,9072,,Half life period in rabbit liver homogenate,Autocuration,Oryctolagus cuniculus,1,9986.0,,Liver,22224,A,U,CHEMBL624696
,BAO_0000019,,,3615,,,,,0,9073,,Half life value in rabbits,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL624697
,BAO_0000218,,In vivo,6253,,178.0,,,0,9074,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Autocuration,Oryctolagus cuniculus,1,9986.0,,Blood,22224,A,U,CHEMBL624698
,BAO_0000218,,In vivo,6253,,178.0,,,0,9075,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Autocuration,Oryctolagus cuniculus,1,9986.0,,Blood,22224,A,U,CHEMBL624699
,BAO_0000218,,In vivo,6077,,,,,0,9076,,Half-life period in rabbits following intravenous administration at 2 mg/kg,Autocuration,Oryctolagus cuniculus,1,9986.0,,,22224,A,U,CHEMBL624700
,BAO_0000218,,,17617,,1969.0,,,1,9077,,AUC 0-8 hr value in rats at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622903
,BAO_0000218,,,17594,,1969.0,,,1,9078,,AUC after administration at 2000 mg/kg/day in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622904
,BAO_0000218,,,6149,,1969.0,,,1,9079,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622905
,BAO_0000218,,,17260,,1969.0,,,1,9080,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622906
,BAO_0000218,,,17260,,1969.0,,,1,9081,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622907
,BAO_0000218,,,6644,,1969.0,,,1,9082,,AUC in rat after oral administration at 10.5 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622908
,BAO_0000218,,,6644,,1969.0,,,1,9083,,AUC in rat after oral administration at 11.2 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622909
,BAO_0000218,,,6644,,1969.0,,,1,9084,,AUC in rat after oral administration at 9.7 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622910
,BAO_0000218,,,6495,,955.0,,,1,9085,,AUC in rat brain after oral administration at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622911
,BAO_0000218,,,6504,,1969.0,,,1,9086,,AUC in rat p.o.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622912
,BAO_0000218,,,17686,,1969.0,,,1,9087,,AUC in rat p.o. at 20 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622913
,BAO_0000218,,,6495,,1969.0,,,1,9088,,AUC in rat plasma after oral administration at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622914
,BAO_0000218,,,216,,1969.0,,,1,9089,,AUC in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622915
,BAO_0000218,,,1908,,1969.0,,,1,9090,,AUC value after IV dose at a dose of 5 mg/kg in rats.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622916
,BAO_0000218,,,1908,,1969.0,,,1,9091,,AUC value after oral dose at a dose of 10 mg/kg in rats.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622917
,BAO_0000218,,In vivo,6685,,1969.0,,,1,9092,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622918
,BAO_0000218,,In vivo,216,,1969.0,,,1,9093,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622919
,BAO_0000218,,In vivo,6049,,1969.0,,,1,9094,,Maximum plasma concentration was evaluated in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622920
,BAO_0000218,,In vivo,2463,,1969.0,,,1,9095,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622921
,BAO_0000218,,In vivo,6679,,1969.0,,,1,9096,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622922
,BAO_0000218,,In vivo,6681,,1969.0,,,1,9097,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622923
,BAO_0000218,,In vivo,4890,,1969.0,,,1,9098,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL877604
,BAO_0000218,,In vivo,6410,,1969.0,,,1,9099,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622924
,BAO_0000218,,In vivo,6410,,1969.0,,,1,9100,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622925
,BAO_0000218,,In vivo,16366,,1969.0,,,1,9101,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622926
,BAO_0000218,,In vivo,6227,,1969.0,,,1,9102,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623625
,BAO_0000218,,In vivo,3598,,1969.0,,,1,9103,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623626
,BAO_0000218,,In vivo,1465,,1969.0,,,1,9104,,Maximum plasma drug concentration was determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623627
,BAO_0000218,,In vivo,4368,,,,,1,9105,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623628
,BAO_0000218,,In vivo,15662,,1969.0,,,1,9106,,Mean peak plasma concentration was observed after intravenous administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623629
,BAO_0000218,,In vivo,15662,,1969.0,,,1,9107,,Mean peak plasma concentration was observed after oral administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623630
,BAO_0000218,,In vivo,5355,,,,,1,9108,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623804
,BAO_0000218,,In vivo,5355,,,,,1,9109,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623805
,BAO_0000218,,In vivo,1567,,1969.0,,,1,9110,,Peak oral plasma concentration was determined in rats by oral administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623806
,BAO_0000218,,In vivo,4026,,1969.0,,,1,9111,,Peak plasma concentration (Cmax) was determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623807
,BAO_0000218,,In vivo,6193,,1969.0,,,1,9112,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623808
,BAO_0000218,,In vivo,4026,,1969.0,,,1,9113,,Peak plasma concentration (Cmax) in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623809
,BAO_0000218,,In vivo,6485,,1969.0,,,1,9114,,Peak plasma concentration at 1 mg/kg peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623810
,BAO_0000218,,In vivo,17655,,1969.0,,,1,9115,,Peak plasma concentration in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623811
,BAO_0000218,,In vivo,14941,,1969.0,,,1,9116,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623812
,BAO_0000218,,In vivo,5394,,,,,1,9117,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877605
,BAO_0000218,,In vivo,4408,,,,,1,9118,,Pharmacokinetic property (Cmax) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623813
,BAO_0000218,,In vivo,5983,,,,,1,9119,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623814
,BAO_0000218,,In vivo,4878,,,,,1,9120,,Cmax in rat after 3mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623815
,BAO_0000218,,In vivo,5862,,,Sprague-Dawley,,1,9121,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623816
,BAO_0000218,,In vivo,4517,,,,,1,9122,,Cmax in rats after 20 mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623145
,BAO_0000218,,In vivo,5932,,1969.0,,,1,9123,,Cmax in rat plasma after 30mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623146
,BAO_0000218,,In vivo,5436,,1969.0,,,1,9124,,Plasma concentration after oral administration of 100 mg/kg to rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623147
,BAO_0000218,,In vivo,4910,,955.0,,,1,9125,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL623042
,BAO_0000218,,In vivo,4950,,,,,1,9126,,Tested for the Cmax in rat at 10 mg/kg per orally,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623043
,BAO_0000218,,In vivo,15078,,,,,1,9127,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623044
,BAO_0000218,,In vivo,15078,,,,,1,9128,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623045
,BAO_0000218,,In vivo,3360,,,,,1,9129,,Bioavailability as oral Cmax in rats at 30 mins,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623046
,BAO_0000218,,In vivo,3360,,,,,1,9130,,Bioavailability as oral Cmax in rats at 6hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623226
,BAO_0000218,,In vivo,15022,,,,,1,9131,,The maximum concentration of compound was measured at the dose of 100 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623227
,BAO_0000218,,In vivo,15022,,,,,1,9132,,The maximum concentration of compound was measured at the dose of 300 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623228
,BAO_0000218,,In vivo,15022,,,,,1,9133,,The maximum concentration of compound was measured at the dose of 30 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623229
,BAO_0000218,,In vivo,5160,,1969.0,,,1,9134,,The maximum plasma levels for the compounds were determined by LC-MS.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623230
,BAO_0000218,,In vivo,15662,,1969.0,,,1,9135,,mean peak plasma concentration was observed after intravenous administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623231
,BAO_0000218,,In vivo,15662,,1969.0,,,1,9136,,mean peak plasma concentration was observed after oral administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623232
,BAO_0000218,,,4709,,,,,1,9137,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623233
,BAO_0000218,,,3535,,,,,1,9138,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623234
,BAO_0000218,,,3535,,,,,1,9139,,Concentration in plasma (portal) following oral dose in rats at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623235
,BAO_0000218,,,3535,,,,,1,9140,,Concentration in plasma (portal) following oral dose in rats at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623236
,BAO_0000218,,,3535,,,,,1,9141,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623237
,BAO_0000218,,,3535,,,,,1,9142,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623238
,BAO_0000218,,,3535,,,,,1,9143,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623239
,BAO_0000218,,In vivo,5005,,1969.0,,,0,9144,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,22224,A,U,CHEMBL623240
,BAO_0000218,,,6326,,1898.0,,,1,9145,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",Intermediate,Rattus norvegicus,1,10116.0,,Hypothalamus,50597,A,N,CHEMBL623241
,BAO_0000218,,,6326,,1898.0,,,1,9146,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",Intermediate,Rattus norvegicus,1,10116.0,,Hypothalamus,50597,A,N,CHEMBL623242
,BAO_0000218,,,6326,,,,,1,9147,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874394
,BAO_0000218,,,6326,,,,,1,9148,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623243
,BAO_0000218,,,17411,,,,,1,9149,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623244
,BAO_0000218,,,16435,,2113.0,,,1,9150,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL623245
,BAO_0000218,,,16435,,2113.0,,,1,9151,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL623246
,BAO_0000218,,,16435,,2113.0,,,1,9152,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL623247
,BAO_0000218,,,16435,,2113.0,,,1,9153,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL623248
,BAO_0000218,,,16435,,2113.0,,,1,9154,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL623249
,BAO_0000218,,,16434,,2107.0,,,1,9155,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625072
,BAO_0000218,,,16434,,2107.0,,,1,9156,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625073
,BAO_0000218,,,16434,,2107.0,,,1,9157,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625074
,BAO_0000218,,,16434,,2107.0,,,1,9158,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625075
,BAO_0000218,,,16434,,2107.0,,,1,9159,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625076
,BAO_0000218,,,16434,,2107.0,,,1,9160,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625077
,BAO_0000218,,,16434,,2107.0,,,1,9161,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625078
,BAO_0000218,,,16434,,2107.0,,,1,9162,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL874395
,BAO_0000218,,,16435,,2107.0,,,1,9163,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625079
,BAO_0000218,,,16435,,2107.0,,,1,9164,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625080
,BAO_0000218,,,16435,,2107.0,,,1,9165,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625081
,BAO_0000218,,,16435,,2107.0,,,1,9166,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625082
,BAO_0000218,,,16435,,2107.0,,,1,9167,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625083
,BAO_0000218,,,16435,,2107.0,,,1,9168,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625084
,BAO_0000218,,,16435,,2107.0,,,1,9169,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625085
,BAO_0000218,,,16435,,2107.0,,,1,9170,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625086
,BAO_0000218,,,16434,,2107.0,,,1,9171,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625087
,BAO_0000218,,,16434,,2107.0,,,1,9172,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625088
,BAO_0000218,,,16434,,2107.0,,,1,9173,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622205
,BAO_0000218,,,16435,,2107.0,,,1,9174,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622206
,BAO_0000218,,,16435,,2107.0,,,1,9175,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622207
,BAO_0000218,,,16435,,2107.0,,,1,9176,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622366
,BAO_0000218,,,16435,,2107.0,,,1,9177,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622367
,BAO_0000218,,,16435,,2107.0,,,1,9178,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL875331
,BAO_0000218,,,16435,,2107.0,,,1,9179,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622368
,BAO_0000218,,,16434,,2048.0,,,1,9180,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622369
,BAO_0000218,,,16434,,2048.0,,,1,9181,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622370
,BAO_0000218,,,16434,,2048.0,,,1,9182,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622371
,BAO_0000218,,,16434,,2048.0,,,1,9183,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622372
,BAO_0000218,,,16434,,2048.0,,,1,9184,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622373
,BAO_0000218,,,16434,,2048.0,,,1,9185,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622374
,BAO_0000218,,,16434,,2048.0,,,1,9186,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622375
,BAO_0000218,,,16434,,2048.0,,,1,9187,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622376
,BAO_0000218,,,16435,,2048.0,,,1,9188,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622377
,BAO_0000218,,,16435,,2048.0,,,1,9189,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622378
,BAO_0000218,,,16435,,2048.0,,,1,9190,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622379
,BAO_0000218,,,16435,,2048.0,,,1,9191,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622380
,BAO_0000218,,,16435,,2048.0,,,1,9192,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622381
,BAO_0000218,,,16435,,2048.0,,,1,9193,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622382
,BAO_0000218,,,16434,,2048.0,,,1,9194,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622383
,BAO_0000218,,,6175,,945.0,,,1,9195,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL875332
,BAO_0000218,,,6175,,945.0,,,1,9196,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL622384
,BAO_0000218,,,6175,,945.0,,,1,9197,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL622385
,BAO_0000218,,,6175,,945.0,,,1,9198,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL622386
,BAO_0000218,,,10839,,,,,1,9199,,The compound was tested for the plasma binding in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622387
,BAO_0000218,,,16459,,,,,1,9200,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622388
,BAO_0000218,,,16459,,,,,1,9201,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622389
,BAO_0000218,,,16459,,,,,1,9202,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622390
,BAO_0000218,,,16459,,,,,1,9203,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622391
,BAO_0000218,,,16459,,,,,1,9204,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622392
,BAO_0000218,,,16459,,,,,1,9205,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622393
,BAO_0000218,,,3278,,,,,1,9206,,Plasma level at 2 hr after administration of the compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622394
,BAO_0000218,,,3278,,,,,1,9207,,plasma level at 2 hr after administration of the compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622395
,BAO_0000218,,,4684,,1977.0,,,1,9208,,Stability in rat serum measured as % recovery at 1 min,Intermediate,Rattus norvegicus,1,10116.0,,Serum,50597,A,N,CHEMBL622396
,BAO_0000218,,,4684,,1977.0,,,1,9209,,Stability in rat serum measured as % recovery at 10 min,Intermediate,Rattus norvegicus,1,10116.0,,Serum,50597,A,N,CHEMBL624894
,BAO_0000218,,,4684,,1977.0,,,1,9210,,Stability in rat serum measured as % recovery at 10 mins,Intermediate,Rattus norvegicus,1,10116.0,,Serum,50597,A,N,CHEMBL624895
,BAO_0000218,,,4684,,1977.0,,,1,9211,,Stability in rat serum measured as % recovery at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,Serum,50597,A,N,CHEMBL624058
,BAO_0000218,,,4684,,1977.0,,,1,9212,,Stability in rat serum measured as % recovery at 3 min,Intermediate,Rattus norvegicus,1,10116.0,,Serum,50597,A,N,CHEMBL624059
,BAO_0000218,,,4684,,1977.0,,,1,9213,,Stability in rat serum measured as % recovery at 3 mins,Intermediate,Rattus norvegicus,1,10116.0,,Serum,50597,A,N,CHEMBL624060
,BAO_0000218,,,4684,,1977.0,,,1,9214,,Stability in rat serum measured as % recovery at 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Serum,50597,A,N,CHEMBL624061
,BAO_0000218,,,4684,,1977.0,,,1,9215,,Stability in rat serum measured as % recovery at 5 mins,Intermediate,Rattus norvegicus,1,10116.0,,Serum,50597,A,N,CHEMBL624062
,BAO_0000218,,In vivo,16456,,,,,1,9216,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624063
,BAO_0000218,,In vivo,16456,,,,,1,9217,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624064
,BAO_0000218,,,723,,1969.0,,,1,9218,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL624065
,BAO_0000218,,,723,,1969.0,,,1,9219,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL624066
,BAO_0000218,,In vivo,5160,,,,,1,9220,,Half life tested in mature male rat at a dose of 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877490
,BAO_0000218,,In vivo,4709,,,,,1,9221,,Half life after intravenous administration of 1 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874442
,BAO_0000218,,In vivo,5633,,,,,1,9222,,Half life period after administration (30 mg/kg) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626890
,BAO_0000218,,In vivo,5302,,,,,1,9223,,Half life period in rat after 5 mg/Kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626891
,BAO_0000218,,In vivo,5302,,,,,1,9224,,Half life period in rat after 5 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626892
,BAO_0000218,,,17791,,,,,1,9225,,Half life period was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626893
,BAO_0000218,,,17791,,,,,1,9226,,Half life period was evaluated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626894
,BAO_0000218,,,17791,,,,,1,9227,,Half life period was evaluated in rat; 0.5-1.0,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626895
,BAO_0000218,,,17791,,,,,1,9228,,Half life period was evaluated in rat; 5.9-7.5,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626896
,BAO_0000218,,,14512,,1969.0,,,1,9229,,Half-life in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626897
,BAO_0000218,,,6230,,,,,1,9230,,Half-life time in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626898
,BAO_0000218,,In vivo,3364,,,,,1,9231,,Terminal half-life after iv administration to rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626899
,BAO_0000218,,In vivo,6874,,,,,1,9232,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626900
,BAO_0000218,,,857,,,,,1,9233,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626901
,BAO_0000218,,In vivo,858,,,,,1,9234,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626902
,BAO_0000218,,In vivo,858,,,,,1,9235,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626903
,BAO_0000218,,In vivo,5355,,,,,1,9236,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874443
,BAO_0000218,,In vivo,5355,,,,,1,9237,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626904
,BAO_0000218,,,6305,,,,,1,9238,,Half life in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626905
,BAO_0000218,,In vivo,13501,,1969.0,,,1,9239,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL873830
,BAO_0000218,,In vivo,17594,,,,,1,9240,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626906
,BAO_0000218,,In vivo,4186,,1969.0,,,1,9241,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL631076
,BAO_0000218,,,2932,,1969.0,,,1,9242,,Biological half-life was measured in plasma of rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL631077
,BAO_0000218,,In vivo,17065,,,,,1,9243,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631078
,BAO_0000218,,In vivo,15765,,,,,1,9244,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631079
,BAO_0000218,,In vivo,2713,,,,,1,9245,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631080
,BAO_0000218,,In vivo,2661,,,,,1,9246,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631081
,BAO_0000218,,In vivo,2661,,,,,1,9247,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631239
,BAO_0000218,,,740,,1969.0,,,1,9248,,Compound was evaluated for plasma half life in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL631240
,BAO_0000218,,,6597,,1969.0,,,1,9249,,AUC value at a dose of 5 mg/kg (p.o.) in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL631241
,BAO_0000218,,,2959,,1969.0,,,1,9250,,AUC value after administration of 20 mg/Kg oral dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL631242
,BAO_0000218,,,17594,,1969.0,,,1,9251,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL631243
,BAO_0000218,,,17596,,1969.0,,,1,9252,,AUC0-96 after administration at 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL874444
,BAO_0000218,,,17594,,1969.0,,,1,9253,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL631244
,BAO_0000218,,,3293,,,,,1,9254,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631245
,BAO_0000218,,,6757,,,,,1,9255,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627162
,BAO_0000218,,,6757,,,,,1,9256,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627163
,BAO_0000218,,,6757,,,,,1,9257,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627164
,BAO_0000218,,,5979,,2113.0,,,1,9258,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627165
,BAO_0000218,,,5979,,,,,1,9259,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627166
,BAO_0000218,,,5979,,,,,1,9260,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627167
,BAO_0000218,,,4026,,,,,1,9261,,Area under curve (AUC) at a dose of 30 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627822
,BAO_0000218,,,5355,,,,,1,9262,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627823
,BAO_0000218,,,5355,,,,,1,9263,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627824
,BAO_0000218,,,5355,,,,,1,9264,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627825
,BAO_0000218,,,5633,,,,,1,9265,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627826
,BAO_0000218,,,1716,,,,,1,9266,,Area under curve (Pharmacokinetic property) was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627827
,BAO_0000218,,,1716,,,,,1,9267,,Area under curve (Pharmacokinetic property) of the compound; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627828
,BAO_0000218,,,4689,,,,,1,9268,,Area under curve after intravenous administration (1 mg/kg) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627829
,BAO_0000218,,,4527,,,,,1,9269,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627830
,BAO_0000218,,,4527,,,,,1,9270,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627831
,BAO_0000218,,,15662,,,,,1,9271,,Area under curve in male SD rats was observed after oral administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627832
,BAO_0000218,,,4413,,,,,1,9272,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627833
,BAO_0000218,,,3598,,,,,1,9273,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627834
,BAO_0000218,,,3598,,,,,1,9274,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,Expert,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628004
,BAO_0000218,,,5964,,,,,1,9275,,Area under curve at 5 mg/kg po was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628005
,BAO_0000218,,,4689,,,,,1,9276,,Area under curve in Rat at a oral dose of 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628006
,BAO_0000218,,,4186,,,,,1,9277,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628007
,BAO_0000218,,,5510,,,,,1,9278,,Area under curve was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625676
,BAO_0000218,,,17858,,,,,1,9279,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631309
,BAO_0000218,,,17804,,,,,1,9280,,Area under curve after intravenous administration at 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631310
,BAO_0000218,,,6106,,,,,1,9281,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631311
,BAO_0000218,,,5964,,,,,1,9282,,Area under curve at 4 hr in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631312
,BAO_0000218,,,4026,,,,,1,9283,,Area under curve at a dose of 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631313
,BAO_0000218,,,4756,,,,,1,9284,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631314
,BAO_0000218,,,4756,,,,,1,9285,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631315
,BAO_0000218,,,5862,,,,,1,9286,,Area under curve for a 2-mpk po dose in SD rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631316
,BAO_0000218,,,5862,,,,,1,9287,,Area under curve in SD rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631317
,BAO_0000218,,,6644,,,,,1,9288,,Area under curve in rat after oral administration at 13 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874471
,BAO_0000218,,,5871,,,,,1,9289,,Area under curve in rat by po administration at 0-24 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631318
,BAO_0000218,,,5919,,1969.0,,,1,9290,,Area under curve in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL631319
,BAO_0000218,,,5939,,,,,1,9291,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631320
,BAO_0000218,,,5939,,,,,1,9292,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631321
,BAO_0000218,,,10,,,,,1,9293,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631322
,BAO_0000218,,,11149,,,,,1,9294,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631323
,BAO_0000218,,,5302,,,,,1,9295,,Area under curve value in rat at a dose of 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631324
,BAO_0000218,,,17796,,,,,1,9296,,Area under curve was determined after oral administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631325
,BAO_0000218,,,4890,,,,,1,9297,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631326
,BAO_0000218,,,6011,,,,,1,9298,,Area under curve was determined after peroral administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631327
,BAO_0000218,,,5375,,,,,1,9299,,Area under curve was determined at a dose 30 mpk administered orally.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631328
,BAO_0000218,,,17764,,,,,1,9300,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631329
,BAO_0000218,,,4368,,,,,1,9301,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627217
,BAO_0000218,,,5610,,,,,1,9302,,Area under curve was determined in male rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626352
,BAO_0000218,,,5833,,,,,1,9303,,Area under curve was determined in rat after PO administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626353
,BAO_0000218,,,4257,,,,,1,9304,,Area under curve was determined in rat after a 3 mg/kg of oral dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626354
,BAO_0000218,,,5937,,,,,1,9305,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626355
,BAO_0000218,,,5932,,,,,1,9306,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626356
,BAO_0000218,,,5932,,,,,1,9307,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626357
,BAO_0000218,,,17411,,,,,1,9308,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626358
,BAO_0000218,,,17411,,,,,1,9309,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626359
,BAO_0000218,,,17771,,1969.0,,,1,9310,,Peak plasma concentration in rat at a dose of 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626360
,BAO_0000218,,,1628,,,,,1,9311,,Plasma concentration at 2 hr in rats was evaluated.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626361
,BAO_0000218,,,1628,,,,,1,9312,,Plasma concentration at 2 hr in rats was evaluated; Not available,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626362
,BAO_0000218,,,17411,,,,,1,9313,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626363
,BAO_0000218,,,4910,,,,,1,9314,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626970
,BAO_0000218,,,4910,,,,,1,9315,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626971
,BAO_0000218,,,4910,,1969.0,,,1,9316,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626972
,BAO_0000218,,,4910,,1969.0,,,1,9317,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626973
,BAO_0000218,,,4910,,1969.0,,,1,9318,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626974
,BAO_0000218,,,4910,,1969.0,,,1,9319,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL874592
,BAO_0000218,,,5510,,,,,1,9320,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626975
,BAO_0000218,,,5510,,,,,1,9321,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626976
,BAO_0000218,,,5510,,,,,1,9322,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626977
,BAO_0000218,,,5510,,,,,1,9323,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626978
,BAO_0000218,,,16427,,,,,1,9324,,PK study was carried to determine the relative absorption ranking in rat.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626979
,BAO_0000218,,In vivo,4689,,1969.0,,,1,9325,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626980
,BAO_0000218,,,11450,,178.0,,,1,9326,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626981
,BAO_0000218,,,11450,,178.0,,,1,9327,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626982
,BAO_0000218,,,11450,,178.0,,,1,9328,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626983
,BAO_0000218,,,11450,,178.0,,,1,9329,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622522
,BAO_0000218,,,11450,,178.0,,,1,9330,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622523
,BAO_0000218,,,11450,,178.0,,,1,9331,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622524
,BAO_0000218,,,11450,,955.0,,,1,9332,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622525
,BAO_0000218,,,11450,,955.0,,,1,9333,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622526
,BAO_0000218,,,11450,,955.0,,,1,9334,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL619849
,BAO_0000218,,,11450,,955.0,,,1,9335,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL619850
,BAO_0000218,,,11450,,955.0,,,1,9336,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL623864
,BAO_0000218,,,11450,,955.0,,,1,9337,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL623865
,BAO_0000218,,,11450,,948.0,,,1,9338,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL623866
,BAO_0000218,,,11450,,948.0,,,1,9339,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL623867
,BAO_0000218,,,11450,,948.0,,,1,9340,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL877615
,BAO_0000218,,,11450,,948.0,,,1,9341,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL623868
,BAO_0000218,,,11450,,948.0,,,1,9342,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL623869
,BAO_0000218,,,11450,,948.0,,,1,9343,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL623870
,BAO_0000218,,,16434,,2048.0,,,1,9344,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL623871
,BAO_0000218,,,16434,,2048.0,,,1,9345,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL623872
,BAO_0000218,,,16435,,2048.0,,,1,9346,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622129
,BAO_0000218,,,16435,,2048.0,,,1,9347,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622130
,BAO_0000218,,,16435,,2048.0,,,1,9348,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622131
,BAO_0000218,,,16435,,2048.0,,,1,9349,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622132
,BAO_0000218,,,16435,,2048.0,,,1,9350,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622133
,BAO_0000218,,,16435,,2048.0,,,1,9351,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622134
,BAO_0000218,,,16435,,2048.0,,,1,9352,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622135
,BAO_0000218,,,16435,,2048.0,,,1,9353,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622136
,BAO_0000218,,,16434,,2385.0,,,1,9354,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL622137
,BAO_0000218,,,16434,,2385.0,,,1,9355,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL622138
,BAO_0000218,,,16434,,2385.0,,,1,9356,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623017
,BAO_0000218,,,16434,,2385.0,,,1,9357,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623018
,BAO_0000218,,,16434,,2385.0,,,1,9358,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623019
,BAO_0000218,,,16434,,2385.0,,,1,9359,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623020
,BAO_0000218,,,16434,,2385.0,,,1,9360,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623021
,BAO_0000218,,,16434,,2385.0,,,1,9361,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623022
,BAO_0000218,,,16435,,2385.0,,,1,9362,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623023
,BAO_0000218,,,16435,,2385.0,,,1,9363,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623024
,BAO_0000218,,,16435,,2385.0,,,1,9364,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623025
,BAO_0000218,,,16435,,2385.0,,,1,9365,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620545
,BAO_0000218,,,16435,,2385.0,,,1,9366,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620546
,BAO_0000218,,,16435,,2385.0,,,1,9367,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620547
,BAO_0000218,,,16435,,2385.0,,,1,9368,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620548
,BAO_0000218,,,16435,,2385.0,,,1,9369,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620549
,BAO_0000218,,,16434,,2385.0,,,1,9370,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620550
,BAO_0000218,,,16434,,2385.0,,,1,9371,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620551
,BAO_0000218,,,16434,,2385.0,,,1,9372,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620552
,BAO_0000218,,,16435,,2385.0,,,1,9373,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620553
,BAO_0000218,,,16435,,2385.0,,,1,9374,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620554
,BAO_0000218,,,16435,,2385.0,,,1,9375,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL875845
,BAO_0000218,,,16435,,2385.0,,,1,9376,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620555
,BAO_0000218,,,16435,,2385.0,,,1,9377,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620556
,BAO_0000218,,,16435,,2385.0,,,1,9378,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620557
,BAO_0000218,,,16434,,,,,1,9379,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620558
,BAO_0000218,,,16434,,,,,1,9380,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620559
,BAO_0000218,,,16434,,,,,1,9381,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622939
,BAO_0000218,,,16434,,,,,1,9382,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622940
,BAO_0000218,,,16434,,,,,1,9383,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622941
,BAO_0000218,,,16434,,,,,1,9384,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622942
,BAO_0000218,,,16434,,,,,1,9385,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622943
,BAO_0000218,,,16434,,,,,1,9386,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622944
,BAO_0000218,,,16435,,,,,1,9387,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622945
,BAO_0000218,,,16435,,,,,1,9388,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622946
,BAO_0000218,,,3341,,,,,1,9389,,Compound was evaluated for terminal half life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622947
,BAO_0000218,,In vivo,3634,,1969.0,,,1,9390,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622948
,BAO_0000218,,In vivo,3634,,1969.0,,,1,9391,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622949
,BAO_0000218,,,4839,,,,,1,9392,,Compound was tested for its half life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622950
,BAO_0000218,,In vivo,5005,,1969.0,,,0,9393,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,Intermediate,Macaca mulatta,1,9544.0,,Plasma,22224,A,U,CHEMBL622951
,BAO_0000366,,,5005,,1969.0,,,0,9394,,Compound was tested for its plasma half life in Sprague Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,22224,A,U,CHEMBL622952
,BAO_0000366,,,5005,,1969.0,,,0,9395,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,22224,A,U,CHEMBL622953
,BAO_0000218,,,1094,,1969.0,,,1,9396,,Compound was tested for plasma half-life period in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL873818
,BAO_0000218,,In vivo,5031,,,,,1,9397,,Elimination half life after i.v. administration of compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622954
,BAO_0000218,,In vivo,6518,,,,,1,9398,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622955
,BAO_0000218,,In vivo,6518,,,,,1,9399,,Elimination half-life after IV dosing at 1 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875229
,BAO_0000218,,In vivo,6518,,,,,1,9400,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622956
,BAO_0000218,,In vivo,6518,,,,,1,9401,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622957
,BAO_0000218,,In vivo,5408,,955.0,,,1,9402,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622958
,BAO_0000218,,In vivo,5408,,1969.0,,,1,9403,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622959
,BAO_0000218,,In vivo,5408,,955.0,,,1,9404,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622960
,BAO_0000218,,In vivo,5408,,1969.0,,,1,9405,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622961
,BAO_0000218,,In vivo,4687,,,,,1,9406,,Evaluated for the half life in rat (in vivo),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622962
,BAO_0000218,,,6640,,,,,1,9407,,Hafl life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622963
,BAO_0000218,,,6640,,,,,1,9408,,Hafl life rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622964
,BAO_0000218,,,6641,,,,,1,9409,,Hafl life rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622965
,BAO_0000218,,,6640,,,,,1,9410,,Hafl life rat; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622966
,BAO_0000218,,,6641,,,,,1,9411,,Hafl life rat; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622967
,BAO_0000218,,In vivo,17411,,2113.0,,,1,9412,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL622968
,BAO_0000218,,In vivo,17411,,2107.0,,,1,9413,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622969
,BAO_0000218,,In vivo,17411,,2048.0,,,1,9414,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL875327
,BAO_0000218,,In vivo,6570,,,,,1,9415,,Half life in rat after 1 mg/kg i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628638
,BAO_0000218,,In vivo,6570,,,,,1,9416,,Half life in rat after 2 mg/kg peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628639
,BAO_0000218,,In vivo,17411,,,,,1,9417,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625840
,BAO_0000218,,In vivo,4722,,,,,1,9418,,Half life of 10 mg/kg oral dose determined in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625841
,BAO_0000218,,In vivo,5978,,,,,1,9419,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625842
,BAO_0000218,,In vivo,5978,,,,,1,9420,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625843
,BAO_0000218,,In vivo,5978,,,,,1,9421,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625844
,BAO_0000218,,In vivo,5978,,,,,1,9422,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL873822
,BAO_0000218,,In vivo,5978,,,,,1,9423,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625845
,BAO_0000218,,In vivo,5978,,,,,1,9424,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627059
,BAO_0000218,,In vivo,5978,,,,,1,9425,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627060
,BAO_0000218,,In vivo,5978,,,,,1,9426,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627061
,BAO_0000218,,In vivo,4762,,,,,1,9427,,Half life of compound at 5 mg/kg after po administration was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627709
,BAO_0000218,,In vivo,5327,,,,,1,9428,,Half life of compound determined after intravenous administration to rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627710
,BAO_0000218,,,4847,,,,,1,9429,,Half life of compound was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627711
,BAO_0000218,,In vivo,17720,,1969.0,,,1,9430,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627712
,BAO_0000218,,In vivo,4723,,,,,1,9431,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627713
,BAO_0000218,,In vivo,4723,,,,,1,9432,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627714
,BAO_0000218,,In vivo,4256,,,,,0,9433,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,Intermediate,Macaca fascicularis,1,9541.0,,,22224,A,U,CHEMBL627889
,BAO_0000218,,In vivo,4256,,,,,0,9434,,Half life determined in rat by intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL627890
,BAO_0000218,,In vivo,4722,,,,,1,9435,,Half life determined in rats after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627891
,BAO_0000218,,In vivo,6535,,1969.0,,,1,9436,,Half life in rat plasma after administration of 2 mg/kg iv,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627892
,BAO_0000218,,In vivo,6535,,1969.0,,,1,9437,,Half life in rat plasma after administration of 2 mg/kg iv,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627893
,BAO_0000218,,,1435,,1969.0,,,1,9438,,Half life in rat plasma was determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627894
,BAO_0000218,,,1435,,1969.0,,,1,9439,,Half life in rat plasma was determined; NA means not applicable,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627895
,BAO_0000218,,,5206,,,,,1,9440,,Half life in rat was tested,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627896
,BAO_0000218,,,6080,,1969.0,,,1,9441,,Half life measured in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627897
,BAO_0000218,,,4449,,,,,1,9442,,Half life recorded in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627898
,BAO_0000218,,,6057,,,,,1,9443,,Half life was calculated,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627899
,BAO_0000218,,,6057,,,,,1,9444,,Half life was calculated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL873823
,BAO_0000218,,,3747,,,,,1,9445,,Half life was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627900
,BAO_0000218,,In vivo,17858,,,,,1,9446,,Half life after 10 mg/kg oral administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627901
,BAO_0000218,,In vivo,16365,,,,,1,9447,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627902
,BAO_0000218,,In vivo,16365,,,,,1,9448,,Half life after administering orally a dose of 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627903
,BAO_0000218,,,5031,,,,,1,9449,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627904
,BAO_0000218,,,4722,,,,,1,9450,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627905
,BAO_0000218,,,6078,,,,,1,9451,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627906
,BAO_0000218,,,6078,,,,,1,9452,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627907
,BAO_0000218,,,6078,,,,,1,9453,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876783
,BAO_0000218,,,6078,,,,,1,9454,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627908
,BAO_0000218,,,17065,,,,,1,9455,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627909
,BAO_0000218,,,1353,,,,,1,9456,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627910
,BAO_0000218,,,1353,,,,,1,9457,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627911
,BAO_0000218,,,1353,,,,,1,9458,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627912
,BAO_0000218,,,1353,,,,,1,9459,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627913
,BAO_0000218,,,1353,,,,,1,9460,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627914
,BAO_0000218,,,16423,,,,,1,9461,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627915
,BAO_0000218,,,16423,,,,,1,9462,,Area under the curve was evaluated after 20 uM/kg of peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627916
,BAO_0000218,,,6062,,,,,1,9463,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627917
,BAO_0000218,,,6056,,,,,1,9464,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627918
,BAO_0000218,,,5182,,,,,1,9465,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627919
,BAO_0000218,,,6410,,,,,1,9466,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627920
,BAO_0000218,,,6410,,,,,1,9467,,Area under the curve was evaluated at an oral dose of 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627921
,BAO_0000218,,,4723,,,,,1,9468,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627922
,BAO_0000218,,,4723,,,,,1,9469,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876784
,BAO_0000218,,,4723,,,,,1,9470,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627923
,BAO_0000218,,,4723,,,,,1,9471,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626208
,BAO_0000218,,,4723,,,,,1,9472,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626209
,BAO_0000218,,,4723,,,,,1,9473,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626210
,BAO_0000218,,,2463,,1969.0,,,1,9474,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627994
,BAO_0000218,,,4709,,,,,1,9475,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627995
,BAO_0000218,,,4075,,,,,1,9476,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627996
,BAO_0000218,,,5394,,,,,1,9477,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627997
,BAO_0000218,,,2661,,,,,1,9478,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627998
,BAO_0000218,,,2661,,,,,1,9479,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628640
,BAO_0000218,,,2661,,,,,1,9480,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628641
,BAO_0000218,,,2661,,,,,1,9481,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628642
,BAO_0000218,,,17791,,,,,1,9482,,Compound was evaluated for area under the curve expressed as (h*ug/ml),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628643
,BAO_0000218,,,2591,,,,,1,9483,,Compound was tested for area under curve in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628644
,BAO_0000218,,,6567,,,,,1,9484,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628645
,BAO_0000218,,,6211,,,,,1,9485,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628646
,BAO_0000218,,,5529,,,,,1,9486,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628647
,BAO_0000218,,,5408,,,,,1,9487,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628648
,BAO_0000218,,,5408,,,,,1,9488,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625358
,BAO_0000218,,,5408,,,,,1,9489,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625359
,BAO_0000218,,,5408,,,,,1,9490,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625360
,BAO_0000218,,,429,,,,,1,9491,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625361
,BAO_0000218,,,429,,,,,1,9492,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625362
,BAO_0000218,,,429,,,,,1,9493,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625363
,BAO_0000218,,,4796,,,,,1,9494,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625364
,BAO_0000218,,,5974,,,,,1,9495,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625365
,BAO_0000218,,,5974,,,,,1,9496,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625366
,BAO_0000218,,,5974,,,,,1,9497,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625367
,BAO_0000218,,,11450,,2113.0,,,1,9498,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625368
,BAO_0000218,,,11450,,2113.0,,,1,9499,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625369
,BAO_0000218,,,11450,,2113.0,,,1,9500,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625370
,BAO_0000218,,,11450,,2113.0,,,1,9501,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625371
,BAO_0000218,,,11450,,2113.0,,,1,9502,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625372
,BAO_0000218,,,11450,,2113.0,,,1,9503,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625373
,BAO_0000218,,,11450,,2107.0,,,1,9504,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625374
,BAO_0000218,,,11450,,2107.0,,,1,9505,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL877593
,BAO_0000218,,,11450,,2107.0,,,1,9506,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625375
,BAO_0000218,,,11450,,2107.0,,,1,9507,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625376
,BAO_0000218,,,11450,,2107.0,,,1,9508,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621973
,BAO_0000218,,,11450,,2107.0,,,1,9509,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621974
,BAO_0000218,,,11450,,2048.0,,,1,9510,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL621975
,BAO_0000218,,,11450,,2048.0,,,1,9511,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622166
,BAO_0000218,,,11450,,2048.0,,,1,9512,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622167
,BAO_0000218,,,11450,,2048.0,,,1,9513,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622168
,BAO_0000218,,,11450,,2048.0,,,1,9514,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622169
,BAO_0000218,,,11450,,2048.0,,,1,9515,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622170
,BAO_0000218,,,11450,,2046.0,,,1,9516,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622171
,BAO_0000218,,,11450,,2046.0,,,1,9517,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622172
,BAO_0000218,,,11450,,2046.0,,,1,9518,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622173
,BAO_0000218,,,11450,,2046.0,,,1,9519,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622174
,BAO_0000218,,,11450,,2046.0,,,1,9520,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622175
,BAO_0000218,,,11450,,2046.0,,,1,9521,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622176
,BAO_0000218,,,11450,,2046.0,,,1,9522,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622177
,BAO_0000218,,,11450,,2046.0,,,1,9523,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622178
,BAO_0000218,,,11450,,2046.0,,,1,9524,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622179
,BAO_0000218,,,11450,,2046.0,,,1,9525,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622180
,BAO_0000218,,,16435,,,,,1,9526,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622181
,BAO_0000218,,,16435,,,,,1,9527,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622182
,BAO_0000218,,,16435,,,,,1,9528,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622183
,BAO_0000218,,,16435,,,,,1,9529,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622184
,BAO_0000218,,,16435,,,,,1,9530,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622185
,BAO_0000218,,,16435,,,,,1,9531,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622186
,BAO_0000218,,,16434,,,,,1,9532,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622187
,BAO_0000218,,,16434,,,,,1,9533,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625002
,BAO_0000218,,,16434,,,,,1,9534,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622090
,BAO_0000218,,,16435,,,,,1,9535,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622091
,BAO_0000218,,,16435,,,,,1,9536,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622092
,BAO_0000218,,,16435,,,,,1,9537,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622093
,BAO_0000218,,,16435,,,,,1,9538,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622094
,BAO_0000218,,,16435,,,,,1,9539,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622095
,BAO_0000218,,,16435,,,,,1,9540,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622264
,BAO_0000218,,,16434,,2106.0,,,1,9541,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL622265
,BAO_0000218,,,16434,,2106.0,,,1,9542,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL622266
,BAO_0000218,,,16434,,2106.0,,,1,9543,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL622267
,BAO_0000218,,,16434,,2106.0,,,1,9544,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL622268
,BAO_0000218,,,16434,,2106.0,,,1,9545,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL622269
,BAO_0000218,,,16434,,2106.0,,,1,9546,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625071
,BAO_0000218,,,16434,,2106.0,,,1,9547,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621621
,BAO_0000218,,,16434,,2106.0,,,1,9548,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621622
,BAO_0000218,,,16435,,2106.0,,,1,9549,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621623
,BAO_0000218,,,16435,,2106.0,,,1,9550,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621624
,BAO_0000218,,,16435,,2106.0,,,1,9551,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621625
,BAO_0000218,,,16435,,2106.0,,,1,9552,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621626
,BAO_0000218,,,16435,,2106.0,,,1,9553,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621627
,BAO_0000218,,,16435,,2106.0,,,1,9554,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621628
,BAO_0000218,,,16435,,2106.0,,,1,9555,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL875328
,BAO_0000218,,,16435,,2106.0,,,1,9556,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621629
,BAO_0000218,,,16434,,2106.0,,,1,9557,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621630
,BAO_0000218,,,16434,,2106.0,,,1,9558,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621631
,BAO_0000218,,,16434,,2106.0,,,1,9559,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621632
,BAO_0000218,,,16435,,2106.0,,,1,9560,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621633
,BAO_0000218,,,16435,,2106.0,,,1,9561,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621634
,BAO_0000218,,,16435,,2106.0,,,1,9562,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621635
,BAO_0000218,,,16435,,2106.0,,,1,9563,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621636
,BAO_0000218,,,16435,,2106.0,,,1,9564,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621637
,BAO_0000218,,,16435,,2106.0,,,1,9565,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL621638
,BAO_0000218,,,16434,,,,,1,9566,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618883
,BAO_0000218,,,16434,,,,,1,9567,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618884
,BAO_0000218,,,16434,,,,,1,9568,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628627
,BAO_0000218,,,16434,,,,,1,9569,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628628
,BAO_0000218,,,16434,,,,,1,9570,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628629
,BAO_0000218,,In vivo,16365,,,,,1,9571,,Half life after administering orally a dose of 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628630
,BAO_0000218,,In vivo,16365,,,,,1,9572,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628631
,BAO_0000218,,In vivo,16365,,,,,1,9573,,Half life after administering intravenously a dose of 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628632
,BAO_0000218,,In vivo,526,,,,,1,9574,,Half life after oral dosing in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628633
,BAO_0000218,,In vivo,16365,,,,,1,9575,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628634
,BAO_0000218,,In vivo,4368,,,,,1,9576,,Half life by intravenous administration of 3.4 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627789
,BAO_0000218,,,3371,,,,,1,9577,,Half life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627790
,BAO_0000218,,,6448,,,,,1,9578,,Half life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627791
,BAO_0000218,,,6453,,,,,1,9579,,Half life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627792
,BAO_0000218,,In vivo,4353,,,,,1,9580,,Half life in rat after intravenous administration of the compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627793
,BAO_0000218,,In vivo,4353,,1969.0,,,1,9581,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627794
,BAO_0000218,,In vivo,4353,,,,,1,9582,,Half life in rat after po administration of the compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627795
,BAO_0000218,,In vivo,4353,,,,,1,9583,,Half life in rat after po administration of the compound; ND means Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627796
,BAO_0000218,,In vivo,4353,,1969.0,,,1,9584,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL875335
,BAO_0000218,,In vivo,4353,,1969.0,,,1,9585,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627797
,BAO_0000218,,In vivo,5789,,,,,1,9586,,Half life in rat i.v.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627798
,BAO_0000218,,In vivo,17686,,,,,1,9587,,Half life in rat i.v. at 2 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627799
,BAO_0000218,,,6495,,,,,1,9588,,Half life in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627800
,BAO_0000218,,In vivo,484,,,,,1,9589,,Half life in rats after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627801
,BAO_0000218,,In vivo,6467,,,,,1,9590,,Half life in rats at the dose of 1.0 mpk by i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627802
,BAO_0000218,,,6642,,,,,1,9591,,Half life in rat,Expert,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627803
,BAO_0000218,,In vivo,16367,,,,,1,9592,,Half life was evaluated after intravenous administration to rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL873820
,BAO_0000218,,,1369,,,,,1,9593,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627804
,BAO_0000218,,,5472,,,,,1,9594,,Half life was evaluated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627805
,BAO_0000218,,,6049,,,,,1,9595,,Half life was evaluated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627806
,BAO_0000218,,,5472,,,,,1,9596,,Half life was evaluated in rat; Not tested,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627107
,BAO_0000218,,In vivo,16366,,,,,1,9597,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627108
,BAO_0000218,,In vivo,11149,,,,,1,9598,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627109
,BAO_0000218,,In vivo,11149,,178.0,,,1,9599,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627110
,BAO_0000218,,In vivo,2891,,,,,0,9600,,Half life was measured in monkey at dose of 10 mg/kg by po administration,Intermediate,Primates,1,9443.0,,,22224,A,U,CHEMBL627111
,BAO_0000218,,In vivo,2891,,,,,0,9601,,Half life was measured in monkey at dose of 10 mg/kg by po administration,Intermediate,Primates,1,9443.0,,,22224,A,U,CHEMBL627112
,BAO_0000218,,In vivo,2891,,,,,0,9602,,Half life was measured in rat at dose of 30 mg/kg by iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL627113
,BAO_0000218,,In vivo,2891,,,,,0,9603,,Half life was measured in rat at dose of 30 mg/kg by po administration,Intermediate,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL627114
,BAO_0000218,,,4026,,,,,1,9604,,Half life (t1/2) was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627115
,BAO_0000218,,,4527,,,,,1,9605,,Half life period at a dose of 10 uM/kg in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627116
,BAO_0000218,,In vivo,4527,,,,,1,9606,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627117
,BAO_0000218,,,5503,,,,,1,9607,,Half life period was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627118
,BAO_0000218,,In vivo,4426,,,,,1,9608,,Half life period after intravenous administration at 20 mpk in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627119
,BAO_0000218,,In vivo,4426,,,,,1,9609,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627120
,BAO_0000218,,In vivo,6109,,,,,1,9610,,Half life period after intravenous administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626922
,BAO_0000218,,In vivo,5654,,,,,1,9611,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626923
,BAO_0000218,,In vivo,5654,,,,,1,9612,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626924
,BAO_0000218,,,4755,,1969.0,,,1,9613,,Half life period in 80% rat plasma at 37 degree Centigrade,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626925
,BAO_0000218,,,5862,,,,,1,9614,,Half life period in SD rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626926
,BAO_0000218,,,1515,,1969.0,,,1,9615,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626927
,BAO_0000218,,,1515,,1969.0,,,1,9616,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626928
,BAO_0000218,,,1515,,1969.0,,,1,9617,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626929
,BAO_0000218,,,1515,,1969.0,,,1,9618,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626930
,BAO_0000218,,,5960,,,,,1,9619,,Half life period in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626931
,BAO_0000218,,,6103,,,,,1,9620,,Half life period in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626932
,BAO_0000218,,,6317,,,,,1,9621,,Half life period in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626933
,BAO_0000218,,In vivo,6644,,,,,1,9622,,Half life period in rat after oral administration at 10.5 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL873826
,BAO_0000218,,In vivo,6644,,,,,1,9623,,Half life period in rat after oral administration at 11.2 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626934
,BAO_0000218,,In vivo,6644,,,,,1,9624,,Half life period in rat after oral administration at 13 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626935
,BAO_0000218,,In vivo,6644,,,,,1,9625,,Half life period in rat after oral administration at 9.7 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626936
,BAO_0000218,,,5974,,,,,1,9626,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626937
,BAO_0000218,,,6295,,,,,1,9627,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625906
,BAO_0000218,,,6296,,,,,1,9628,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625907
,BAO_0000218,,,16427,,,,,1,9629,,PK study was carried to determine AUC (area under curve) value in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625908
,BAO_0000218,,,16367,,,,,1,9630,,Pharmacokinetic parameter AUC after intravenous administration to rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625909
,BAO_0000218,,,16367,,,,,1,9631,,Pharmacokinetic parameter AUC after oral administration to rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625910
,BAO_0000218,,,16365,,,,,1,9632,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625911
,BAO_0000218,,,16365,,,,,1,9633,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625912
,BAO_0000218,,,16365,,,,,1,9634,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626538
,BAO_0000218,,,16365,,,,,1,9635,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876794
,BAO_0000218,,,16365,,,,,1,9636,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626539
,BAO_0000218,,,16365,,,,,1,9637,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626540
,BAO_0000218,,,5394,,,,,1,9638,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626541
,BAO_0000218,,,5394,,,,,1,9639,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626542
,BAO_0000218,,,2792,,,,,1,9640,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626543
,BAO_0000218,,,2792,,,,,1,9641,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626544
,BAO_0000218,,,2792,,,,,1,9642,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626545
,BAO_0000218,,,2792,,,,,1,9643,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626546
,BAO_0000218,,,5334,,,,,1,9644,,Pharmacokinetic parameter area under curve was reported,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626547
,BAO_0000218,,,4408,,,,,1,9645,,Pharmacokinetic property (AUC) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626548
,BAO_0000218,,,5983,,,,,1,9646,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626549
,BAO_0000218,,,4397,,,,,1,9647,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626550
,BAO_0000218,,,4397,,,,,1,9648,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626551
,BAO_0000218,,,5491,,,,,1,9649,,Pharmacokinetic property was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623777
,BAO_0000218,,,5491,,,,,1,9650,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623778
,BAO_0000218,,,5491,,,,,1,9651,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623779
,BAO_0000218,,,4199,,1969.0,,,1,9652,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623780
,BAO_0000218,,,4199,,1969.0,,,1,9653,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622015
,BAO_0000218,,,4199,,1969.0,,,1,9654,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622016
,BAO_0000218,,,5173,,,,,1,9655,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622017
,BAO_0000218,,,5173,,,,,1,9656,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622018
,BAO_0000218,,,5173,,,,,1,9657,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622019
,BAO_0000218,,,5173,,,,,1,9658,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622020
,BAO_0000218,,,16366,,,,,1,9659,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622021
,BAO_0000218,,,16366,,,,,1,9660,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622022
,BAO_0000218,,,5327,,,,,1,9661,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622023
,BAO_0000218,,,6681,,,,,1,9662,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622024
,BAO_0000218,,,12873,,,,,1,9663,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622693
,BAO_0000218,,,12873,,,,,1,9664,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622694
,BAO_0000218,,,6685,,,,,1,9665,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622695
,BAO_0000218,,,6685,,,,,1,9666,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622696
,BAO_0000218,,,6685,,,,,1,9667,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622697
,BAO_0000218,,,6619,,,,,1,9668,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622874
,BAO_0000218,,,6619,,,,,1,9669,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622875
,BAO_0000218,,,10363,,,,,1,9670,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622876
,BAO_0000218,,,4796,,,,,1,9671,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622877
,BAO_0000218,,,4910,,,,,1,9672,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622878
,BAO_0000218,,,4910,,1969.0,,,1,9673,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622879
,BAO_0000218,,,4839,,,,,1,9674,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877602
,BAO_0000218,,,15078,,,,,1,9675,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622880
,BAO_0000218,,,15078,,,,,1,9676,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622881
,BAO_0000218,,,15078,,,,,1,9677,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622882
,BAO_0000218,,,15078,,,,,1,9678,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622883
,BAO_0000218,,,11450,,2046.0,,,1,9679,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622884
,BAO_0000218,,,11450,,2046.0,,,1,9680,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622885
,BAO_0000218,,,8151,,,,,1,9681,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622886
,BAO_0000218,,,8151,,,,,1,9682,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622887
,BAO_0000218,,,8151,,1088.0,,,1,9683,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL622888
,BAO_0000218,,In vivo,8677,,178.0,,,1,9684,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622889
,BAO_0000218,,In vivo,8677,,178.0,,,1,9685,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622890
,BAO_0000218,,In vivo,8677,,178.0,,,1,9686,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622891
,BAO_0000218,,In vivo,8677,,178.0,,,1,9687,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL877603
,BAO_0000218,,In vivo,8677,,955.0,,,1,9688,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622892
,BAO_0000218,,In vivo,8677,,955.0,,,1,9689,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622893
,BAO_0000218,,In vivo,8677,,955.0,,,1,9690,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622894
,BAO_0000218,,In vivo,8677,,955.0,,,1,9691,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622895
,BAO_0000218,,In vivo,8677,,955.0,,,1,9692,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622896
,BAO_0000218,,In vivo,8677,,948.0,,,1,9693,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL622897
,BAO_0000218,,In vivo,8677,,948.0,,,1,9694,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL622898
,BAO_0000218,,In vivo,8677,,948.0,,,1,9695,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL622899
,BAO_0000218,,In vivo,8677,,2113.0,,,1,9696,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL622900
,BAO_0000218,,In vivo,8677,,2113.0,,,1,9697,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624114
,BAO_0000218,,In vivo,8677,,2113.0,,,1,9698,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624115
,BAO_0000218,,In vivo,8677,,2113.0,,,1,9699,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624116
,BAO_0000218,,In vivo,8677,,2107.0,,,1,9700,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624117
,BAO_0000218,,In vivo,8677,,2107.0,,,1,9701,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624118
,BAO_0000218,,In vivo,8677,,2107.0,,,1,9702,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624119
,BAO_0000218,,In vivo,8677,,2107.0,,,1,9703,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624120
,BAO_0000218,,In vivo,8677,,2048.0,,,1,9704,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624121
,BAO_0000218,,In vivo,8677,,2048.0,,,1,9705,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624122
,BAO_0000218,,In vivo,8677,,2048.0,,,1,9706,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624123
,BAO_0000218,,In vivo,8677,,2048.0,,,1,9707,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624124
,BAO_0000218,,In vivo,8677,,2385.0,,,1,9708,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624125
,BAO_0000218,,In vivo,8677,,2385.0,,,1,9709,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624126
,BAO_0000218,,In vivo,8677,,2385.0,,,1,9710,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624127
,BAO_0000218,,In vivo,8677,,2385.0,,,1,9711,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624128
,BAO_0000218,,In vivo,8677,,14.0,,,1,9712,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL624129
,BAO_0000218,,In vivo,8677,,14.0,,,1,9713,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL624130
,BAO_0000218,,In vivo,8677,,14.0,,,1,9714,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL622340
,BAO_0000218,,In vivo,8677,,14.0,,,1,9715,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL622341
,BAO_0000218,,In vivo,8677,,160.0,,,1,9716,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL622342
,BAO_0000218,,In vivo,8677,,160.0,,,1,9717,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL622343
,BAO_0000218,,In vivo,8677,,160.0,,,1,9718,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL622344
,BAO_0000218,,In vivo,8677,,160.0,,,1,9719,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL622345
,BAO_0000218,,In vivo,8677,,2106.0,,,1,9720,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL622346
,BAO_0000218,,In vivo,8677,,2106.0,,,1,9721,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL622347
,BAO_0000218,,In vivo,8677,,2106.0,,,1,9722,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL622348
,BAO_0000218,,In vivo,8677,,2106.0,,,1,9723,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL622349
,BAO_0000218,,,16434,,,,,1,9724,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622350
,BAO_0000218,,,16434,,,,,1,9725,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622351
,BAO_0000218,,,16434,,,,,1,9726,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622352
,BAO_0000218,,,16435,,,,,1,9727,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622353
,BAO_0000218,,,16435,,,,,1,9728,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622354
,BAO_0000218,,,16435,,,,,1,9729,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622355
,BAO_0000218,,,16435,,,,,1,9730,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622356
,BAO_0000218,,,16435,,,,,1,9731,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622357
,BAO_0000218,,,16435,,,,,1,9732,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622358
,BAO_0000218,,,16435,,,,,1,9733,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622359
,BAO_0000218,,,16435,,,,,1,9734,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874393
,BAO_0000218,,,16434,,,,,1,9735,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622872
,BAO_0000218,,,16434,,,,,1,9736,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622873
,BAO_0000218,,,16434,,,,,1,9737,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623047
,BAO_0000218,,,16435,,,,,1,9738,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623048
,BAO_0000218,,,16435,,,,,1,9739,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623049
,BAO_0000218,,,16435,,,,,1,9740,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623050
,BAO_0000218,,,16435,,,,,1,9741,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623051
,BAO_0000218,,,16435,,,,,1,9742,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623052
,BAO_0000218,,,16435,,,,,1,9743,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626343
,BAO_0000218,,,16434,,,,,1,9744,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626344
,BAO_0000218,,,16434,,,,,1,9745,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626345
,BAO_0000218,,,16434,,,,,1,9746,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626346
,BAO_0000218,,,16434,,,,,1,9747,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626347
,BAO_0000218,,,16434,,,,,1,9748,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626348
,BAO_0000218,,,16434,,,,,1,9749,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626349
,BAO_0000218,,,16435,,,,,1,9750,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL626350
,BAO_0000218,,,16435,,,,,1,9751,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626351
,BAO_0000218,,,16435,,,,,1,9752,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627650
,BAO_0000218,,,16435,,,,,1,9753,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL627651
,BAO_0000218,,,16435,,,,,1,9754,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627652
,BAO_0000218,,,16435,,,,,1,9755,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627653
,BAO_0000218,,,13091,,,,,1,9756,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627654
,BAO_0000218,,,13091,,,,,1,9757,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627835
,BAO_0000218,,,13091,,,,,1,9758,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627836
,BAO_0000218,,,13091,,,,,1,9759,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627837
,BAO_0000218,,,13091,,,,,1,9760,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627838
,BAO_0000218,,,13091,,,,,1,9761,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875338
,BAO_0000218,,,13091,,,,,1,9762,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627839
,BAO_0000218,,,13091,,,,,1,9763,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627840
,BAO_0000218,,,13091,,,,,1,9764,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627841
,BAO_0000218,,,13091,,,,,1,9765,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627842
,BAO_0000218,,,13091,,,,,1,9766,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627843
,BAO_0000218,,,13091,,,,,1,9767,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627844
,BAO_0000218,,,13091,,,,,1,9768,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627845
,BAO_0000218,,In vivo,5874,,,,,1,9769,,Half life period in rat by iv administration at a dose of 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627846
,BAO_0000218,,,1515,,1969.0,,,1,9770,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627847
,BAO_0000218,,,1515,,1969.0,,,1,9771,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL873821
,BAO_0000218,,,1515,,1969.0,,,1,9772,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626079
,BAO_0000218,,,1515,,1969.0,,,1,9773,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626080
,BAO_0000218,,,5491,,1969.0,,,1,9774,,Half life period was evaluated in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626081
,BAO_0000218,,,5491,,1969.0,,,1,9775,,Half life period was evaluated in rat plasma; Not tested,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL875344
,BAO_0000218,,,1918,,,,,1,9776,,Half life period was evaluated in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626082
,BAO_0000218,,In vivo,1918,,,,,1,9777,,"Half life period was evaluated in rats, iv",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626250
,BAO_0000218,,In vivo,6113,,,,,1,9778,,Half life period after intravenous administration at 5 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626251
,BAO_0000218,,In vivo,5546,,,,,1,9779,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626252
,BAO_0000218,,In vivo,5553,,,,,1,9780,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626253
,BAO_0000218,,,4188,,1969.0,,,1,9781,,Half life stability of compound was evaluated in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626254
,BAO_0000218,,In vivo,6215,,,,,1,9782,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626255
,BAO_0000218,,In vivo,6141,,,,,1,9783,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626256
,BAO_0000218,,In vivo,5182,,,,,1,9784,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626257
,BAO_0000218,,In vivo,5182,,,,,1,9785,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626258
,BAO_0000218,,In vivo,5710,,,,,1,9786,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626259
,BAO_0000218,,In vivo,5789,,,,,1,9787,,Half in rat i.v.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626260
,BAO_0000218,,In vivo,6011,,,,,1,9788,,Half period in rat after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875345
,BAO_0000218,,In vivo,17594,,,,,1,9789,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626261
,BAO_0000218,,In vitro,12357,,2107.0,,,1,9790,,Half-life measured in in vitro Cathepsin B assay in rat liver,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626262
,BAO_0000218,,,5210,,,,,1,9791,,Half-life of compound was determined in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626263
,BAO_0000218,,In vivo,17596,,,,,1,9792,,Half-life at 10 mg/kg in rat upon intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625270
,BAO_0000218,,,6672,,,,,1,9793,,Half-life determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625271
,BAO_0000218,,,6673,,,,,1,9794,,Half-life determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625272
,BAO_0000218,,In vivo,4910,,955.0,,,1,9795,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625273
,BAO_0000218,,,3741,,1969.0,,,1,9796,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625274
,BAO_0000218,,In vivo,17671,,,,,1,9797,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625275
,BAO_0000218,,In vivo,4910,,1969.0,,,1,9798,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625276
,BAO_0000218,,,17537,,1969.0,,,1,9799,,Half-life in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625277
,BAO_0000218,,,4965,,1969.0,,,1,9800,,Half-life in rat plasma was determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625278
,BAO_0000218,,,17537,,1969.0,,,1,9801,,Half-life in rat plasma; Not tested,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625279
,BAO_0000218,,,6124,,1977.0,,,1,9802,,Half-life in rat serum,Intermediate,Rattus norvegicus,1,10116.0,,Serum,50597,A,N,CHEMBL625280
,BAO_0000218,,,6124,,1977.0,,,1,9803,,Half-life in rat serum; na is not available,Intermediate,Rattus norvegicus,1,10116.0,,Serum,50597,A,N,CHEMBL876797
,BAO_0000218,,,6078,,,,,1,9804,,Half-life was calculated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625281
,BAO_0000218,,,17668,,1969.0,,,1,9805,,Half-life was calculated in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL873827
,BAO_0000218,,,3185,,,,,1,9806,,Half-life was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625282
,BAO_0000218,,,4883,,,,,1,9807,,Half-life was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625283
,BAO_0000218,,In vivo,2959,,,,,1,9808,,Half-life after administration of 20 mg/Kg oral dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625284
,BAO_0000218,,In vivo,4029,,,,,1,9809,,Half-life after administration of 3.2 mg/kg intravenously in male rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625285
,BAO_0000218,,In vivo,4029,,,,,1,9810,,Half-life after intravenous administration in female rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625286
,BAO_0000218,,In vivo,4029,,,,,1,9811,,Half-life after intravenous administration in male rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625287
,BAO_0000218,,In vivo,6180,,,,,1,9812,,Half-life after intravenous dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625288
,BAO_0000218,,,1557,,2107.0,,,1,9813,,Half-life in a rat liver homogenate preparation,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625289
,BAO_0000218,,,12500,,1969.0,,,1,9814,,Half-life in plasma of rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625290
,BAO_0000218,,,12500,,1969.0,,,1,9815,,Half-life in plasma of rat at dose of 3-10 mgkg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL876798
,BAO_0000218,,,5064,,,,,1,9816,,Half-life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625291
,BAO_0000218,,,5145,,,,,1,9817,,Half-life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625292
,BAO_0000218,,,5147,,,,,1,9818,,Half-life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625293
,BAO_0000218,,,5833,,,,,1,9819,,Half-life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622832
,BAO_0000218,,,6596,,,,,1,9820,,Half-life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622833
,BAO_0000218,,,17655,,,,,1,9821,,Half-life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622834
,BAO_0000218,,In vivo,6495,,,,,1,9822,,Half-life in rat after oral administration at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622835
,BAO_0000218,,In vivo,17538,,,,,1,9823,,Half-life in rat after po administration at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622836
,BAO_0000218,,In vivo,17538,,,,,1,9824,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622837
,BAO_0000218,,In vivo,10,,,,,1,9825,,Half-life in rat at 3 mg/kg dose administered intravenously,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622838
,BAO_0000218,,,17669,,955.0,,,1,9826,,Half-life in rat brain homogenate,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622839
,BAO_0000218,,,17065,,1969.0,,,1,9827,,Half-life in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622840
,BAO_0000218,,,4333,,,,,1,9828,,Half-life in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622841
,BAO_0000218,,,6827,,,,,1,9829,,Half-life in Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622842
,BAO_0000218,,In vitro,889,,1969.0,,,1,9830,,Half-life in vitro in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622843
,BAO_0000218,,In vitro,889,,1969.0,,,1,9831,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622844
,BAO_0000218,,,3747,,,,,1,9832,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622845
,BAO_0000218,,,15022,,,,,1,9833,,The area under the curve of compound was measured at the dose of 100 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622846
,BAO_0000218,,,15022,,,,,1,9834,,The area under the curve of compound was measured at the dose of 300 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622847
,BAO_0000218,,,15022,,,,,1,9835,,The area under the curve of compound was measured at the dose of 30 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622848
,BAO_0000218,,In vivo,3360,,,,,1,9836,,Bioavailability as oral AUC in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622849
,BAO_0000218,,,5334,,1969.0,,,1,9837,,The plasma concentration versus time curve (AUC) was determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622850
,BAO_0000218,,,17411,,,,,1,9838,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876807
,BAO_0000218,,,17411,,,,,1,9839,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622851
,BAO_0000218,,,17411,,,,,1,9840,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622852
,BAO_0000218,,,6570,,,,,1,9841,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622853
,BAO_0000218,,,6570,,,,,1,9842,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622854
,BAO_0000218,,,17411,,,,,1,9843,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622855
,BAO_0000218,,,14941,,1969.0,,,1,9844,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622856
,BAO_0000218,,,14941,,1969.0,,,1,9845,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622857
,BAO_0000218,,,17538,,1969.0,,,1,9846,,AUC in rat after po administration at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622858
,BAO_0000218,,,17752,,1969.0,,,1,9847,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622859
,BAO_0000218,,,17509,,,,,1,9848,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622860
,BAO_0000218,,,17509,,,,,1,9849,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622861
,BAO_0000218,,,17509,,,,,1,9850,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622862
,BAO_0000218,,,17509,,,,,1,9851,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622863
,BAO_0000218,,,17509,,,,,1,9852,,Area under curve value 6 hr after po administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623817
,BAO_0000218,,,17717,,,,,1,9853,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623818
,BAO_0000218,,,17717,,,,,1,9854,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623819
,BAO_0000218,,,17717,,,,,1,9855,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623820
,BAO_0000218,,,17717,,,,,1,9856,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623821
,BAO_0000218,,,6642,,1969.0,,,1,9857,,AUC normalized for dose (AUCN) in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623822
,BAO_0000218,,,6640,,,,,1,9858,,Area under curve in rat after p.o. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623823
,BAO_0000218,,,6641,,,,,1,9859,,Area under curve in rat after p.o. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623824
,BAO_0000218,,,6641,,,,,1,9860,,Area under curve in rat after p.o. administration; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623825
,BAO_0000218,,,6641,,,,,1,9861,,Area under curve in rat after peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622070
,BAO_0000218,,,3603,,,,,1,9862,,Area under curve (carotid artery) value of the compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622071
,BAO_0000218,,,3550,,,,,1,9863,,Bioavailability expressed as the area under curve of rat carotid artery,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622072
,BAO_0000218,,,15662,,,,,1,9864,,Area under curve in male SD rats was observed after intravenous administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622073
,BAO_0000218,,,17720,,,,,1,9865,,Area under curve of the compound was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622074
,BAO_0000218,,,5407,,,,,1,9866,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622075
,BAO_0000218,,,17752,,1969.0,,,1,9867,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622076
,BAO_0000218,,,17752,,1969.0,,,1,9868,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622077
,BAO_0000218,,,3603,,,,,1,9869,,Area under curve (portal vein) value of the compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622078
,BAO_0000218,,,3550,,,,,1,9870,,Bioavailability expressed as the area under curve of rat portal vein,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622079
,BAO_0000218,,,17655,,1969.0,,,1,9871,,Area Under plasma concentration time curve in rat upon peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622080
,BAO_0000218,,,17582,,,,,1,9872,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877612
,BAO_0000218,,,17582,,,,,1,9873,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622081
,BAO_0000218,,,17791,,,,,1,9874,,Compound was evaluated for oral bioavailability in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622082
,BAO_0000218,,,17791,,,,,1,9875,,Compound was evaluated for oral bioavailability in rats after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622083
,BAO_0000218,,,17791,,,,,1,9876,,Compound was evaluated for oral bioavailability in rats; 30-80,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622084
,BAO_0000218,,,17791,,,,,1,9877,,Compound was evaluated for oral bioavailability in rats; 50-60,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622085
,BAO_0000218,,,17791,,,,,1,9878,,Compound was evaluated for oral bioavailability in rats; no data,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622086
,BAO_0000218,,,17791,,,,,1,9879,,Compound was evaluated for oral bioavailability in rats; peptide,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622087
,BAO_0000218,,,7768,,178.0,,,1,9880,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622088
,BAO_0000218,,,7768,,178.0,,,1,9881,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622089
,BAO_0000218,,,7768,,178.0,,,1,9882,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL623685
,BAO_0000218,,,7768,,178.0,,,1,9883,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL623686
,BAO_0000218,,In vivo,8677,,945.0,,,1,9884,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL623687
,BAO_0000218,,In vivo,8677,,945.0,,,1,9885,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL623688
,BAO_0000218,,In vivo,8677,,945.0,,,1,9886,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL623689
,BAO_0000218,,In vivo,8677,,945.0,,,1,9887,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Stomach,50597,A,N,CHEMBL622485
,BAO_0000218,,In vivo,8677,,2046.0,,,1,9888,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622486
,BAO_0000218,,In vivo,8677,,2046.0,,,1,9889,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL877613
,BAO_0000218,,In vivo,8677,,2046.0,,,1,9890,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622487
,BAO_0000218,,In vivo,8677,,2046.0,,,1,9891,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622488
,BAO_0000218,,In vivo,8677,,948.0,,,1,9892,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL622489
,BAO_0000218,,,6899,,1088.0,,,1,9893,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL622490
,BAO_0000218,,,6899,,1088.0,,,1,9894,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL622491
,BAO_0000218,,,6899,,2107.0,,,1,9895,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622492
,BAO_0000218,,,6899,,1088.0,,,1,9896,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL622493
,BAO_0000218,,,6899,,1088.0,,,1,9897,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL622494
,BAO_0000218,,,8677,,2385.0,,,1,9898,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL622495
,BAO_0000218,,,6899,,,,,1,9899,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622496
,BAO_0000218,,,6899,,1088.0,,,1,9900,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL622497
,BAO_0000218,,,2189,,,,,1,9901,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622498
,BAO_0000218,,,2189,,1088.0,,,1,9902,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL624918
,BAO_0000218,,,2189,,1088.0,,,1,9903,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL624919
,BAO_0000218,,In vivo,10839,,178.0,,,1,9904,,Biodistribution of compound in rat blood after 5 min of administration,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624920
,BAO_0000218,,In vivo,10839,,178.0,,,1,9905,,Biodistribution of compound in rat blood after 5 min of administration.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624921
,BAO_0000218,,In vivo,10839,,955.0,,,1,9906,,Biodistribution of compound in rat brain after 5 min of administration,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL624922
,BAO_0000218,,In vivo,10839,,948.0,,,1,9907,,Biodistribution of compound in rat heart after 5 min of administration,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624923
,BAO_0000218,,In vivo,10839,,948.0,,,1,9908,,Biodistribution of compound in rat heart after 5 min of administration.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624924
,BAO_0000218,,In vivo,10839,,2113.0,,,1,9909,,Biodistribution of compound in rat kidney after 5 min of administration,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624925
,BAO_0000218,,In vivo,10839,,2113.0,,,1,9910,,Biodistribution of compound in rat kidney after 5 min of administration.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624926
,BAO_0000218,,In vivo,10839,,2107.0,,,1,9911,,Biodistribution of compound in rat liver after 5 min of administration,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624927
,BAO_0000218,,In vivo,10839,,2107.0,,,1,9912,,Biodistribution of compound in rat liver after 5 min of administration.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL874402
,BAO_0000218,,In vivo,10839,,2048.0,,,1,9913,,Biodistribution of compound in rat lung after 5 min of administration,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624928
,BAO_0000218,,In vivo,10839,,2048.0,,,1,9914,,Biodistribution of compound in rat lung after 5 min of administration.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624929
,BAO_0000218,,In vivo,10839,,2385.0,,,1,9915,,Biodistribution of compound in rat muscle after 5 min of administration,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624930
,BAO_0000218,,In vivo,10839,,2385.0,,,1,9916,,Biodistribution of compound in rat muscle after 5 min of administration.,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624931
,BAO_0000218,,,4043,,948.0,,,1,9917,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624932
,BAO_0000218,,,4043,,948.0,,,1,9918,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624933
,BAO_0000218,,,4043,,2107.0,,,1,9919,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624934
,BAO_0000218,,,4043,,2107.0,,,1,9920,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624935
,BAO_0000218,,,4043,,,,,1,9921,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624936
,BAO_0000218,,,4043,,,,,1,9922,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624937
,BAO_0000218,,,4043,,2106.0,,,1,9923,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL624938
,BAO_0000218,,,4043,,2106.0,,,1,9924,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL624939
,BAO_0000218,,,4043,,,,,1,9925,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624940
,BAO_0000218,,,4043,,,,,1,9926,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874403
,BAO_0000218,,,1446,,,,,1,9927,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624941
,BAO_0000218,,,9971,,1088.0,,,1,9928,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL624942
,BAO_0000218,,,9971,,1088.0,,,1,9929,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL624943
,BAO_0000218,,In vivo,5765,,,,,1,9930,,% Bioavailability after 1 day of the drug administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624944
,BAO_0000218,,In vivo,5765,,,,,1,9931,,% Bioavailability after 4 day of the drug administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624945
,BAO_0000218,,In vivo,4257,,,,,1,9932,,Absolute bioavailability was evaluated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624946
,BAO_0000218,,,13091,,,,,1,9933,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624947
,BAO_0000218,,,13091,,,,,1,9934,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624948
,BAO_0000218,,,13091,,,,,1,9935,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624949
,BAO_0000218,,,13091,,2113.0,,,1,9936,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL622025
,BAO_0000218,,,13091,,2113.0,,,1,9937,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL622026
,BAO_0000218,,,13091,,2113.0,,,1,9938,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL622027
,BAO_0000218,,,13091,,2113.0,,,1,9939,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL622028
,BAO_0000218,,,13091,,2107.0,,,1,9940,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622029
,BAO_0000218,,,13091,,2107.0,,,1,9941,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622208
,BAO_0000218,,,13091,,2107.0,,,1,9942,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622209
,BAO_0000218,,,13091,,2107.0,,,1,9943,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622210
,BAO_0000218,,,13091,,,,,1,9944,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622211
,BAO_0000218,,,13091,,,,,1,9945,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622212
,BAO_0000218,,,13091,,,,,1,9946,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622213
,BAO_0000218,,,13091,,,,,1,9947,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874404
,BAO_0000218,,,13091,,2385.0,,,1,9948,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620452
,BAO_0000218,,,13091,,2385.0,,,1,9949,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620453
,BAO_0000218,,,13091,,2385.0,,,1,9950,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL620454
,BAO_0000218,,,13091,,2385.0,,,1,9951,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624067
,BAO_0000218,,,13091,,,,,1,9952,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624068
,BAO_0000218,,,13091,,992.0,,,1,9953,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,Intermediate,Rattus norvegicus,1,10116.0,,Female gonad,50597,A,N,CHEMBL624069
,BAO_0000218,,,13091,,992.0,,,1,9954,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,Female gonad,50597,A,N,CHEMBL624070
,BAO_0000218,,,13091,,992.0,,,1,9955,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,Female gonad,50597,A,N,CHEMBL624071
,BAO_0000218,,,13091,,995.0,,,1,9956,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL624072
,BAO_0000218,,,13091,,995.0,,,1,9957,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL624073
,BAO_0000218,,,13091,,995.0,,,1,9958,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL624788
,BAO_0000218,,,13091,,995.0,,,1,9959,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL624789
,BAO_0000218,,,13091,,,,,1,9960,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624790
,BAO_0000218,,,13091,,,,,1,9961,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624791
,BAO_0000218,,,13091,,,,,1,9962,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624792
,BAO_0000218,,,13091,,,,,1,9963,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624793
,BAO_0000218,,,13091,,2385.0,,,1,9964,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL877491
,BAO_0000218,,,13091,,2385.0,,,1,9965,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624957
,BAO_0000218,,,13091,,2385.0,,,1,9966,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624958
,BAO_0000218,,,13091,,2385.0,,,1,9967,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624959
,BAO_0000218,,,11977,,,,,1,9968,,Dissociation constant was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624960
,BAO_0000218,,,14941,,,,,1,9969,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624961
,BAO_0000218,,,15078,,,,,1,9970,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624962
,BAO_0000218,,,15078,,,,,1,9971,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624963
,BAO_0000218,,,4755,,,,,1,9972,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624964
,BAO_0000218,,,589,,,,,1,9973,,LogP value was evaluated in the in situ rat gut perfusion assay,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624965
,BAO_0000218,,In vivo,17582,,,,,1,9974,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624966
,BAO_0000218,,In vivo,5031,,,,,1,9975,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624967
,BAO_0000218,,In vivo,17764,,,,,1,9976,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624968
,BAO_0000218,,,17720,,,,,1,9977,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624969
,BAO_0000218,,,2862,,,,,1,9978,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,Expert,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL624970
,BAO_0000218,,,16423,,,,,1,9979,,Half-life was evaluated after 10 uM/kg of intra arterial administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624971
,BAO_0000218,,In vivo,16423,,,,,1,9980,,Half-life was evaluated after 20 uM/kg of peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624972
,BAO_0000218,,In vivo,6005,,,,,1,9981,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624973
,BAO_0000218,,,2938,,1969.0,,,1,9982,,Half-life was evaluated in plasma of rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL624974
,BAO_0000218,,In vivo,6410,,,,,1,9983,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624975
,BAO_0000218,,In vivo,6410,,,,,1,9984,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877492
,BAO_0000218,,In vivo,6062,,,,,1,9985,,Half-life was measured in rat after an iv dose of 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624976
,BAO_0000218,,In vivo,6571,,,,,1,9986,,Half-life period of compound in rats after peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624977
,BAO_0000218,,,3136,,1969.0,,,1,9987,,Half-life period of compound was measured in rat plasma.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626848
,BAO_0000218,,,3136,,1969.0,,,1,9988,,Half-life period of compound was measured in rat plasma; ND is not determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626849
,BAO_0000218,,,3136,,1969.0,,,1,9989,,Half-life period of compound was measured in rat plasma; not determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626850
,BAO_0000218,,In vivo,4521,,,,,1,9990,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626851
,BAO_0000218,,In vivo,5871,,,,,1,9991,,Half-life period in rat by iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626852
,BAO_0000218,,In vivo,6077,,,,,1,9992,,Half-life period in rats following intravenous administration at 2 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626853
,BAO_0000218,,In vivo,6679,,,,,1,9993,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626854
,BAO_0000218,,,5144,,,,,1,9994,,Half-life period was determined for the compound in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627486
,BAO_0000218,,In vivo,4498,,,,,1,9995,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627487
,BAO_0000218,,In vivo,4498,,,,,1,9996,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627488
,BAO_0000218,,In vivo,1908,,,,,1,9997,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627489
,BAO_0000218,,In vivo,6211,,,,,1,9998,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627490
,BAO_0000218,,In vivo,5529,,,,,1,9999,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL873829
,BAO_0000218,,In vivo,6444,,,,,1,10000,,Half-life was determined in rat at a dose of 1 mpk i.v.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627655
,BAO_0000218,,In vivo,6444,,,,,1,10001,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625994
,BAO_0000218,,In vivo,6444,,,,,1,10002,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625995
,BAO_0000218,,,5207,,,,,1,10003,,Half-life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625996
,BAO_0000218,,In vitro,530,,1969.0,,,1,10004,,In vitro half life in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625850
,BAO_0000218,,In vitro,1116,,1969.0,,,1,10005,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625851
,BAO_0000218,,In vitro,3219,,,,,1,10006,,In vitro half life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625852
,BAO_0000218,,In vivo,6109,,,,,1,10007,,In vivo half life period after intravenous administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625853
,BAO_0000218,,In vivo,17582,,,,,1,10008,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625854
,BAO_0000218,,In vivo,17582,,,,,1,10009,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874450
,BAO_0000218,,In vivo,5974,,,,,1,10010,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625855
,BAO_0000218,,In vivo,5974,,,,,1,10011,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625856
,BAO_0000218,,In vivo,5974,,,,,1,10012,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625857
,BAO_0000218,,In vivo,5974,,,,,1,10013,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL873831
,BAO_0000218,,In vivo,17853,,,,,1,10014,,Longer half-life in rat (i.v.) at 0.5 mpk,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625858
,BAO_0000218,,In vivo,17853,,,,,1,10015,,Longer half-life in rat (p.o.) at 2.0 mpk,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625859
,BAO_0000218,,,3457,,,,,1,10016,,Pharmacokinetic property (half life) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625860
,BAO_0000218,,In vivo,2792,,,,,1,10017,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625861
,BAO_0000218,,In vivo,2792,,,,,1,10018,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625862
,BAO_0000218,,In vivo,2792,,,,,1,10019,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625863
,BAO_0000218,,In vivo,2792,,,,,1,10020,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625864
,BAO_0000218,,In vivo,5739,,,,,1,10021,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625865
,BAO_0000218,,In vivo,15765,,,,,1,10022,,Pharmacokinetic half time was determined intravenously in rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625866
,BAO_0000218,,In vivo,6567,,1969.0,,,1,10023,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625867
,BAO_0000218,,,2448,,1969.0,,,1,10024,,Plasma half life of hydrolysis of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625868
,BAO_0000218,,In vivo,5423,,1969.0,,,1,10025,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625869
,BAO_0000218,,,4853,,1969.0,,,1,10026,,Plasma half life period was calculated in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL874451
,BAO_0000218,,,4514,,1969.0,,,1,10027,,Plasma half-life in Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625870
,BAO_0000218,,,4514,,1969.0,,,1,10028,,Plasma half-life in Sprague-Dawley rats; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625871
,BAO_0000218,,,1500,,1969.0,,,1,10029,,Plasma half-life in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625872
,BAO_0000218,,,1500,,1969.0,,,1,10030,,Plasma half-life in rats; <MQL,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625873
,BAO_0000218,,,5334,,1969.0,,,1,10031,,Plasma half-life period (0-8 h) was determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625874
,BAO_0000218,,,5334,,1969.0,,,1,10032,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625875
,BAO_0000218,,In vivo,5334,,1969.0,,,1,10033,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625876
,BAO_0000218,,In vivo,5334,,1969.0,,,1,10034,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL631258
,BAO_0000218,,,4956,,1969.0,,,1,10035,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL631259
,BAO_0000218,,,4956,,1969.0,,,1,10036,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL631260
,BAO_0000218,,,7768,,178.0,,,1,10037,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631261
,BAO_0000218,,,7768,,178.0,,,1,10038,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631262
,BAO_0000218,,,7768,,178.0,,,1,10039,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631263
,BAO_0000218,,,7768,,,,,1,10040,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631264
,BAO_0000218,,,7768,,,,,1,10041,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631265
,BAO_0000218,,,7768,,,,,1,10042,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631266
,BAO_0000218,,,7768,,,,,1,10043,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631267
,BAO_0000218,,,7768,,,,,1,10044,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631268
,BAO_0000218,,,7768,,,,,1,10045,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631269
,BAO_0000218,,,7768,,,,,1,10046,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631270
,BAO_0000218,,,7768,,948.0,,,1,10047,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631271
,BAO_0000218,,,7768,,948.0,,,1,10048,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631272
,BAO_0000218,,,7768,,948.0,,,1,10049,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631273
,BAO_0000218,,,7768,,948.0,,,1,10050,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631274
,BAO_0000218,,,7768,,948.0,,,1,10051,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631275
,BAO_0000218,,,7768,,948.0,,,1,10052,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626984
,BAO_0000218,,,7768,,948.0,,,1,10053,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626985
,BAO_0000218,,,7768,,2107.0,,,1,10054,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626986
,BAO_0000218,,,7768,,2107.0,,,1,10055,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626987
,BAO_0000218,,,7768,,2107.0,,,1,10056,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626988
,BAO_0000218,,,7768,,2107.0,,,1,10057,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626989
,BAO_0000218,,,7768,,2107.0,,,1,10058,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626990
,BAO_0000218,,,7768,,2107.0,,,1,10059,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626991
,BAO_0000218,,,7768,,2107.0,,,1,10060,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626992
,BAO_0000218,,,7768,,2048.0,,,1,10061,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626993
,BAO_0000218,,,7768,,2048.0,,,1,10062,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL874593
,BAO_0000218,,,7768,,2048.0,,,1,10063,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626994
,BAO_0000218,,,7768,,2048.0,,,1,10064,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626995
,BAO_0000218,,,7768,,2048.0,,,1,10065,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626190
,BAO_0000218,,,7768,,2048.0,,,1,10066,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626191
,BAO_0000218,,,7768,,2048.0,,,1,10067,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626364
,BAO_0000218,,,7768,,2046.0,,,1,10068,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626365
,BAO_0000218,,,7768,,2046.0,,,1,10069,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626366
,BAO_0000218,,,7768,,2046.0,,,1,10070,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626367
,BAO_0000218,,,7768,,2046.0,,,1,10071,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626368
,BAO_0000218,,,7768,,2046.0,,,1,10072,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626369
,BAO_0000218,,,7768,,2046.0,,,1,10073,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626370
,BAO_0000218,,In vivo,4498,,,,,1,10074,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626371
,BAO_0000218,,In vivo,4498,,,,,1,10075,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626372
,BAO_0000218,,In vivo,3603,,,,,1,10076,,Bioavailability after a dose of 10 mg/kg p.o.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626373
,BAO_0000218,,In vivo,6215,,,,,1,10077,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626374
,BAO_0000218,,In vivo,5710,,,,,1,10078,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626375
,BAO_0000218,,In vivo,5710,,,,,1,10079,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626376
,BAO_0000218,,In vivo,5676,,,,,1,10080,,Bioavailability in rat po was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626377
,BAO_0000218,,In vivo,17667,,,,,1,10081,,Bioavailability of compound at 10 mg/kg in rat after oral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626378
,BAO_0000218,,In vivo,17667,,,,,1,10082,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626379
,BAO_0000218,,In vivo,6848,,,,,1,10083,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626380
,BAO_0000218,,In vivo,6848,,,,,1,10084,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626381
,BAO_0000218,,In vivo,17267,,,,,1,10085,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626382
,BAO_0000218,,In vivo,6362,,,,,1,10086,,Bioavailability in rat (Sprague-Dawley) (female),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626383
,BAO_0000218,,In vivo,17671,,,,,1,10087,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874652
,BAO_0000218,,In vivo,17671,,,,,1,10088,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626384
,BAO_0000218,,In vivo,4333,,,,,1,10089,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626385
,BAO_0000218,,In vivo,6077,,,,,1,10090,,Bioavailability in rat at an oral dose of 2 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626386
,BAO_0000218,,In vivo,3278,,,,,1,10091,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626387
,BAO_0000218,,In vivo,5964,,,,,1,10092,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626388
,BAO_0000218,,In vivo,4884,,,,,1,10093,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626389
,BAO_0000218,,In vivo,4905,,,,,1,10094,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626390
,BAO_0000218,,In vivo,4884,,,,,1,10095,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626391
,BAO_0000218,,In vivo,6850,,,,,1,10096,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626392
,BAO_0000218,,In vivo,2864,,,,,1,10097,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626393
,BAO_0000218,,In vivo,5780,,,,,1,10098,,Bioavailability was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623026
,BAO_0000218,,In vivo,1465,,,,,1,10099,,Bioavailability,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623027
,BAO_0000218,,In vivo,5199,,,,,1,10100,,Bioavailability,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623028
,BAO_0000218,,In vivo,5765,,,,,1,10101,,Bioavailability in rat after 1 day dosing,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623029
,BAO_0000218,,In vivo,5765,,,,,1,10102,,Bioavailability in rat after 4 day dosing,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623030
,BAO_0000218,,In vivo,6518,,,,,1,10103,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623031
,BAO_0000218,,In vivo,6518,,,,,1,10104,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623032
,BAO_0000218,,In vivo,6518,,,,,1,10105,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623033
,BAO_0000218,,In vivo,6518,,,,,1,10106,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623034
,BAO_0000218,,In vivo,2083,,,,,1,10107,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623035
,BAO_0000218,,In vivo,17260,,,,,1,10108,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623036
,BAO_0000218,,In vivo,4956,,,,,1,10109,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623037
,BAO_0000218,,In vivo,4368,,,,,1,10110,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623038
,BAO_0000218,,In vivo,17752,,1969.0,,,1,10111,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL874385
,BAO_0000218,,In vivo,1446,,,,,1,10112,,Bioavailability in rat (Fisher) (fasted),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623039
,BAO_0000218,,In vivo,2891,,,,,0,10113,,Bioavailability in monkey after po administration of 10 mg/kg dose,Intermediate,Primates,1,9443.0,,,22224,A,U,CHEMBL623040
,BAO_0000218,,In vivo,2891,,,,,0,10114,,Oral bioavailability in monkey (dose 10 mg/kg),Intermediate,Primates,1,9443.0,,,22224,A,U,CHEMBL623041
,BAO_0000218,,In vivo,6672,,,,,1,10115,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623741
,BAO_0000218,,In vivo,6673,,,,,1,10116,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623742
,BAO_0000218,,In vivo,17655,,,,,1,10117,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623743
,BAO_0000218,,In vivo,17796,,,,,1,10118,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623744
,BAO_0000218,,In vivo,17853,,,,,1,10119,,Bioavailability in rat (dose 2.0 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623745
,BAO_0000218,,In vivo,4521,,,,,1,10120,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623746
,BAO_0000218,,In vivo,4940,,,,,1,10121,,Oral bioavailability in rat (dose 5 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623747
,BAO_0000218,,In vivo,2891,,,,,0,10122,,Bioavailability in rat after po administration of 30 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL623748
,BAO_0000218,,In vivo,2891,,,,,0,10123,,Bioavailability in rat after po administration of 30 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL623916
,BAO_0000218,,In vivo,4521,,,,,1,10124,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623917
,BAO_0000218,,In vivo,17686,,,,,1,10125,,Bioavailability in rat (dose 2 mg/kg i.v.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623918
,BAO_0000218,,In vivo,17796,,,,,1,10126,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874386
,BAO_0000218,,In vivo,17796,,1969.0,,,1,10127,,Bioavailability in rat; Only traces detected in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623919
,BAO_0000218,,In vivo,5064,,,,,1,10128,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623920
,BAO_0000218,,In vivo,5147,,,,,1,10129,,Bioavailability upon oral administration of compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623148
,BAO_0000218,,In vivo,1916,,,,,1,10130,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623149
,BAO_0000218,,In vivo,6049,,,,,1,10131,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623150
,BAO_0000218,,In vivo,1445,,,,,1,10132,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623151
,BAO_0000218,,In vivo,1445,,,,,1,10133,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623152
,BAO_0000218,,,2862,,,,,1,10134,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,Expert,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL623153
,BAO_0000218,,,2862,,,,,1,10135,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,Expert,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL623154
,BAO_0000218,,,4194,,,,,1,10136,,In vitro and metabolic stability was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623155
,BAO_0000218,,,4194,,,,,1,10137,,In vitro metabolic stability in rat hepatocytes,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623156
,BAO_0000218,,,5486,,,,,1,10138,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623157
401.0,BAO_0000218,,In vitro,17582,,2107.0,,Hepatocyte,1,10139,,Metabolic rate for compound was observed in rat hepatocytes,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL623158
,BAO_0000218,,,5600,,,,,1,10140,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623159
,BAO_0000218,,,14294,,,,,1,10141,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874390
,BAO_0000218,,,14294,,,,,1,10142,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623160
,BAO_0000218,,,14294,,,,,1,10143,,Metabolism of compound in rat S9 microsomes; Trace,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623161
,BAO_0000218,,,17847,,,,,1,10144,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623162
,BAO_0000218,,,11020,,,,,1,10145,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623163
,BAO_0000218,,,11020,,,,,1,10146,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623164
,BAO_0000218,,,11020,,,,,1,10147,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623165
,BAO_0000218,,,11020,,,,,1,10148,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623166
,BAO_0000218,,,11020,,,,,1,10149,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624983
,BAO_0000218,,,11020,,,,,1,10150,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624984
,BAO_0000218,,,11020,,,,,1,10151,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624985
,BAO_0000218,,,11020,,,,,1,10152,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622970
,BAO_0000218,,,11020,,,,,1,10153,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622971
,BAO_0000218,,,11020,,,,,1,10154,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622972
,BAO_0000218,,,11020,,,,,1,10155,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622973
,BAO_0000218,,,11020,,,,,1,10156,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622974
,BAO_0000218,,,11020,,,,,1,10157,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622975
,BAO_0000218,,,11020,,,,,1,10158,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622976
,BAO_0000218,,,11020,,,,,1,10159,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622977
,BAO_0000218,,,11020,,,,,1,10160,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624351
,BAO_0000218,,,11020,,,,,1,10161,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624352
,BAO_0000218,,,11020,,,,,1,10162,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624353
,BAO_0000218,,,11020,,,,,1,10163,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622397
,BAO_0000218,,,11020,,,,,1,10164,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622398
,BAO_0000218,,,11020,,,,,1,10165,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622399
,BAO_0000218,,,11020,,,,,1,10166,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622400
,BAO_0000218,,,11020,,,,,1,10167,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628428
,BAO_0000218,,,11020,,,,,1,10168,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628590
,BAO_0000218,,,11020,,,,,1,10169,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628591
,BAO_0000218,,,11020,,,,,1,10170,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628592
,BAO_0000218,,,11020,,,,,1,10171,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628593
,BAO_0000218,,,11020,,,,,1,10172,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875333
,BAO_0000218,,,11020,,,,,1,10173,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628594
,BAO_0000218,,,4969,,1969.0,,,1,10174,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628595
,BAO_0000218,,,6737,,1969.0,,,1,10175,,Stability in rat plasma was determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628596
,BAO_0000218,,,6737,,1969.0,,,1,10176,,Stability in rat plasma was determined; ND= no data,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628597
,BAO_0000218,,,5089,,1969.0,,,1,10177,,Tested for plasma half life period in rat (0-8 hr),Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628598
,BAO_0000218,,,5089,,1969.0,,,1,10178,,Tested for plasma half life period in rat (0-8 hr); Not determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628599
,BAO_0000218,,In vivo,1466,,,,,1,10179,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628600
,BAO_0000218,,In vivo,1466,,,,,1,10180,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628601
,BAO_0000218,,,4950,,,,,1,10181,,Tested for the half life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628602
,BAO_0000218,,In vitro,2412,,,,,1,10182,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628603
,BAO_0000218,,In vitro,2412,,,,,1,10183,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628604
,BAO_0000218,,In vitro,2412,,,,,1,10184,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628605
,BAO_0000218,,In vitro,2412,,,,,1,10185,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628606
,BAO_0000218,,In vitro,2412,,,,,1,10186,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628607
,BAO_0000218,,,15022,,,,,1,10187,,The biological half life the compound was measured at the dose of 100 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628608
,BAO_0000218,,,15022,,,,,1,10188,,The biological half life the compound was measured at the dose of 30 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628609
,BAO_0000218,,,406,,1969.0,,,1,10189,,The compound was evaluated for plasma half life period in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628610
,BAO_0000218,,In vivo,15078,,,,,1,10190,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL873819
,BAO_0000218,,In vivo,15078,,,,,1,10191,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628611
,BAO_0000218,,In vivo,5247,,,,,1,10192,,The pharmacokinetic parameter half-life period in vivo in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628612
,BAO_0000218,,In vivo,5041,,,,,1,10193,,"The pharmacokinetic property, Half-life was determined",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628613
,BAO_0000218,,In vivo,5041,,,,,1,10194,,"The pharmacokinetic property, Half-life in rat in vivo",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628614
,BAO_0000218,,In vivo,5041,,,,,1,10195,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628615
,BAO_0000218,,In vivo,5041,,,,,1,10196,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628616
,BAO_0000218,,,3918,,1969.0,,,1,10197,,The plasma half life period in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627924
,BAO_0000218,,,2906,,2107.0,,,1,10198,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627925
,BAO_0000218,,In vivo,6467,,,,,1,10199,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627926
,BAO_0000218,,,5510,,,,,1,10200,,t1/2 (apparent elimination)of the compound was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627927
,BAO_0000218,,,3788,,,,,1,10201,,t1/2 value in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627928
,BAO_0000218,,,17796,,,,,1,10202,,Half life in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627539
,BAO_0000218,,In vivo,12873,,1969.0,,,1,10203,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL876790
,BAO_0000218,,In vivo,5983,,,,,1,10204,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL858186
,BAO_0000218,,,15765,,,,,1,10205,,Half-life period in fasted rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627540
,BAO_0000218,,In vivo,2661,,,,,1,10206,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627541
,BAO_0000218,,In vivo,2661,,,,,1,10207,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627715
,BAO_0000218,,In vivo,429,,,,,1,10208,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627716
,BAO_0000218,,,17655,,,,,1,10209,,Maximum time required to achieve Cmax was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627717
,BAO_0000218,,In vivo,17717,,,,,1,10210,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627718
,BAO_0000218,,In vivo,17717,,,,,1,10211,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627719
,BAO_0000218,,In vivo,17717,,,,,1,10212,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627720
,BAO_0000218,,In vivo,6570,,,,,1,10213,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627721
,BAO_0000218,,In vivo,6570,,,,,1,10214,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627722
,BAO_0000218,,In vivo,5978,,,,,1,10215,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627723
,BAO_0000218,,In vivo,5978,,,,,1,10216,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626058
,BAO_0000218,,In vivo,5978,,,,,1,10217,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626059
,BAO_0000218,,In vivo,5978,,,,,1,10218,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626060
,BAO_0000218,,In vivo,17720,,1969.0,,,1,10219,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626061
,BAO_0000218,,In vivo,4723,,,,,1,10220,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876791
,BAO_0000218,,In vivo,4723,,,,,1,10221,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626062
,BAO_0000218,,In vivo,4756,,,,,1,10222,,Tmax at the dose of 2 mg/Kg administered perorally in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626063
,BAO_0000218,,In vivo,4756,,,,,1,10223,,Tmax at the dose of 5 mg/Kg administered perorally in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626064
,BAO_0000218,,In vivo,17720,,1969.0,,,1,10224,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626065
,BAO_0000218,,In vivo,17720,,1969.0,,,1,10225,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626066
,BAO_0000218,,In vivo,1466,,,,,1,10226,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626067
,BAO_0000218,,,7449,,,,,1,10227,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL626068
,BAO_0000218,,,7449,,,,,1,10228,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL626069
,BAO_0000218,,,7449,,,,,1,10229,,Percent total excretion of 3-methoxyacetaminophen glucuronide,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL626070
,BAO_0000218,,,7449,,,,,1,10230,,Percent total excretion of N-methoxyacetaminophen glucuronide,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL626071
,BAO_0000218,,,7449,,,,,1,10231,,Percent total excretion of N-methoxyacetaminophen sulfate,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL626072
,BAO_0000218,,,7449,,,,,1,10232,,Percent total excretion of acetaminophen,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL626073
,BAO_0000218,,,7768,,2046.0,,,1,10233,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626741
,BAO_0000218,,,17655,,,,,1,10234,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626742
,BAO_0000218,,,17735,,,,,1,10235,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626743
,BAO_0000218,,,5960,,,,,1,10236,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876792
,BAO_0000218,,,17735,,,,,1,10237,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626744
,BAO_0000218,,,7116,,,,,1,10238,,Compound was tested for antidiuretic activity in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626745
,BAO_0000218,,In vivo,4878,,1969.0,,,1,10239,,AUC in rat after 3mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626746
,BAO_0000218,,,5939,,,,,1,10240,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626747
,BAO_0000218,,,5939,,,,,1,10241,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626748
,BAO_0000218,,,16367,,,,,1,10242,,Bioavailability administered orally at a dose of 10 mg/kg to rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626749
,BAO_0000218,,,16366,,,,,1,10243,,Oral Bioavailability was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626750
,BAO_0000218,,,4426,,,,,1,10244,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626751
,BAO_0000218,,,4426,,,,,1,10245,,Oral bioavailability in rat; Not performed.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626913
,BAO_0000218,,,5041,,,,,1,10246,,Bioavailability,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626914
,BAO_0000218,,,5041,,,,,1,10247,,Bioavailability was determined; ND denotes no data,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626915
,BAO_0000218,,,1500,,,,,1,10248,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626916
,BAO_0000218,,,1500,,,,,1,10249,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626917
,BAO_0000218,,,17409,,,,,1,10250,,Binding towards rat plasma protein at 10 uM,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626918
,BAO_0000218,,,17409,,,,,1,10251,,Binding towards rat plasma protein at 100 uM,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626919
,BAO_0000218,,In vivo,2959,,,,,1,10252,,Bioavailability in rat (dose 20 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626920
,BAO_0000218,,In vivo,13501,,,,,1,10253,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621976
,BAO_0000218,,In vivo,6567,,,,,1,10254,,Bioavailability in rat after 5 mg/kg oral gavage,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877599
,BAO_0000218,,In vivo,6571,,,,,1,10255,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621977
,BAO_0000218,,In vivo,6715,,,,,1,10256,,Bioavailability in rat (dose 1 mg/kg i.v.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621978
,BAO_0000218,,In vivo,6715,,,,,1,10257,,Bioavailability in rat (dose 3 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621979
,BAO_0000218,,In vivo,2932,,,,,1,10258,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621980
,BAO_0000218,,In vivo,4171,,,,,1,10259,,Bioavailability of the compound in rats after administration of 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621981
,BAO_0000218,,In vivo,17509,,,,,1,10260,,Bioavailability after administration of 10 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621982
,BAO_0000218,,In vivo,17509,,,,,1,10261,,Bioavailability after administration of 2 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL882953
,BAO_0000218,,In vivo,4527,,,,,1,10262,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621983
,BAO_0000218,,In vivo,4026,,,,,1,10263,,Bioavailability in dogs was determined; high,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621984
,BAO_0000218,,In vivo,6659,,,,,1,10264,,Bioavailability in monkey after intravenous administration at 1 mpk,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621985
,BAO_0000218,,In vivo,6659,,,,,1,10265,,Bioavailability in monkey after peroral administration at 10 mpk,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621986
,BAO_0000218,,In vivo,6659,,,,,1,10266,,Bioavailability in rat after intravenous administration at 1 mpk,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621987
,BAO_0000218,,In vivo,6659,,,,,1,10267,,Bioavailability in rat after intravenous administration at 2 mpk,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL877600
,BAO_0000218,,In vivo,6659,,,,,1,10268,,Bioavailability in rat after peroral administration at 30 mpk,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621988
,BAO_0000218,,In vivo,6659,,,,,1,10269,,Bioavailability in rat after peroral administration at at 100 mpk,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL621989
,BAO_0000218,,In vivo,6597,,,,,1,10270,,Bioavailability in rats was evaluated,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621990
,BAO_0000218,,In vivo,1202,,,,,1,10271,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621991
,BAO_0000218,,In vivo,1202,,,,,1,10272,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621992
,BAO_0000218,,In vivo,1202,,,,,1,10273,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621993
,BAO_0000218,,In vivo,1202,,,,,1,10274,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621994
,BAO_0000218,,In vivo,5207,,,,,1,10275,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621995
,BAO_0000218,,In vivo,5970,,,,,1,10276,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621996
,BAO_0000218,,In vivo,17538,,,,,1,10277,,Oral bioavailability in rat (dose 10 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621997
,BAO_0000218,,In vivo,17538,,,,,1,10278,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621998
,BAO_0000218,,In vivo,1466,,,,,1,10279,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621999
,BAO_0000218,,In vivo,2879,,,,,1,10280,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622000
,BAO_0000218,,In vivo,2879,,,,,1,10281,,Bioavailability was measured in rat after oral administration; 2-4,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622001
,BAO_0000218,,In vivo,2879,,,,,1,10282,,Bioavailability was measured in rat after oral administration; 3-7,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622002
,BAO_0000218,,In vivo,3777,,,,,1,10283,,Bioavailability in rat (intraduodenal administration),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622003
,BAO_0000218,,In vivo,3777,,,,,1,10284,,Bioavailability in rat (intraduodenal administration),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877601
,BAO_0000218,,In vivo,3777,,,,,1,10285,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624871
,BAO_0000218,,In vivo,3777,,,,,1,10286,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622004
,BAO_0000218,,In vivo,5423,,,,,1,10287,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL882954
,BAO_0000218,,In vivo,16365,,,,,1,10288,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622005
,BAO_0000218,,In vivo,16365,,,,,1,10289,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622006
,BAO_0000218,,In vivo,4239,,,,,1,10290,,Bioavailability was measured in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622007
,BAO_0000218,,In vivo,5438,,,,,1,10291,,Bioavailability was reported,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622008
,BAO_0000218,,In vivo,5334,,,,,1,10292,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622009
,BAO_0000218,,In vivo,5334,,,,,1,10293,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622010
,BAO_0000218,,In vivo,4199,,,,,1,10294,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622011
,BAO_0000218,,In vivo,4199,,,,,1,10295,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622012
,BAO_0000218,,In vivo,4199,,,,,1,10296,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622013
,BAO_0000218,,In vivo,4890,,,,,1,10297,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622014
,BAO_0000218,,In vivo,2792,,,,,1,10298,,Bioavailability was determined at 3 mg/kg po dose in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624749
,BAO_0000218,,In vivo,5529,,,,,1,10299,,Oral bioavailability in rat (dose 2 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624750
,BAO_0000218,,In vivo,6685,,,,,1,10300,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624751
,BAO_0000218,,In vivo,6685,,,,,1,10301,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624752
,BAO_0000218,,In vivo,6685,,,,,1,10302,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624753
,BAO_0000218,,In vivo,6005,,,,,1,10303,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624754
,BAO_0000218,,In vivo,6410,,,,,1,10304,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624755
,BAO_0000218,,In vivo,6410,,,,,1,10305,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624756
,BAO_0000218,,In vivo,6103,,,,,1,10306,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624757
,BAO_0000218,,In vivo,6410,,,,,1,10307,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624758
,BAO_0000218,,In vivo,6410,,,,,1,10308,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622270
,BAO_0000218,,In vivo,5353,,,,,1,10309,,Bioavailability in rat (Sprague-Dawley),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622271
,BAO_0000218,,In vivo,4727,,,,,1,10310,,Bioavailability in rat at the dose of 2 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622272
,BAO_0000218,,In vivo,17804,,,,,1,10311,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622273
,BAO_0000218,,In vivo,5809,,,,,1,10312,,Bioavailability in rat (cannulated) (dose 2 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622274
,BAO_0000218,,In vivo,17804,,,,,1,10313,,Bioavailability value of compound in rats was determined after peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622275
,BAO_0000218,,In vivo,3634,,,,,1,10314,,Oral bioavailability in rat (dose 20 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622276
,BAO_0000218,,In vivo,3341,,,,,1,10315,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622277
,BAO_0000218,,In vivo,2690,,,,,1,10316,,Oral bioavailability in rat (dose 5 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622278
,BAO_0000218,,In vivo,3184,,,,,1,10317,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622279
,BAO_0000218,,In vivo,740,,,,,1,10318,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622280
,BAO_0000218,,In vivo,1806,,,,,1,10319,,Compound was evaluated for oral bioavailability in rats; 15-27 %,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624083
,BAO_0000218,,In vivo,4891,,,,,1,10320,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624084
,BAO_0000218,,In vivo,3634,,,,,1,10321,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624085
,BAO_0000218,,In vivo,64,,,,,1,10322,,Compound was tested for bioavailability in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624086
,BAO_0000218,,In vivo,4839,,,,,1,10323,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624087
,BAO_0000218,,In vivo,1094,,,,,1,10324,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624088
,BAO_0000218,,In vivo,5005,,,,,0,10325,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,Intermediate,Macaca mulatta,1,9544.0,,,22224,A,U,CHEMBL624089
,BAO_0000218,,In vivo,5005,,,,,0,10326,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL624090
,BAO_0000218,,In vivo,4687,,,,,1,10327,,Evaluated for the bioavailability in rat (in vivo),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624091
,BAO_0000218,,In vivo,17804,,,,,1,10328,,F value of compound in rats was determined after peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624092
,BAO_0000218,,In vivo,5974,,,,,1,10329,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624093
,BAO_0000218,,In vivo,5974,,,,,1,10330,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624094
,BAO_0000218,,In vivo,5974,,,,,1,10331,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624095
,BAO_0000218,,In vivo,5974,,,,,1,10332,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624096
,BAO_0000218,,In vivo,1088,,,,,1,10333,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624097
,BAO_0000218,,In vivo,1742,,,,,1,10334,,Maximum fall in carotid flow in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624098
,BAO_0000218,,In vivo,4689,,,,,1,10335,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874392
,BAO_0000218,,In vivo,2463,,,,,1,10336,,Oral bioavailability in rat (dose 5 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624099
,BAO_0000218,,In vivo,5654,,,,,1,10337,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624100
,BAO_0000218,,In vivo,5654,,,,,1,10338,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624101
,BAO_0000218,,In vivo,6874,,,,,1,10339,,Oral bioavailability in rat (male Wistar),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624102
,BAO_0000218,,In vivo,5633,,,,,1,10340,,Oral bioavailability after administration (30 mg/kg) in rat; good,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624103
,BAO_0000218,,In vivo,5496,,,,,1,10341,,Oral bioavailability at the dose of 2 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624104
,BAO_0000218,,In vivo,2358,,,,,1,10342,,Oral bioavailability determined in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624105
,BAO_0000218,,In vivo,16456,,,,,1,10343,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624106
,BAO_0000218,,In vivo,5302,,,,,1,10344,,Oral bioavailability in rat (dose single 10 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624107
,BAO_0000218,,In vivo,5302,,,,,1,10345,,Oral bioavailability in rat (dose single 10 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623943
,BAO_0000218,,In vivo,5302,,,,,1,10346,,Oral bioavailability in rat (dose 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623944
,BAO_0000218,,,11020,,,,,1,10347,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623945
,BAO_0000218,,,11020,,,,,1,10348,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623946
,BAO_0000218,,,11020,,,,,1,10349,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623947
,BAO_0000218,,,11020,,,,,1,10350,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623948
,BAO_0000218,,,11020,,,,,1,10351,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623949
,BAO_0000218,,,11020,,,,,1,10352,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623950
,BAO_0000218,,,11020,,,,,1,10353,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874398
,BAO_0000218,,,11020,,,,,1,10354,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623951
,BAO_0000218,,,11020,,,,,1,10355,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623952
,BAO_0000218,,,11020,,,,,1,10356,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623953
,BAO_0000218,,,11020,,,,,1,10357,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623954
,BAO_0000218,,,11020,,,,,1,10358,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623955
,BAO_0000218,,,11020,,,,,1,10359,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623956
,BAO_0000218,,,11020,,,,,1,10360,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627807
,BAO_0000218,,,11020,,,,,1,10361,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627808
,BAO_0000218,,,11020,,,,,1,10362,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627809
,BAO_0000218,,,11020,,,,,1,10363,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627810
,BAO_0000218,,,11020,,,,,1,10364,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627811
,BAO_0000218,,,11020,,,,,1,10365,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627812
,BAO_0000218,,,11020,,,,,1,10366,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627813
,BAO_0000218,,,11020,,,,,1,10367,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627814
,BAO_0000218,,,11020,,,,,1,10368,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875336
,BAO_0000218,,,11020,,,,,1,10369,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627815
,BAO_0000218,,,11020,,,,,1,10370,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627816
,BAO_0000218,,,11020,,,,,1,10371,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627817
,BAO_0000218,,,11020,,,,,1,10372,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627818
,BAO_0000218,,,11020,,,,,1,10373,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627819
,BAO_0000218,,,11020,,,,,1,10374,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627820
,BAO_0000218,,,11020,,,,,1,10375,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627821
,BAO_0000218,,,11020,,,,,1,10376,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628464
,BAO_0000218,,,11020,,,,,1,10377,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626239
,BAO_0000218,,,11020,,,,,1,10378,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626240
,BAO_0000218,,,11020,,,,,1,10379,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626241
,BAO_0000218,,,11020,,,,,1,10380,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626242
,BAO_0000218,,,11020,,,,,1,10381,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626243
,BAO_0000218,,,11020,,,,,1,10382,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626244
,BAO_0000218,,,11020,,,,,1,10383,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626907
,BAO_0000218,,,11020,,,,,1,10384,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626908
,BAO_0000218,,,11020,,,,,1,10385,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626909
,BAO_0000218,,,11020,,,,,1,10386,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626910
,BAO_0000218,,,7449,,,,,1,10387,,Percent total excretion of acetaminophen cysteine conjugate,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL875342
,BAO_0000218,,,7449,,,,,1,10388,,Percent total excretion of acetaminophen glucuronide,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL626911
,BAO_0000218,,,7449,,,,,1,10389,,Percent total excretion of acetaminophen sulfate,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL626912
,BAO_0000218,,,7449,,,,,1,10390,,Percent total excretion of acetaminophen-mercapturic acid,Intermediate,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL627065
,BAO_0000218,,,3172,,1088.0,,,1,10391,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL627066
,BAO_0000218,,In vivo,16456,,,,,1,10392,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627067
,BAO_0000218,,In vivo,10839,,2385.0,,,0,10393,,Biodistribution of compound in rat muscle after 5 min of administration,Autocuration,ratrat,1,8656.0,,Muscle tissue,22224,A,U,CHEMBL627068
,BAO_0000218,,In vivo,10839,,2385.0,,,0,10394,,Biodistribution of compound in rat muscle after 5 min of administration.,Autocuration,ratrat,1,8656.0,,Muscle tissue,22224,A,U,CHEMBL627069
,BAO_0000218,,In vivo,5334,,,,,0,10395,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,Ovis aries,1,9940.0,,,22224,A,U,CHEMBL627070
,BAO_0000218,,In vivo,5334,,,,,0,10396,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,Ovis aries,1,9940.0,,,22224,A,U,CHEMBL627071
,BAO_0000218,,In vivo,5334,,,,,0,10397,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,Ovis aries,1,9940.0,,,22224,A,U,CHEMBL627072
,BAO_0000218,,In vivo,5334,,,,,0,10398,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,Ovis aries,1,9940.0,,,22224,A,U,CHEMBL627073
,BAO_0000218,,In vivo,5334,,,,,0,10399,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,Ovis aries,1,9940.0,,,22224,A,U,CHEMBL625387
,BAO_0000218,,In vivo,5334,,,,,0,10400,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,Ovis aries,1,9940.0,,,22224,A,U,CHEMBL625388
,BAO_0000218,,In vivo,5334,,1969.0,,,0,10401,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,Ovis aries,1,9940.0,,Plasma,22224,A,U,CHEMBL625389
,BAO_0000218,,In vivo,5334,,1969.0,,,0,10402,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,Ovis aries,1,9940.0,,Plasma,22224,A,U,CHEMBL875343
,BAO_0000218,,,1735,,,,,1,10403,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),Intermediate,Serpentes,1,8570.0,,,50497,A,N,CHEMBL876795
,BAO_0000218,,,1469,,,,,1,10404,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,Intermediate,Serpentes,1,8570.0,,,50497,A,N,CHEMBL626552
,BAO_0000218,,,1336,,,,,1,10405,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,Intermediate,Serpentes,1,8570.0,,,50497,A,N,CHEMBL626553
,BAO_0000366,,,12403,,1969.0,,,0,10406,,The human biological plasma half life of the compound,Autocuration,Homo sapiens,1,9606.0,,Plasma,22224,A,U,CHEMBL626554
,BAO_0000218,,,8151,,1088.0,,,1,10407,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626555
,BAO_0000218,,,8004,,,,,1,10408,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626556
,BAO_0000218,,,8004,,,,,1,10409,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626557
,BAO_0000218,,,8004,,,,,1,10410,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626558
,BAO_0000218,,,8004,,,,,1,10411,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626559
,BAO_0000218,,,8004,,,,,1,10412,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626560
,BAO_0000218,,,8004,,,,,1,10413,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876803
,BAO_0000218,,,8004,,,,,1,10414,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627964
,BAO_0000218,,,8004,,,,,1,10415,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627965
,BAO_0000218,,,8004,,,,,1,10416,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627966
,BAO_0000218,,,8004,,,,,1,10417,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627967
,BAO_0000218,,,8004,,,,,1,10418,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627968
,BAO_0000218,,,8004,,,,,1,10419,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627969
,BAO_0000218,,,8004,,,,,1,10420,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627970
,BAO_0000218,,,8004,,178.0,,,1,10421,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627971
,BAO_0000218,,,8004,,178.0,,,1,10422,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627972
,BAO_0000357,,,15917,,,,,9,10423,,Dissociation constant against binding to human cyclophilin A,Expert,Homo sapiens,1,9606.0,,,180,B,D,CHEMBL856029
,BAO_0000019,,,12396,,,,,8,10424,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,Expert,Bos taurus,1,9913.0,,,11591,B,H,CHEMBL627973
,BAO_0000019,,,7065,,,,,0,10425,,-Log C was determined by performing the electroshock minimum test,Autocuration,,1,,,,22224,A,U,CHEMBL627974
,BAO_0000019,,,7065,,,,,0,10426,,-Log C was determined by performing the foot shock test,Autocuration,,1,,,,22224,A,U,CHEMBL627975
,BAO_0000019,,,7065,,,,,0,10427,,-Log C was determined by performing the incl screen test,Autocuration,,1,,,,22224,A,U,CHEMBL627976
,BAO_0000019,,,7065,,,,,0,10428,,-Log C was determined by performing the maximum electroshock test,Autocuration,,1,,,,22224,A,U,CHEMBL627977
,BAO_0000019,,,7065,,,,,0,10429,,-Log C was determined by performing the pentylenetetrazole test,Autocuration,,1,,,,22224,A,U,CHEMBL627978
,BAO_0000019,,,12415,,,,,0,10430,,Tested for experimental arotinoid inhibitory dose,Autocuration,,1,,,,22224,A,U,CHEMBL627979
,BAO_0000019,,,10256,,,,,0,10431,,Negative log transformed activity,Autocuration,,1,,,,22224,A,U,CHEMBL876804
,BAO_0000019,,,7991,,,,,0,10432,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",Autocuration,,1,,,,22224,A,U,CHEMBL627980
,BAO_0000218,,,14342,,,,,1,10433,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,Intermediate,Cavia porcellus,1,10141.0,,,50512,A,N,CHEMBL627981
,BAO_0000218,,,14342,,,,,1,10434,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,Intermediate,Cavia porcellus,1,10141.0,,,50512,A,N,CHEMBL627982
,BAO_0000218,,,14342,,,,,1,10435,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,Intermediate,Cavia porcellus,1,10141.0,,,50512,A,N,CHEMBL627983
,BAO_0000218,,,14342,,2116.0,,,1,10436,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,Intermediate,Cavia porcellus,1,10141.0,,Ileum,50512,A,N,CHEMBL627984
,BAO_0000100,,,6047,,,,,0,10437,,Solubility in water was determined; values expressed as -log,Autocuration,,1,,,,22229,P,U,CHEMBL627985
,BAO_0000019,,,17269,,,,,0,10438,,Ratio of Kcat to that of Km was determined,Autocuration,,1,,,,22224,A,U,CHEMBL627986
,BAO_0000019,,,10026,,,,,0,10439,,Observed first order rate constant,Autocuration,,1,,,,22224,A,U,CHEMBL627987
,BAO_0000019,,,14583,,,,,0,10440,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,Autocuration,,1,,,,22224,A,U,CHEMBL627988
,BAO_0000218,,In vivo,2661,,,,,1,10441,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627989
,BAO_0000218,,In vivo,2661,,,,,1,10442,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627990
,BAO_0000218,,In vivo,4029,,,,,1,10443,,Oral Bioavailability after administration of 10 mg/kg in male rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876805
,BAO_0000218,,In vivo,17735,,,,,1,10444,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627991
,BAO_0000218,,In vivo,4576,,,,,1,10445,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627992
,BAO_0000218,,In vivo,17582,,,,,1,10446,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627993
,BAO_0000218,,In vivo,17651,,,,,1,10447,,Oral bioavailability at 1 mg/kg was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622817
,BAO_0000218,,In vivo,17651,,,,,1,10448,,Oral bioavailability at 10 mg/kg was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622818
,BAO_0000218,,In vivo,17670,,,,,1,10449,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622819
,BAO_0000218,,In vivo,5045,,,,,1,10450,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL872267
,BAO_0000218,,In vivo,1696,,,,,1,10451,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622820
,BAO_0000218,,In vivo,17764,,,,,1,10452,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622821
,BAO_0000218,,In vivo,6448,,,,,1,10453,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622822
,BAO_0000218,,In vivo,6596,,,,,1,10454,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622823
,BAO_0000218,,In vivo,17547,,,,,1,10455,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622824
,BAO_0000218,,In vivo,17771,,,,,1,10456,,Oral bioavailability in rat at a dose of 3 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622825
,BAO_0000218,,In vivo,6495,,,,,1,10457,,Oral bioavailability in rat after oral administration at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622901
,BAO_0000218,,In vivo,4558,,,,,1,10458,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622902
,BAO_0000218,,In vivo,17596,,,,,1,10459,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621844
,BAO_0000218,,In vivo,6827,,,,,1,10460,,Oral bioavailability in Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621845
,BAO_0000218,,In vivo,4026,,,,,1,10461,,Oral bioavailability,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621846
,BAO_0000218,,In vivo,10,,,,,1,10462,,Oral bioavailability in rat (dose 30 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621847
,BAO_0000218,,In vivo,17717,,,,,1,10463,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877609
,BAO_0000218,,In vivo,17717,,,,,1,10464,,Bioavailability in rat (dose 3 mg/kg i.v.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621848
,BAO_0000218,,In vivo,17717,,,,,1,10465,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621849
,BAO_0000218,,In vivo,17717,,,,,1,10466,,Oral bioavailability in rat (dose 60 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622030
,BAO_0000218,,In vivo,4796,,,,,1,10467,,Percent oral bioavailability determined in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622031
,BAO_0000218,,In vivo,4883,,,,,1,10468,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622032
,BAO_0000218,,In vivo,2137,,,,,1,10469,,The compound was evaluated for bioavailability in rats; 32-51,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622033
,BAO_0000218,,In vivo,2959,,,,,1,10470,,Bioavailability in rat (dose 20 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622034
,BAO_0000218,,In vivo,1361,,,,,1,10471,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622035
,BAO_0000218,,In vivo,4727,,,,,1,10472,,Bioavailability percent in rat at the dose of 2 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL882966
,BAO_0000218,,In vivo,16423,,,,,1,10473,,Bioavailability was evaluated after 20 uM/kg of peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622036
,BAO_0000218,,In vivo,5206,,,,,1,10474,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622037
,BAO_0000218,,In vivo,6448,,,,,1,10475,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622038
,BAO_0000218,,In vivo,17723,,,,,1,10476,,Bioavailability in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622039
,BAO_0000218,,In vivo,17738,,178.0,,,1,10477,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622040
,BAO_0000218,,In vivo,17738,,178.0,,,1,10478,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622041
,BAO_0000218,,In vivo,17738,,178.0,,,1,10479,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622042
,BAO_0000218,,In vivo,17738,,178.0,,,1,10480,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622043
,BAO_0000218,,In vivo,17738,,178.0,,,1,10481,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622044
,BAO_0000218,,In vivo,17738,,10000001.0,,,1,10482,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL622045
,BAO_0000218,,In vivo,17738,,10000001.0,,,1,10483,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL622046
,BAO_0000218,,In vivo,17738,,10000001.0,,,1,10484,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL622047
,BAO_0000218,,In vivo,17738,,10000001.0,,,1,10485,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL877610
,BAO_0000218,,In vivo,17738,,955.0,,,1,10486,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622048
,BAO_0000218,,In vivo,17738,,955.0,,,1,10487,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622049
,BAO_0000218,,In vivo,17738,,955.0,,,1,10488,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622050
,BAO_0000218,,In vivo,17738,,955.0,,,1,10489,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622051
,BAO_0000218,,In vivo,17738,,,,,1,10490,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622052
,BAO_0000218,,In vivo,17738,,,,,1,10491,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622053
,BAO_0000218,,In vivo,17738,,,,,1,10492,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622054
,BAO_0000218,,In vivo,17738,,,,,1,10493,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622055
,BAO_0000218,,In vivo,5237,,,,,1,10494,,Oral bioavailability in rats was determined; High,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622056
,BAO_0000218,,In vivo,5503,,,,,1,10495,,Oral bioavailability in the rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622057
,BAO_0000218,,In vivo,15765,,,,,1,10496,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628008
,BAO_0000218,,In vivo,15660,,,,,1,10497,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622058
,BAO_0000218,,In vivo,5978,,,,,1,10498,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622059
,BAO_0000218,,In vivo,5978,,,,,1,10499,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622060
,BAO_0000218,,In vivo,5978,,,,,1,10500,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622061
,BAO_0000218,,In vivo,5978,,,,,1,10501,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622062
,BAO_0000218,,In vivo,5656,,,,,1,10502,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622063
,BAO_0000218,,In vivo,3598,,,,,1,10503,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877611
,BAO_0000218,,In vivo,4216,,,,,1,10504,,Oral bioavailability of compound in Sprague Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622064
,BAO_0000218,,In vivo,17839,,,,,1,10505,,Oral bioavailability of compound in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622065
,BAO_0000218,,In vivo,6570,,,,,1,10506,,Oral bioavailability in rat (dose 2 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622066
,BAO_0000218,,In vivo,5334,,,,,1,10507,,Oral bioavailability of compound in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622067
,BAO_0000218,,In vivo,6886,,,,,1,10508,,Oral bioavailability of compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622068
,BAO_0000218,,In vivo,5210,,,,,1,10509,,Oral bioavailability of compound was determined in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622069
,BAO_0000218,,In vivo,4170,,,,,1,10510,,Oral bioavailability at a dose of 30 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624796
,BAO_0000218,,In vivo,6028,,,,,1,10511,,Oral bioavailability in rat (dose 10 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624797
,BAO_0000218,,In vivo,6028,,,,,1,10512,,Oral bioavailability in rat (dose 10 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623053
,BAO_0000218,,In vivo,6078,,,,,1,10513,,Oral bioavailability evaluated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623054
,BAO_0000218,,In vivo,6168,,,,,1,10514,,Oral bioavailability in fasted rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623055
,BAO_0000218,,In vivo,6168,,,,,1,10515,,Oral bioavailability in fed rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623056
,BAO_0000218,,In vivo,5160,,,,,1,10516,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623057
,BAO_0000218,,In vivo,6057,,,,,1,10517,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623058
,BAO_0000218,,In vivo,6535,,,,,1,10518,,Oral bioavailability in rat (dose 10 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623059
,BAO_0000218,,In vivo,6535,,,,,1,10519,,Oral bioavailability in rat after administration of 10 mg/kg po,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623060
,BAO_0000218,,In vivo,4194,,,,,1,10520,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623061
,BAO_0000218,,In vivo,6230,,,,,1,10521,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623062
,BAO_0000218,,In vivo,6619,,,,,1,10522,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623063
,BAO_0000218,,In vivo,17607,,,,,1,10523,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623064
,BAO_0000218,,In vivo,4942,,,,,1,10524,,Oral bioavailability in ratrs,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623065
,BAO_0000218,,In vivo,4942,,,,,1,10525,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623066
,BAO_0000218,,In vivo,6646,,,,,1,10526,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623067
,BAO_0000218,,In vivo,5237,,,,,1,10527,,Oral bioavailability in rats was determined; High,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623068
,BAO_0000218,,In vivo,6646,,,,,1,10528,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623069
,BAO_0000218,,In vivo,4449,,,,,1,10529,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623070
,BAO_0000218,,In vivo,6057,,,,,1,10530,,Oral bioavailability was calculated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623071
,BAO_0000218,,In vivo,2552,,,,,1,10531,,Oral bioavailability,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623072
,BAO_0000218,,In vivo,5496,,,,,1,10532,,Oral bioavailability,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623073
,BAO_0000218,,In vivo,6484,,,,,1,10533,,Oral bioavailability,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623074
,BAO_0000218,,In vivo,6485,,,,,1,10534,,Oral bioavailability,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623075
,BAO_0000218,,In vivo,6616,,,,,1,10535,,Oral bioavailability after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623076
,BAO_0000218,,In vivo,4969,,,,,1,10536,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623077
,BAO_0000218,,In vivo,5862,,,,,1,10537,,Oral bioavailability in rat (Sprague-Dawley),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623078
,BAO_0000218,,In vivo,4514,,,,,1,10538,,Oral bioavailability in Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623079
,BAO_0000218,,In vivo,4514,,,,,1,10539,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623080
,BAO_0000218,,In vivo,4514,,,,,1,10540,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623081
,BAO_0000218,,In vivo,5546,,,,,1,10541,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623082
,BAO_0000218,,In vivo,6168,,,,,1,10542,,Oral bioavailability in fasted rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874400
,BAO_0000218,,In vivo,6168,,,,,1,10543,,Oral bioavailability in fed rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623083
,BAO_0000218,,In vivo,3624,,,,,1,10544,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623084
,BAO_0000218,,In vivo,5213,,,,,1,10545,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623085
,BAO_0000218,,In vivo,5496,,,,,1,10546,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623086
,BAO_0000218,,In vivo,5553,,,,,1,10547,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623087
,BAO_0000218,,In vivo,5833,,,,,1,10548,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623088
,BAO_0000218,,In vivo,5836,,,,,1,10549,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623089
,BAO_0000218,,In vivo,5865,,,,,1,10550,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623090
,BAO_0000218,,In vivo,5960,,,,,1,10551,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623091
,BAO_0000218,,In vivo,6249,,,,,1,10552,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623092
,BAO_0000218,,In vivo,6448,,,,,1,10553,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623093
,BAO_0000218,,In vivo,6453,,,,,1,10554,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874401
,BAO_0000218,,In vivo,6640,,,,,1,10555,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623094
,BAO_0000218,,In vivo,17607,,,,,1,10556,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623095
,BAO_0000218,,In vivo,5939,,,,,1,10557,,Oral bioavailability in rat after peroral administration at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623096
,BAO_0000218,,In vivo,5939,,,,,1,10558,,Oral bioavailability in rat after peroral administration at 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624913
,BAO_0000218,,In vivo,6281,,,,,1,10559,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624914
,BAO_0000218,,In vivo,5874,,,,,1,10560,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624915
,BAO_0000218,,In vivo,5213,,,,,1,10561,,Oral bioavailability in rat; Not measured,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624916
,BAO_0000218,,In vivo,4964,,,,,1,10562,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624917
,BAO_0000218,,,11020,,,,,1,10563,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625157
,BAO_0000218,,,6251,,2107.0,,,1,10564,,In vitro metabolic potential in rat liver microsomes,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625158
,BAO_0000218,,In vivo,1568,,,,,1,10565,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625159
,BAO_0000218,,In vivo,3032,,,,,1,10566,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625160
,BAO_0000218,,In vivo,3748,,,,,1,10567,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625161
,BAO_0000218,,In vivo,401,,,,,1,10568,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625162
,BAO_0000218,,In vivo,6512,,,,,1,10569,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625163
,BAO_0000218,,In vivo,17617,,,,,1,10570,,Oral bioavailability in rats at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625164
,BAO_0000218,,In vivo,6679,,,,,1,10571,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625165
,BAO_0000218,,In vivo,6742,,,,,1,10572,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625166
,BAO_0000218,,,589,,,,,1,10573,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625167
,BAO_0000218,,,589,,,,,1,10574,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625168
,BAO_0000218,,In vivo,3185,,,,,1,10575,,Plasma clearance of the compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625169
,BAO_0000218,,In vivo,17596,,,,,1,10576,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626264
,BAO_0000218,,In vivo,2713,,,,,1,10577,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626265
,BAO_0000218,,In vivo,12500,,1969.0,,,1,10578,,The compound was tested for plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626266
,BAO_0000218,,In vivo,12500,,1969.0,,,1,10579,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626267
,BAO_0000218,,,2713,,,,,1,10580,,Plasma concentration upon oral administration of 1 mg/Kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626268
,BAO_0000218,,,1446,,,,,1,10581,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626269
,BAO_0000218,,,6227,,,,,1,10582,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626270
,BAO_0000218,,,4709,,,,,1,10583,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626271
,BAO_0000218,,,5510,,,,,1,10584,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626272
,BAO_0000218,,,5510,,,,,1,10585,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626273
,BAO_0000218,,,5510,,,,,1,10586,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875346
,BAO_0000218,,,5510,,,,,1,10587,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626274
,BAO_0000218,,,4514,,,,,1,10588,,Compound was tested for protein binding in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626275
,BAO_0000218,,,2713,,,,,1,10589,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624646
,BAO_0000218,,,2713,,,,,1,10590,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624647
,BAO_0000218,,,5340,,2107.0,,,1,10591,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624648
,BAO_0000218,,,12058,,,,,1,10592,,Area under curve ratio was determined (po/iv) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624649
,BAO_0000218,,,11195,,,,,1,10593,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624650
,BAO_0000218,,,11195,,,,,1,10594,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624651
,BAO_0000218,,,11195,,,,,1,10595,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624652
,BAO_0000218,,,6495,,,,,1,10596,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624653
,BAO_0000218,,,6078,,,,,1,10597,,Ratio of AUCbrain to AUCplasma,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624654
,BAO_0000218,,,5656,,,,,1,10598,,Ratio of brain to plasma,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624655
,BAO_0000218,,,4910,,,,,1,10599,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624656
,BAO_0000218,,,4910,,,,,1,10600,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624657
,BAO_0000218,,,4910,,,,,1,10601,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624658
,BAO_0000218,,,10130,,,,,1,10602,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624659
,BAO_0000218,,,10130,,,,,1,10603,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624660
,BAO_0000218,,,10130,,,,,1,10604,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624661
,BAO_0000218,,,5213,,,,,1,10605,,Steady state brain :blood ratio was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624662
,BAO_0000218,,,4910,,,,,1,10606,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625199
,BAO_0000218,,,4910,,,,,1,10607,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625200
,BAO_0000218,,,4910,,,,,1,10608,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625201
,BAO_0000218,,,4910,,,,,1,10609,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625202
,BAO_0000218,,,2083,,,,,1,10610,,Percentage recovery after 3h incubation with rat hapatocytes was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625203
,BAO_0000218,,,2082,,,,,1,10611,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625204
,BAO_0000218,,,2082,,,,,1,10612,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625205
,BAO_0000218,,,6351,,,,,1,10613,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625206
,BAO_0000019,,,14583,,,,,0,10614,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",Autocuration,,1,,,,22224,A,U,CHEMBL625207
,BAO_0000019,,,14583,,,,,0,10615,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,Autocuration,,1,,,,22224,A,U,CHEMBL625208
495.0,BAO_0000218,,,4608,,,,Caco-2,1,10616,,In vivo absorption in Caco-2 cell line monolayers was determined,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL625209
,BAO_0000100,,,13668,,,,,0,10617,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625210
,BAO_0000218,,,5669,,,,,1,10618,,Area under curve was determine after peroral administration at 10 mpk in Rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625211
,BAO_0000218,,,5669,,,,,1,10619,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,Intermediate,Macaca mulatta,1,9544.0,,,50797,A,N,CHEMBL625212
,BAO_0000218,,,5669,,,,,1,10620,,Area under curve was determine after peroral administration at 160 mpk in Rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625213
,BAO_0000218,,,5669,,,,,1,10621,,Area under curve was determine after peroral administration at 20 mpk in Rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625214
,BAO_0000218,,,5669,,,,,1,10622,,Area under curve was determine after peroral administration at 50 mpk in Rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874542
,BAO_0000100,,,6472,,,,,0,10623,,Calculated partition coefficient (clogP) (AlogP),Autocuration,,1,,,,22229,P,U,CHEMBL625215
,BAO_0000019,,,15106,,,,,0,10624,,Activated partial thromboplastin time measured,Autocuration,,1,,,,22224,A,U,CHEMBL625216
,BAO_0000100,,,15207,,,,,0,10625,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),Autocuration,,1,,,,22224,P,U,CHEMBL625217
,BAO_0000100,,,15207,,,,,0,10626,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),Autocuration,,1,,,,22224,P,U,CHEMBL625218
,BAO_0000218,,,13941,,1969.0,,,1,10627,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL622864
,BAO_0000218,,,13941,,1969.0,,,1,10628,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622865
,BAO_0000218,,,13941,,1969.0,,,1,10629,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622866
,BAO_0000218,,,13941,,1969.0,,,1,10630,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL622867
,BAO_0000218,,,15240,,1969.0,,,1,10631,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,Intermediate,Cavia porcellus,1,10141.0,,Plasma,50512,A,N,CHEMBL876808
,BAO_0000019,,,10655,,955.0,,,0,10632,,AUC in brain,Autocuration,,1,,,Brain,22224,A,U,CHEMBL627725
,BAO_0000019,,,10655,,1977.0,,,0,10633,,AUC in serum,Autocuration,,1,,,Serum,22224,A,U,CHEMBL627726
,BAO_0000019,,,6504,,1969.0,,,0,10634,,AUC was determined,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL627727
,BAO_0000019,,,10615,,1969.0,,,0,10635,,AUC of the compound.,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL627728
,BAO_0000019,,,10353,,1969.0,,,0,10636,,AUC value (0-4 hr),Autocuration,,1,,,Plasma,22224,A,U,CHEMBL627729
,BAO_0000019,,,14907,,1969.0,,,0,10637,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",Autocuration,,1,,,Plasma,22224,A,U,CHEMBL627730
,BAO_0000019,,,14907,,1969.0,,,0,10638,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL627731
,BAO_0000019,,,14907,,1969.0,,,0,10639,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",Autocuration,,1,,,Plasma,22224,A,U,CHEMBL627732
,BAO_0000019,,,14907,,1969.0,,,0,10640,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",Autocuration,,1,,,Plasma,22224,A,U,CHEMBL627733
,BAO_0000218,,,16359,,1969.0,,,1,10641,,AUC(area under curve) was determined after intravenous administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627734
,BAO_0000218,,,16359,,1969.0,,,1,10642,,AUC(area under curve) was determined after oral administration in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627735
,BAO_0000218,,,15240,,1969.0,,,1,10643,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,Intermediate,Cavia porcellus,1,10141.0,,Plasma,50512,A,N,CHEMBL627736
,BAO_0000218,,,15240,,1969.0,,,1,10644,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL876809
,BAO_0000019,,,15469,,,,,0,10645,,Area Under Curve after oral dosing of 100 uM/Kg,Autocuration,,1,,,,22224,A,U,CHEMBL627737
,BAO_0000019,,,15469,,,,,0,10646,,Area Under Curve after oral dosing of 30 uM/Kg,Autocuration,,1,,,,22224,A,U,CHEMBL627738
,BAO_0000019,,,13520,,,,,0,10647,,Area Under Curve was measured by ploting the graph between concentration verses time,Autocuration,,1,,,,22224,A,U,CHEMBL627739
,BAO_0000218,,,17025,,,,,1,10648,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626143
,BAO_0000218,,,17025,,,,,0,10649,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL626144
,BAO_0000218,,,17025,,,,,1,10650,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL626145
,BAO_0000218,,,17025,,,,,1,10651,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626146
,BAO_0000218,,,12032,,178.0,,,1,10652,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626147
,BAO_0000019,,,10291,,,,,0,10653,,Area under curve (AUC) was determined,Autocuration,,1,,,,22224,A,U,CHEMBL626148
,BAO_0000218,,,5767,,,,,0,10654,,Area under curve (AUC) following ip administration at 1 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL626149
,BAO_0000019,,,1434,,,,,0,10655,,Area under curve (AUC) was determined; ND is Not determined,Autocuration,,1,,,,22224,A,U,CHEMBL626150
,BAO_0000218,,,14925,,,,,1,10656,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626151
,BAO_0000218,,,14925,,,,,1,10657,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626152
,BAO_0000218,,,14925,,,,,1,10658,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626153
,BAO_0000019,,,1434,,,,,0,10659,,Area under curve (AUR) was determined,Autocuration,,1,,,,22224,A,U,CHEMBL626154
,BAO_0000019,,,11883,,,,,0,10660,,Area under curve at 1 uM/dg administered intravenously,Autocuration,,1,,,,22224,A,U,CHEMBL626155
,BAO_0000019,,,11883,,,,,0,10661,,Area under curve at 10 uM/dg administered perorally,Autocuration,,1,,,,22224,A,U,CHEMBL626156
,BAO_0000019,,,11883,,,,,0,10662,,Area under curve at 2 uM/dg administered intravenously,Autocuration,,1,,,,22224,A,U,CHEMBL626157
,BAO_0000019,,,11883,,,,,0,10663,,Area under curve at 20 uM/dg administered perorally,Autocuration,,1,,,,22224,A,U,CHEMBL626158
,BAO_0000218,,,15233,,,,,1,10664,,Area under curve at a peroral dose of 3 mg/kg in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626159
,BAO_0000218,,,15233,,,,,1,10665,,Area under curve at a peroral dose of 3 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626160
,BAO_0000218,,,15233,,,,,1,10666,,Area under curve at an iv dose of 1 mg/kg in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626161
,BAO_0000218,,,15233,,,,,1,10667,,Area under curve at an iv dose of 1 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626162
,BAO_0000019,,,12978,,,,,0,10668,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,Autocuration,,1,,,,22224,A,U,CHEMBL626163
,BAO_0000019,,,12978,,,,,0,10669,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,Autocuration,,1,,,,22224,A,U,CHEMBL626164
,BAO_0000218,,,11355,,,,,1,10670,,Area under curve measured as conc vs time after intravenous administration to mice.,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626165
,BAO_0000218,,,11355,,,,,1,10671,,Area under curve measured as conc vs time after peroral administration to mice.,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626166
,BAO_0000218,,,12923,,,,,1,10672,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626167
,BAO_0000218,,,12923,,,,,1,10673,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626168
,BAO_0000218,,,12923,,,,,1,10674,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL877463
,BAO_0000218,,,12923,,,,,1,10675,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626169
,BAO_0000218,,In vivo,17738,,948.0,,,1,10676,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626170
,BAO_0000218,,In vivo,17738,,948.0,,,1,10677,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626171
,BAO_0000218,,In vivo,17738,,948.0,,,1,10678,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626172
,BAO_0000218,,In vivo,17738,,948.0,,,1,10679,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626173
,BAO_0000218,,In vivo,17738,,2113.0,,,1,10680,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626174
,BAO_0000218,,In vivo,17738,,2113.0,,,1,10681,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626175
,BAO_0000218,,In vivo,17738,,2113.0,,,1,10682,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626176
,BAO_0000218,,In vivo,17738,,2113.0,,,1,10683,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626177
,BAO_0000218,,In vivo,17738,,2113.0,,,1,10684,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL622499
,BAO_0000218,,In vivo,17738,,2107.0,,,1,10685,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622500
,BAO_0000218,,In vivo,17738,,2107.0,,,1,10686,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622501
,BAO_0000218,,In vivo,17738,,2107.0,,,1,10687,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622502
,BAO_0000218,,In vivo,17738,,2107.0,,,1,10688,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622503
,BAO_0000218,,In vivo,17738,,2107.0,,,1,10689,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL877614
,BAO_0000218,,In vivo,17738,,2048.0,,,1,10690,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624839
,BAO_0000218,,In vivo,17738,,2048.0,,,1,10691,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624840
,BAO_0000218,,In vivo,17738,,2048.0,,,1,10692,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624841
,BAO_0000218,,In vivo,17738,,2048.0,,,1,10693,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624842
,BAO_0000218,,In vivo,17738,,2385.0,,,1,10694,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624843
,BAO_0000218,,In vivo,17738,,2385.0,,,1,10695,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624844
,BAO_0000218,,In vivo,17738,,2385.0,,,1,10696,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624845
,BAO_0000218,,In vivo,17738,,2385.0,,,1,10697,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL621904
,BAO_0000218,,In vivo,11195,,178.0,,,1,10698,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL621905
,BAO_0000218,,In vivo,11195,,178.0,,,1,10699,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL874382
,BAO_0000218,,In vivo,11195,,178.0,,,1,10700,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL621906
,BAO_0000218,,In vivo,11195,,955.0,,,1,10701,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL621907
,BAO_0000218,,In vivo,11195,,955.0,,,1,10702,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622096
,BAO_0000218,,In vivo,11195,,955.0,,,1,10703,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622097
,BAO_0000218,,In vivo,11195,,948.0,,,1,10704,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL622098
,BAO_0000218,,In vivo,11195,,948.0,,,1,10705,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL622099
,BAO_0000218,,In vivo,11195,,948.0,,,1,10706,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL622100
,BAO_0000218,,In vivo,11195,,2113.0,,,1,10707,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL622101
,BAO_0000218,,In vivo,11195,,2113.0,,,1,10708,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL622102
,BAO_0000218,,In vivo,11195,,2113.0,,,1,10709,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL622103
,BAO_0000218,,In vivo,11195,,2107.0,,,1,10710,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622104
,BAO_0000218,,In vivo,11195,,2107.0,,,1,10711,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622105
,BAO_0000218,,In vivo,11195,,2107.0,,,1,10712,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622106
,BAO_0000218,,In vivo,11195,,2048.0,,,1,10713,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622107
,BAO_0000218,,In vivo,11195,,2048.0,,,1,10714,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622108
,BAO_0000218,,In vivo,11195,,2048.0,,,1,10715,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622109
,BAO_0000218,,In vivo,11195,,2385.0,,,1,10716,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL622110
,BAO_0000218,,In vivo,11195,,2385.0,,,1,10717,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL622111
,BAO_0000218,,In vivo,11195,,2385.0,,,1,10718,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL874383
,BAO_0000218,,In vivo,11195,,14.0,,,1,10719,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL622112
,BAO_0000218,,In vivo,11195,,14.0,,,1,10720,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL622113
,BAO_0000218,,In vivo,11195,,14.0,,,1,10721,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL622114
,BAO_0000218,,In vivo,11195,,2106.0,,,1,10722,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL622115
,BAO_0000218,,In vivo,11195,,2106.0,,,1,10723,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL622116
,BAO_0000218,,In vivo,6193,,,,,1,10724,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622117
,BAO_0000218,,In vivo,6803,,,,,1,10725,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622118
,BAO_0000218,,In vivo,6647,,,,,1,10726,,Oral bioavailability in rats at 6 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622119
,BAO_0000218,,In vivo,6647,,,,,1,10727,,Oral bioavailability in rat (dose 6 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622120
,BAO_0000218,,In vivo,6647,,,,,1,10728,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622121
,BAO_0000218,,In vivo,6640,,,,,1,10729,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622122
,BAO_0000218,,In vivo,6641,,,,,1,10730,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622123
,BAO_0000218,,In vivo,6641,,,,,1,10731,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622124
,BAO_0000218,,In vivo,6642,,,,,1,10732,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622125
,BAO_0000218,,In vivo,5472,,,,,1,10733,,Oral bioavailability,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622126
,BAO_0000218,,In vivo,6141,,,,,1,10734,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620455
,BAO_0000218,,In vivo,4390,,,,,1,10735,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620456
,BAO_0000218,,In vivo,5472,,,,,1,10736,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620457
,BAO_0000218,,In vivo,5472,,,,,1,10737,,Oral bioavailability was evaluated; Not tested,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620458
,BAO_0000218,,In vivo,5438,,,,,1,10738,,Oral bioavailability,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620459
,BAO_0000218,,In vivo,4883,,,,,1,10739,,Oral bioavailability in rat by oral dosing,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620460
,BAO_0000218,,In vivo,1908,,,,,1,10740,,Oral bioavailability in rat (dose 10 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620461
,BAO_0000218,,In vivo,4853,,,,,1,10741,,Oral bioavailability in rat (Sprague-Dawley),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620462
,BAO_0000218,,In vivo,4853,,,,,1,10742,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620463
,BAO_0000218,,In vivo,4853,,,,,1,10743,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620464
,BAO_0000218,,In vivo,4853,,,,,1,10744,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620465
,BAO_0000218,,In vivo,4853,,,,,1,10745,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620466
,BAO_0000218,,In vivo,4853,,,,,1,10746,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620467
,BAO_0000218,,In vivo,4853,,,,,1,10747,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620468
,BAO_0000218,,In vivo,12873,,,,,1,10748,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620469
,BAO_0000218,,In vivo,12873,,,,,1,10749,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620470
,BAO_0000218,,In vivo,3169,,,,,1,10750,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620471
,BAO_0000218,,In vivo,6305,,,,,1,10751,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620472
,BAO_0000218,,In vivo,4762,,,,,1,10752,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620473
,BAO_0000218,,In vivo,17847,,,,,1,10753,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620474
,BAO_0000218,,In vivo,6211,,,,,1,10754,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620475
,BAO_0000218,,In vivo,6011,,,,,1,10755,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620476
,BAO_0000218,,In vivo,6317,,,,,1,10756,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620477
,BAO_0000218,,In vivo,6644,,,,,1,10757,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620478
,BAO_0000218,,In vivo,6644,,,,,1,10758,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618768
,BAO_0000218,,In vivo,6644,,,,,1,10759,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618769
,BAO_0000218,,In vivo,6644,,,,,1,10760,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618770
,BAO_0000218,,In vivo,6113,,,,,1,10761,,Oral bioavailability (dose 20 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618771
,BAO_0000218,,In vivo,5937,,,,,1,10762,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618772
,BAO_0000218,,In vivo,5711,,,,,1,10763,,Oral bioavailability in rat at 10 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618773
,BAO_0000218,,In vivo,17717,,,,,1,10764,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875842
,BAO_0000218,,In vivo,17717,,,,,1,10765,,Bioavailability in rat (dose 3 mg/kg i.v.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618774
,BAO_0000218,,In vivo,17717,,,,,1,10766,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618775
,BAO_0000218,,In vivo,17717,,,,,1,10767,,Oral bioavailability in rat (dose 60 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618776
,BAO_0000218,,In vivo,4722,,,,,1,10768,,Percent bioavailability (F) in rats after iv administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618777
,BAO_0000218,,In vivo,4722,,,,,1,10769,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618778
,BAO_0000218,,In vivo,4353,,,,,1,10770,,Bioavailability in rat (dose 5 uM/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618779
,BAO_0000218,,In vivo,15662,,,,,1,10771,,Oral bioavailability,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618780
,BAO_0000218,,In vivo,4756,,,,,1,10772,,Bioavailability in rat (dose 2 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618781
,BAO_0000218,,In vivo,4756,,,,,1,10773,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618782
,BAO_0000218,,In vivo,3436,,,,,1,10774,,Oral bioavailability in rat (dose 20 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618783
,BAO_0000218,,In vivo,17800,,,,,1,10775,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618784
,BAO_0000218,,In vivo,15762,,,,,1,10776,,Percent oral bioavailability evaluated in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618785
,BAO_0000218,,In vivo,5089,,,,,1,10777,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618786
,BAO_0000218,,In vivo,5089,,,,,1,10778,,Percent oral bioavailability in rat; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618787
,BAO_0000218,,In vivo,3185,,,,,1,10779,,Oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618788
,BAO_0000218,,In vivo,5145,,,,,1,10780,,Bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618789
,BAO_0000218,,In vivo,3457,,,,,1,10781,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618790
,BAO_0000218,,In vivo,3457,,,,,1,10782,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618791
,BAO_0000218,,In vivo,5983,,,,,1,10783,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875843
,BAO_0000218,,In vivo,5739,,,,,1,10784,,Oral bioavailability in rat (dose 20 mg/kg p.o.),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL618792
,BAO_0000218,,In vivo,3579,,,,,1,10785,,Cmax at a dose of 30 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623395
,BAO_0000218,,In vivo,17788,,,,,0,10786,,Cmax in monkeys at a dose of 1 mg/kg,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL623396
,BAO_0000218,,In vivo,14956,,,,,1,10787,,Cmax in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623397
,BAO_0000218,,In vivo,17788,,,,,1,10788,,Cmax in rats at a dose of 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623398
,BAO_0000218,,In vivo,9750,,,,,1,10789,,Cmax was measured in mice after an oral dose of 50 mg/kg.,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623399
,BAO_0000218,,In vivo,12767,,,,,0,10790,,"Cmax value at a dose of 12.7 uM/kg, po",Autocuration,,1,,,,22224,A,U,CHEMBL623400
,BAO_0000218,,In vivo,12767,,,,,0,10791,,"Cmax value at a dose of 6.3 uM/kg, iv",Autocuration,,1,,,,22224,A,U,CHEMBL623401
,BAO_0000218,,In vivo,12767,,,,,0,10792,,"Cmax value at a dose of 7.1 uM/kg, iv",Autocuration,,1,,,,22224,A,U,CHEMBL623402
,BAO_0000218,,In vivo,12703,,,,,0,10793,,Cmax value of compound was determined after 1 hr,Autocuration,,1,,,,22224,A,U,CHEMBL623403
,BAO_0000218,,In vivo,15778,,,,,0,10794,,Cmax value of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL623404
,BAO_0000218,,In vivo,12818,,,,,1,10795,,Cmax value administered intraintestinal in rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625997
,BAO_0000218,,In vivo,14964,,,,,1,10796,,Cmax value administered perorally was determined in rat; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625998
,BAO_0000218,,In vivo,15808,,,,,0,10797,,Cmax value at the dose of 2.3 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL625999
,BAO_0000218,,In vivo,15808,,,,,0,10798,,Cmax value at the dose of 5 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL626000
,BAO_0000218,,In vivo,15778,,,,,0,10799,,Cmax value in the period of 8 hr after dosing. ,Autocuration,,1,,,,22224,A,U,CHEMBL626001
,BAO_0000218,,In vivo,3715,,,,,0,10800,,Cmax value at a oral dose of 20 mg/kg; Not tested,Autocuration,,1,,,,22224,A,U,CHEMBL626002
,BAO_0000218,,In vivo,3715,,,,,0,10801,,Cmax value at a oral dose of 20 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL626003
,BAO_0000218,,In vivo,1446,,,,,1,10802,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626004
,BAO_0000218,,In vivo,15240,,,,,1,10803,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,Intermediate,Cavia porcellus,1,10141.0,,,50512,A,N,CHEMBL626005
,BAO_0000218,,In vivo,15240,,,,,1,10804,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626006
,BAO_0000218,,In vivo,14810,,1969.0,,,1,10805,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626007
,BAO_0000218,,In vivo,14239,,1969.0,,,1,10806,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL626008
,BAO_0000218,,In vivo,12555,,2107.0,,,1,10807,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,Intermediate,Canis lupus familiaris,1,9615.0,,Liver,50588,A,N,CHEMBL626009
,BAO_0000218,,In vivo,10754,,,,,1,10808,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626010
,BAO_0000218,,In vivo,10754,,178.0,,,1,10809,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL626011
,BAO_0000218,,In vivo,10754,,178.0,,,1,10810,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL626012
,BAO_0000218,,In vivo,10754,,178.0,,,1,10811,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL626013
,BAO_0000218,,In vivo,10754,,178.0,,,1,10812,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL626014
,BAO_0000218,,In vivo,10754,,178.0,,,1,10813,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL877496
,BAO_0000218,,In vivo,14600,,,,,1,10814,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,F,N,CHEMBL626015
,BAO_0000218,,In vivo,14600,,,,,1,10815,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,F,N,CHEMBL626016
,BAO_0000218,,In vivo,14600,,,,,1,10816,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,F,N,CHEMBL626017
,BAO_0000218,,In vivo,13543,,1969.0,,,1,10817,,Bioavailability as maximal plasma concentration in dogs,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626018
,BAO_0000218,,In vivo,13543,,1969.0,,,1,10818,,Bioavailability as maximal plasma concentration in dogs,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626692
,BAO_0000218,,In vivo,13543,,1969.0,,,1,10819,,Bioavailability as maximal plasma concentration in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626693
,BAO_0000218,,In vivo,13543,,1969.0,,,0,10820,,Bioavailability as maximal plasma concentration in rats,Autocuration,Rattus norvegicus,1,10116.0,,Plasma,22224,A,U,CHEMBL626694
,BAO_0000218,,In vivo,14600,,178.0,,,1,10821,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,Canis lupus familiaris,1,9615.0,,Blood,50588,A,N,CHEMBL626695
,BAO_0000218,,In vivo,14600,,178.0,,,1,10822,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,Canis lupus familiaris,1,9615.0,,Blood,50588,A,N,CHEMBL626696
,BAO_0000218,,In vivo,14600,,178.0,,,1,10823,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,Canis lupus familiaris,1,9615.0,,Blood,50588,A,N,CHEMBL626697
,BAO_0000218,,In vivo,14600,,178.0,,,1,10824,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,Intermediate,Canis lupus familiaris,1,9615.0,,Blood,50588,A,N,CHEMBL626859
,BAO_0000218,,In vivo,14600,,178.0,,,1,10825,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,Canis lupus familiaris,1,9615.0,,Blood,50588,A,N,CHEMBL626860
,BAO_0000218,,In vivo,14600,,178.0,,,1,10826,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,Canis lupus familiaris,1,9615.0,,Blood,50588,A,N,CHEMBL626861
,BAO_0000218,,In vivo,14681,,,,,1,10827,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626296
,BAO_0000218,,In vivo,15905,,,,,0,10828,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL626297
,BAO_0000218,,In vivo,15905,,1969.0,,,0,10829,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL626298
,BAO_0000218,,In vivo,13304,,1969.0,,,1,10830,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626299
,BAO_0000218,,In vivo,15137,,1969.0,,,1,10831,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626300
,BAO_0000218,,In vivo,15137,,1969.0,,,1,10832,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626301
,BAO_0000218,,In vivo,15137,,1969.0,,,1,10833,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626962
,BAO_0000218,,In vivo,15137,,1969.0,,,1,10834,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626963
,BAO_0000218,,In vivo,15137,,1969.0,,,1,10835,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626964
,BAO_0000218,,In vivo,14839,,1969.0,,,1,10836,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,Intermediate,Macaca fascicularis,1,9541.0,,Plasma,100710,A,N,CHEMBL626965
,BAO_0000218,,In vivo,14839,,1969.0,,,1,10837,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL626966
,BAO_0000218,,In vivo,14839,,1969.0,,,1,10838,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL626967
,BAO_0000218,,In vivo,14839,,1969.0,,,1,10839,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,Intermediate,Macaca fascicularis,1,9541.0,,Plasma,100710,A,N,CHEMBL626968
,BAO_0000218,,,8418,,948.0,,,1,10840,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626969
,BAO_0000218,,,8418,,948.0,,,1,10841,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL627126
,BAO_0000218,,,8418,,948.0,,,1,10842,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631276
,BAO_0000218,,,8418,,948.0,,,1,10843,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631277
,BAO_0000218,,,8418,,948.0,,,1,10844,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631278
,BAO_0000218,,,8418,,948.0,,,1,10845,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL874457
,BAO_0000218,,,8418,,948.0,,,1,10846,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631279
,BAO_0000218,,,8418,,948.0,,,1,10847,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631280
,BAO_0000218,,,8418,,948.0,,,1,10848,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631281
,BAO_0000218,,,8418,,948.0,,,1,10849,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631968
,BAO_0000218,,,8418,,948.0,,,1,10850,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631969
,BAO_0000218,,,8418,,948.0,,,1,10851,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631970
,BAO_0000218,,,8418,,948.0,,,1,10852,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631971
,BAO_0000218,,,8418,,948.0,,,1,10853,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL631972
,BAO_0000218,,,8418,,948.0,,,1,10854,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL630435
,BAO_0000218,,,8418,,948.0,,,1,10855,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL630436
,BAO_0000218,,,8418,,948.0,,,1,10856,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL630437
,BAO_0000218,,,8418,,948.0,,,1,10857,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL630438
,BAO_0000218,,,8418,,948.0,,,1,10858,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL630439
,BAO_0000218,,,8418,,2113.0,,,1,10859,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL630440
,BAO_0000218,,,8418,,2113.0,,,1,10860,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL630441
,BAO_0000218,,,8418,,2113.0,,,1,10861,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL630442
,BAO_0000218,,,8418,,2113.0,,,1,10862,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625234
,BAO_0000218,,,8418,,2113.0,,,1,10863,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625235
,BAO_0000218,,,8418,,2113.0,,,1,10864,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625236
,BAO_0000218,,,8418,,2113.0,,,1,10865,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625237
,BAO_0000218,,,8418,,2113.0,,,1,10866,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626125
,BAO_0000218,,,8418,,2113.0,,,1,10867,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626126
,BAO_0000218,,,8418,,2113.0,,,1,10868,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626127
,BAO_0000218,,,8418,,2113.0,,,1,10869,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626128
,BAO_0000218,,,8418,,2113.0,,,1,10870,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626129
,BAO_0000218,,,8418,,2113.0,,,1,10871,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626130
,BAO_0000218,,,8418,,2113.0,,,1,10872,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626131
,BAO_0000218,,,8418,,2113.0,,,1,10873,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626132
,BAO_0000218,,,8418,,2113.0,,,1,10874,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626752
,BAO_0000218,,,8418,,2113.0,,,1,10875,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626753
,BAO_0000218,,,8418,,2113.0,,,1,10876,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626754
,BAO_0000218,,,8418,,2113.0,,,1,10877,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626755
,BAO_0000218,,,8418,,2107.0,,,1,10878,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626756
,BAO_0000218,,,8418,,2107.0,,,1,10879,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626757
,BAO_0000218,,,8418,,2107.0,,,1,10880,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626758
,BAO_0000218,,,8418,,2107.0,,,1,10881,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626759
,BAO_0000218,,,8418,,2107.0,,,1,10882,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626760
,BAO_0000218,,,6996,,,,,1,10883,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626394
,BAO_0000218,,,6996,,,,,1,10884,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626395
,BAO_0000218,,,6996,,,,,1,10885,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626396
,BAO_0000218,,,6996,,,,,1,10886,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626397
,BAO_0000218,,,6996,,,,,1,10887,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626398
,BAO_0000218,,,6996,,,,,1,10888,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626399
,BAO_0000218,,,6996,,,,,1,10889,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874653
,BAO_0000218,,,6996,,,,,1,10890,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626400
,BAO_0000218,,,6996,,,,,1,10891,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626401
,BAO_0000218,,,6996,,,,,1,10892,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626402
,BAO_0000218,,,6996,,,,,1,10893,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626403
,BAO_0000218,,,6996,,,,,1,10894,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626404
,BAO_0000218,,,6996,,,,,1,10895,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626405
,BAO_0000218,,,6996,,,,,1,10896,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625529
,BAO_0000218,,,6996,,,,,1,10897,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625530
,BAO_0000218,,,6996,,,,,1,10898,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625531
,BAO_0000218,,,6996,,,,,1,10899,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625532
,BAO_0000218,,,6996,,,,,1,10900,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625533
,BAO_0000218,,,6996,,,,,1,10901,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875474
,BAO_0000218,,,6996,,,,,1,10902,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625534
,BAO_0000218,,,6996,,,,,1,10903,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625535
,BAO_0000218,,,6996,,,,,1,10904,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625536
,BAO_0000218,,,6996,,,,,1,10905,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625537
,BAO_0000218,,,6996,,,,,1,10906,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625538
,BAO_0000218,,,6996,,,,,1,10907,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625539
,BAO_0000218,,,6996,,,,,1,10908,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625540
,BAO_0000218,,,6996,,,,,1,10909,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625541
,BAO_0000218,,,6996,,,,,1,10910,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625542
,BAO_0000218,,,6996,,,,,1,10911,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625543
,BAO_0000218,,,6996,,,,,1,10912,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625544
,BAO_0000218,,,6996,,,,,1,10913,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625545
,BAO_0000218,,,6996,,,,,1,10914,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625546
,BAO_0000218,,,6996,,,,,1,10915,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625547
,BAO_0000218,,,6996,,,,,1,10916,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625548
,BAO_0000218,,,6996,,,,,1,10917,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625549
,BAO_0000218,,,6996,,,,,1,10918,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625550
,BAO_0000218,,,6996,,,,,1,10919,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625551
,BAO_0000218,,,6996,,,,,1,10920,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL875475
,BAO_0000218,,,6996,,,,,1,10921,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625552
,BAO_0000218,,,6996,,,,,1,10922,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625553
,BAO_0000218,,,6996,,,,,1,10923,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625554
,BAO_0000218,,,6996,,,,,1,10924,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625555
,BAO_0000218,,,6996,,,,,1,10925,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625556
,BAO_0000218,,,6996,,,,,1,10926,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624986
,BAO_0000218,,,6996,,,,,1,10927,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624987
,BAO_0000218,,,6996,,,,,1,10928,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624988
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10929,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL624989
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10930,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL624990
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10931,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL874391
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10932,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL624991
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10933,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL624992
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10934,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL624993
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10935,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL624994
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10936,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL624995
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10937,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL624996
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10938,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL624997
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10939,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL624998
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10940,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL624999
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10941,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL882955
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10942,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL625000
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10943,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL625001
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10944,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL625089
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10945,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL625090
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10946,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL625091
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10947,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL625092
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10948,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL625093
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10949,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL625094
,BAO_0000218,,In vivo,9025,,1637.0,,,1,10950,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL625095
,BAO_0000218,,In vivo,2249,,,,,1,10951,,Compound was evaluated for its bioavailability in the dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625096
,BAO_0000218,,In vivo,2249,,,,,1,10952,,Compound was evaluated for its bioavailability in the rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625097
,BAO_0000218,,In vivo,17515,,,,,0,10953,,Compound was evaluated for oral bioavailability,Autocuration,,1,,,,22224,A,U,CHEMBL882956
,BAO_0000218,,In vivo,14541,,,,,1,10954,,Compound was evaluated for percentage of Oral bioavailability in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625098
,BAO_0000218,,In vivo,12797,,,,,0,10955,,Bioavailability in guinea pig,Autocuration,Cavia porcellus,1,10141.0,,,22224,A,U,CHEMBL625099
,BAO_0000218,,In vivo,12797,,,,,1,10956,,Compound was evaluated for the oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625100
,BAO_0000218,,In vivo,12797,,,,,1,10957,,Compound was evaluated for the oral bioavailability in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625101
,BAO_0000218,,In vivo,12797,,,,,1,10958,,Compound was evaluated for the oral bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874396
,BAO_0000218,,In vivo,11727,,,,,0,10959,,Bioavailability in dog (dosed i.v.),Autocuration,Canis lupus familiaris,1,9615.0,,,22224,F,U,CHEMBL625102
,BAO_0000218,,In vivo,13249,,,,,1,10960,,Compound was tested for in vivo bioavailability in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625103
,BAO_0000218,,In vivo,13249,,,,,1,10961,,Compound was tested for in vivo bioavailability in hamsters,Intermediate,Cricetinae,1,10026.0,,,100712,A,N,CHEMBL625104
,BAO_0000218,,In vivo,13249,,,,,0,10962,,Compound was tested for in vivo bioavailability in monkey,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL625105
,BAO_0000218,,In vivo,13249,,,,,1,10963,,Compound was tested for in vivo bioavailability in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625106
,BAO_0000218,,In vivo,9552,,,,,0,10964,,Oral bioavailability in mouse,Autocuration,Mus musculus,1,10090.0,,,22224,A,U,CHEMBL625107
,BAO_0000218,,In vivo,9552,,,,,1,10965,,Compound was tested for percent of oral bioavailability in mice; 56-74,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625108
,BAO_0000218,,In vivo,14839,,,,,0,10966,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),Autocuration,Mus musculus,1,10090.0,,,22224,A,U,CHEMBL625109
,BAO_0000218,,In vivo,14839,,,,,0,10967,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),Autocuration,Macaca fascicularis,1,9541.0,,,22224,A,U,CHEMBL625110
,BAO_0000218,,In vivo,14839,,,,,0,10968,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),Autocuration,Macaca fascicularis,1,9541.0,,,22224,A,U,CHEMBL625111
,BAO_0000218,,In vivo,14839,,,,,1,10969,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625112
,BAO_0000218,,In vivo,14839,,,,,1,10970,,Oral bioavailability in nude mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL875334
,BAO_0000218,,In vivo,11219,,,,,0,10971,,Bioavailability in monkey (i.d. dosing),Autocuration,Primates,1,9443.0,,,22224,A,U,CHEMBL628617
,BAO_0000218,,In vivo,9552,,,,,0,10972,,Bioavailability in rat,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL628618
,BAO_0000218,,In vivo,11732,,,,,0,10973,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,Autocuration,,1,,,,22224,A,U,CHEMBL628619
,BAO_0000218,,In vivo,11732,,,,,0,10974,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,Autocuration,,1,,,,22224,A,U,CHEMBL628620
,BAO_0000218,,In vivo,14839,,,,,1,10975,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL628621
,BAO_0000218,,In vivo,14839,,,,,1,10976,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL628622
,BAO_0000218,,In vivo,14839,,,,,1,10977,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL628623
,BAO_0000218,,In vivo,14839,,1969.0,,,1,10978,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,Intermediate,Macaca fascicularis,1,9541.0,,Plasma,100710,A,N,CHEMBL628624
,BAO_0000218,,In vivo,14839,,1969.0,,,1,10979,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL628625
,BAO_0000218,,In vivo,14839,,1969.0,,,1,10980,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,Intermediate,Macaca fascicularis,1,9541.0,,Plasma,100710,A,N,CHEMBL628626
,BAO_0000218,,In vivo,14839,,1969.0,,,1,10981,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL627041
,BAO_0000218,,In vivo,14839,,1969.0,,,1,10982,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL627042
,BAO_0000218,,In vivo,14839,,1969.0,,,1,10983,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL627043
,BAO_0000218,,In vivo,13932,,1969.0,,,0,10984,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL627044
,BAO_0000218,,In vivo,11637,,1969.0,,,1,10985,,Cmax in mouse plasma,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL627045
,BAO_0000218,,In vivo,11637,,1969.0,,,0,10986,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL627046
,BAO_0000218,,In vivo,13960,,1969.0,,,1,10987,,Maximal plasma concentration in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627047
,BAO_0000218,,In vivo,15905,,1969.0,,,1,10988,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627048
,BAO_0000218,,In vivo,14062,,,,,1,10989,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627049
,BAO_0000218,,In vivo,14062,,,,,1,10990,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627050
,BAO_0000218,,In vivo,14062,,,,,1,10991,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627051
,BAO_0000218,,In vivo,14062,,,,,1,10992,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627052
,BAO_0000218,,In vivo,14062,,,,,1,10993,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627053
,BAO_0000218,,In vivo,14062,,,,,1,10994,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627054
,BAO_0000218,,In vivo,15011,,,,,1,10995,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627055
,BAO_0000218,,In vivo,15011,,,,,1,10996,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627056
,BAO_0000218,,In vivo,15011,,,,,1,10997,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627057
,BAO_0000218,,In vivo,15011,,,,,1,10998,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627058
,BAO_0000218,,In vivo,15011,,,,,1,10999,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626211
,BAO_0000218,,In vivo,10291,,,,,0,11000,,Maximum Concentration of the compound.,Autocuration,,1,,,,22224,A,U,CHEMBL626212
,BAO_0000218,,In vivo,14599,,,,,1,11001,,Maximum Concentration was measured after iv administration into Beagle dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626213
,BAO_0000218,,In vivo,14599,,,,,1,11002,,Maximum Concentration was measured after iv administration into Beagle dog.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626214
,BAO_0000218,,In vivo,14599,,,,,1,11003,,Maximum Concentration was measured after po administration into Beagle dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626215
,BAO_0000218,,In vivo,14599,,,,,1,11004,,Maximum Concentration was measured after po administration into Beagle dog.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626216
,BAO_0000218,,In vivo,12767,,178.0,,,0,11005,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,Autocuration,,1,,,Blood,22224,A,U,CHEMBL626217
,BAO_0000218,,In vivo,12767,,178.0,,,0,11006,,Maximum blood level reached after an iv dose of 12.2 uM/kg,Autocuration,,1,,,Blood,22224,A,U,CHEMBL626218
,BAO_0000218,,In vivo,12767,,178.0,,,0,11007,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,Autocuration,,1,,,Blood,22224,A,U,CHEMBL626219
,BAO_0000218,,In vivo,12767,,178.0,,,0,11008,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,Autocuration,,1,,,Blood,22224,A,U,CHEMBL626220
,BAO_0000218,,In vivo,12767,,178.0,,,0,11009,,Maximum blood level reached after an oral dose of 5.0 mg/kg,Autocuration,,1,,,Blood,22224,A,U,CHEMBL626221
,BAO_0000218,,In vivo,12767,,178.0,,,0,11010,,Maximum blood level reached at dose of 10.6 uM/kg orally,Autocuration,,1,,,Blood,22224,A,U,CHEMBL626222
,BAO_0000218,,In vivo,14706,,,,,1,11011,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,Intermediate,Cavia porcellus,1,10141.0,,,50512,A,N,CHEMBL626223
,BAO_0000218,,In vivo,14706,,,,,1,11012,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,Intermediate,Cavia porcellus,1,10141.0,,,50512,A,N,CHEMBL626224
,BAO_0000218,,In vivo,14793,,955.0,,,1,11013,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL626225
,BAO_0000218,,In vivo,14793,,955.0,,,1,11014,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL626226
,BAO_0000218,,In vivo,14793,,955.0,,,1,11015,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL626227
,BAO_0000218,,In vivo,14793,,955.0,,,1,11016,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL626228
,BAO_0000218,,In vivo,14793,,,,,1,11017,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626229
,BAO_0000218,,In vivo,14793,,,,,1,11018,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626921
,BAO_0000218,,In vivo,14793,,,,,1,11019,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876793
,BAO_0000218,,In vivo,14793,,,,,1,11020,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625309
,BAO_0000218,,In vivo,10524,,,,,1,11021,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Intermediate,Bacillus subtilis,1,1423.0,,,50278,A,N,CHEMBL625310
,BAO_0000218,,In vivo,11871,,,,,0,11022,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL625311
,BAO_0000218,,In vivo,11871,,,,,1,11023,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625312
,BAO_0000218,,In vivo,3437,,,,,0,11024,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,Autocuration,,1,,,,22224,A,U,CHEMBL625313
,BAO_0000218,,In vivo,12038,,,,,1,11025,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625314
,BAO_0000218,,In vivo,12038,,,,,1,11026,,Maximum concentration in male rats after iv administration of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625315
,BAO_0000218,,,8418,,2107.0,,,1,11027,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625316
,BAO_0000218,,,8418,,2107.0,,,1,11028,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625317
,BAO_0000218,,,8418,,2107.0,,,1,11029,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625318
,BAO_0000218,,,8418,,2107.0,,,1,11030,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625319
,BAO_0000218,,,8418,,2107.0,,,1,11031,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625320
,BAO_0000218,,,8418,,2107.0,,,1,11032,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625321
,BAO_0000218,,,8418,,2107.0,,,1,11033,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625322
,BAO_0000218,,,8418,,2107.0,,,1,11034,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL876801
,BAO_0000218,,,8418,,2107.0,,,1,11035,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625323
,BAO_0000218,,,8418,,2107.0,,,1,11036,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625324
,BAO_0000218,,,8418,,2107.0,,,1,11037,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625325
,BAO_0000218,,,8418,,2107.0,,,1,11038,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625326
,BAO_0000218,,,8418,,2107.0,,,1,11039,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625327
,BAO_0000218,,,8418,,2107.0,,,1,11040,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625328
,BAO_0000218,,,8418,,2048.0,,,1,11041,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625329
,BAO_0000218,,,8418,,2048.0,,,1,11042,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625330
,BAO_0000218,,,8418,,2048.0,,,1,11043,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627774
,BAO_0000218,,,8418,,2048.0,,,1,11044,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627775
,BAO_0000218,,,8418,,2048.0,,,1,11045,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627949
,BAO_0000218,,,8418,,2048.0,,,1,11046,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627950
,BAO_0000218,,,8418,,2048.0,,,1,11047,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627951
,BAO_0000218,,,8418,,2048.0,,,1,11048,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627952
,BAO_0000218,,,8418,,2048.0,,,1,11049,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627953
,BAO_0000218,,,8418,,2048.0,,,1,11050,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627954
,BAO_0000218,,,8418,,2048.0,,,1,11051,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627955
,BAO_0000218,,,8418,,2048.0,,,1,11052,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627956
,BAO_0000218,,,8418,,2048.0,,,1,11053,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL876802
,BAO_0000218,,,8418,,2048.0,,,1,11054,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627957
,BAO_0000218,,,8418,,2048.0,,,1,11055,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627958
,BAO_0000218,,,8418,,2048.0,,,1,11056,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627959
,BAO_0000218,,,8418,,2048.0,,,1,11057,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627960
,BAO_0000218,,,8418,,2048.0,,,1,11058,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627961
,BAO_0000218,,,8418,,2048.0,,,1,11059,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627962
,BAO_0000218,,,9796,,,,,1,11060,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627963
,BAO_0000218,,,9796,,,,,1,11061,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624759
,BAO_0000218,,,9796,,,,,1,11062,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624760
,BAO_0000218,,,9796,,,,,1,11063,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624761
,BAO_0000218,,,9796,,,,,1,11064,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877607
,BAO_0000218,,,9796,,2107.0,,,1,11065,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624762
,BAO_0000218,,,9796,,2107.0,,,1,11066,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624763
,BAO_0000218,,,9796,,2107.0,,,1,11067,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624764
,BAO_0000218,,,9796,,2107.0,,,1,11068,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624765
,BAO_0000218,,,9796,,2107.0,,,1,11069,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624766
,BAO_0000218,,,6996,,,,,1,11070,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624767
,BAO_0000218,,,6996,,,,,1,11071,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624768
,BAO_0000218,,,6996,,,,,1,11072,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624769
,BAO_0000218,,,6996,,,,,1,11073,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624770
,BAO_0000218,,,6996,,,,,1,11074,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624771
,BAO_0000218,,,6996,,,,,1,11075,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624772
,BAO_0000218,,,6996,,,,,1,11076,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624773
,BAO_0000218,,,6996,,,,,1,11077,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624774
,BAO_0000218,,,6996,,,,,1,11078,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624775
,BAO_0000218,,,6996,,,,,1,11079,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624776
,BAO_0000218,,,6996,,,,,1,11080,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624777
,BAO_0000218,,,6996,,,,,1,11081,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624778
,BAO_0000218,,,6996,,,,,1,11082,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624779
,BAO_0000218,,,6996,,,,,1,11083,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624780
,BAO_0000218,,,6996,,,,,1,11084,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624781
,BAO_0000218,,,6996,,,,,1,11085,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877608
,BAO_0000218,,,6996,,,,,1,11086,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624782
,BAO_0000218,,,6996,,,,,1,11087,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624783
,BAO_0000218,,,6996,,,,,1,11088,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624784
,BAO_0000218,,,6996,,,,,1,11089,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624785
,BAO_0000218,,,6996,,,,,1,11090,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624786
,BAO_0000218,,,6996,,,,,1,11091,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624787
,BAO_0000218,,,6996,,,,,1,11092,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628676
,BAO_0000218,,,6996,,,,,1,11093,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621842
,BAO_0000218,,,6996,,,,,1,11094,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL621843
,BAO_0000218,,,6996,,,,,1,11095,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623873
,BAO_0000218,,,6996,,,,,1,11096,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623874
,BAO_0000218,,,6996,,,,,1,11097,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623875
,BAO_0000218,,,6996,,,,,1,11098,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623876
,BAO_0000218,,,6996,,,,,1,11099,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL623877
,BAO_0000218,,,6996,,,,,1,11100,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL623878
,BAO_0000218,,,6996,,,,,1,11101,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL623879
,BAO_0000218,,,6996,,,,,1,11102,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL623880
,BAO_0000218,,,6996,,,,,1,11103,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL623881
,BAO_0000218,,,6996,,,,,1,11104,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL623957
,BAO_0000218,,,6996,,,,,1,11105,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL623958
,BAO_0000218,,,6996,,,,,1,11106,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL623959
,BAO_0000218,,,6996,,,,,1,11107,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL623960
,BAO_0000218,,,6996,,,,,1,11108,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL623961
,BAO_0000218,,,6996,,,,,1,11109,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL623962
,BAO_0000218,,,6996,,,,,1,11110,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624676
,BAO_0000218,,,6996,,,,,1,11111,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624677
,BAO_0000218,,,6996,,,,,1,11112,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624678
,BAO_0000218,,,6996,,,,,1,11113,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624679
,BAO_0000218,,,6996,,,,,1,11114,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624680
,BAO_0000218,,In vivo,11732,,,,,0,11115,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,Autocuration,,1,,,,22224,A,U,CHEMBL624849
,BAO_0000218,,In vivo,11732,,,,,0,11116,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,Autocuration,,1,,,,22224,A,U,CHEMBL624850
,BAO_0000218,,In vivo,11732,,,,,0,11117,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,Autocuration,,1,,,,22224,A,U,CHEMBL874399
,BAO_0000218,,In vivo,11732,,,,,0,11118,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,Autocuration,,1,,,,22224,A,U,CHEMBL624851
,BAO_0000218,,In vivo,11732,,,,,0,11119,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,Autocuration,,1,,,,22224,A,U,CHEMBL624852
,BAO_0000218,,In vivo,13359,,,,,0,11120,,Oral bioavailability in rat (dose 10 mg/kg),Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL624853
,BAO_0000218,,In vivo,16618,,,,,0,11121,,Oral bioavailability in rat (Sprague-Dawley),Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL624854
,BAO_0000218,,In vivo,13960,,,,,0,11122,,Oral bioavailability in rat,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL624855
,BAO_0000218,,In vivo,13917,,,,,0,11123,,Oral bioavailability in rats was determined in vivo,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL624856
,BAO_0000218,,In vivo,14266,,,,,0,11124,,Oral bioavailability in dog,Autocuration,Canis lupus familiaris,1,9615.0,,,22224,A,U,CHEMBL882957
,BAO_0000218,,In vivo,12359,,,,,0,11125,,Oral bioavailability of compound in monkey,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL624857
,BAO_0000218,,In vivo,12359,,,,,1,11126,,Oral bioavailability of compound in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622202
,BAO_0000218,,In vivo,12359,,,,,0,11127,,Bioavailability in rat of PMEA prodrug,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL622203
,BAO_0000218,,In vivo,12359,,,,,1,11128,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625522
,BAO_0000218,,In vivo,10791,,,,,0,11129,,Serum conc at 3 hours following 25 mg/kg dose,Autocuration,Macaca mulatta,1,9544.0,,,22224,A,U,CHEMBL622868
,BAO_0000218,,In vivo,10791,,1088.0,,,0,11130,,Urine conc 0-5 hours following 25 mg/kg dose,Autocuration,Macaca mulatta,1,9544.0,,Urine,22224,A,U,CHEMBL622869
,BAO_0000218,,In vivo,10791,,1088.0,,,0,11131,,Urine conc 0-24 hours following 25 mg/kg dose,Autocuration,Macaca mulatta,1,9544.0,,Urine,22224,A,U,CHEMBL622870
,BAO_0000218,,In vivo,138,,,,,0,11132,,Oral bioavailability in African green monkeys; 20-25,Autocuration,Chlorocebus aethiops,1,9534.0,,,22224,A,U,CHEMBL622871
,BAO_0000218,,In vivo,14521,,,,,1,11133,,Oral bioavailability in cynomolgus monkey.,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL620560
,BAO_0000218,,In vivo,13953,,,,,0,11134,,Oral bioavailability in dog,Autocuration,Canis lupus familiaris,1,9615.0,,,22224,A,U,CHEMBL620561
,BAO_0000218,,In vivo,12836,,,,,1,11135,,Oral bioavailability in dog at 10 mg/kg oral dose,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL620562
,BAO_0000218,,In vivo,12836,,,,,1,11136,,Oral bioavailability in hamster at 10 mg/kg oral dose,Intermediate,Cricetinae,1,10026.0,,,100712,A,N,CHEMBL620563
,BAO_0000218,,In vivo,12836,,,,,1,11137,,Oral bioavailability in rat at 10 mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL620564
,BAO_0000218,,In vivo,14521,,,,,0,11138,,Oral bioavailability in rat,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL872265
,BAO_0000218,,In vivo,13953,,,,,0,11139,,Oral bioavailability in rat,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL620565
,BAO_0000218,,In vivo,6799,,,,,0,11140,,Oral bioavailability,Autocuration,Eutheria,1,9347.0,,,22224,A,U,CHEMBL620566
,BAO_0000218,,In vivo,11311,,,,,0,11141,,Oral bioavailability was determined; range 49-102%,Autocuration,,1,,,,22224,A,U,CHEMBL620567
,BAO_0000218,,In vivo,4013,,,,,1,11142,,Oral bioavailability was determined in dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL620568
,BAO_0000218,,In vivo,4013,,,,,0,11143,,Oral bioavailability in rat,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL620569
,BAO_0000218,,In vivo,17591,,,,,0,11144,,Oral bioavailability,Autocuration,Eutheria,1,9347.0,,,22224,A,U,CHEMBL620570
,BAO_0000218,,In vivo,17591,,,,,0,11145,,Oral bioavailability was determined; Not orally available,Autocuration,,1,,,,22224,A,U,CHEMBL620571
,BAO_0000218,,In vivo,15011,,,,,1,11146,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL620572
,BAO_0000218,,In vivo,15011,,,,,0,11147,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),Autocuration,Mus musculus,1,10090.0,,,22224,A,U,CHEMBL620573
,BAO_0000218,,In vivo,15011,,,,,0,11148,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,Autocuration,Mus musculus,1,10090.0,,,22224,A,U,CHEMBL620574
,BAO_0000218,,In vivo,9552,,,,,0,11149,,Oral bioavailability in Rhesus monkey,Autocuration,Macaca mulatta,1,9544.0,,,22224,A,U,CHEMBL620575
,BAO_0000218,,In vivo,9552,,,,,0,11150,,Oral bioavailability in dog (female mongrel),Autocuration,Canis lupus familiaris,1,9615.0,,,22224,A,U,CHEMBL620576
,BAO_0000218,,In vivo,3639,,,,,0,11151,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,Autocuration,,1,,,,22224,A,U,CHEMBL875846
,BAO_0000218,,In vivo,13397,,,,,0,11152,,Oral bioavailability in dog,Autocuration,Canis lupus familiaris,1,9615.0,,,22224,A,U,CHEMBL620577
,BAO_0000218,,In vivo,3031,,,,,0,11153,,Percentage Bioavailability was evaluated.,Autocuration,,1,,,,22224,A,U,CHEMBL620578
,BAO_0000218,,In vivo,12818,,,,,0,11154,,Bioavailability in rat administered i.d.,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL620579
,BAO_0000218,,In vivo,4847,,,,,0,11155,,Bioavailability,Autocuration,Eutheria,1,9347.0,,,22224,A,U,CHEMBL621248
,BAO_0000218,,In vivo,12421,,,,,0,11156,,Bioavailability in dog (male Beagle) i.v. administration,Autocuration,Canis lupus familiaris,1,9615.0,,,22224,A,U,CHEMBL625390
,BAO_0000218,,In vivo,11966,,,,,0,11157,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL625391
,BAO_0000218,,In vivo,11218,,,,,0,11158,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),Autocuration,Primates,1,9443.0,,,22224,A,U,CHEMBL872266
,BAO_0000218,,In vivo,13129,,,,,0,11159,,Oral bioavailability in rat (Sprague-Dawley) (male),Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL625392
,BAO_0000218,,In vivo,12350,,,,,1,11160,,The oral bioavailability was measured on rats after oral administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625393
,BAO_0000218,,In vivo,2231,,,,,1,11161,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625394
,BAO_0000218,,In vivo,2231,,,,,1,11162,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Intermediate,Macaca mulatta,1,9544.0,,,50797,A,N,CHEMBL625395
,BAO_0000218,,In vivo,12187,,,,,0,11163,,Bioavailability in rat (dose 10 mg/kg i.d.),Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL625396
,BAO_0000218,,In vivo,12421,,,,,0,11164,,Bioavailability in dog (male Beagle) i.v. administration,Autocuration,Canis lupus familiaris,1,9615.0,,,22224,A,U,CHEMBL625397
,BAO_0000218,,In vivo,13256,,,,,1,11165,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625398
,BAO_0000218,,In vivo,13256,,178.0,,,1,11166,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL625399
,BAO_0000218,,In vivo,13256,,2037.0,,,1,11167,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,Cerebellum,50594,A,N,CHEMBL626074
,BAO_0000218,,In vivo,13256,,,,,1,11168,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626075
,BAO_0000218,,In vivo,2231,,1969.0,,,1,11169,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626076
,BAO_0000218,,In vivo,2231,,1969.0,,,1,11170,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Intermediate,Macaca mulatta,1,9544.0,,Plasma,50797,A,N,CHEMBL626077
,BAO_0000218,,In vivo,12178,,178.0,,,1,11171,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626078
,BAO_0000218,,In vivo,12178,,178.0,,,0,11172,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),Autocuration,,1,,,Blood,22224,A,U,CHEMBL625846
,BAO_0000218,,In vivo,12178,,178.0,,,0,11173,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),Autocuration,,1,,,Blood,22224,A,U,CHEMBL625847
,BAO_0000218,,In vivo,15633,,,,,1,11174,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,Expert,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625848
,BAO_0000218,,In vivo,14258,,1969.0,,,1,11175,,Maximum concentration of compound in plasma administered orally to rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625849
,BAO_0000218,,In vivo,14224,,1969.0,,,1,11176,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626023
,BAO_0000218,,In vivo,14224,,1969.0,,,1,11177,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626024
,BAO_0000218,,In vivo,14224,,1969.0,,,1,11178,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626025
,BAO_0000218,,In vivo,5566,,,,,0,11179,,Maximum concentration after 10 mg/kg by oral administration,Autocuration,,1,,,,22224,A,U,CHEMBL626026
,BAO_0000218,,In vivo,16935,,,,,0,11180,,Maximum concentration at a dose of 1.5 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL626027
,BAO_0000218,,In vivo,16935,,,,,0,11181,,Maximum concentration at a dose of 2.0 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL626028
,BAO_0000218,,In vivo,14224,,1969.0,,,1,11182,,Maximum concentration in dog plasma,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626029
,BAO_0000218,,In vivo,12536,,1969.0,,,0,11183,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL626030
,BAO_0000218,,In vivo,12536,,1969.0,,,0,11184,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL626031
,BAO_0000218,,In vivo,12536,,1969.0,,,0,11185,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL626032
,BAO_0000218,,In vivo,12536,,1969.0,,,0,11186,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL626033
,BAO_0000218,,In vivo,12536,,1969.0,,,0,11187,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL626034
,BAO_0000218,,In vivo,9994,,1969.0,,,1,11188,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626035
,BAO_0000218,,In vivo,1434,,1969.0,,,0,11189,,Maximum concentration in plasma at Tmax,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL626036
,BAO_0000218,,In vivo,12836,,1969.0,,,1,11190,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,Expert,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626037
,BAO_0000218,,In vivo,12836,,1969.0,,,1,11191,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,Intermediate,Cricetinae,1,10026.0,,Plasma,100712,A,N,CHEMBL626038
,BAO_0000218,,In vivo,12836,,1969.0,,,1,11192,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626039
,BAO_0000218,,In vivo,12545,,1969.0,,,1,11193,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626040
,BAO_0000218,,In vivo,13856,,1969.0,,,1,11194,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,Intermediate,Oryctolagus cuniculus,1,9986.0,,Plasma,50592,A,N,CHEMBL626041
,BAO_0000218,,In vivo,3550,,,,,0,11195,,Maximum concentration was calculated,Autocuration,,1,,,,22224,A,U,CHEMBL626042
,BAO_0000218,,In vivo,2632,,,,,0,11196,,Maximum concentration was calculated.,Autocuration,,1,,,,22224,A,U,CHEMBL626043
,BAO_0000218,,In vivo,5566,,,,,0,11197,,Maximum concentration at a peroral dose of 10 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL626044
,BAO_0000218,,In vivo,11883,,,,,0,11198,,Maximum concentration of the drug at 10 uM/dg administered perorally,Autocuration,,1,,,,22224,A,U,CHEMBL626045
,BAO_0000218,,In vivo,11883,,,,,0,11199,,Maximum concentration of the drug at 2 uM/dg administered intravenously,Autocuration,,1,,,,22224,A,U,CHEMBL626046
,BAO_0000218,,In vivo,14122,,1969.0,,,1,11200,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626047
,BAO_0000218,,In vivo,14122,,1969.0,,,1,11201,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",Intermediate,Cricetinae,1,10026.0,,Plasma,100712,A,N,CHEMBL626048
,BAO_0000218,,In vivo,14122,,1969.0,,,1,11202,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626049
,BAO_0000218,,In vivo,12542,,1969.0,,,1,11203,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626050
,BAO_0000218,,In vivo,12542,,1969.0,,,1,11204,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL874541
,BAO_0000218,,In vivo,12542,,1969.0,,,1,11205,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,Intermediate,Cricetinae,1,10026.0,,Plasma,100712,A,N,CHEMBL622826
,BAO_0000218,,In vivo,12542,,1969.0,,,1,11206,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,Intermediate,Cricetinae,1,10026.0,,Plasma,100712,A,N,CHEMBL622827
,BAO_0000218,,In vivo,12542,,1969.0,,,1,11207,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622828
,BAO_0000218,,In vivo,14080,,1969.0,,,1,11208,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622829
,BAO_0000218,,In vivo,11911,,,,,1,11209,,Maximum concentration reached following intravenous administration in male rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876806
,BAO_0000218,,In vivo,13204,,,,,1,11210,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL622830
,BAO_0000218,,In vivo,13204,,,,,1,11211,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622831
,BAO_0000218,,In vivo,14346,,,,,1,11212,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626794
,BAO_0000218,,In vivo,14346,,,,,1,11213,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626795
,BAO_0000218,,In vivo,14346,,,,,1,11214,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626796
,BAO_0000218,,In vivo,14346,,,,,1,11215,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626797
,BAO_0000218,,In vivo,14127,,,,,1,11216,,Maximum drug concentration is determined after oral dosing in rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626798
,BAO_0000218,,In vivo,14339,,,,,1,11217,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626799
,BAO_0000218,,In vivo,14339,,,,,1,11218,,Maximum observed concentration in oral (5 mg/kg) fed dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626800
,BAO_0000218,,In vivo,13494,,1969.0,,,0,11219,,Maximum plasma concentration,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL626801
,BAO_0000218,,In vivo,14925,,1969.0,,,1,11220,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL876816
,BAO_0000218,,In vivo,14474,,1969.0,,,1,11221,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626802
,BAO_0000218,,In vivo,14474,,1969.0,,,1,11222,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626803
,BAO_0000218,,In vivo,13917,,1969.0,,,0,11223,,Maximum plasma concentration following oral administration of 30 umol/kg,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL626804
,BAO_0000218,,,9796,,1969.0,,,1,11224,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626805
,BAO_0000218,,,9796,,1969.0,,,1,11225,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626309
,BAO_0000218,,,9796,,1969.0,,,1,11226,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626310
,BAO_0000218,,,9796,,1969.0,,,1,11227,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626311
,BAO_0000218,,,9796,,1969.0,,,1,11228,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626312
,BAO_0000218,,,9796,,995.0,,,1,11229,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL626313
,BAO_0000218,,,9796,,995.0,,,1,11230,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL626314
,BAO_0000218,,,9796,,995.0,,,1,11231,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL626315
,BAO_0000218,,,9796,,995.0,,,1,11232,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL626316
,BAO_0000218,,,9796,,995.0,,,1,11233,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL626317
,BAO_0000218,,,8363,,,,,1,11234,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626318
,BAO_0000218,,,8363,,,,,1,11235,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626319
,BAO_0000218,,,8363,,,,,1,11236,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626320
,BAO_0000218,,,8363,,,,,1,11237,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875053
,BAO_0000218,,,8363,,,,,1,11238,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626321
,BAO_0000218,,,8363,,,,,1,11239,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626322
,BAO_0000218,,,8363,,,,,1,11240,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626323
,BAO_0000218,,,8363,,,,,1,11241,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626324
,BAO_0000218,,,8363,,,,,1,11242,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626325
,BAO_0000218,,,8363,,,,,1,11243,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626326
,BAO_0000218,,,8363,,,,,1,11244,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626327
,BAO_0000218,,,8363,,,,,1,11245,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626328
,BAO_0000218,,,8684,,178.0,,,1,11246,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626329
,BAO_0000218,,,8684,,178.0,,,1,11247,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626330
,BAO_0000218,,,8684,,178.0,,,1,11248,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626331
,BAO_0000218,,,8684,,178.0,,,1,11249,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626332
,BAO_0000218,,,8684,,178.0,,,1,11250,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626333
,BAO_0000218,,,8684,,178.0,,,1,11251,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626334
,BAO_0000218,,,8684,,178.0,,,1,11252,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626335
,BAO_0000218,,,8684,,178.0,,,1,11253,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624798
,BAO_0000218,,,8684,,955.0,,,1,11254,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL624799
,BAO_0000218,,,8684,,955.0,,,1,11255,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL624800
,BAO_0000218,,,8684,,955.0,,,1,11256,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL624801
,BAO_0000218,,,8684,,955.0,,,1,11257,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL624802
,BAO_0000218,,,8684,,955.0,,,1,11258,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL624803
,BAO_0000218,,,8684,,955.0,,,1,11259,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL624804
,BAO_0000218,,,8684,,955.0,,,1,11260,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL624805
,BAO_0000218,,,8684,,955.0,,,1,11261,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL624806
,BAO_0000218,,,8684,,,,,1,11262,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624807
,BAO_0000218,,,8684,,,,,1,11263,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624808
,BAO_0000218,,,8684,,,,,1,11264,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624809
,BAO_0000218,,,8684,,,,,1,11265,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624810
,BAO_0000218,,,8684,,,,,1,11266,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877618
,BAO_0000218,,,8684,,,,,1,11267,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624811
,BAO_0000218,,,8684,,,,,1,11268,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624812
,BAO_0000218,,,8684,,,,,1,11269,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624813
,BAO_0000218,,,8684,,,,,1,11270,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624814
,BAO_0000218,,,8684,,,,,1,11271,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624815
,BAO_0000218,,,8684,,,,,1,11272,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624816
,BAO_0000218,,,8684,,,,,1,11273,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624817
,BAO_0000218,,,6996,,,,,1,11274,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624818
,BAO_0000218,,,6996,,,,,1,11275,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624819
,BAO_0000218,,,6996,,,,,1,11276,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624820
,BAO_0000218,,,6996,,,,,1,11277,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624821
,BAO_0000218,,,6996,,,,,1,11278,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624822
,BAO_0000218,,,6996,,,,,1,11279,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624823
,BAO_0000218,,,15599,,,,,1,11280,,Observed diffusion coefficient in organic solvent for Escherichia coli,Intermediate,Escherichia coli,1,562.0,,,50212,A,N,CHEMBL624824
,BAO_0000218,,,9614,,178.0,,,1,11281,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624825
,BAO_0000218,,,9614,,178.0,,,1,11282,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624826
,BAO_0000218,,,9614,,2081.0,,,1,11283,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,Rattus norvegicus,1,10116.0,,Cardiac atrium,50597,A,N,CHEMBL876817
,BAO_0000218,,,9614,,2081.0,,,1,11284,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Cardiac atrium,50597,A,N,CHEMBL624827
,BAO_0000218,,,9614,,,,,1,11285,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624828
,BAO_0000218,,,9614,,,,,1,11286,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624829
,BAO_0000218,,,9614,,2107.0,,,1,11287,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624830
,BAO_0000218,,,9614,,2107.0,,,1,11288,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624831
,BAO_0000218,,,9614,,2081.0,,,1,11289,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,Rattus norvegicus,1,10116.0,,Cardiac atrium,50597,A,N,CHEMBL624832
,BAO_0000218,,,9614,,2081.0,,,1,11290,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Cardiac atrium,50597,A,N,CHEMBL624833
,BAO_0000218,,,9614,,,,,1,11291,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624834
,BAO_0000218,,,9614,,,,,1,11292,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624835
,BAO_0000218,,,9614,,2106.0,,,1,11293,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL624836
,BAO_0000218,,,9614,,2106.0,,,1,11294,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL624837
,BAO_0000218,,,9071,,178.0,,,1,11295,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624838
,BAO_0000218,,,9071,,178.0,,,1,11296,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622188
,BAO_0000218,,,9071,,948.0,,,1,11297,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL622189
,BAO_0000218,,,9071,,948.0,,,1,11298,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL622190
,BAO_0000218,,,9071,,948.0,,,1,11299,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL625170
,BAO_0000218,,,9071,,2113.0,,,1,11300,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625171
,BAO_0000218,,,9071,,2113.0,,,1,11301,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625172
,BAO_0000218,,,9071,,2113.0,,,1,11302,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625173
,BAO_0000218,,,9071,,2107.0,,,1,11303,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625174
,BAO_0000218,,,9071,,2107.0,,,1,11304,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625175
,BAO_0000218,,,9071,,2107.0,,,1,11305,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625176
,BAO_0000218,,,9071,,2048.0,,,1,11306,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625177
,BAO_0000218,,,9071,,2048.0,,,1,11307,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625178
,BAO_0000218,,,9071,,2048.0,,,1,11308,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625179
,BAO_0000218,,,9071,,2048.0,,,1,11309,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625180
,BAO_0000218,,,10677,,,,,0,11310,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",Autocuration,,1,,,,22224,A,U,CHEMBL625181
,BAO_0000218,,,9750,,1088.0,,,1,11311,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,Intermediate,Mus musculus,1,10090.0,,Urine,50594,A,N,CHEMBL625182
,BAO_0000218,,,8319,,,,,1,11312,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625183
,BAO_0000218,,,8319,,,,,1,11313,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875848
,BAO_0000218,,,8319,,,,,1,11314,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622260
,BAO_0000218,,,8319,,,,,1,11315,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622261
,BAO_0000218,,,8319,,,,,1,11316,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622262
,BAO_0000218,,,8319,,2113.0,,,1,11317,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL622263
,BAO_0000218,,,8319,,2113.0,,,1,11318,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL622418
,BAO_0000218,,,8319,,2107.0,,,1,11319,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622419
,BAO_0000218,,In vivo,13256,,,,,1,11320,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623388
,BAO_0000218,,In vivo,13256,,2107.0,,,1,11321,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL623389
,BAO_0000218,,In vivo,13256,,,,,1,11322,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623390
,BAO_0000218,,In vivo,13256,,,,,1,11323,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623391
,BAO_0000218,,In vivo,13256,,178.0,,,1,11324,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL623392
,BAO_0000218,,In vivo,13256,,2037.0,,,1,11325,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,Cerebellum,50594,A,N,CHEMBL623393
,BAO_0000218,,In vivo,13256,,,,,1,11326,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623394
,BAO_0000218,,In vivo,13256,,,,,1,11327,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL618885
,BAO_0000218,,In vivo,13256,,2107.0,,,1,11328,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL618886
,BAO_0000218,,In vivo,13256,,,,,1,11329,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL618887
,BAO_0000218,,In vivo,13256,,,,,1,11330,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL619535
,BAO_0000218,,In vivo,13256,,178.0,,,1,11331,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL619536
,BAO_0000218,,In vivo,13256,,2037.0,,,1,11332,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,Cerebellum,50594,A,N,CHEMBL619537
,BAO_0000218,,In vivo,13256,,,,,1,11333,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL619705
,BAO_0000218,,In vivo,13256,,,,,1,11334,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL619706
,BAO_0000218,,In vivo,13256,,2107.0,,,1,11335,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL619707
,BAO_0000218,,In vivo,13256,,,,,1,11336,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL619708
,BAO_0000218,,In vivo,13256,,,,,1,11337,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625219
,BAO_0000218,,In vivo,13256,,178.0,,,1,11338,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL625220
,BAO_0000218,,In vivo,13256,,2037.0,,,1,11339,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,Cerebellum,50594,A,N,CHEMBL625221
,BAO_0000218,,In vivo,13256,,,,,1,11340,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625222
,BAO_0000218,,In vivo,13256,,,,,1,11341,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625223
,BAO_0000218,,In vivo,13256,,2107.0,,,1,11342,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL625224
,BAO_0000218,,In vivo,13256,,,,,1,11343,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625225
,BAO_0000218,,In vivo,8829,,178.0,,,1,11344,,Biodistribution in Rat blood after 24 hours of iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625226
,BAO_0000218,,In vivo,8829,,178.0,,,1,11345,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625227
,BAO_0000218,,In vivo,8829,,178.0,,,1,11346,,Biodistribution in Rat blood after 30 minutes of iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625228
,BAO_0000218,,In vivo,8829,,178.0,,,1,11347,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL875354
,BAO_0000218,,In vivo,8829,,178.0,,,1,11348,,Biodistribution in Rat blood after 5 minutes of iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625229
,BAO_0000218,,In vivo,8829,,178.0,,,1,11349,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625230
,BAO_0000218,,In vivo,8829,,948.0,,,1,11350,,Biodistribution in Rat heart after 24 hours of iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL625231
,BAO_0000218,,In vivo,8829,,948.0,,,1,11351,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL625900
,BAO_0000218,,In vivo,8829,,948.0,,,1,11352,,Biodistribution in Rat heart after 30 minutes of iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL625901
,BAO_0000218,,In vivo,8829,,948.0,,,1,11353,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL625902
,BAO_0000218,,In vivo,8829,,948.0,,,1,11354,,Biodistribution in Rat heart after 5 minutes of iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL625903
,BAO_0000218,,In vivo,8829,,948.0,,,1,11355,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL625904
,BAO_0000218,,In vivo,8829,,2107.0,,,1,11356,,Biodistribution in Rat liver after 24 hours of iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625905
,BAO_0000218,,In vivo,8829,,2107.0,,,1,11357,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627861
,BAO_0000218,,In vivo,8829,,2107.0,,,1,11358,,Biodistribution in Rat liver after 30 minutes of iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627862
,BAO_0000218,,In vivo,8829,,2107.0,,,1,11359,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627863
,BAO_0000218,,In vivo,8829,,2107.0,,,1,11360,,Biodistribution in Rat liver after 30 minutes of iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627769
,BAO_0000218,,In vivo,13249,,1969.0,,,1,11361,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL627770
,BAO_0000218,,In vivo,13622,,,,,1,11362,,Cmax in cynomolgus monkey (PO dose),Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL627771
,BAO_0000218,,In vivo,13622,,,,,1,11363,,Cmax in rat (PO dose),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627772
,BAO_0000218,,In vivo,13622,,,,,1,11364,,Cmax in rat (PO dose),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627773
,BAO_0000218,,In vivo,13494,,1969.0,,,1,11365,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621922
,BAO_0000218,,In vivo,12170,,1969.0,,,1,11366,,Cmax in rat plasma after oral dose (10 mg/kg),Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621923
,BAO_0000218,,In vivo,12170,,1969.0,,,0,11367,,Cmax in plasma after oral dose (10 mg/kg),Autocuration,,1,,,Plasma,22224,A,U,CHEMBL621924
,BAO_0000218,,In vivo,17025,,1969.0,,,1,11368,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL621925
,BAO_0000218,,In vivo,17025,,1969.0,,,0,11369,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,Autocuration,Simiiformes,1,314293.0,,Plasma,22224,A,U,CHEMBL621926
,BAO_0000218,,In vivo,17025,,1969.0,,,1,11370,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,Intermediate,Oryctolagus cuniculus,1,9986.0,,Plasma,50592,A,N,CHEMBL621927
,BAO_0000218,,In vivo,17025,,1969.0,,,1,11371,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621928
,BAO_0000218,,In vivo,14187,,1969.0,,,1,11372,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621929
,BAO_0000218,,In vivo,14816,,1969.0,,,1,11373,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL621930
,BAO_0000218,,In vivo,17820,,1969.0,,,1,11374,,Maximum plasma concentration after oral dosing in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621931
,BAO_0000218,,In vivo,14380,,1969.0,,,0,11375,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL621932
,BAO_0000218,,In vivo,14380,,1969.0,,,0,11376,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL621933
,BAO_0000218,,In vivo,14691,,1969.0,,,1,11377,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL621934
,BAO_0000218,,In vivo,14691,,1969.0,,,1,11378,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL621935
,BAO_0000218,,In vivo,13375,,1969.0,,,1,11379,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL621936
,BAO_0000218,,In vivo,6236,,1969.0,,,0,11380,,Maximum plasma concentration was determined,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL621937
,BAO_0000218,,In vivo,14380,,1969.0,,,0,11381,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL621938
,BAO_0000218,,In vivo,14380,,1969.0,,,0,11382,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL621939
,BAO_0000218,,In vivo,14380,,1969.0,,,0,11383,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL621940
,BAO_0000218,,In vivo,14380,,1969.0,,,0,11384,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL621941
,BAO_0000218,,In vivo,14380,,1969.0,,,0,11385,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL621942
,BAO_0000218,,In vivo,14380,,1969.0,,,0,11386,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL626178
,BAO_0000218,,In vivo,14380,,1969.0,,,0,11387,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL626179
,BAO_0000218,,In vivo,14380,,1969.0,,,0,11388,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL626180
,BAO_0000218,,In vivo,13622,,1969.0,,,1,11389,,Plasma Cmax in rat (PO dose),Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626181
,BAO_0000218,,In vivo,15372,,,,,1,11390,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626182
,BAO_0000218,,In vivo,15372,,,,,1,11391,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626183
,BAO_0000218,,In vivo,15372,,,,,1,11392,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626184
,BAO_0000218,,In vivo,15372,,,,,1,11393,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626185
,BAO_0000218,,In vivo,14925,,1969.0,,,1,11394,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626186
,BAO_0000218,,In vivo,14925,,1969.0,,,1,11395,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL877589
,BAO_0000218,,In vivo,11883,,,,,0,11396,,Maximum concentration of the drug at 1 uM/dg administered intravenously,Autocuration,,1,,,,22224,A,U,CHEMBL626187
,BAO_0000218,,In vivo,11883,,,,,0,11397,,Maximum concentration of the drug at 20 uM/dg administered perorally,Autocuration,,1,,,,22224,A,U,CHEMBL626188
,BAO_0000218,,In vivo,13391,,,,,0,11398,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL626189
,BAO_0000218,,In vivo,13391,,178.0,,,0,11399,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,,1,,,Blood,22224,A,U,CHEMBL626855
,BAO_0000218,,In vivo,13391,,178.0,,,0,11400,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,,1,,,Blood,22224,A,U,CHEMBL623781
,BAO_0000218,,In vivo,13391,,178.0,,,0,11401,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,,1,,,Blood,22224,A,U,CHEMBL623782
,BAO_0000218,,In vivo,16360,,1969.0,,,1,11402,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623783
,BAO_0000218,,In vivo,3673,,1969.0,,,1,11403,,Cmax in dog plasma after 1mg/kg oral dose,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL623784
,BAO_0000218,,In vivo,14431,,1969.0,,,1,11404,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL623785
,BAO_0000218,,In vivo,14431,,1969.0,,,1,11405,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623786
,BAO_0000218,,In vivo,14964,,,,,1,11406,,Oral maximum concentration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623787
,BAO_0000218,,In vivo,14964,,,,,1,11407,,Oral maximum concentration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623788
,BAO_0000218,,In vivo,14209,,1969.0,,,1,11408,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL623789
,BAO_0000218,,In vivo,11355,,178.0,,,1,11409,,Peak concentration in blood after intravenous administration to mice,Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL623790
,BAO_0000218,,In vivo,11355,,178.0,,,1,11410,,Peak concentration in blood after peroral administration to mice,Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL623791
,BAO_0000218,,In vivo,11966,,1969.0,,,1,11411,,Peak concentration in rat plasma was determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623792
,BAO_0000218,,In vivo,8918,,1969.0,,,0,11412,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,Autocuration,Simiiformes,1,314293.0,,Plasma,22224,A,U,CHEMBL623793
,BAO_0000218,,In vivo,8918,,1969.0,,,1,11413,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL623794
,BAO_0000218,,In vivo,8918,,1969.0,,,1,11414,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623795
,BAO_0000218,,,8684,,,,,1,11415,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623796
,BAO_0000218,,,8684,,,,,1,11416,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623797
,BAO_0000218,,,8684,,,,,1,11417,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623798
,BAO_0000218,,,8684,,,,,1,11418,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623799
,BAO_0000218,,,8684,,160.0,,,1,11419,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL624490
,BAO_0000218,,,8684,,160.0,,,1,11420,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL624491
,BAO_0000218,,,8684,,160.0,,,1,11421,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL624492
,BAO_0000218,,,8684,,160.0,,,1,11422,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL624493
,BAO_0000218,,,8684,,160.0,,,1,11423,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL877595
,BAO_0000218,,,8684,,160.0,,,1,11424,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL624494
,BAO_0000218,,,8684,,160.0,,,1,11425,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL624495
,BAO_0000218,,,8684,,160.0,,,1,11426,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL624681
,BAO_0000218,,,8684,,,,,1,11427,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624682
,BAO_0000218,,,8684,,,,,1,11428,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624683
,BAO_0000218,,,8684,,,,,1,11429,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624684
,BAO_0000218,,,8684,,,,,1,11430,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624685
,BAO_0000218,,,8684,,,,,1,11431,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624686
,BAO_0000218,,,8684,,,,,1,11432,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624687
,BAO_0000218,,,8684,,,,,1,11433,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624688
,BAO_0000218,,,8684,,,,,1,11434,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627161
,BAO_0000218,,,8684,,,,,1,11435,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622127
,BAO_0000218,,,8684,,,,,1,11436,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622128
,BAO_0000218,,,8684,,,,,1,11437,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874384
,BAO_0000218,,,8684,,,,,1,11438,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624898
,BAO_0000218,,,8684,,,,,1,11439,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624899
,BAO_0000218,,,8684,,,,,1,11440,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624900
,BAO_0000218,,,8684,,,,,1,11441,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624901
,BAO_0000218,,,8684,,,,,1,11442,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624902
,BAO_0000218,,,8684,,,,,1,11443,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624903
,BAO_0000218,,,8684,,,,,1,11444,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624904
,BAO_0000218,,,8684,,,,,1,11445,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624905
,BAO_0000218,,,8684,,,,,1,11446,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624906
,BAO_0000218,,,8684,,,,,1,11447,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624907
,BAO_0000218,,,8684,,,,,1,11448,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624908
,BAO_0000218,,,8684,,,,,1,11449,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624909
,BAO_0000218,,,8684,,,,,1,11450,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624910
,BAO_0000218,,,8684,,2385.0,,,1,11451,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624911
,BAO_0000218,,,8684,,2385.0,,,1,11452,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL874388
,BAO_0000218,,,8684,,2385.0,,,1,11453,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL624912
,BAO_0000218,,,8684,,2385.0,,,1,11454,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL622930
,BAO_0000218,,,8684,,2385.0,,,1,11455,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623121
,BAO_0000218,,,8684,,2385.0,,,1,11456,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623122
,BAO_0000218,,,8684,,2385.0,,,1,11457,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623123
,BAO_0000218,,,8684,,2385.0,,,1,11458,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623124
,BAO_0000218,,,8684,,,,,1,11459,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623125
,BAO_0000218,,,8684,,,,,1,11460,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623126
,BAO_0000218,,,8684,,,,,1,11461,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623127
,BAO_0000218,,,8684,,,,,1,11462,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623128
,BAO_0000218,,,8684,,,,,1,11463,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623129
,BAO_0000218,,,8684,,,,,1,11464,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623130
,BAO_0000218,,,8684,,,,,1,11465,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623131
,BAO_0000218,,,8684,,,,,1,11466,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623132
,BAO_0000218,,,8319,,2107.0,,,1,11467,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL623133
,BAO_0000218,,,8319,,,,,1,11468,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623134
,BAO_0000218,,,8319,,,,,1,11469,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874389
,BAO_0000218,,,8319,,,,,1,11470,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623135
,BAO_0000218,,,8319,,,,,1,11471,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623136
,BAO_0000218,,,8319,,,,,1,11472,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623137
,BAO_0000218,,,8319,,,,,1,11473,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623138
,BAO_0000218,,,8319,,2113.0,,,1,11474,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL623139
,BAO_0000218,,,8319,,2113.0,,,1,11475,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL623140
,BAO_0000218,,,8319,,2107.0,,,1,11476,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL623141
,BAO_0000218,,,8319,,2107.0,,,1,11477,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL623142
,BAO_0000218,,,8319,,,,,1,11478,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623143
,BAO_0000218,,,14571,,1088.0,,,1,11479,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,Intermediate,Mus musculus,1,10090.0,,Urine,50594,A,N,CHEMBL623144
,BAO_0000218,,,14571,,1088.0,,,1,11480,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623405
,BAO_0000218,,,8319,,,,,1,11481,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624074
,BAO_0000218,,,8319,,,,,1,11482,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624075
,BAO_0000218,,,8319,,,,,1,11483,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624076
,BAO_0000218,,,8319,,,,,1,11484,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624077
,BAO_0000218,,,8319,,,,,1,11485,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624078
,BAO_0000218,,,8319,,2113.0,,,1,11486,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624079
,BAO_0000218,,,8319,,2113.0,,,1,11487,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624261
,BAO_0000218,,,8319,,,,,1,11488,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624262
,BAO_0000218,,,8319,,,,,1,11489,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624263
,BAO_0000218,,,8319,,,,,1,11490,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624264
,BAO_0000218,,,8319,,,,,1,11491,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624265
,BAO_0000218,,,8319,,,,,1,11492,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624266
,BAO_0000218,,,8319,,,,,1,11493,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624267
,BAO_0000218,,,8319,,,,,1,11494,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624268
,BAO_0000218,,,8319,,,,,1,11495,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875227
,BAO_0000218,,,8319,,2113.0,,,1,11496,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624269
,BAO_0000218,,,8319,,2113.0,,,1,11497,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624270
,BAO_0000218,,,8319,,,,,1,11498,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624271
,BAO_0000218,,,8319,,,,,1,11499,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624272
,BAO_0000218,,,8319,,,,,1,11500,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624273
,BAO_0000218,,,12064,,1088.0,,,1,11501,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL624274
,BAO_0000218,,,12064,,1088.0,,,1,11502,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL624275
,BAO_0000218,,,12064,,1088.0,,,1,11503,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL624276
,BAO_0000218,,,12038,,1088.0,,,1,11504,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL624277
,BAO_0000019,,,14314,,,,,0,11505,,% dose converted to 2-amino-5-chlorophenyl sulfate,Autocuration,,1,,,,22224,A,U,CHEMBL624278
,BAO_0000019,,,14314,,,,,0,11506,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),Autocuration,,1,,,,22224,A,U,CHEMBL624279
,BAO_0000218,,,11488,,1988.0,,,1,11507,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,Rattus norvegicus,1,10116.0,,Feces,50597,A,N,CHEMBL624280
,BAO_0000218,,,11488,,1988.0,,,1,11508,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,Rattus norvegicus,1,10116.0,,Feces,50597,A,N,CHEMBL624281
,BAO_0000218,,,11488,,1988.0,,,1,11509,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,Rattus norvegicus,1,10116.0,,Feces,50597,A,N,CHEMBL622933
,BAO_0000218,,,11488,,1988.0,,,1,11510,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,Rattus norvegicus,1,10116.0,,Feces,50597,A,N,CHEMBL622934
,BAO_0000218,,In vivo,8829,,2107.0,,,1,11511,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622935
,BAO_0000218,,In vivo,8829,,2107.0,,,1,11512,,Biodistribution in Rat liver after 5 minutes of iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622936
,BAO_0000218,,In vivo,8829,,2107.0,,,1,11513,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL875228
,BAO_0000218,,In vivo,8829,,2048.0,,,1,11514,,Biodistribution in Rat lung after 24 hours of iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622937
,BAO_0000218,,In vivo,8829,,2048.0,,,1,11515,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622938
,BAO_0000218,,In vivo,8829,,2048.0,,,1,11516,,Biodistribution in Rat lung after 30 minutes of iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL619736
,BAO_0000218,,In vivo,8829,,2048.0,,,1,11517,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625117
,BAO_0000218,,In vivo,8829,,2048.0,,,1,11518,,Biodistribution in Rat lung after 5 minutes of iv administration,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625118
,BAO_0000218,,In vivo,8829,,2048.0,,,1,11519,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625119
,BAO_0000218,,In vivo,14972,,2037.0,,,1,11520,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL625120
,BAO_0000218,,In vivo,14972,,,,,1,11521,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625121
,BAO_0000218,,In vivo,14972,,10000006.0,,,1,11522,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",Intermediate,Rattus norvegicus,1,10116.0,,Thalamus,50597,A,N,CHEMBL625122
,BAO_0000218,,In vivo,14608,,178.0,,,1,11523,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL622204
,BAO_0000218,,In vivo,14608,,178.0,,,1,11524,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL877503
,BAO_0000218,,In vivo,14608,,178.0,,,1,11525,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627127
,BAO_0000218,,In vivo,14608,,10000000.0,,,0,11526,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,Autocuration,,1,,,Hippocampus,22224,A,U,CHEMBL627128
,BAO_0000218,,In vivo,14608,,10000000.0,,,0,11527,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,Autocuration,,1,,,Hippocampus,22224,A,U,CHEMBL627129
,BAO_0000218,,In vivo,14608,,10000000.0,,,0,11528,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,Autocuration,,1,,,Hippocampus,22224,A,U,CHEMBL627130
,BAO_0000218,,In vivo,14608,,955.0,,,1,11529,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL627131
,BAO_0000218,,In vivo,14608,,955.0,,,1,11530,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL627132
,BAO_0000218,,In vivo,14608,,955.0,,,1,11531,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL627133
,BAO_0000218,,In vivo,14608,,2037.0,,,1,11532,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL627134
,BAO_0000218,,In vivo,14608,,2037.0,,,1,11533,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL627135
,BAO_0000218,,In vivo,14608,,2037.0,,,1,11534,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL627136
,BAO_0000218,,In vivo,14608,,,,,1,11535,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628435
,BAO_0000218,,In vivo,14608,,,,,1,11536,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628436
,BAO_0000218,,In vivo,14608,,,,,1,11537,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628437
,BAO_0000218,,In vivo,14608,,948.0,,,1,11538,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL628438
,BAO_0000218,,In vivo,14608,,948.0,,,1,11539,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL628439
,BAO_0000218,,In vivo,14608,,948.0,,,1,11540,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL628440
,BAO_0000218,,In vivo,14608,,10000000.0,,,1,11541,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL628441
,BAO_0000218,,In vivo,14608,,10000000.0,,,1,11542,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL628442
,BAO_0000218,,In vivo,14608,,10000000.0,,,1,11543,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL628443
,BAO_0000218,,In vivo,14608,,2113.0,,,1,11544,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL628444
,BAO_0000218,,In vivo,14608,,2113.0,,,1,11545,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL628445
,BAO_0000218,,In vivo,14608,,2113.0,,,1,11546,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL877504
,BAO_0000218,,In vivo,14608,,2107.0,,,1,11547,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628446
,BAO_0000218,,In vivo,14608,,2107.0,,,1,11548,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626874
,BAO_0000218,,In vivo,14608,,2107.0,,,1,11549,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626875
,BAO_0000218,,In vivo,14608,,2048.0,,,1,11550,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626876
,BAO_0000218,,In vivo,14608,,2048.0,,,1,11551,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626877
,BAO_0000218,,In vivo,14608,,2048.0,,,1,11552,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626878
,BAO_0000218,,In vivo,14608,,2385.0,,,1,11553,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL626879
,BAO_0000218,,In vivo,8918,,1969.0,,,0,11554,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,Autocuration,Simiiformes,1,314293.0,,Plasma,22224,A,U,CHEMBL626880
,BAO_0000218,,In vivo,8918,,1969.0,,,1,11555,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL626881
,BAO_0000218,,In vivo,8918,,1969.0,,,1,11556,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626882
,BAO_0000218,,In vivo,14470,,1969.0,,,1,11557,,Peak plasma concentration was measured in dogs,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626883
,BAO_0000218,,In vivo,14393,,,,,1,11558,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626884
,BAO_0000218,,In vivo,14886,,,,,1,11559,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626885
,BAO_0000218,,In vivo,14886,,,,,1,11560,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626886
,BAO_0000218,,In vivo,14886,,,,,1,11561,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626887
,BAO_0000218,,In vivo,14393,,,,,1,11562,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626888
,BAO_0000218,,In vivo,13465,,,,,1,11563,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626889
,BAO_0000218,,In vivo,13465,,,,,0,11564,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL626761
,BAO_0000218,,In vivo,13465,,,,,1,11565,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626762
,BAO_0000218,,In vivo,13465,,,,,1,11566,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626763
,BAO_0000218,,In vivo,13465,,,,,1,11567,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626764
,BAO_0000218,,In vivo,13465,,,,,1,11568,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626765
,BAO_0000218,,In vivo,13465,,,,,1,11569,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626766
,BAO_0000218,,In vivo,13465,,,,,1,11570,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626767
,BAO_0000218,,In vivo,13465,,,,,1,11571,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626768
,BAO_0000218,,In vivo,13465,,,,,1,11572,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626769
,BAO_0000218,,In vivo,13465,,,,,1,11573,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL874463
,BAO_0000218,,In vivo,13465,,,,,0,11574,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL626770
,BAO_0000218,,In vivo,13465,,,,,0,11575,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL626771
,BAO_0000218,,In vivo,13465,,,,,1,11576,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626772
,BAO_0000218,,In vivo,14731,,,,,1,11577,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL626773
,BAO_0000218,,In vivo,14731,,,,,1,11578,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626774
,BAO_0000218,,In vivo,13376,,,,,1,11579,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626775
,BAO_0000218,,In vivo,13376,,,,,1,11580,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626776
,BAO_0000218,,In vivo,14443,,,,,1,11581,,Maximum concentration (Cmax) in rat when administered orally,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626777
,BAO_0000218,,In vivo,13465,,1969.0,,,0,11582,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,Autocuration,Simiiformes,1,314293.0,,Plasma,22224,A,U,CHEMBL626778
,BAO_0000218,,In vivo,16359,,,,,0,11583,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL626779
,BAO_0000218,,In vivo,16359,,,,,0,11584,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL626780
,BAO_0000218,,In vivo,15618,,1969.0,,,0,11585,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL626781
,BAO_0000218,,In vivo,14554,,,,,1,11586,,Pharmacokinetic profile Cmax was evaluated in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632164
,BAO_0000218,,In vivo,11537,,,,,1,11587,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL632165
,BAO_0000218,,In vivo,11537,,,,,1,11588,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL632166
,BAO_0000218,,In vivo,11537,,,,,1,11589,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL632167
,BAO_0000218,,In vivo,11537,,,,,1,11590,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL632168
,BAO_0000218,,In vivo,2021,,1969.0,,,0,11591,,Cmax in rat plasma,Autocuration,Rattus norvegicus,1,10116.0,,Plasma,22224,A,U,CHEMBL632169
,BAO_0000218,,In vivo,5932,,1969.0,,,1,11592,,Cmax in dog plasma after 30mg/kg oral dose,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL632170
,BAO_0000218,,In vivo,5932,,1969.0,,,1,11593,,Cmax in rat plasma after 30mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL632171
,BAO_0000218,,In vivo,17320,,1969.0,,,1,11594,,Plasma level in rats at 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL632172
,BAO_0000218,,In vivo,15831,,1969.0,,,1,11595,,Tested for maximum plasma concentration in mice,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL632173
,BAO_0000218,,In vivo,15078,,,,,1,11596,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632174
,BAO_0000218,,In vivo,14941,,,,,1,11597,,The Cmax values in female wistar rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632175
,BAO_0000218,,In vivo,15343,,1969.0,,,1,11598,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL632176
,BAO_0000218,,In vivo,15343,,1969.0,,,1,11599,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL632177
,BAO_0000218,,In vivo,14856,,1969.0,,,1,11600,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL632178
,BAO_0000218,,In vivo,13129,,,,,1,11601,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632179
,BAO_0000218,,In vivo,13098,,178.0,,,1,11602,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL632180
,BAO_0000218,,In vivo,13098,,178.0,,,1,11603,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL632181
,BAO_0000218,,In vivo,13098,,178.0,,,1,11604,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL632182
,BAO_0000218,,In vivo,15478,,178.0,,,0,11605,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,Autocuration,Mus musculus,1,10090.0,,Blood,22224,A,U,CHEMBL632183
,BAO_0000218,,In vivo,15341,,,,,1,11606,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL632184
,BAO_0000218,,In vivo,15341,,,,,1,11607,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874470
,BAO_0000218,,,8684,,,,,1,11608,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631302
,BAO_0000218,,,8684,,,,,1,11609,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631303
,BAO_0000218,,,8684,,,,,1,11610,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631304
,BAO_0000218,,,8684,,,,,1,11611,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631305
,BAO_0000218,,,8684,,,,,1,11612,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631306
,BAO_0000218,,,8684,,,,,1,11613,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631307
,BAO_0000218,,,8684,,,,,1,11614,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631308
,BAO_0000218,,,8684,,,,,1,11615,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625557
,BAO_0000218,,,8684,,2106.0,,,1,11616,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625558
,BAO_0000218,,,8684,,2106.0,,,1,11617,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625559
,BAO_0000218,,,8684,,2106.0,,,1,11618,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625560
,BAO_0000218,,,8684,,2106.0,,,1,11619,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625561
,BAO_0000218,,,8684,,2106.0,,,1,11620,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625562
,BAO_0000218,,,8684,,2106.0,,,1,11621,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL875320
,BAO_0000218,,,8684,,2106.0,,,1,11622,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625563
,BAO_0000218,,,8684,,2106.0,,,1,11623,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625564
,BAO_0000218,,,8684,,995.0,,,1,11624,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL625565
,BAO_0000218,,,8684,,995.0,,,1,11625,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL625566
,BAO_0000218,,,8684,,995.0,,,1,11626,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL625567
,BAO_0000218,,,8684,,995.0,,,1,11627,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL625568
,BAO_0000218,,,8684,,995.0,,,1,11628,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL628217
,BAO_0000218,,,8684,,995.0,,,1,11629,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL628218
,BAO_0000218,,,8684,,995.0,,,1,11630,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL628219
,BAO_0000218,,,8684,,995.0,,,1,11631,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL628220
,BAO_0000019,,,8926,,,,,0,11632,,Distribution in the blood after 120 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628221
,BAO_0000019,,,8926,,,,,0,11633,,Distribution in the blood after 15 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628222
,BAO_0000019,,,8926,,,,,0,11634,,Distribution in the blood after 30 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628223
,BAO_0000019,,,8926,,,,,0,11635,,Distribution in the blood after 5 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628224
,BAO_0000019,,,8926,,,,,0,11636,,Distribution in the blood after 60 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628225
,BAO_0000019,,,8926,,,,,0,11637,,Distribution in the blood after 90 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628226
,BAO_0000019,,,8926,,,,,0,11638,,Distribution in the bone after 120 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628227
,BAO_0000019,,,8926,,,,,0,11639,,Distribution in the bone after 15 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL875481
,BAO_0000019,,,8926,,,,,0,11640,,Distribution in the bone after 30 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628228
,BAO_0000019,,,8926,,,,,0,11641,,Distribution in the bone after 5 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628229
,BAO_0000019,,,8926,,,,,0,11642,,Distribution in the bone after 60 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628230
,BAO_0000019,,,8926,,,,,0,11643,,Distribution in the bone after 90 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628231
,BAO_0000019,,,8926,,,,,0,11644,,Distribution in the heart after 120 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628232
,BAO_0000019,,,8926,,,,,0,11645,,Distribution in the heart after 15 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628233
,BAO_0000019,,,8926,,,,,0,11646,,Distribution in the heart after 30 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628234
,BAO_0000019,,,8926,,,,,0,11647,,Distribution in the heart after 5 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628235
,BAO_0000019,,,8926,,,,,0,11648,,Distribution in the heart after 60 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628236
,BAO_0000019,,,8926,,,,,0,11649,,Distribution in the heart after 90 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628237
,BAO_0000019,,,8926,,,,,0,11650,,Distribution in the kidneys after 120 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628238
,BAO_0000019,,,8926,,,,,0,11651,,Distribution in the kidneys after 15 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628239
,BAO_0000019,,,8926,,,,,0,11652,,Distribution in the kidneys after 30 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628240
,BAO_0000019,,,8926,,,,,0,11653,,Distribution in the kidneys after 5 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628241
,BAO_0000019,,,8926,,,,,0,11654,,Distribution in the kidneys after 60 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628242
,BAO_0000019,,,8926,,,,,0,11655,,Distribution in the kidneys after 90 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL875482
,BAO_0000019,,,8926,,,,,0,11656,,Distribution in the liver after 120 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628243
,BAO_0000019,,,8926,,,,,0,11657,,Distribution in the liver after 15 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628244
,BAO_0000019,,,8926,,,,,0,11658,,Distribution in the liver after 30 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628245
,BAO_0000019,,,8926,,,,,0,11659,,Distribution in the liver after 5 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628246
,BAO_0000019,,,8926,,,,,0,11660,,Distribution in the liver after 60 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628247
,BAO_0000019,,,8926,,,,,0,11661,,Distribution in the liver after 90 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628248
,BAO_0000019,,,8926,,,,,0,11662,,Distribution in the lung after 120 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628249
,BAO_0000218,,,14839,,,,,1,11663,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625452
,BAO_0000218,,,14839,,,,,1,11664,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625453
,BAO_0000218,,,14839,,,,,1,11665,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625454
,BAO_0000218,,,14839,,,,,1,11666,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623844
,BAO_0000218,,,12178,,,,,1,11667,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623845
,BAO_0000218,,,12178,,,,,1,11668,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623846
,BAO_0000218,,,12178,,,,,0,11669,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,Autocuration,,1,,,,22224,A,U,CHEMBL623847
,BAO_0000218,,,12186,,,,,1,11670,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL623848
,BAO_0000218,,,12186,,,,,1,11671,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL623849
,BAO_0000218,,,12186,,,,,1,11672,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL623850
,BAO_0000218,,,12186,,,,,1,11673,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL623851
,BAO_0000218,,,12187,,,,,0,11674,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL623852
,BAO_0000218,,,12187,,,,,1,11675,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Intermediate,Mustela putorius furo,1,9669.0,,,50506,A,N,CHEMBL624551
,BAO_0000218,,,12187,,,,,1,11676,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Intermediate,Mustela putorius furo,1,9669.0,,,50506,A,N,CHEMBL624552
,BAO_0000218,,,12187,,,,,0,11677,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL624553
,BAO_0000218,,,12187,,,,,0,11678,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL624554
,BAO_0000218,,,12187,,,,,1,11679,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624555
,BAO_0000218,,,12187,,,,,1,11680,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624741
,BAO_0000218,,,14122,,,,,1,11681,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624742
,BAO_0000218,,,14122,,,,,1,11682,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",Intermediate,Cricetinae,1,10026.0,,,100712,A,N,CHEMBL624743
,BAO_0000218,,,14122,,,,,1,11683,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877606
,BAO_0000218,,,13391,,,,,0,11684,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL624744
,BAO_0000218,,,13391,,178.0,,,0,11685,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,,1,,,Blood,22224,A,U,CHEMBL624745
,BAO_0000218,,,13391,,178.0,,,0,11686,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,,1,,,Blood,22224,A,U,CHEMBL624746
,BAO_0000218,,,13391,,178.0,,,0,11687,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,,1,,,Blood,22224,A,U,CHEMBL624747
,BAO_0000019,,,16360,,,,,0,11688,,Oral absorption expressed as Area under curve was determined,Autocuration,,1,,,,22224,A,U,CHEMBL624748
,BAO_0000218,,,3673,,,,,1,11689,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL622504
,BAO_0000218,,,14122,,,,,1,11690,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL622505
,BAO_0000218,,,14122,,,,,1,11691,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Intermediate,Cricetinae,1,10026.0,,,100712,A,N,CHEMBL622506
,BAO_0000218,,,14122,,,,,1,11692,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Intermediate,Cricetinae,1,10026.0,,,100712,A,N,CHEMBL622507
,BAO_0000218,,,14122,,,,,1,11693,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622508
,BAO_0000019,,,13889,,,,,0,11694,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL622509
,BAO_0000218,,,14393,,,,,1,11695,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622510
,BAO_0000218,,,17279,,,,,1,11696,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622511
,BAO_0000218,,,14548,,,,,1,11697,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL622512
,BAO_0000218,,,14548,,,,,1,11698,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL622513
,BAO_0000218,,,14548,,,,,1,11699,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL622514
,BAO_0000218,,,14548,,,,,1,11700,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL622515
,BAO_0000218,,,14548,,,,,1,11701,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL622516
,BAO_0000218,,,14548,,,,,1,11702,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622517
,BAO_0000218,,,14548,,,,,1,11703,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622518
,BAO_0000218,,,14548,,,,,1,11704,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622519
,BAO_0000218,,In vivo,14608,,2385.0,,,1,11705,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL622520
,BAO_0000218,,In vivo,14608,,2385.0,,,1,11706,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL622521
,BAO_0000218,,In vivo,14608,,14.0,,,1,11707,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,Mus musculus,1,10090.0,,Zone of skin,50594,A,N,CHEMBL625113
,BAO_0000218,,In vivo,14608,,14.0,,,1,11708,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL625114
,BAO_0000218,,In vivo,14608,,14.0,,,1,11709,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL874397
,BAO_0000218,,In vivo,14608,,2106.0,,,1,11710,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625115
,BAO_0000218,,In vivo,14608,,2106.0,,,1,11711,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625116
,BAO_0000218,,In vivo,14608,,2106.0,,,1,11712,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL623932
,BAO_0000218,,In vivo,14608,,2435.0,,,1,11713,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL623933
,BAO_0000218,,In vivo,14608,,2435.0,,,1,11714,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL623934
,BAO_0000218,,In vivo,14608,,2435.0,,,1,11715,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL623935
,BAO_0000218,,In vivo,14608,,2046.0,,,1,11716,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL623936
,BAO_0000218,,In vivo,14608,,2046.0,,,1,11717,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL623937
,BAO_0000218,,In vivo,14608,,2046.0,,,1,11718,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL623938
,BAO_0000218,,,15383,,,,,1,11719,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623939
,BAO_0000218,,,15383,,,,,1,11720,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623940
,BAO_0000218,,,15383,,,,,1,11721,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623941
,BAO_0000218,,,15383,,,,,1,11722,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627216
,BAO_0000218,,,15383,,,,,1,11723,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623942
,BAO_0000218,,,15383,,955.0,,,1,11724,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL618793
,BAO_0000218,,,15383,,955.0,,,1,11725,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL618794
,BAO_0000218,,,15383,,955.0,,,1,11726,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL618795
,BAO_0000218,,,15383,,,,,1,11727,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL618796
,BAO_0000218,,,15383,,,,,1,11728,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL618797
,BAO_0000218,,,15383,,2113.0,,,1,11729,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL618798
,BAO_0000218,,,15383,,2113.0,,,1,11730,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL618799
,BAO_0000218,,,15383,,2113.0,,,1,11731,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL618800
,BAO_0000218,,,15383,,2113.0,,,1,11732,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL618801
,BAO_0000218,,,15383,,2113.0,,,1,11733,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL618802
,BAO_0000218,,,15383,,2113.0,,,1,11734,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL618803
,BAO_0000218,,,15383,,2107.0,,,1,11735,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL618804
,BAO_0000218,,,15383,,2107.0,,,1,11736,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL618805
,BAO_0000218,,,15383,,2107.0,,,1,11737,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL618806
,BAO_0000218,,,15383,,2107.0,,,1,11738,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL618807
,BAO_0000218,,,15383,,2107.0,,,1,11739,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL618808
,BAO_0000218,,,15383,,2107.0,,,1,11740,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL618809
,BAO_0000218,,,15383,,2385.0,,,1,11741,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,Mus musculus,1,10090.0,,Muscle tissue,50594,A,N,CHEMBL618810
,BAO_0000218,,,15383,,2385.0,,,1,11742,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,Mus musculus,1,10090.0,,Muscle tissue,50594,A,N,CHEMBL618811
,BAO_0000218,,,15383,,2385.0,,,1,11743,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,Mus musculus,1,10090.0,,Muscle tissue,50594,A,N,CHEMBL875844
,BAO_0000218,,,15383,,2385.0,,,1,11744,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,Mus musculus,1,10090.0,,Muscle tissue,50594,A,N,CHEMBL618812
,BAO_0000218,,,15383,,2385.0,,,1,11745,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,Mus musculus,1,10090.0,,Muscle tissue,50594,A,N,CHEMBL618813
,BAO_0000218,,,15383,,,,,1,11746,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL618814
,BAO_0000218,,,15383,,,,,1,11747,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL618815
,BAO_0000218,,,15383,,,,,1,11748,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL618816
,BAO_0000218,,,15383,,,,,1,11749,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL618817
,BAO_0000218,,,15383,,,,,1,11750,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL620544
,BAO_0000218,,In vivo,15341,,,,,1,11751,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626230
,BAO_0000218,,In vivo,15341,,,,,1,11752,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626231
,BAO_0000218,,In vivo,15341,,,,,1,11753,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626232
,BAO_0000218,,In vivo,14906,,1969.0,,,1,11754,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626233
,BAO_0000218,,In vivo,14906,,1969.0,,,1,11755,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626234
,BAO_0000218,,In vivo,14906,,1969.0,,,1,11756,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL875341
,BAO_0000218,,In vivo,14215,,1969.0,,,1,11757,,The maximum plasma concentration (100 mg/kg) administered orally in human,Intermediate,Homo sapiens,1,9606.0,,Plasma,50587,A,N,CHEMBL626235
,BAO_0000218,,In vivo,14215,,1969.0,,,0,11758,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,Autocuration,Callithrix,1,9481.0,,Plasma,22224,A,U,CHEMBL626236
,BAO_0000218,,In vivo,14215,,1969.0,,,0,11759,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,Autocuration,Simiiformes,1,314293.0,,Plasma,22224,A,U,CHEMBL626237
,BAO_0000218,,In vivo,14215,,1969.0,,,1,11760,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626238
,BAO_0000218,,In vivo,14215,,1969.0,,,1,11761,,The maximum plasma concentration (200 mg/kg) administered orally in human,Intermediate,Homo sapiens,1,9606.0,,Plasma,50587,A,N,CHEMBL622412
,BAO_0000218,,In vivo,14215,,1969.0,,,1,11762,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623114
,BAO_0000218,,In vivo,14215,,1969.0,,,0,11763,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,Autocuration,Callithrix,1,9481.0,,Plasma,22224,A,U,CHEMBL623115
,BAO_0000218,,In vivo,14215,,1969.0,,,0,11764,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,Autocuration,Simiiformes,1,314293.0,,Plasma,22224,A,U,CHEMBL623116
,BAO_0000218,,In vivo,14215,,1969.0,,,0,11765,,The maximum plasma concentration (30 mg/kg) administered orally in dog,Autocuration,Canis lupus familiaris,1,9615.0,,Plasma,22224,A,U,CHEMBL623117
,BAO_0000218,,In vivo,14215,,1969.0,,,1,11766,,The maximum plasma concentration (400 mg/kg) administered orally in human,Intermediate,Homo sapiens,1,9606.0,,Plasma,50587,A,N,CHEMBL623118
,BAO_0000218,,In vivo,14215,,1969.0,,,1,11767,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623119
,BAO_0000218,,In vivo,14215,,1969.0,,,1,11768,,The maximum plasma concentration (50 mg/kg) administered orally in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623120
,BAO_0000218,,In vivo,14215,,1969.0,,,1,11769,,The maximum plasma concentration (800 mg/kg) administered orally in human,Intermediate,Homo sapiens,1,9606.0,,Plasma,50587,A,N,CHEMBL623286
,BAO_0000218,,In vivo,14067,,1969.0,,,1,11770,,The maximum plasma concentration was measured on rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623287
,BAO_0000218,,In vivo,12350,,1969.0,,,1,11771,,The maximum plasma concentration was measured on rats after oral administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623288
,BAO_0000218,,In vivo,14813,,1969.0,,,1,11772,,Plasma drug Cmax in rat (PO dose),Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623289
,BAO_0000218,,In vivo,12536,,,,,0,11773,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,Autocuration,,1,,,,22224,A,U,CHEMBL623290
,BAO_0000218,,In vivo,14169,,1969.0,,,1,11774,,maximum Plasma concentration in Dog was determined after Peroral administration,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL623291
,BAO_0000218,,In vivo,14169,,1969.0,,,1,11775,,maximum Plasma concentration in Rats was determined after Peroral administration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623292
,BAO_0000218,,In vivo,15604,,1969.0,,,1,11776,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL623293
,BAO_0000218,,In vivo,15604,,1969.0,,,0,11777,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Autocuration,Simiiformes,1,314293.0,,Plasma,22224,A,U,CHEMBL623294
,BAO_0000218,,In vivo,15604,,1969.0,,,1,11778,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623295
,BAO_0000218,,In vivo,14387,,,,,1,11779,,maximum concentration was measured when administered through oral route in mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623296
,BAO_0000218,,,15115,,,,,1,11780,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL875349
,BAO_0000019,,,15115,,,,,0,11781,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL623297
,BAO_0000019,,,15115,,,,,0,11782,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL623298
,BAO_0000019,,,15115,,,,,0,11783,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL623299
,BAO_0000218,,,16359,,,,,1,11784,,Pharmacokinetic parameter was evaluated in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623300
,BAO_0000218,,,12829,,,,,1,11785,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623301
,BAO_0000218,,,12829,,,,,1,11786,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623302
,BAO_0000218,,,12829,,,,,1,11787,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623303
,BAO_0000218,,,12829,,,,,1,11788,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623304
,BAO_0000218,,,12829,,,,,1,11789,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623305
,BAO_0000218,,,15137,,1969.0,,,1,11790,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623306
,BAO_0000218,,,15137,,1969.0,,,1,11791,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623307
,BAO_0000218,,,15137,,1969.0,,,1,11792,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL623308
,BAO_0000218,,,15137,,1969.0,,,1,11793,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL623309
,BAO_0000218,,,13509,,,,,1,11794,,Plasma Concentration after 120 min of oral administration to mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623310
,BAO_0000218,,,13509,,,,,1,11795,,Plasma Concentration after 30 min of oral administration to mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623311
,BAO_0000218,,,13509,,,,,1,11796,,Plasma Concentration after 60 min of oral administration to mice,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL623312
,BAO_0000218,,,13509,,,,,1,11797,,Plasma Concentration after 60 min of oral administration to mice; Not determined,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL875350
,BAO_0000218,,,13509,,,,,1,11798,,Plasma Concentration after 90 min of oral administration to mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL628635
,BAO_0000218,,,12064,,,,,1,11799,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628636
,BAO_0000218,,,12064,,,,,1,11800,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628637
,BAO_0000218,,,12064,,,,,1,11801,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628058
,BAO_0000218,,,10677,,,,,1,11802,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628059
,BAO_0000218,,,10677,,,,,1,11803,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628060
,BAO_0000019,,,8926,,,,,0,11804,,Distribution in the lung after 15 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628061
,BAO_0000019,,,8926,,,,,0,11805,,Distribution in the lung after 30 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628062
,BAO_0000019,,,8926,,,,,0,11806,,Distribution in the lung after 5 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628063
,BAO_0000019,,,8926,,,,,0,11807,,Distribution in the lung after 60 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628064
,BAO_0000019,,,8926,,,,,0,11808,,Distribution in the lung after 90 min of intravenous administration,Autocuration,,1,,,,22224,A,U,CHEMBL628065
,BAO_0000019,,,8926,,2385.0,,,0,11809,,Distribution in the muscle after 120 min of intravenous administration,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL628066
,BAO_0000019,,,8926,,2385.0,,,0,11810,,Distribution in the muscle after 15 min of intravenous administration,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL628067
,BAO_0000218,,,8926,,2385.0,,,1,11811,,Distribution in the muscle after 30 min of intravenous administration,Intermediate,Mus musculus,1,10090.0,,Muscle tissue,50594,A,N,CHEMBL874646
,BAO_0000019,,,8926,,2385.0,,,0,11812,,Distribution in the muscle after 5 min of intravenous administration,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL628068
,BAO_0000019,,,8926,,2385.0,,,0,11813,,Distribution in the muscle after 60 min of intravenous administration,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL628069
,BAO_0000019,,,8926,,2385.0,,,0,11814,,Distribution in the muscle after 90 min of intravenous administration,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL628070
,BAO_0000019,,,8926,,2106.0,,,0,11815,,Distribution in the spleen after 120 min of intravenous administration,Autocuration,,1,,,Spleen,22224,A,U,CHEMBL628071
,BAO_0000019,,,8926,,2106.0,,,0,11816,,Distribution in the spleen after 15 min of intravenous administration,Autocuration,,1,,,Spleen,22224,A,U,CHEMBL628072
,BAO_0000019,,,8926,,2106.0,,,0,11817,,Distribution in the spleen after 30 min of intravenous administration,Autocuration,,1,,,Spleen,22224,A,U,CHEMBL628073
,BAO_0000019,,,8926,,2106.0,,,0,11818,,Distribution in the spleen after 5 min of intravenous administration,Autocuration,,1,,,Spleen,22224,A,U,CHEMBL628074
,BAO_0000019,,,8926,,2106.0,,,0,11819,,Distribution in the spleen after 60 min of intravenous administration,Autocuration,,1,,,Spleen,22224,A,U,CHEMBL628075
,BAO_0000019,,,8926,,2106.0,,,0,11820,,Distribution in the spleen after 90 min of intravenous administration,Autocuration,,1,,,Spleen,22224,A,U,CHEMBL628076
,BAO_0000218,,,7570,,1235.0,,,1,11821,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Adrenal cortex,50597,A,N,CHEMBL628077
,BAO_0000218,,,7570,,178.0,,,1,11822,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628078
,BAO_0000218,,,7570,,2107.0,,,1,11823,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628079
,BAO_0000218,,,7570,,992.0,,,1,11824,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Female gonad,50597,A,N,CHEMBL628080
,BAO_0000218,,,7570,,2046.0,,,1,11825,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL628081
,BAO_0000218,,,7570,,1235.0,,,1,11826,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Adrenal cortex,50597,A,N,CHEMBL628082
,BAO_0000218,,,7570,,178.0,,,1,11827,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL874647
,BAO_0000218,,,7570,,2107.0,,,1,11828,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626406
,BAO_0000218,,,7570,,992.0,,,1,11829,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Female gonad,50597,A,N,CHEMBL626407
,BAO_0000218,,,7570,,2046.0,,,1,11830,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626408
,BAO_0000218,,,8608,,178.0,,,1,11831,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626409
,BAO_0000218,,,8608,,178.0,,,1,11832,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626410
,BAO_0000218,,,8608,,178.0,,,1,11833,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626411
,BAO_0000218,,,8608,,178.0,,,1,11834,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626412
,BAO_0000218,,,8608,,178.0,,,1,11835,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626413
,BAO_0000218,,,8608,,178.0,,,1,11836,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626414
,BAO_0000218,,,8608,,178.0,,,1,11837,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626415
,BAO_0000218,,,8608,,178.0,,,1,11838,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626416
,BAO_0000218,,,8608,,178.0,,,1,11839,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627062
,BAO_0000218,,,8608,,178.0,,,1,11840,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627063
,BAO_0000218,,,8608,,178.0,,,1,11841,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627064
,BAO_0000218,,,8608,,178.0,,,1,11842,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627227
,BAO_0000218,,,8608,,178.0,,,1,11843,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627228
,BAO_0000218,,,8608,,178.0,,,1,11844,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627229
,BAO_0000218,,,8608,,178.0,,,1,11845,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625792
,BAO_0000218,,,8608,,178.0,,,1,11846,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625793
,BAO_0000218,,,8608,,178.0,,,1,11847,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625794
,BAO_0000218,,,8608,,178.0,,,1,11848,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625795
,BAO_0000218,,,13792,,,,,1,11849,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625796
,BAO_0000218,,,13376,,,,,1,11850,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625797
,BAO_0000218,,,13376,,,,,1,11851,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625798
,BAO_0000218,,,14380,,,,,0,11852,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,,1,,,,22224,A,U,CHEMBL875613
,BAO_0000218,,,14380,,,,,0,11853,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,,1,,,,22224,A,U,CHEMBL625799
,BAO_0000218,,,14380,,,,,0,11854,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,Autocuration,,1,,,,22224,A,U,CHEMBL625800
,BAO_0000218,,,14380,,,,,0,11855,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,Autocuration,,1,,,,22224,A,U,CHEMBL625801
,BAO_0000218,,,14380,,,,,0,11856,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,Autocuration,,1,,,,22224,A,U,CHEMBL625802
,BAO_0000218,,,14380,,,,,0,11857,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,,1,,,,22224,A,U,CHEMBL625803
,BAO_0000019,,,14380,,,,,0,11858,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,Autocuration,,1,,,,22224,A,U,CHEMBL625804
,BAO_0000218,,,14380,,,,,0,11859,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,Autocuration,,1,,,,22224,A,U,CHEMBL622530
,BAO_0000218,,,13701,,,,,1,11860,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL622531
,BAO_0000218,,,13701,,,,,1,11861,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL622532
,BAO_0000218,,,13701,,,,,1,11862,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623176
,BAO_0000218,,,13701,,,,,1,11863,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623177
,BAO_0000218,,,13701,,,,,1,11864,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623178
,BAO_0000218,,,13701,,,,,1,11865,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623179
,BAO_0000218,,,13701,,,,,1,11866,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623180
,BAO_0000218,,,13701,,,,,1,11867,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623181
,BAO_0000218,,,13701,,,,,1,11868,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL624131
,BAO_0000218,,,13701,,,,,1,11869,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL624132
,BAO_0000218,,,13701,,,,,1,11870,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL624133
,BAO_0000218,,,13701,,,,,1,11871,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL624846
,BAO_0000218,,,13701,,,,,1,11872,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL624847
,BAO_0000218,,,13701,,,,,1,11873,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL624848
,BAO_0000218,,,13701,,,,,1,11874,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625012
,BAO_0000218,,,13701,,,,,1,11875,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625013
,BAO_0000218,,,13701,,,,,1,11876,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625014
,BAO_0000218,,,13701,,,,,1,11877,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625015
,BAO_0000218,,,13701,,,,,1,11878,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625016
,BAO_0000218,,,13701,,,,,1,11879,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625017
,BAO_0000218,,,13701,,,,,1,11880,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625018
,BAO_0000218,,,13701,,,,,1,11881,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625019
,BAO_0000218,,,13701,,,,,1,11882,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625020
,BAO_0000218,,,13701,,,,,1,11883,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625021
,BAO_0000218,,,14393,,,,,1,11884,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625022
,BAO_0000218,,,14731,,,,,1,11885,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625023
,BAO_0000218,,,14731,,,,,1,11886,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL625024
,BAO_0000218,,,14731,,,,,1,11887,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL627626
,BAO_0000218,,,13758,,955.0,,,0,11888,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,Autocuration,,1,,,Brain,22224,A,U,CHEMBL627627
,BAO_0000218,,,13758,,1977.0,,,0,11889,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,Autocuration,,1,,,Serum,22224,A,U,CHEMBL627628
,BAO_0000218,,,13758,,955.0,,,0,11890,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,Autocuration,,1,,,Brain,22224,A,U,CHEMBL627629
,BAO_0000218,,,13758,,1977.0,,,0,11891,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,Autocuration,,1,,,Serum,22224,A,U,CHEMBL627630
,BAO_0000019,,,16359,,,,,0,11892,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),Autocuration,,1,,,,22224,A,U,CHEMBL627631
,BAO_0000218,,,16359,,,,,0,11893,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),Autocuration,,1,,,,22224,A,U,CHEMBL629515
,BAO_0000218,,,15383,,2106.0,,,1,11894,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL629516
,BAO_0000218,,,15383,,2106.0,,,1,11895,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL629517
,BAO_0000218,,,15383,,2106.0,,,1,11896,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL629518
,BAO_0000218,,,15383,,,,,1,11897,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL877499
,BAO_0000218,,,15383,,,,,1,11898,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629519
,BAO_0000218,,,15383,,,,,1,11899,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629520
,BAO_0000218,,,15383,,,,,1,11900,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629521
,BAO_0000218,,,14439,,,,,1,11901,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629522
,BAO_0000218,,,14439,,,,,1,11902,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629523
,BAO_0000218,,,14439,,,,,1,11903,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629524
,BAO_0000218,,,14439,,,,,1,11904,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629525
,BAO_0000218,,,14439,,,,,1,11905,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629526
,BAO_0000218,,,14439,,,,,1,11906,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629527
,BAO_0000218,,,14439,,,,,1,11907,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629528
,BAO_0000218,,,14439,,,,,1,11908,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629529
,BAO_0000218,,,14439,,,,,1,11909,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629530
,BAO_0000218,,,14439,,,,,1,11910,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629531
,BAO_0000218,,,14439,,,,,1,11911,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL628656
,BAO_0000218,,,14439,,,,,1,11912,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL628657
,BAO_0000218,,In vivo,13751,,,,,1,11913,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628658
,BAO_0000218,,In vivo,13751,,,,,1,11914,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628659
,BAO_0000218,,In vivo,13751,,,,,1,11915,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877500
,BAO_0000218,,In vivo,13751,,,,,1,11916,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628660
,BAO_0000218,,In vivo,13751,,,,,1,11917,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628661
,BAO_0000218,,In vivo,13751,,,,,1,11918,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628662
,BAO_0000218,,In vivo,13751,,,,,1,11919,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628663
,BAO_0000218,,In vivo,13751,,,,,1,11920,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628664
,BAO_0000218,,In vivo,13751,,178.0,,,1,11921,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628665
,BAO_0000218,,In vivo,13751,,178.0,,,1,11922,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628666
,BAO_0000218,,In vivo,13751,,178.0,,,1,11923,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628667
,BAO_0000218,,In vivo,13751,,178.0,,,1,11924,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628668
,BAO_0000218,,In vivo,13751,,178.0,,,1,11925,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628669
,BAO_0000218,,In vivo,13751,,178.0,,,1,11926,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628670
,BAO_0000218,,In vivo,13751,,178.0,,,1,11927,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628671
,BAO_0000218,,In vivo,13751,,10000001.0,,,1,11928,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL628672
,BAO_0000218,,In vivo,13751,,10000001.0,,,1,11929,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL630300
,BAO_0000218,,In vivo,13751,,10000001.0,,,1,11930,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL629787
,BAO_0000218,,In vivo,13751,,10000001.0,,,1,11931,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL629788
,BAO_0000218,,In vivo,13751,,955.0,,,1,11932,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL629789
,BAO_0000218,,In vivo,13751,,955.0,,,1,11933,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL629790
,BAO_0000218,,In vivo,13751,,955.0,,,1,11934,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL629791
,BAO_0000218,,In vivo,13751,,955.0,,,1,11935,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL629792
,BAO_0000218,,In vivo,13751,,955.0,,,1,11936,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL629793
,BAO_0000218,,In vivo,13751,,955.0,,,1,11937,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL629794
,BAO_0000218,,,10677,,,,,1,11938,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874459
,BAO_0000218,,,10677,,,,,1,11939,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629795
,BAO_0000218,,,10677,,,,,1,11940,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629796
,BAO_0000218,,,10677,,,,,1,11941,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629797
,BAO_0000218,,,10677,,,,,1,11942,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629798
,BAO_0000218,,In vivo,10911,,2369.0,,,1,11943,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Adrenal gland,50597,A,N,CHEMBL629799
,BAO_0000218,,In vivo,10911,,2369.0,,,1,11944,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Adrenal gland,50597,A,N,CHEMBL629800
,BAO_0000218,,In vivo,10911,,2369.0,,,1,11945,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Adrenal gland,50597,A,N,CHEMBL629801
,BAO_0000218,,In vivo,10911,,2369.0,,,1,11946,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,Intermediate,Rattus norvegicus,1,10116.0,,Adrenal gland,50597,A,N,CHEMBL629802
,BAO_0000218,,In vivo,10911,,2369.0,,,1,11947,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Adrenal gland,50597,A,N,CHEMBL629803
,BAO_0000218,,In vivo,10911,,178.0,,,1,11948,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL629804
,BAO_0000218,,In vivo,10911,,178.0,,,1,11949,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL629805
,BAO_0000218,,In vivo,10911,,178.0,,,1,11950,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL629806
,BAO_0000218,,In vivo,10911,,178.0,,,1,11951,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL629807
,BAO_0000218,,In vivo,10911,,178.0,,,1,11952,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL629808
,BAO_0000218,,In vivo,10911,,955.0,,,1,11953,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL629809
,BAO_0000218,,In vivo,10911,,955.0,,,1,11954,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL629810
,BAO_0000218,,In vivo,10911,,955.0,,,1,11955,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL629811
,BAO_0000218,,In vivo,10911,,955.0,,,1,11956,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL629812
,BAO_0000218,,In vivo,10911,,955.0,,,1,11957,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL629813
,BAO_0000218,,In vivo,10911,,955.0,,,1,11958,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL874460
,BAO_0000218,,In vivo,10911,,,,,1,11959,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629814
,BAO_0000218,,In vivo,10911,,,,,1,11960,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629815
,BAO_0000218,,In vivo,10911,,,,,1,11961,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629816
,BAO_0000218,,In vivo,10911,,,,,1,11962,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629817
,BAO_0000218,,In vivo,10911,,2113.0,,,1,11963,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626643
,BAO_0000218,,In vivo,10911,,2113.0,,,1,11964,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626644
,BAO_0000218,,In vivo,10911,,2113.0,,,1,11965,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626806
,BAO_0000218,,In vivo,10911,,2113.0,,,1,11966,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626807
,BAO_0000218,,In vivo,10911,,2107.0,,,1,11967,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627261
,BAO_0000218,,In vivo,10911,,2107.0,,,1,11968,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627262
,BAO_0000218,,In vivo,10911,,2107.0,,,1,11969,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627263
,BAO_0000218,,In vivo,10911,,2107.0,,,1,11970,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627264
,BAO_0000218,,In vivo,10911,,2048.0,,,1,11971,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627265
,BAO_0000218,,In vivo,10911,,2048.0,,,1,11972,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627266
,BAO_0000218,,In vivo,10911,,2048.0,,,1,11973,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627267
,BAO_0000218,,In vivo,10911,,2048.0,,,1,11974,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627268
,BAO_0000218,,In vivo,10911,,2385.0,,,1,11975,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627269
,BAO_0000218,,In vivo,10911,,2385.0,,,1,11976,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627270
,BAO_0000218,,,8608,,,,,1,11977,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627271
,BAO_0000218,,,8608,,,,,1,11978,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627946
,BAO_0000218,,,8608,,,,,1,11979,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875472
,BAO_0000218,,,8608,,,,,1,11980,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627947
,BAO_0000218,,,8608,,,,,1,11981,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627948
,BAO_0000218,,,8608,,,,,1,11982,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628113
,BAO_0000218,,,8608,,,,,1,11983,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628114
,BAO_0000218,,,8608,,,,,1,11984,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628115
,BAO_0000218,,,8608,,,,,1,11985,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628116
,BAO_0000218,,,8608,,,,,1,11986,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628117
,BAO_0000218,,,8608,,,,,1,11987,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628118
,BAO_0000218,,,8608,,,,,1,11988,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628119
,BAO_0000218,,,8608,,,,,1,11989,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628120
,BAO_0000218,,,8608,,,,,1,11990,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628121
,BAO_0000218,,,8608,,,,,1,11991,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628122
,BAO_0000218,,,8608,,,,,1,11992,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627297
,BAO_0000218,,,8608,,,,,1,11993,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627298
,BAO_0000218,,,8608,,,,,1,11994,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627299
,BAO_0000218,,,8608,,,,,1,11995,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627300
,BAO_0000218,,,8608,,,,,1,11996,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627301
,BAO_0000218,,,8608,,,,,1,11997,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627302
,BAO_0000218,,,8608,,,,,1,11998,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627303
,BAO_0000218,,,8608,,,,,1,11999,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627304
,BAO_0000218,,,8608,,,,,1,12000,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627305
,BAO_0000218,,,8608,,,,,1,12001,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627306
,BAO_0000218,,,8608,,,,,1,12002,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623982
,BAO_0000218,,,8608,,,,,1,12003,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623983
,BAO_0000218,,,8608,,,,,1,12004,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623984
,BAO_0000218,,,8608,,,,,1,12005,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623985
,BAO_0000218,,,8608,,,,,1,12006,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623986
,BAO_0000218,,,8608,,,,,1,12007,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623987
,BAO_0000218,,,8608,,,,,1,12008,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623988
,BAO_0000218,,,8608,,,,,1,12009,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623989
,BAO_0000218,,,8608,,,,,1,12010,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622215
,BAO_0000218,,,8608,,,,,1,12011,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622216
,BAO_0000218,,,8608,,,,,1,12012,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877481
,BAO_0000218,,,16359,,,,,0,12013,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),Autocuration,,1,,,,22224,A,U,CHEMBL622217
,BAO_0000218,,,13701,,,,,1,12014,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL622218
,BAO_0000218,,,14554,,,,,1,12015,,Pharmacokinetic profile AUC was evaluated in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622219
,BAO_0000019,,,6241,,,,,0,12016,,Pharmacokinetic property (Area under curve),Autocuration,,1,,,,22224,A,U,CHEMBL622220
,BAO_0000218,,,11537,,,,,1,12017,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL622221
,BAO_0000218,,,11537,,,,,1,12018,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL622222
,BAO_0000218,,,11537,,,,,1,12019,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL622223
,BAO_0000218,,,11537,,,,,1,12020,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL622224
,BAO_0000019,,,13118,,,,,0,12021,,Plasma concentration (AUC) was determined,Autocuration,,1,,,,22224,A,U,CHEMBL622225
,BAO_0000019,,,13118,,,,,0,12022,,Plasma concentration (AUC) was determined; Not detectable,Autocuration,,1,,,,22224,A,U,CHEMBL622226
,BAO_0000218,,,9562,,,,,1,12023,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),Intermediate,Cavia porcellus,1,10141.0,,,50512,A,N,CHEMBL624154
,BAO_0000218,,,10363,,,,,1,12024,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624155
,BAO_0000218,,,10363,,,,,1,12025,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624156
,BAO_0000218,,,10363,,,,,1,12026,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624157
,BAO_0000218,,,10363,,,,,1,12027,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624158
,BAO_0000218,,,12504,,,,,1,12028,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624159
,BAO_0000218,,,12504,,,,,1,12029,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624160
,BAO_0000218,,,12504,,,,,1,12030,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624161
,BAO_0000218,,,12504,,,,,1,12031,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624162
,BAO_0000218,,,13317,,,,,1,12032,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624163
,BAO_0000218,,,15078,,,,,1,12033,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624164
,BAO_0000218,,,14941,,,,,1,12034,,The AUC(0-infinity) values in female wistar rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624165
,BAO_0000218,,,15078,,,,,1,12035,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624166
,BAO_0000218,,,15078,,,,,1,12036,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624167
,BAO_0000218,,,14941,,,,,1,12037,,The AUC(0-t)values in female wistar rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624168
,BAO_0000218,,,14067,,,,,1,12038,,The Area under the concentration time curve of compound was measured on rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624169
,BAO_0000218,,,14215,,,,,1,12039,,The area under curve (100 mg/kg) administered orally in humans,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL624170
,BAO_0000218,,,14215,,,,,0,12040,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,Autocuration,Callithrix,1,9481.0,,,22224,A,U,CHEMBL624171
,BAO_0000218,,,14215,,,,,0,12041,,The area under curve (12.5 mg/kg) administered intravenously in monkey,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL624172
,BAO_0000218,,,14215,,,,,1,12042,,The area under curve (15 mg/kg) administered intravenously in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624173
,BAO_0000218,,,14215,,,,,1,12043,,The area under curve (200 mg/kg) administered orally in humans,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL877488
,BAO_0000218,,,14215,,,,,1,12044,,The area under curve (25 mg/kg) administered intravenously in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624174
,BAO_0000218,,,14215,,,,,0,12045,,The area under curve (25 mg/kg) administered orally in marmoset,Autocuration,Callithrix,1,9481.0,,,22224,A,U,CHEMBL624175
,BAO_0000218,,,14215,,,,,0,12046,,The area under curve (25 mg/kg) administered orally in monkey,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL624176
,BAO_0000218,,,14215,,,,,1,12047,,The area under curve (30 mg/kg) administered orally in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624177
,BAO_0000218,,,14215,,,,,1,12048,,The area under curve (400 mg/kg) administered orally in humans,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL624178
,BAO_0000218,,,14215,,,,,1,12049,,The area under curve (50 mg/kg) administered orally in fasted rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624179
,BAO_0000218,,,14215,,,,,1,12050,,The area under curve (50 mg/kg) administered orally in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627689
,BAO_0000218,,,14215,,,,,1,12051,,The area under curve (800 mg/kg) administered orally in humans,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL627690
,BAO_0000019,,,11324,,,,,0,12052,,The compound was evaluated for area under the curve,Autocuration,,1,,,,22224,A,U,CHEMBL627691
,BAO_0000019,,,11324,,,,,0,12053,,The compound was evaluated for area under the curve in marmosets,Autocuration,Callithrix,1,9481.0,,,22224,A,U,CHEMBL627692
,BAO_0000019,,,11324,,,,,0,12054,,The compound was evaluated for area under the curve in marmosets,Autocuration,Callithrix,1,9481.0,,,22224,A,U,CHEMBL627693
,BAO_0000218,,,13875,,,,,1,12055,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627694
,BAO_0000218,,,13875,,,,,1,12056,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627695
,BAO_0000218,,,13875,,,,,0,12057,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),Autocuration,,1,,,,22224,A,U,CHEMBL627696
,BAO_0000218,,,13875,,,,,1,12058,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627697
,BAO_0000218,,,13875,,,,,1,12059,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627698
,BAO_0000218,,,13875,,,,,1,12060,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627699
,BAO_0000218,,,13807,,,,,1,12061,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627700
,BAO_0000218,,,14127,,,,,1,12062,,Total drug exposure is determined after oral dosing in rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627701
,BAO_0000218,,,15116,,,,,0,12063,,Total drug exposure (5 mg/kg) when administered intravenously,Autocuration,,1,,,,22224,A,U,CHEMBL627702
,BAO_0000218,,,15116,,,,,0,12064,,Total drug exposure (5 mg/kg) when administered orally,Autocuration,,1,,,,22224,A,U,CHEMBL627703
,BAO_0000218,,,15604,,,,,0,12065,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL626873
,BAO_0000218,,,15604,,,,,1,12066,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629583
,BAO_0000218,,,15604,,,,,1,12067,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL629584
,BAO_0000218,,,15604,,,,,1,12068,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL629585
,BAO_0000218,,In vivo,13751,,955.0,,,1,12069,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL629586
,BAO_0000218,,In vivo,13751,,955.0,,,1,12070,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL629587
,BAO_0000218,,In vivo,13751,,,,,1,12071,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629588
,BAO_0000218,,In vivo,13751,,,,,1,12072,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629589
,BAO_0000218,,In vivo,13751,,,,,1,12073,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629590
,BAO_0000218,,In vivo,13751,,,,,1,12074,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629591
,BAO_0000218,,In vivo,13751,,,,,1,12075,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629592
,BAO_0000218,,In vivo,13751,,,,,1,12076,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629593
,BAO_0000218,,In vivo,13751,,,,,1,12077,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629594
,BAO_0000218,,In vivo,13751,,948.0,,,1,12078,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL629595
,BAO_0000218,,In vivo,13751,,948.0,,,1,12079,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL630290
,BAO_0000218,,In vivo,13751,,948.0,,,1,12080,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL627137
,BAO_0000218,,In vivo,13751,,948.0,,,1,12081,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL627138
,BAO_0000218,,In vivo,13751,,948.0,,,1,12082,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL627139
,BAO_0000218,,In vivo,13751,,948.0,,,1,12083,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL627140
,BAO_0000218,,In vivo,13751,,948.0,,,1,12084,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL627141
,BAO_0000218,,In vivo,13751,,2113.0,,,1,12085,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627142
,BAO_0000218,,In vivo,13751,,2113.0,,,1,12086,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627143
,BAO_0000218,,In vivo,13751,,2113.0,,,1,12087,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL874449
,BAO_0000218,,In vivo,13751,,2113.0,,,1,12088,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627144
,BAO_0000218,,In vivo,13751,,2113.0,,,1,12089,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627145
,BAO_0000218,,In vivo,13751,,2113.0,,,1,12090,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627146
,BAO_0000218,,In vivo,13751,,2113.0,,,1,12091,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627147
,BAO_0000218,,In vivo,13751,,2107.0,,,1,12092,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627148
,BAO_0000218,,In vivo,13751,,2048.0,,,1,12093,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627149
,BAO_0000218,,In vivo,13751,,2048.0,,,1,12094,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL632160
,BAO_0000218,,In vivo,13751,,2048.0,,,1,12095,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL632161
,BAO_0000218,,In vivo,13751,,2048.0,,,1,12096,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL632162
,BAO_0000218,,In vivo,13751,,2048.0,,,1,12097,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL632163
,BAO_0000218,,In vivo,13751,,2048.0,,,1,12098,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL874469
,BAO_0000218,,In vivo,13751,,2048.0,,,1,12099,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627182
,BAO_0000218,,In vivo,13751,,2385.0,,,1,12100,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627183
,BAO_0000218,,In vivo,13751,,2385.0,,,1,12101,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627184
,BAO_0000218,,In vivo,13751,,2385.0,,,1,12102,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627185
,BAO_0000218,,In vivo,13751,,2385.0,,,1,12103,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627186
,BAO_0000218,,In vivo,13751,,2385.0,,,1,12104,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627187
,BAO_0000218,,In vivo,13751,,2385.0,,,1,12105,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627188
,BAO_0000218,,In vivo,13751,,2385.0,,,1,12106,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627189
,BAO_0000218,,In vivo,13751,,,,,1,12107,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627190
,BAO_0000218,,In vivo,13751,,2107.0,,,1,12108,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627191
,BAO_0000218,,In vivo,13751,,2107.0,,,1,12109,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627192
,BAO_0000218,,In vivo,13751,,2107.0,,,1,12110,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627193
,BAO_0000218,,In vivo,10911,,2385.0,,,1,12111,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL874590
,BAO_0000218,,In vivo,10911,,2385.0,,,1,12112,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627194
,BAO_0000218,,In vivo,10911,,2385.0,,,1,12113,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627195
,BAO_0000218,,In vivo,10911,,992.0,,,1,12114,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Female gonad,50597,A,N,CHEMBL627196
,BAO_0000218,,In vivo,10911,,992.0,,,1,12115,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Female gonad,50597,A,N,CHEMBL627197
,BAO_0000218,,In vivo,10911,,992.0,,,1,12116,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Female gonad,50597,A,N,CHEMBL627198
,BAO_0000218,,In vivo,10911,,992.0,,,1,12117,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,Intermediate,Rattus norvegicus,1,10116.0,,Female gonad,50597,A,N,CHEMBL627199
,BAO_0000218,,In vivo,10911,,992.0,,,1,12118,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Female gonad,50597,A,N,CHEMBL627200
,BAO_0000218,,In vivo,10911,,1969.0,,,1,12119,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627201
,BAO_0000218,,In vivo,10911,,1969.0,,,1,12120,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627202
,BAO_0000218,,In vivo,10911,,1969.0,,,1,12121,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627203
,BAO_0000218,,In vivo,10911,,1969.0,,,1,12122,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627204
,BAO_0000218,,In vivo,10911,,2106.0,,,1,12123,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL627205
,BAO_0000218,,In vivo,10911,,2106.0,,,1,12124,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL627206
,BAO_0000218,,In vivo,10911,,2106.0,,,1,12125,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL627207
,BAO_0000218,,In vivo,10911,,2106.0,,,1,12126,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL627208
,BAO_0000218,,In vivo,10911,,2046.0,,,1,12127,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL627209
,BAO_0000218,,In vivo,10911,,2046.0,,,1,12128,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL627210
,BAO_0000218,,In vivo,10911,,2046.0,,,1,12129,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL627211
,BAO_0000218,,In vivo,10911,,2046.0,,,1,12130,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL627212
,BAO_0000218,,In vivo,10911,,995.0,,,1,12131,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL627213
,BAO_0000218,,In vivo,10911,,995.0,,,1,12132,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL626599
,BAO_0000218,,In vivo,10911,,995.0,,,1,12133,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL626600
,BAO_0000218,,In vivo,10911,,995.0,,,1,12134,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL626601
,BAO_0000019,,,8081,,,,,0,12135,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,Autocuration,,1,,,,22224,A,U,CHEMBL627484
,BAO_0000218,,,17248,,1969.0,,,1,12136,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),Intermediate,Macaca fascicularis,1,9541.0,,Plasma,100710,A,N,CHEMBL627485
,BAO_0000218,,,17248,,1969.0,,,1,12137,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,Intermediate,Macaca fascicularis,1,9541.0,,Plasma,100710,A,N,CHEMBL628147
,BAO_0000218,,,17248,,1969.0,,,1,12138,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,Intermediate,Macaca fascicularis,1,9541.0,,Plasma,100710,A,N,CHEMBL628148
,BAO_0000218,,,17248,,1969.0,,,1,12139,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL628149
,BAO_0000218,,,17248,,1969.0,,,1,12140,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL628150
,BAO_0000218,,,17248,,1969.0,,,1,12141,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL628318
,BAO_0000218,,,17248,,1969.0,,,1,12142,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL628319
,BAO_0000218,,,15592,,,,,1,12143,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL875609
,BAO_0000019,,,7040,,,,,0,12144,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,Autocuration,,1,,,,22224,A,U,CHEMBL628320
,BAO_0000019,,,7040,,,,,0,12145,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,Autocuration,,1,,,,22224,A,U,CHEMBL628321
,BAO_0000019,,,7040,,,,,0,12146,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,Autocuration,,1,,,,22224,A,U,CHEMBL628322
,BAO_0000019,,,7040,,,,,0,12147,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,Autocuration,,1,,,,22224,A,U,CHEMBL628323
,BAO_0000019,,,7040,,,,,0,12148,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,Autocuration,,1,,,,22224,A,U,CHEMBL628324
,BAO_0000019,,,7040,,,,,0,12149,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,Autocuration,,1,,,,22224,A,U,CHEMBL628325
,BAO_0000019,,,7040,,,,,0,12150,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,Autocuration,,1,,,,22224,A,U,CHEMBL628326
,BAO_0000218,,,9614,,1236.0,,,1,12151,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",Intermediate,Canis lupus familiaris,1,9615.0,,Adrenal medulla,50588,A,N,CHEMBL628327
,BAO_0000218,,,9614,,1236.0,,,1,12152,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",Intermediate,Canis lupus familiaris,1,9615.0,,Adrenal medulla,50588,A,N,CHEMBL628328
,BAO_0000218,,,9614,,178.0,,,1,12153,,"Concentration of compound in blood of dog 1, after administering intravenously",Intermediate,Canis lupus familiaris,1,9615.0,,Blood,50588,A,N,CHEMBL628329
,BAO_0000218,,,8608,,2107.0,,,1,12154,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628330
,BAO_0000218,,,8608,,2107.0,,,1,12155,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628331
,BAO_0000218,,,8608,,2107.0,,,1,12156,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628332
,BAO_0000218,,,8608,,2107.0,,,1,12157,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628333
,BAO_0000218,,,8608,,2107.0,,,1,12158,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628334
,BAO_0000218,,,8608,,2107.0,,,1,12159,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628335
,BAO_0000218,,,8608,,2107.0,,,1,12160,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628336
,BAO_0000218,,,8608,,2107.0,,,1,12161,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628337
,BAO_0000218,,,8608,,2107.0,,,1,12162,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628338
,BAO_0000218,,,8608,,2107.0,,,1,12163,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL875610
,BAO_0000218,,,8608,,2107.0,,,1,12164,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628339
,BAO_0000218,,,8608,,2107.0,,,1,12165,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628340
,BAO_0000218,,,8608,,2107.0,,,1,12166,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628341
,BAO_0000218,,,8608,,2107.0,,,1,12167,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622214
,BAO_0000218,,,8608,,2107.0,,,1,12168,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL623167
,BAO_0000218,,,8608,,2107.0,,,1,12169,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL623168
,BAO_0000218,,,8608,,2107.0,,,1,12170,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL623169
,BAO_0000218,,,8608,,2107.0,,,1,12171,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL623170
,BAO_0000218,,,8608,,2048.0,,,1,12172,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627224
,BAO_0000218,,,8608,,2048.0,,,1,12173,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL875634
,BAO_0000218,,,8608,,2048.0,,,1,12174,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627225
,BAO_0000218,,,8608,,2048.0,,,1,12175,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627226
,BAO_0000218,,,8608,,2048.0,,,1,12176,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626083
,BAO_0000218,,,8608,,2048.0,,,1,12177,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626084
,BAO_0000218,,,8608,,2048.0,,,1,12178,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626085
,BAO_0000218,,,8608,,2048.0,,,1,12179,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626086
,BAO_0000218,,,8608,,2048.0,,,1,12180,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626087
,BAO_0000218,,,8608,,2048.0,,,1,12181,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626088
,BAO_0000218,,,8608,,2048.0,,,1,12182,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626089
,BAO_0000218,,,8608,,2048.0,,,1,12183,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626090
,BAO_0000218,,,8608,,2048.0,,,1,12184,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626091
,BAO_0000218,,,8608,,2048.0,,,1,12185,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626092
,BAO_0000218,,,8608,,2048.0,,,1,12186,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626093
,BAO_0000218,,,8608,,2048.0,,,1,12187,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626094
,BAO_0000218,,,8608,,2048.0,,,1,12188,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626095
,BAO_0000218,,,8608,,2048.0,,,1,12189,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL626096
,BAO_0000218,,,15604,,,,,0,12190,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL626097
,BAO_0000218,,,15604,,,,,1,12191,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626098
,BAO_0000218,,,1806,,1969.0,,,0,12192,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL626099
,BAO_0000218,,,1806,,1969.0,,,0,12193,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL626100
,BAO_0000218,,,17237,,1969.0,,,1,12194,,AUC 0-inf in dog,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626101
,BAO_0000218,,,17237,,1969.0,,,1,12195,,AUC 0-inf in guinea pig,Intermediate,Cavia porcellus,1,10141.0,,Plasma,50512,A,N,CHEMBL626102
,BAO_0000218,,,17237,,1969.0,,,1,12196,,AUC 0-t in dog,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626103
,BAO_0000218,,,17237,,1969.0,,,1,12197,,AUC 0-t in guinea pig,Intermediate,Cavia porcellus,1,10141.0,,Plasma,50512,A,N,CHEMBL628391
,BAO_0000218,,,15194,,,,,1,12198,,The compound was tested for brain to plasma partition in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628392
,BAO_0000218,,,15194,,,,,1,12199,,The compound was tested for brain to plasma partition in rat.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628393
,BAO_0000019,,,8787,,178.0,,,0,12200,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,Autocuration,,1,,,Blood,22224,A,U,CHEMBL628394
,BAO_0000218,,,17025,,,,,1,12201,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628395
,BAO_0000218,,,17025,,,,,0,12202,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL628396
,BAO_0000218,,,17025,,,,,1,12203,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL628397
,BAO_0000218,,,17025,,,,,1,12204,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628398
,BAO_0000218,,,4236,,,,,1,12205,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,Intermediate,Macaca mulatta,1,9544.0,,,50797,A,N,CHEMBL628399
,BAO_0000218,,,15343,,,,,1,12206,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628400
,BAO_0000218,,,15343,,,,,1,12207,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874907
,BAO_0000019,,,17720,,,,,0,12208,,Area under curve of the compound was determined,Autocuration,,1,,,,22224,A,U,CHEMBL628401
,BAO_0000218,,,17788,,1969.0,,,0,12209,,AUC in monkeys at a dose of 1 mg/kg,Autocuration,Simiiformes,1,314293.0,,Plasma,22224,A,U,CHEMBL628402
,BAO_0000218,,,17788,,1969.0,,,1,12210,,AUC in rats at a dose of 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628403
,BAO_0000019,,,8778,,,,,0,12211,,Compound was evaluated for the overall absorbance loss at pH of 2,Autocuration,,1,,,,22224,A,U,CHEMBL628404
,BAO_0000019,,,8778,,,,,0,12212,,Compound was evaluated for the overall absorbance loss at pH of 4,Autocuration,,1,,,,22224,A,U,CHEMBL628405
,BAO_0000019,,,8778,,,,,0,12213,,Compound was evaluated for the overall absorbance loss at pH of 7,Autocuration,,1,,,,22224,A,U,CHEMBL628406
,BAO_0000218,,,2249,,,,,1,12214,,Compound was evaluated for its absorption in the rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628407
,BAO_0000218,,,8881,,1088.0,,,1,12215,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628408
,BAO_0000218,,,8881,,1088.0,,,1,12216,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629171
,BAO_0000218,,,8881,,1088.0,,,1,12217,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629172
,BAO_0000218,,,8881,,1088.0,,,1,12218,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629173
,BAO_0000218,,,15286,,,,,1,12219,,In vitro percent permeability into rat ileum,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629174
,BAO_0000218,,,15286,,,,,1,12220,,In vitro percent permeability into rat ileum; Range is 10-17,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629175
,BAO_0000218,,,15286,,,,,1,12221,,In vitro percent permeability into rat ileum; Range is 10-18,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629176
,BAO_0000218,,,15286,,,,,1,12222,,In vitro percent permeability into rat ileum; Range is 10-19,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629177
,BAO_0000218,,,15286,,,,,1,12223,,In vitro percent permeability into rat ileum; Range is 12-15,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629178
,BAO_0000218,,,15286,,,,,1,12224,,In vitro percent permeability into rat ileum; Range is 13-19,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631869
,BAO_0000218,,,15286,,,,,1,12225,,In vitro percent permeability into rat ileum; Range is 14-17,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631870
,BAO_0000218,,,15286,,,,,1,12226,,In vitro percent permeability into rat ileum; Range is 15-18,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631871
,BAO_0000218,,,15286,,,,,1,12227,,In vitro percent permeability into rat ileum; Range is 2-5,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631872
,BAO_0000221,,,15286,,2116.0,,,0,12228,,In vitro percent permeability into rat ileum; Range is 23-42,Autocuration,,1,,,Ileum,22224,A,U,CHEMBL875775
,BAO_0000218,,,15286,,,,,1,12229,,In vitro percent permeability into rat ileum; Range is 28-36,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631873
,BAO_0000218,,,15286,,,,,1,12230,,In vitro percent permeability into rat ileum; Range is 29-35,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631874
,BAO_0000218,,,15286,,,,,1,12231,,In vitro percent permeability into rat ileum; Range is 46-66,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631875
,BAO_0000218,,,15286,,,,,1,12232,,In vitro percent permeability into rat ileum; Range is 50-68,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631876
,BAO_0000218,,,15286,,,,,1,12233,,In vitro percent permeability into rat ileum; Range is 78-81,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631877
,BAO_0000218,,,15286,,,,,1,12234,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631878
,BAO_0000218,,,15286,,,,,1,12235,,In vitro percent permeability into rat ileum; nd indicates not detected,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631879
,BAO_0000218,,,15286,,,,,1,12236,,In vitro percent permeability into rat ileum; nt indicates not detected,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631880
,BAO_0000218,,,15286,,,,,1,12237,,In vitro percent permeability into rat ileum; nt indicates not tested,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631881
,BAO_0000218,,,13770,,,,,1,12238,,Compound was tested for oral absorption in bile-duct cannulated rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631882
,BAO_0000218,,,13770,,,,,1,12239,,Compound was tested for oral absorption in bile-duct cannulated rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630749
,BAO_0000218,,,5202,,,,,1,12240,,Oral absorption using Caco-2 cell monolayers.,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL630750
,BAO_0000218,,,14920,,,,,1,12241,,Percent of the drug absorbed after administration to humans was determined,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL630253
,BAO_0000218,,,14103,,1969.0,,,1,12242,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL630254
,BAO_0000218,,,14103,,1969.0,,,1,12243,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL630255
,BAO_0000218,,,14103,,1969.0,,,1,12244,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL630256
,BAO_0000218,,In vivo,13751,,2107.0,,,1,12245,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL875781
,BAO_0000218,,In vivo,13751,,2107.0,,,1,12246,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL630257
,BAO_0000218,,In vivo,13751,,2107.0,,,1,12247,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL630258
,BAO_0000218,,,15807,,,,,1,12248,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630259
,BAO_0000218,,,15807,,2435.0,,,1,12249,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL630260
,BAO_0000218,,,15807,,2435.0,,,1,12250,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL630261
,BAO_0000218,,,14950,,,,,1,12251,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630262
,BAO_0000218,,,14950,,,,,1,12252,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630263
,BAO_0000218,,,14950,,,,,1,12253,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630264
,BAO_0000218,,,14950,,,,,1,12254,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630265
,BAO_0000218,,,14950,,,,,1,12255,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630266
,BAO_0000218,,,14950,,2113.0,,,1,12256,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL630267
,BAO_0000218,,,14950,,2113.0,,,1,12257,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL630268
,BAO_0000218,,,14950,,,,,1,12258,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630269
,BAO_0000218,,,14950,,,,,1,12259,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630270
,BAO_0000218,,,14950,,2048.0,,,1,12260,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL630141
,BAO_0000218,,,14950,,2048.0,,,1,12261,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL630142
,BAO_0000218,,,14950,,2385.0,,,1,12262,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL630143
,BAO_0000218,,,14950,,2385.0,,,1,12263,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL630144
,BAO_0000218,,,14950,,2367.0,,,1,12264,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,Intermediate,Rattus norvegicus,1,10116.0,,Prostate gland,50597,A,N,CHEMBL630145
,BAO_0000218,,,14950,,2367.0,,,1,12265,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,Intermediate,Rattus norvegicus,1,10116.0,,Prostate gland,50597,A,N,CHEMBL630146
,BAO_0000218,,,14950,,,,,1,12266,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630147
,BAO_0000218,,,14950,,,,,1,12267,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630148
,BAO_0000218,,,14950,,,,,1,12268,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630149
,BAO_0000218,,,14950,,2106.0,,,1,12269,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL630150
,BAO_0000218,,,14950,,2106.0,,,1,12270,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL630151
,BAO_0000218,,,14950,,2046.0,,,1,12271,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL632031
,BAO_0000218,,,14950,,2046.0,,,1,12272,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL632032
,BAO_0000218,,,14950,,,,,1,12273,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632033
,BAO_0000218,,,14950,,,,,1,12274,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632034
,BAO_0000218,,,14950,,2385.0,,,1,12275,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL632035
,BAO_0000218,,,14950,,,,,1,12276,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632036
,BAO_0000218,,,14950,,2046.0,,,1,12277,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL632037
,BAO_0000218,,,8631,,178.0,,,1,12278,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL632038
,BAO_0000218,,,8631,,178.0,,,1,12279,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL632039
,BAO_0000218,,,8631,,178.0,,,1,12280,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL632040
,BAO_0000218,,,8631,,178.0,,,1,12281,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL632041
,BAO_0000218,,,9614,,178.0,,,1,12282,,"Concentration of compound in blood of dog 2, after administering intravenously",Intermediate,Canis lupus familiaris,1,9615.0,,Blood,50588,A,N,CHEMBL632042
,BAO_0000218,,,9614,,,,,1,12283,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL632043
,BAO_0000218,,,9614,,,,,1,12284,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL632044
,BAO_0000218,,,9614,,2107.0,,,1,12285,,"Concentration of compound in liver of dog 1, after administering intravenously",Intermediate,Canis lupus familiaris,1,9615.0,,Liver,50588,A,N,CHEMBL632045
,BAO_0000218,,,9614,,2107.0,,,1,12286,,"Concentration of compound in liver of dog 2, after administering intravenously",Intermediate,Canis lupus familiaris,1,9615.0,,Liver,50588,A,N,CHEMBL632046
,BAO_0000218,,,9614,,2048.0,,,1,12287,,"Concentration of compound in lung of dog 1, after administering intravenously",Intermediate,Canis lupus familiaris,1,9615.0,,Lung,50588,A,N,CHEMBL632047
,BAO_0000218,,,9614,,2048.0,,,1,12288,,"Concentration of compound in lung of dog 2, after administering intravenously",Intermediate,Canis lupus familiaris,1,9615.0,,Lung,50588,A,N,CHEMBL632048
,BAO_0000218,,,9614,,2385.0,,,1,12289,,"Concentration of compound in muscle of dog 1, after administering intravenously",Intermediate,Canis lupus familiaris,1,9615.0,,Muscle tissue,50588,A,N,CHEMBL632049
,BAO_0000218,,,9614,,2385.0,,,1,12290,,"Concentration of compound in muscle of dog 2, after administering intravenously",Intermediate,Canis lupus familiaris,1,9615.0,,Muscle tissue,50588,A,N,CHEMBL876418
,BAO_0000218,,,9614,,2106.0,,,1,12291,,"Concentration of compound in spleen of dog 1,after administering intravenously",Intermediate,Canis lupus familiaris,1,9615.0,,Spleen,50588,A,N,CHEMBL632050
,BAO_0000218,,,9614,,2106.0,,,1,12292,,"Concentration of compound in spleen of dog 2, after administering intravenously",Intermediate,Canis lupus familiaris,1,9615.0,,Spleen,50588,A,N,CHEMBL632051
,BAO_0000218,,,10353,,,,,0,12293,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,Autocuration,,1,,,,22224,F,U,CHEMBL632052
,BAO_0000218,,,10353,,,,,0,12294,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,Autocuration,,1,,,,22224,F,U,CHEMBL632053
,BAO_0000218,,,10353,,,,,0,12295,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,Autocuration,,1,,,,22224,A,U,CHEMBL632054
,BAO_0000218,,,10353,,,,,0,12296,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,Autocuration,,1,,,,22224,F,U,CHEMBL632055
,BAO_0000218,,,10353,,,,,0,12297,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,Autocuration,,1,,,,22224,F,U,CHEMBL631181
,BAO_0000218,,,9196,,,,,0,12298,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL631182
,BAO_0000218,,,9196,,,,,0,12299,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL631183
,BAO_0000218,,,9196,,,,,0,12300,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL631184
,BAO_0000218,,,9196,,,,,0,12301,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL629774
,BAO_0000218,,,9196,,,,,0,12302,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL629775
,BAO_0000218,,,9196,,,,,0,12303,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL876549
,BAO_0000218,,,9196,,,,,0,12304,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628172
,BAO_0000218,,,9196,,,,,0,12305,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628173
,BAO_0000218,,,9196,,,,,0,12306,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628174
,BAO_0000218,,,9196,,,,,0,12307,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628175
,BAO_0000218,,,9196,,,,,0,12308,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628176
,BAO_0000218,,,9196,,,,,0,12309,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628177
,BAO_0000218,,,9196,,,,,0,12310,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628178
,BAO_0000218,,,9196,,,,,0,12311,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628179
,BAO_0000218,,,9196,,,,,0,12312,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,Autocuration,,1,,,,22224,A,U,CHEMBL628180
,BAO_0000218,,,9196,,,,,0,12313,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628181
,BAO_0000218,,,9196,,,,,0,12314,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628182
,BAO_0000218,,,9196,,,,,0,12315,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628183
,BAO_0000218,,,9196,,,,,0,12316,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,Autocuration,,1,,,,22224,A,U,CHEMBL628184
,BAO_0000218,,,9196,,,,,0,12317,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628185
,BAO_0000218,,,9196,,,,,0,12318,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL875617
,BAO_0000218,,,9196,,,,,0,12319,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,Autocuration,,1,,,,22224,A,U,CHEMBL628186
,BAO_0000218,,,9196,,,,,0,12320,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628187
,BAO_0000218,,,9196,,,,,0,12321,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628188
,BAO_0000218,,,9196,,,,,0,12322,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628189
,BAO_0000218,,,9196,,,,,0,12323,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,Autocuration,,1,,,,22224,A,U,CHEMBL628190
,BAO_0000218,,,9196,,,,,0,12324,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628191
,BAO_0000218,,,9196,,,,,0,12325,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,Autocuration,,1,,,,22224,A,U,CHEMBL626513
,BAO_0000218,,,8608,,2046.0,,,1,12326,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626514
,BAO_0000218,,,8608,,2046.0,,,1,12327,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626515
,BAO_0000218,,,8608,,2046.0,,,1,12328,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626516
,BAO_0000218,,,8608,,2046.0,,,1,12329,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626517
,BAO_0000218,,,8608,,2046.0,,,1,12330,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626518
,BAO_0000218,,,8608,,2046.0,,,1,12331,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626519
,BAO_0000218,,,8608,,2046.0,,,1,12332,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626520
,BAO_0000218,,,8608,,2046.0,,,1,12333,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626521
,BAO_0000218,,,8608,,2046.0,,,1,12334,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626522
,BAO_0000218,,,8608,,2046.0,,,1,12335,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626523
,BAO_0000218,,,8608,,2046.0,,,1,12336,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626524
,BAO_0000218,,,8608,,2046.0,,,1,12337,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626688
,BAO_0000218,,,8608,,2046.0,,,1,12338,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626689
,BAO_0000218,,,8608,,2046.0,,,1,12339,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626690
,BAO_0000218,,,8608,,2046.0,,,1,12340,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626691
,BAO_0000218,,,8608,,2046.0,,,1,12341,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL627319
,BAO_0000218,,,8608,,2046.0,,,1,12342,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL624052
,BAO_0000218,,,8608,,2046.0,,,1,12343,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL624053
,BAO_0000218,,,8085,,,,,1,12344,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624054
,BAO_0000218,,,8085,,,,,1,12345,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624055
,BAO_0000218,,,8085,,,,,1,12346,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624056
,BAO_0000218,,,8085,,995.0,,,1,12347,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL624057
,BAO_0000218,,,8085,,995.0,,,1,12348,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL622281
,BAO_0000218,,,8085,,995.0,,,1,12349,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL622282
,BAO_0000218,,,8085,,995.0,,,1,12350,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL622283
,BAO_0000218,,,8085,,995.0,,,1,12351,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL622284
,BAO_0000218,,,8085,,995.0,,,1,12352,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL622285
,BAO_0000218,,,8085,,995.0,,,1,12353,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL622286
,BAO_0000100,,,7657,,,,,0,12354,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,Autocuration,,1,,,,22224,P,U,CHEMBL622287
,BAO_0000218,,,8935,,,,,1,12355,,Partition coefficient (logD7.4),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL622288
,BAO_0000218,,,13792,,,,,1,12356,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL622289
,BAO_0000218,,,13792,,955.0,,,1,12357,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL622290
,BAO_0000218,,,13792,,,,,1,12358,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL622291
,BAO_0000218,,,13792,,955.0,,,1,12359,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL622292
,BAO_0000218,,,13792,,,,,1,12360,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL622293
,BAO_0000218,,,13792,,955.0,,,1,12361,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL622294
,BAO_0000218,,,13792,,,,,1,12362,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL622295
,BAO_0000218,,,13792,,955.0,,,1,12363,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL622296
,BAO_0000218,,,14103,,1969.0,,,1,12364,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL874409
,BAO_0000218,,,14103,,1969.0,,,1,12365,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622297
,BAO_0000218,,,14103,,1969.0,,,1,12366,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622298
,BAO_0000218,,,14103,,1969.0,,,1,12367,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622299
,BAO_0000218,,,14103,,1969.0,,,1,12368,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622300
,BAO_0000218,,,14103,,1969.0,,,1,12369,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622301
,BAO_0000218,,,14103,,1969.0,,,1,12370,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622302
,BAO_0000218,,,14103,,1969.0,,,1,12371,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622303
,BAO_0000218,,,14103,,1969.0,,,1,12372,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622304
,BAO_0000218,,,14103,,1969.0,,,1,12373,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622305
,BAO_0000218,,,14103,,1969.0,,,1,12374,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622306
,BAO_0000218,,,14103,,1969.0,,,1,12375,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626864
,BAO_0000218,,,14103,,1969.0,,,1,12376,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626865
,BAO_0000218,,,14103,,1969.0,,,1,12377,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626866
,BAO_0000218,,,14103,,1969.0,,,1,12378,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626867
,BAO_0000218,,,14103,,1969.0,,,1,12379,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626868
,BAO_0000218,,,14103,,1969.0,,,1,12380,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626869
,BAO_0000218,,,14103,,1969.0,,,1,12381,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626870
,BAO_0000218,,,14103,,1969.0,,,1,12382,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626871
,BAO_0000218,,,14103,,1969.0,,,1,12383,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626872
,BAO_0000218,,,14103,,1969.0,,,1,12384,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL632185
,BAO_0000218,,,14103,,1969.0,,,1,12385,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL632186
,BAO_0000019,,,12904,,,,,0,12386,,Amount of acetic acid produced by the compound,Autocuration,,1,,,,22224,A,U,CHEMBL629310
,BAO_0000019,,,12904,,,,,0,12387,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,Autocuration,,1,,,,22224,A,U,CHEMBL629311
,BAO_0000218,,,9663,,,,,1,12388,,Log of (Cbrain/Cblood) in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629312
,BAO_0000221,,,7652,,,,,0,12389,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),Autocuration,,1,,,,22224,A,U,CHEMBL629313
,BAO_0000221,,,7652,,,,,0,12390,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),Autocuration,,1,,,,22224,A,U,CHEMBL629314
,BAO_0000221,,,7652,,,,,0,12391,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),Autocuration,,1,,,,22224,A,U,CHEMBL629315
,BAO_0000219,,,7652,,,,,0,12392,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),Autocuration,,1,,,,22224,B,U,CHEMBL629316
,BAO_0000221,,,7652,,,,,0,12393,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),Autocuration,,1,,,,22224,A,U,CHEMBL629317
,BAO_0000019,,,7652,,,,,0,12394,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),Autocuration,,1,,,,22224,A,U,CHEMBL629318
,BAO_0000019,,,7652,,,,,0,12395,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),Autocuration,,1,,,,22224,A,U,CHEMBL877497
,BAO_0000019,,,7652,,,,,0,12396,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),Autocuration,,1,,,,22224,A,U,CHEMBL629319
,BAO_0000019,,,7652,,,,,0,12397,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),Autocuration,,1,,,,22224,A,U,CHEMBL629320
,BAO_0000019,,,7652,,,,,0,12398,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),Autocuration,,1,,,,22224,A,U,CHEMBL629496
,BAO_0000019,,,7652,,,,,0,12399,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),Autocuration,,1,,,,22224,A,U,CHEMBL629497
,BAO_0000019,,,7652,,,,,0,12400,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),Autocuration,,1,,,,22224,A,U,CHEMBL629498
,BAO_0000019,,,7652,,,,,0,12401,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),Autocuration,,1,,,,22224,A,U,CHEMBL629499
,BAO_0000019,,,7652,,,,,0,12402,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),Autocuration,,1,,,,22224,A,U,CHEMBL629500
,BAO_0000019,,,7652,,,,,0,12403,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),Autocuration,,1,,,,22224,A,U,CHEMBL629501
,BAO_0000019,,,7652,,,,,0,12404,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),Autocuration,,1,,,,22224,A,U,CHEMBL629502
,BAO_0000218,,In vivo,8267,,,,,0,12405,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,Autocuration,,1,,,,22224,F,U,CHEMBL629503
,BAO_0000218,,,8267,,,,,1,12406,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL629504
,BAO_0000019,,,14479,,,,,0,12407,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,Autocuration,,1,,,,22224,A,U,CHEMBL629505
,BAO_0000019,,,17515,,,,,0,12408,,Compound was evaluated for total body clearance,Autocuration,,1,,,,22224,A,U,CHEMBL629506
,BAO_0000019,,,17515,,,,,0,12409,,Compound was evaluated for volume of distribution at steady state,Autocuration,,1,,,,22224,A,U,CHEMBL629507
,BAO_0000019,,,8142,,,,,0,12410,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,Autocuration,,1,,,,22224,A,U,CHEMBL877498
,BAO_0000019,,,14849,,,,,0,12411,,Percentage of the diamine which is monoprotonated at pH 7.4,Autocuration,,1,,,,22224,A,U,CHEMBL629508
,BAO_0000019,,,7653,,,,,0,12412,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,Autocuration,,1,,,,22224,A,U,CHEMBL629509
,BAO_0000218,,,8631,,178.0,,,1,12413,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL629510
,BAO_0000218,,,8631,,178.0,,,1,12414,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL629511
,BAO_0000218,,,8631,,178.0,,,1,12415,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL629512
,BAO_0000218,,,8631,,178.0,,,1,12416,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL629513
,BAO_0000218,,,8631,,178.0,,,1,12417,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL629514
,BAO_0000218,,,8631,,178.0,,,1,12418,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628447
,BAO_0000218,,,8631,,178.0,,,1,12419,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628448
,BAO_0000218,,,8631,,178.0,,,1,12420,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628449
,BAO_0000218,,,8631,,178.0,,,1,12421,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631119
,BAO_0000218,,,8631,,178.0,,,1,12422,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631120
,BAO_0000218,,,8631,,178.0,,,1,12423,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631121
,BAO_0000218,,,8631,,178.0,,,1,12424,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL874458
,BAO_0000218,,,8631,,178.0,,,1,12425,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631122
,BAO_0000218,,,8631,,178.0,,,1,12426,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631123
,BAO_0000218,,,8631,,178.0,,,1,12427,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631124
,BAO_0000218,,,8631,,178.0,,,1,12428,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631125
,BAO_0000218,,,8631,,178.0,,,1,12429,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631290
,BAO_0000218,,,8631,,178.0,,,1,12430,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631291
,BAO_0000218,,,8631,,178.0,,,1,12431,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631292
,BAO_0000218,,,8631,,178.0,,,1,12432,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631293
,BAO_0000218,,,8631,,178.0,,,1,12433,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631294
,BAO_0000218,,,8631,,178.0,,,1,12434,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631295
,BAO_0000218,,,8631,,178.0,,,1,12435,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631296
,BAO_0000218,,,8631,,178.0,,,1,12436,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631297
,BAO_0000218,,,10263,,,,,0,12437,,Maximum biodistribution (Bmax) was determined.,Autocuration,,1,,,,22224,A,U,CHEMBL631298
,BAO_0000218,,,12364,,,,,1,12438,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL631299
,BAO_0000218,,,12364,,,,,1,12439,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL631300
,BAO_0000218,,,12364,,,,,1,12440,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL631301
,BAO_0000218,,,12364,,,,,1,12441,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL630291
,BAO_0000218,,,14793,,,,,0,12442,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,,1,,,,22224,A,U,CHEMBL630292
,BAO_0000218,,,14793,,,,,0,12443,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,Autocuration,,1,,,,22224,A,U,CHEMBL630293
,BAO_0000218,,,14793,,,,,0,12444,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,Autocuration,,1,,,,22224,A,U,CHEMBL630294
,BAO_0000218,,,14793,,,,,0,12445,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,,1,,,,22224,A,U,CHEMBL630295
,BAO_0000218,,,14793,,,,,0,12446,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,,1,,,,22224,A,U,CHEMBL630296
,BAO_0000218,,,14793,,,,,0,12447,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,Autocuration,,1,,,,22224,A,U,CHEMBL626782
,BAO_0000218,,,14793,,,,,0,12448,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,Autocuration,,1,,,,22224,A,U,CHEMBL626783
,BAO_0000218,,,14793,,,,,0,12449,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,,1,,,,22224,A,U,CHEMBL626784
,BAO_0000218,,,14793,,,,,0,12450,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,,1,,,,22224,A,U,CHEMBL626785
,BAO_0000218,,,14793,,,,,0,12451,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,Autocuration,,1,,,,22224,A,U,CHEMBL626786
,BAO_0000218,,,9196,,,,,0,12452,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL626787
,BAO_0000218,,,9196,,,,,0,12453,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,Autocuration,,1,,,,22224,A,U,CHEMBL626788
,BAO_0000218,,,9196,,,,,0,12454,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL625927
,BAO_0000218,,,8374,,178.0,,,1,12455,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625928
,BAO_0000218,,,8374,,178.0,,,1,12456,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625929
,BAO_0000218,,,8374,,178.0,,,1,12457,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625930
,BAO_0000218,,,8374,,178.0,,,1,12458,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625931
,BAO_0000218,,,8374,,178.0,,,1,12459,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627230
,BAO_0000218,,,8374,,178.0,,,1,12460,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627231
,BAO_0000218,,,8374,,178.0,,,1,12461,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627232
,BAO_0000218,,,8374,,178.0,,,1,12462,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627233
,BAO_0000218,,,8374,,178.0,,,1,12463,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL875470
,BAO_0000218,,,8374,,178.0,,,1,12464,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627234
,BAO_0000218,,,8374,,178.0,,,1,12465,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627235
,BAO_0000218,,,8374,,178.0,,,1,12466,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627236
,BAO_0000218,,,8374,,178.0,,,1,12467,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627237
,BAO_0000218,,,8374,,178.0,,,1,12468,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627238
,BAO_0000218,,,8374,,178.0,,,1,12469,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627239
,BAO_0000218,,,8374,,178.0,,,1,12470,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627240
,BAO_0000218,,,8374,,178.0,,,1,12471,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627241
,BAO_0000218,,,8374,,178.0,,,1,12472,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627242
,BAO_0000218,,,8374,,178.0,,,1,12473,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627243
,BAO_0000218,,,8374,,178.0,,,1,12474,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627244
,BAO_0000218,,,8374,,178.0,,,1,12475,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627245
,BAO_0000218,,,8374,,178.0,,,1,12476,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627246
,BAO_0000218,,,8374,,178.0,,,1,12477,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627247
,BAO_0000218,,,8374,,178.0,,,1,12478,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627248
,BAO_0000218,,,8374,,178.0,,,1,12479,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627249
,BAO_0000218,,,8374,,178.0,,,1,12480,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625569
,BAO_0000218,,,8374,,178.0,,,1,12481,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625570
,BAO_0000218,,,8374,,178.0,,,1,12482,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625571
,BAO_0000218,,,8374,,178.0,,,1,12483,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625572
,BAO_0000218,,,8374,,178.0,,,1,12484,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625573
,BAO_0000218,,,8374,,178.0,,,1,12485,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625574
,BAO_0000218,,,8374,,178.0,,,1,12486,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626245
,BAO_0000218,,,8374,,178.0,,,1,12487,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626246
,BAO_0000218,,,9196,,,,,0,12488,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL626247
,BAO_0000218,,,9196,,,,,0,12489,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL626248
,BAO_0000218,,,9196,,,,,0,12490,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL626249
,BAO_0000218,,,9196,,,,,0,12491,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL626420
,BAO_0000218,,,9196,,,,,0,12492,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL626421
,BAO_0000218,,,9196,,,,,0,12493,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL626422
,BAO_0000218,,,9196,,,,,0,12494,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL626423
,BAO_0000218,,,9196,,,,,0,12495,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL626424
,BAO_0000218,,,12023,,,,,1,12496,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626425
,BAO_0000218,,,12023,,,,,1,12497,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875476
,BAO_0000218,,,12023,,,,,1,12498,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL626426
,BAO_0000100,,,10580,,,,,0,12499,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,Autocuration,,1,,,,22224,P,U,CHEMBL626427
,BAO_0000100,,,10580,,,,,0,12500,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,Autocuration,,1,,,,22224,P,U,CHEMBL626428
,BAO_0000019,,,16032,,,,,0,12501,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,Autocuration,,1,,,,22224,A,U,CHEMBL626429
,BAO_0000019,,,16032,,1088.0,,,0,12502,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,Autocuration,,1,,,Urine,22224,A,U,CHEMBL625025
,BAO_0000218,,,8594,,178.0,,,1,12503,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625026
,BAO_0000218,,,8594,,178.0,,,1,12504,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625027
,BAO_0000218,,,8594,,178.0,,,1,12505,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL874410
,BAO_0000218,,,8594,,178.0,,,1,12506,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625028
,BAO_0000218,,,8594,,178.0,,,1,12507,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625029
,BAO_0000218,,,8594,,178.0,,,1,12508,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625030
,BAO_0000218,,,8594,,178.0,,,1,12509,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625031
,BAO_0000218,,,8594,,178.0,,,1,12510,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625032
,BAO_0000218,,,8594,,178.0,,,1,12511,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625033
,BAO_0000218,,,8594,,178.0,,,1,12512,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625034
,BAO_0000218,,,8594,,948.0,,,1,12513,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624872
,BAO_0000218,,,8594,,948.0,,,1,12514,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624873
,BAO_0000218,,,8594,,948.0,,,1,12515,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624874
,BAO_0000218,,,8594,,948.0,,,1,12516,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624875
,BAO_0000218,,,8594,,948.0,,,1,12517,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624876
,BAO_0000218,,,8594,,948.0,,,1,12518,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624877
,BAO_0000218,,,8594,,948.0,,,1,12519,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624878
,BAO_0000218,,,8594,,948.0,,,1,12520,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624879
,BAO_0000218,,,8594,,948.0,,,1,12521,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624880
,BAO_0000218,,,8594,,948.0,,,1,12522,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624881
,BAO_0000218,,,8594,,948.0,,,1,12523,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL624882
,BAO_0000218,,,8594,,2113.0,,,1,12524,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624883
,BAO_0000218,,,8594,,2113.0,,,1,12525,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624884
,BAO_0000218,,,8594,,2113.0,,,1,12526,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624885
,BAO_0000218,,,8594,,2113.0,,,1,12527,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624886
,BAO_0000218,,,8594,,2113.0,,,1,12528,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624887
,BAO_0000218,,,8594,,2113.0,,,1,12529,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624888
,BAO_0000218,,,8594,,2113.0,,,1,12530,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624889
,BAO_0000218,,,8594,,2113.0,,,1,12531,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL624890
,BAO_0000218,,,8594,,2113.0,,,1,12532,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621964
,BAO_0000218,,,8594,,2113.0,,,1,12533,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL621965
,BAO_0000218,,,8594,,2107.0,,,1,12534,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621966
,BAO_0000218,,,8594,,2107.0,,,1,12535,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL621967
,BAO_0000218,,,8594,,2107.0,,,1,12536,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL622164
,BAO_0000019,,,7653,,,,,0,12537,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),Autocuration,,1,,,,22224,A,U,CHEMBL623097
,BAO_0000019,,,7653,,,,,0,12538,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),Autocuration,,1,,,,22224,A,U,CHEMBL623098
,BAO_0000019,,,7653,,,,,0,12539,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,Autocuration,,1,,,,22224,A,U,CHEMBL623099
,BAO_0000019,,,7653,,,,,0,12540,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,Autocuration,,1,,,,22224,A,U,CHEMBL623100
,BAO_0000218,,,9104,,,,,1,12541,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628673
,BAO_0000218,,,9104,,,,,1,12542,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628674
,BAO_0000218,,,9104,,,,,1,12543,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628675
,BAO_0000218,,,9104,,,,,1,12544,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627644
,BAO_0000218,,,9104,,,,,1,12545,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627645
,BAO_0000218,,,9104,,,,,1,12546,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627646
,BAO_0000218,,,9104,,,,,1,12547,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627647
,BAO_0000218,,,9104,,,,,1,12548,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627648
,BAO_0000218,,,12902,,,,,1,12549,,Free level in rat plasma,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627649
,BAO_0000019,,,6614,,,,,0,12550,,Level reaching in blood plasma of rat or human was determined,Autocuration,,1,,,,22224,A,U,CHEMBL628313
,BAO_0000218,,,9663,,,,,1,12551,,Log (Cbrain/Cblood) in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628314
,BAO_0000019,,,17658,,,,,0,12552,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,Autocuration,,1,,,,22224,A,U,CHEMBL628315
,BAO_0000019,,,17658,,,,,0,12553,,Mean percentage of compound transport through membrane; expressed as membrane transport,Autocuration,,1,,,,22224,A,U,CHEMBL628316
,BAO_0000218,,,14314,,,,,0,12554,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL628317
,BAO_0000019,,,7385,,,,,0,12555,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,Autocuration,,1,,,,22224,A,U,CHEMBL628473
,BAO_0000019,,,7385,,,,,0,12556,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",Autocuration,,1,,,,22224,A,U,CHEMBL628474
,BAO_0000019,,,7385,,,,,0,12557,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,Autocuration,,1,,,,22224,A,U,CHEMBL628475
,BAO_0000019,,,1329,,,,,0,12558,,Net water uptake by a carrier mediated transport (%cm) mechanism,Autocuration,,1,,,,22224,A,U,CHEMBL628476
,BAO_0000218,,,12187,,,,,0,12559,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL628477
,BAO_0000218,,,12187,,,,,1,12560,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Intermediate,Mustela putorius furo,1,9669.0,,,50506,A,N,CHEMBL628478
,BAO_0000218,,,12187,,,,,1,12561,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Intermediate,Mustela putorius furo,1,9669.0,,,50506,A,N,CHEMBL628479
,BAO_0000218,,,12187,,,,,0,12562,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL628480
,BAO_0000218,,,12187,,,,,0,12563,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL628481
,BAO_0000218,,,12187,,,,,1,12564,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628482
,BAO_0000218,,,12187,,,,,1,12565,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628483
,BAO_0000218,,,9278,,1969.0,,,1,12566,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628484
,BAO_0000218,,,9278,,1969.0,,,1,12567,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628485
,BAO_0000218,,,9278,,1969.0,,,1,12568,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",Intermediate,Macaca fascicularis,1,9541.0,,Plasma,100710,A,N,CHEMBL628486
,BAO_0000218,,,9278,,1969.0,,,1,12569,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",Intermediate,Homo sapiens,1,9606.0,,Plasma,50587,A,N,CHEMBL628487
,BAO_0000218,,,9278,,1969.0,,,1,12570,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628488
,BAO_0000218,,,9278,,1969.0,,,1,12571,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628489
,BAO_0000218,,,9278,,1969.0,,,1,12572,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628490
,BAO_0000218,,,12186,,,,,1,12573,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL628491
,BAO_0000218,,,12186,,,,,1,12574,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL877507
,BAO_0000218,,,12186,,,,,0,12575,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Autocuration,,1,,,,22224,A,U,CHEMBL628492
,BAO_0000019,,,12041,,,,,0,12576,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL628493
,BAO_0000019,,,12041,,,,,0,12577,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL628494
,BAO_0000019,,,12041,,,,,0,12578,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL628495
,BAO_0000218,,,6737,,,,,1,12579,,Permeability in Caco-2 assay at 10E-6,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL628496
,BAO_0000218,,,13758,,955.0,,,0,12580,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,Autocuration,,1,,,Brain,22224,A,U,CHEMBL628497
,BAO_0000218,,,13758,,955.0,,,0,12581,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,Autocuration,,1,,,Brain,22224,A,U,CHEMBL628498
,BAO_0000019,,,5676,,,,,0,12582,,Plasma protein binding was determined,Autocuration,,1,,,,22224,A,U,CHEMBL628499
,BAO_0000218,,,14793,,,,,0,12583,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,Autocuration,,1,,,,22224,A,U,CHEMBL627656
,BAO_0000218,,,14793,,,,,0,12584,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,,1,,,,22224,A,U,CHEMBL627657
,BAO_0000218,,,14793,,,,,0,12585,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,,1,,,,22224,A,U,CHEMBL626808
,BAO_0000218,,,14793,,,,,0,12586,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,Autocuration,,1,,,,22224,A,U,CHEMBL626809
,BAO_0000218,,,14793,,,,,0,12587,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,Autocuration,,1,,,,22224,A,U,CHEMBL626810
,BAO_0000218,,,14793,,,,,0,12588,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,,1,,,,22224,A,U,CHEMBL626811
,BAO_0000218,,,14793,,,,,0,12589,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,,1,,,,22224,A,U,CHEMBL874465
,BAO_0000218,,,14793,,,,,0,12590,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,Autocuration,,1,,,,22224,A,U,CHEMBL626812
,BAO_0000218,,,14793,,,,,0,12591,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,Autocuration,,1,,,,22224,A,U,CHEMBL626813
,BAO_0000218,,,14793,,,,,0,12592,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,Autocuration,,1,,,,22224,A,U,CHEMBL626814
,BAO_0000019,,,14000,,,,,0,12593,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,Autocuration,,1,,,,22224,A,U,CHEMBL626815
,BAO_0000019,,,5948,,,,,0,12594,,Partition coefficient (logP),Autocuration,,1,,,,22224,A,U,CHEMBL628566
,BAO_0000100,,,13824,,,,,0,12595,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),Autocuration,,1,,,,22229,P,U,CHEMBL628567
,BAO_0000100,,,10778,,,,,0,12596,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL628568
,BAO_0000218,,In vivo,17237,,,,,1,12597,,C max in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628569
,BAO_0000218,,In vivo,17237,,,,,1,12598,,C max in guinea pig,Intermediate,Cavia porcellus,1,10141.0,,,50512,A,N,CHEMBL628570
,BAO_0000218,,In vivo,2809,,,,,0,12599,,C max value was evaluated,Autocuration,,1,,,,22224,A,U,CHEMBL628571
,BAO_0000218,,In vivo,11954,,,,,0,12600,,Cmax value after oral dose of 0.1 mg//kg,Autocuration,,1,,,,22224,A,U,CHEMBL628572
,BAO_0000218,,In vivo,11954,,,,,0,12601,,Cmax value after oral dose of 0.3 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL628573
,BAO_0000218,,In vivo,11954,,,,,0,12602,,Cmax value after oral dose of 1 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL628574
,BAO_0000218,,In vivo,11954,,,,,0,12603,,Cmax value after oral dose of 10 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL628575
,BAO_0000218,,In vivo,11954,,,,,0,12604,,Cmax value after oral dose of 23.4 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL628576
,BAO_0000218,,In vivo,11954,,,,,0,12605,,Cmax value after oral dose of 3 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL628577
,BAO_0000218,,In vivo,11954,,,,,0,12606,,Cmax value after oral dose of 3.87 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL628578
,BAO_0000218,,In vivo,12768,,,,,1,12607,,Cmax value in female Beagle dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL874466
,BAO_0000218,,In vivo,12768,,,,,1,12608,,Cmax value in male rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628579
,BAO_0000218,,In vivo,12780,,1969.0,,,1,12609,,Cmax value in rat plasma when administered 20 mg/kg perorally,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628580
,BAO_0000218,,In vivo,15592,,1969.0,,,1,12610,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL628581
,BAO_0000218,,In vivo,15592,,1969.0,,,1,12611,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL628582
,BAO_0000218,,,17025,,,,,1,12612,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628583
,BAO_0000218,,,17025,,,,,0,12613,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL625782
,BAO_0000218,,,17025,,,,,1,12614,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL625783
,BAO_0000218,,,17025,,,,,1,12615,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625784
,BAO_0000218,,,4236,,1969.0,,,1,12616,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,Intermediate,Macaca mulatta,1,9544.0,,Plasma,50797,A,N,CHEMBL625785
,BAO_0000218,,,15791,,,,,1,12617,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625786
,BAO_0000019,,,11149,,,,,0,12618,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,Autocuration,,1,,,,22224,A,U,CHEMBL874467
,BAO_0000218,,,15592,,,,,1,12619,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625787
,BAO_0000218,,,15778,,,,,1,12620,,cytotoxicity against HIV protease enzyme.,Intermediate,Human immunodeficiency virus,1,12721.0,,,50677,A,N,CHEMBL625964
,BAO_0000218,,,12745,,,,,1,12621,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625965
,BAO_0000218,,,12745,,,,,1,12622,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625966
,BAO_0000218,,In vivo,13941,,1969.0,,,1,12623,,The plasma clearance in dog.,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL625967
,BAO_0000218,,In vivo,13941,,1969.0,,,1,12624,,The plasma clearance in rat.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625968
,BAO_0000218,,In vivo,16449,,1969.0,,,1,12625,,Clearance from plasma in male Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625969
,BAO_0000218,,In vivo,16449,,1969.0,,,1,12626,,Clearance from plasma in male cynomolgus monkeys,Intermediate,Macaca fascicularis,1,9541.0,,Plasma,100710,A,N,CHEMBL625970
,BAO_0000218,,In vivo,14224,,1969.0,,,1,12627,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL625971
,BAO_0000218,,In vivo,14224,,1969.0,,,1,12628,,Clearance of compound in dog plasma,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL625972
,BAO_0000218,,In vivo,14224,,1969.0,,,1,12629,,Clearance of compound in human plasma,Intermediate,Homo sapiens,1,9606.0,,Plasma,50587,A,N,CHEMBL625973
,BAO_0000218,,In vivo,14317,,,,,1,12630,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625974
,BAO_0000218,,In vivo,14317,,,,,1,12631,,Clearance of compound when administered intravenously as an individual dose to a single dog.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625975
,BAO_0000218,,In vivo,14224,,1969.0,,,1,12632,,"Clearance (10 mg/kg, intravenously) in dog plasma",Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL625976
,BAO_0000218,,In vivo,17237,,,,,1,12633,,Clearance value in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625977
,BAO_0000218,,In vivo,17237,,,,,1,12634,,Clearance value in guinea pig,Intermediate,Cavia porcellus,1,10141.0,,,50512,A,N,CHEMBL625978
,BAO_0000218,,In vivo,14187,,,,,1,12635,,Clearance values in rats after iv administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874468
,BAO_0000218,,In vivo,4806,,1969.0,,,0,12636,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL625421
,BAO_0000218,,In vivo,15025,,,,,1,12637,,In vivo clearance (5 mg/kg) was determined in rabbits,Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL625422
,BAO_0000218,,In vivo,13197,,,,,1,12638,,Plasma Clearance rate was determined for the compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625423
,BAO_0000218,,In vivo,13197,,,,,0,12639,,Plasma Clearance rate was determined for the compound in squirrel monkeys,Autocuration,Saimiri,1,9520.0,,,22224,A,U,CHEMBL625424
,BAO_0000218,,In vivo,13960,,,,,1,12640,,Plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625425
,BAO_0000218,,In vivo,17820,,,,,0,12641,,Plasma clearance of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL625426
,BAO_0000218,,In vivo,14706,,,,,1,12642,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,Intermediate,Cavia porcellus,1,10141.0,,,50512,A,N,CHEMBL625427
,BAO_0000218,,In vivo,14706,,,,,1,12643,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,Intermediate,Cavia porcellus,1,10141.0,,,50512,A,N,CHEMBL625428
,BAO_0000218,,In vivo,6504,,,,,0,12644,,Plasma clearance was determined,Autocuration,,1,,,,22224,A,U,CHEMBL625429
,BAO_0000218,,In vivo,14925,,,,,1,12645,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625430
,BAO_0000218,,In vivo,13197,,,,,1,12646,,Plasma clearance rate was determined for the compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625431
,BAO_0000218,,In vivo,13197,,,,,0,12647,,Plasma clearance rate was determined for the compound in squirrel monkeys,Autocuration,Saimiri,1,9520.0,,,22224,A,U,CHEMBL627307
,BAO_0000218,,In vivo,3437,,,,,0,12648,,Slow clearance (CL) was determined,Autocuration,,1,,,,22224,A,U,CHEMBL627308
,BAO_0000218,,,9196,,,,,0,12649,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL627309
,BAO_0000218,,,9196,,,,,0,12650,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,Autocuration,,1,,,,22224,A,U,CHEMBL627310
,BAO_0000218,,,9196,,,,,0,12651,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL627311
,BAO_0000218,,,9196,,,,,0,12652,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL627312
,BAO_0000218,,,9196,,,,,0,12653,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL627313
,BAO_0000218,,,9196,,,,,0,12654,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL627314
,BAO_0000218,,,9196,,,,,0,12655,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL627315
,BAO_0000218,,,9196,,,,,0,12656,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL627316
,BAO_0000218,,,9196,,,,,0,12657,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL627317
,BAO_0000218,,,9196,,,,,0,12658,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL627318
,BAO_0000218,,,9196,,,,,0,12659,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL627999
,BAO_0000218,,,9196,,,,,0,12660,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628000
,BAO_0000218,,,9196,,,,,0,12661,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628001
,BAO_0000218,,,9196,,,,,0,12662,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL628002
,BAO_0000218,,,9196,,,,,0,12663,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL625610
,BAO_0000218,,,9196,,,,,0,12664,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL625611
,BAO_0000218,,,9196,,,,,0,12665,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL625612
,BAO_0000218,,,9196,,,,,0,12666,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL625613
,BAO_0000218,,,9196,,,,,0,12667,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL875479
,BAO_0000218,,,9196,,,,,0,12668,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL625614
,BAO_0000218,,,9196,,,,,0,12669,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,Autocuration,,1,,,,22224,A,U,CHEMBL625615
,BAO_0000218,,,9196,,,,,0,12670,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,Autocuration,,1,,,,22224,A,U,CHEMBL626302
,BAO_0000218,,,8374,,178.0,,,1,12671,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626303
,BAO_0000218,,,8374,,178.0,,,1,12672,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627420
,BAO_0000218,,,13477,,,,,1,12673,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627421
,BAO_0000218,,,13477,,,,,1,12674,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625695
,BAO_0000218,,,13477,,,,,1,12675,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625696
,BAO_0000218,,,10009,,955.0,,,1,12676,,Distribution of compound in mice brain was measured after 1 hr,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL875606
,BAO_0000218,,,10009,,955.0,,,1,12677,,Distribution of compound in mice brain was measured after 24 hr r,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL625697
,BAO_0000218,,,10009,,955.0,,,1,12678,,Distribution of compound in mice brain was measured after 2 hr,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL625698
,BAO_0000218,,,10009,,955.0,,,1,12679,,Distribution of compound in mice brain was measured after 3 hr,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL625699
,BAO_0000218,,,10009,,955.0,,,1,12680,,Distribution of compound in mice brain was measured after 6 hr,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL625700
,BAO_0000218,,,10009,,,,,1,12681,,Distribution of compound in mice liver was measured after 1 hr,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625701
,BAO_0000218,,,10009,,,,,1,12682,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625702
,BAO_0000218,,,10009,,,,,1,12683,,Distribution of compound in mice liver was measured after 2 hr,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625703
,BAO_0000218,,,10009,,,,,1,12684,,Distribution of compound in mice liver was measured after 3 hr,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625704
,BAO_0000218,,,10009,,,,,1,12685,,Distribution of compound in mice liver was measured after 6 hr,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625705
,BAO_0000218,,,8170,,1236.0,,,1,12686,,Distribution in dog adrenal medulla 30 min after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Adrenal medulla,50588,A,N,CHEMBL625706
,BAO_0000218,,,8170,,1236.0,,,1,12687,,Distribution in dog adrenal medulla 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Adrenal medulla,50588,A,N,CHEMBL625707
,BAO_0000218,,,8170,,,,,1,12688,,Distribution in female dog Ovary 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625708
,BAO_0000218,,,8170,,,,,1,12689,,Distribution in female dog Ovary 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625709
,BAO_0000218,,,8170,,,,,1,12690,,Distribution in female dog adipose 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624180
,BAO_0000218,,,8170,,,,,1,12691,,Distribution in female dog adipose 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624181
,BAO_0000218,,,8170,,1235.0,,,1,12692,,Distribution in female dog adrenal cortex 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Adrenal cortex,50588,A,N,CHEMBL624182
,BAO_0000218,,,8170,,1235.0,,,1,12693,,Distribution in female dog adrenal cortex 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Adrenal cortex,50588,A,N,CHEMBL624183
,BAO_0000218,,,8594,,2107.0,,,1,12694,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624184
,BAO_0000218,,,8594,,2107.0,,,1,12695,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL877489
,BAO_0000218,,,8594,,2107.0,,,1,12696,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624185
,BAO_0000218,,,8594,,2107.0,,,1,12697,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624186
,BAO_0000218,,,8594,,2107.0,,,1,12698,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624187
,BAO_0000218,,,8594,,2107.0,,,1,12699,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL624188
,BAO_0000218,,,8594,,2048.0,,,1,12700,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624189
,BAO_0000218,,,8594,,2048.0,,,1,12701,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624190
,BAO_0000218,,,8594,,2048.0,,,1,12702,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624191
,BAO_0000218,,,8594,,2048.0,,,1,12703,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624192
,BAO_0000218,,,8594,,2048.0,,,1,12704,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624193
,BAO_0000218,,,8594,,2048.0,,,1,12705,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624194
,BAO_0000218,,,8594,,2048.0,,,1,12706,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624891
,BAO_0000218,,,8594,,2048.0,,,1,12707,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624892
,BAO_0000218,,,8594,,2048.0,,,1,12708,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL624893
,BAO_0000218,,,8594,,2048.0,,,1,12709,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627632
,BAO_0000218,,,8594,,,,,1,12710,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627633
,BAO_0000218,,,8594,,,,,1,12711,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627634
,BAO_0000218,,,8594,,,,,1,12712,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627635
,BAO_0000218,,,8594,,,,,1,12713,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627636
,BAO_0000218,,,8594,,,,,1,12714,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626816
,BAO_0000218,,,8594,,,,,1,12715,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626817
,BAO_0000218,,,8594,,,,,1,12716,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626818
,BAO_0000218,,,8594,,,,,1,12717,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626819
,BAO_0000218,,,8594,,,,,1,12718,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626820
,BAO_0000218,,,8594,,,,,1,12719,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626821
,BAO_0000218,,,8594,,2046.0,,,1,12720,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626822
,BAO_0000218,,,8594,,2046.0,,,1,12721,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626823
,BAO_0000218,,,8594,,2046.0,,,1,12722,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626824
,BAO_0000218,,,8594,,2046.0,,,1,12723,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626825
,BAO_0000218,,,8594,,2046.0,,,1,12724,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626826
,BAO_0000218,,,8594,,2046.0,,,1,12725,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626827
,BAO_0000218,,,8594,,2046.0,,,1,12726,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626828
,BAO_0000218,,,8594,,2046.0,,,1,12727,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626829
,BAO_0000218,,,8594,,2046.0,,,1,12728,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL626830
,BAO_0000218,,,8594,,,,,1,12729,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627150
,BAO_0000218,,,8594,,,,,1,12730,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627151
,BAO_0000218,,,8594,,,,,1,12731,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627152
,BAO_0000218,,,8594,,,,,1,12732,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627153
,BAO_0000019,,,12904,,,,,0,12733,,Rate of acetate production by the compound was determined,Autocuration,,1,,,,22224,A,U,CHEMBL627154
,BAO_0000019,,,12904,,,,,0,12734,,Rate of acetate production by the compound was determined; Not determined,Autocuration,,1,,,,22224,A,U,CHEMBL627155
,BAO_0000019,,,3730,,,,,0,12735,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,Autocuration,,1,,,,22224,A,U,CHEMBL627156
,BAO_0000019,,,3627,,,,,0,12736,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,Autocuration,,1,,,,22224,A,U,CHEMBL627157
,BAO_0000218,,,13799,,,,,1,12737,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL627158
,BAO_0000218,,,13799,,1969.0,,,1,12738,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Intermediate,Oryctolagus cuniculus,1,9986.0,,Plasma,50592,A,N,CHEMBL627159
,BAO_0000218,,,13799,,,,,1,12739,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627160
,BAO_0000218,,,13799,,,,,1,12740,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628540
,BAO_0000218,,,13799,,1969.0,,,1,12741,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628541
,BAO_0000218,,,13799,,1969.0,,,1,12742,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628542
,BAO_0000100,,,6629,,,,,0,12743,,Solubility after at a pH 1.2,Autocuration,,1,,,,22229,P,U,CHEMBL628543
,BAO_0000100,,,6629,,,,,0,12744,,Solubility after at pH 1.2,Autocuration,,1,,,,22229,P,U,CHEMBL628544
,BAO_0000100,,,6629,,,,,0,12745,,Solubility after injection of water,Autocuration,,1,,,,22229,P,U,CHEMBL628545
,BAO_0000019,,,14000,,,,,0,12746,,Statistical significance of IC 50 values; Expressed as R value,Autocuration,,1,,,,22224,A,U,CHEMBL628546
,BAO_0000019,,,8267,,,,,0,12747,,Systemic availability with respect to methyldopa was determined,Autocuration,,1,,,,22224,A,U,CHEMBL874455
,BAO_0000218,,,13799,,,,,1,12748,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628547
,BAO_0000218,,,13799,,1969.0,,,1,12749,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL628548
,BAO_0000218,,,7132,,1988.0,,,1,12750,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL628549
,BAO_0000218,,,7132,,1988.0,,,1,12751,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL628550
,BAO_0000218,,,7132,,1988.0,,,1,12752,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL628551
,BAO_0000218,,,7132,,1088.0,,,1,12753,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL628552
,BAO_0000218,,,7132,,1088.0,,,1,12754,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL628553
,BAO_0000218,,,7132,,1088.0,,,1,12755,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL628554
,BAO_0000218,,,7132,,1088.0,,,1,12756,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL628555
,BAO_0000218,,,7132,,1088.0,,,1,12757,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL628556
,BAO_0000218,,,7132,,2113.0,,,1,12758,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",Intermediate,Oryctolagus cuniculus,1,9986.0,,Kidney,50592,A,N,CHEMBL628557
,BAO_0000218,,,7132,,1988.0,,,1,12759,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL628558
,BAO_0000218,,,7132,,1988.0,,,1,12760,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL628559
,BAO_0000218,,,7132,,1988.0,,,1,12761,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL628560
,BAO_0000218,,,7132,,1088.0,,,1,12762,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL874456
,BAO_0000218,,,7132,,1988.0,,,1,12763,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL628561
,BAO_0000218,,,7132,,1988.0,,,1,12764,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL628562
,BAO_0000218,,,7132,,1088.0,,,1,12765,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL628563
,BAO_0000218,,,7132,,1088.0,,,1,12766,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL628564
,BAO_0000218,,,7132,,1088.0,,,1,12767,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL628565
,BAO_0000218,,,7132,,1088.0,,,1,12768,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL631248
,BAO_0000218,,,7132,,1088.0,,,1,12769,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL631249
,BAO_0000218,,,7132,,2113.0,,,1,12770,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",Intermediate,Oryctolagus cuniculus,1,9986.0,,Kidney,50592,A,N,CHEMBL627214
,BAO_0000218,,,7132,,1988.0,,,1,12771,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL874591
,BAO_0000218,,,7132,,1988.0,,,1,12772,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL627215
,BAO_0000218,,,7132,,1988.0,,,1,12773,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL625471
,BAO_0000218,,,7132,,,,,1,12774,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL625472
,BAO_0000218,,,7132,,,,,1,12775,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL625473
,BAO_0000218,,In vivo,13317,,,,,1,12776,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625474
,BAO_0000218,,In vivo,15341,,,,,1,12777,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625475
,BAO_0000218,,In vivo,15341,,,,,1,12778,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625476
,BAO_0000218,,In vivo,15341,,,,,1,12779,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625477
,BAO_0000218,,In vivo,15341,,,,,1,12780,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625478
,BAO_0000218,,In vitro,12801,,,,,1,12781,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,Intermediate,Rattus norvegicus,1,10116.0,,esophageal tunica muscularis mucosae,50597,A,N,CHEMBL625479
,BAO_0000218,,In vitro,12801,,,,,1,12782,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,Intermediate,Rattus norvegicus,1,10116.0,,esophageal tunica muscularis mucosae,50597,A,N,CHEMBL625480
,BAO_0000218,,In vivo,14856,,1969.0,,,1,12783,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625481
,BAO_0000218,,In vivo,14062,,,,,1,12784,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625482
,BAO_0000218,,In vivo,14062,,,,,1,12785,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625483
,BAO_0000218,,In vivo,14062,,,,,1,12786,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625484
,BAO_0000218,,In vivo,14062,,,,,1,12787,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625485
,BAO_0000218,,In vivo,14346,,1969.0,,,1,12788,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL625486
,BAO_0000218,,In vivo,14346,,1969.0,,,1,12789,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625487
,BAO_0000218,,In vivo,14346,,1969.0,,,1,12790,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625488
,BAO_0000218,,In vivo,14346,,1969.0,,,1,12791,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625489
,BAO_0000218,,In vivo,14346,,1969.0,,,1,12792,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625490
,BAO_0000218,,In vivo,14346,,1969.0,,,1,12793,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL625491
,BAO_0000218,,In vivo,14346,,1969.0,,,1,12794,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625492
,BAO_0000218,,In vivo,15711,,1969.0,,,1,12795,,plasma clearance in human,Intermediate,Homo sapiens,1,9606.0,,Plasma,50587,A,N,CHEMBL625493
,BAO_0000218,,In vivo,14886,,,,,1,12796,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625494
,BAO_0000218,,In vivo,14886,,,,,1,12797,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625495
,BAO_0000218,,In vivo,14886,,,,,1,12798,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625496
,BAO_0000100,,,4115,,,,,0,12799,,1-Octanol/water partition coefficient measured at 7.4,Autocuration,,1,,,,22229,P,U,CHEMBL625497
,BAO_0000100,,,13733,,,,,0,12800,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625498
,BAO_0000019,,,12102,,,,,0,12801,,Partition coefficient (logP),Autocuration,,1,,,,22224,A,U,CHEMBL625499
,BAO_0000100,,,12676,,,,,0,12802,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625500
,BAO_0000100,,,13733,,,,,0,12803,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625501
,BAO_0000100,,,13740,,,,,0,12804,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625502
,BAO_0000100,,,12766,,,,,0,12805,,Calculated partition coefficient (clogP) (relative to BAY K 8644),Autocuration,,1,,,,22229,P,U,CHEMBL625503
,BAO_0000100,,,2764,,,,,0,12806,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625504
,BAO_0000100,,,12355,,,,,0,12807,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625505
,BAO_0000100,,,11314,,,,,0,12808,,Calculated partition coefficient of the compound,Autocuration,,1,,,,22229,P,U,CHEMBL625506
,BAO_0000019,,,12706,,,,,0,12809,,Partition coefficient (logP),Autocuration,,1,,,,22224,A,U,CHEMBL625507
,BAO_0000100,,,12645,,,,,0,12810,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625508
,BAO_0000100,,,13668,,,,,0,12811,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625509
,BAO_0000100,,,12819,,,,,0,12812,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625510
,BAO_0000100,,,13668,,,,,0,12813,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL883125
,BAO_0000100,,,13017,,,,,0,12814,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625511
,BAO_0000019,,,2448,,,,,0,12815,,Partition coefficient of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL874650
,BAO_0000019,,,11526,,,,,0,12816,,Partition coefficient of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL625512
,BAO_0000019,,,12426,,,,,0,12817,,Partition coefficient of compound was determined,Autocuration,,1,,,,22224,A,U,CHEMBL625513
,BAO_0000019,,,2448,,,,,0,12818,,Partition coefficient was determined,Autocuration,,1,,,,22224,A,U,CHEMBL625514
,BAO_0000100,,,12001,,,,,0,12819,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625515
,BAO_0000100,,,12426,,,,,0,12820,,partition coefficient of compound was determined,Autocuration,,1,,,,22229,P,U,CHEMBL625516
,BAO_0000218,,In vivo,13204,,,,,1,12821,,The total body administered intravenously in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625517
,BAO_0000218,,In vivo,13204,,,,,1,12822,,The total body administered intravenously in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625518
,BAO_0000218,,,13889,,,,,1,12823,,Time taken for the administration to female NIH mice weighing 25-30 g.,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625519
,BAO_0000019,,,13889,,,,,0,12824,,Time taken for the administration,Autocuration,,1,,,,22224,A,U,CHEMBL625520
,BAO_0000218,,In vivo,17025,,,,,1,12825,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL874651
,BAO_0000218,,In vivo,17025,,,,,0,12826,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL625521
,BAO_0000218,,In vivo,17025,,,,,1,12827,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL623171
,BAO_0000218,,In vivo,17025,,,,,1,12828,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623853
,BAO_0000019,,,15067,,,,,0,12829,,Plasma clearance for the compound was determined.,Autocuration,,1,,,,22224,A,U,CHEMBL623854
,BAO_0000100,,,3091,,,,,0,12830,,CLog P value of the compound,Autocuration,,1,,,,22224,P,U,CHEMBL874405
,BAO_0000100,,,15592,,,,,0,12831,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL623855
,BAO_0000100,,,14738,,,,,0,12832,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL623856
,BAO_0000100,,,14738,,,,,0,12833,,ClogP value of the compound; nd ='no data',Autocuration,,1,,,,22224,P,U,CHEMBL623857
,BAO_0000100,,,14738,,,,,0,12834,,ClogP value of the compound; nd ='not determined',Autocuration,,1,,,,22224,P,U,CHEMBL623858
,BAO_0000100,,,6076,,,,,0,12835,,CLog P was determined,Autocuration,,1,,,,22224,P,U,CHEMBL623859
,BAO_0000100,,,17840,,,,,0,12836,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL839829
,BAO_0000019,,,13589,,,,,0,12837,,CLogP was calculated,Autocuration,,1,,,,22224,A,U,CHEMBL623860
,BAO_0000019,,,17655,,,,,0,12838,,CLogP value was determined,Autocuration,,1,,,,22224,A,U,CHEMBL623861
,BAO_0000019,,,5867,,,,,0,12839,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,Autocuration,,1,,,,22224,A,U,CHEMBL623862
,BAO_0000100,,,5867,,,,,0,12840,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL874406
,BAO_0000100,,,10783,,,,,0,12841,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL623863
,BAO_0000100,,,14849,,,,,0,12842,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL624021
,BAO_0000218,,,8170,,1236.0,,,1,12843,,Distribution in female dog adrenal medulla 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Adrenal medulla,50588,A,N,CHEMBL624022
,BAO_0000218,,,8170,,1236.0,,,1,12844,,Distribution in female dog adrenal medulla 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Adrenal medulla,50588,A,N,CHEMBL624023
,BAO_0000218,,,8170,,,,,1,12845,,Distribution in female dog bile 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624024
,BAO_0000218,,,8170,,,,,1,12846,,Distribution in female dog bile 72 hr after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624025
,BAO_0000218,,,8170,,,,,1,12847,,Distribution in female dog blood 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624026
,BAO_0000218,,,8170,,,,,1,12848,,Distribution in female dog blood 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624027
,BAO_0000218,,,8170,,,,,1,12849,,Distribution in female dog heart 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624028
,BAO_0000218,,,8170,,,,,1,12850,,Distribution in female dog heart 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624029
,BAO_0000218,,,8170,,,,,1,12851,,Distribution in female dog kidney 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624030
,BAO_0000218,,,8170,,,,,1,12852,,Distribution in female dog kidney 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624031
,BAO_0000218,,,8170,,160.0,,,1,12853,,Distribution in female dog large intestine 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Intestine,50588,A,N,CHEMBL624032
,BAO_0000218,,,8170,,160.0,,,1,12854,,Distribution in female dog large intestine 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Intestine,50588,A,N,CHEMBL874407
,BAO_0000218,,,8170,,,,,1,12855,,Distribution in female dog liver 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624033
,BAO_0000218,,,8170,,,,,1,12856,,Distribution in female dog liver 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624034
,BAO_0000218,,,8170,,,,,1,12857,,Distribution in female dog lung 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624035
,BAO_0000218,,,8170,,,,,1,12858,,Distribution in female dog lung 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624036
,BAO_0000218,,,8170,,2385.0,,,1,12859,,Distribution in female dog muscle 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Muscle tissue,50588,A,N,CHEMBL624037
,BAO_0000218,,,8170,,2385.0,,,1,12860,,Distribution in female dog muscle 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Muscle tissue,50588,A,N,CHEMBL624038
,BAO_0000218,,,8170,,,,,1,12861,,Distribution in female dog pancreas 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624039
,BAO_0000218,,,8170,,,,,1,12862,,Distribution in female dog pancreas 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624040
,BAO_0000218,,,8170,,160.0,,,1,12863,,Distribution in female dog small intestine 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Intestine,50588,A,N,CHEMBL624041
,BAO_0000218,,,8170,,160.0,,,1,12864,,Distribution in female dog small intestine 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Intestine,50588,A,N,CHEMBL624042
,BAO_0000218,,,8170,,2106.0,,,1,12865,,Distribution in female dog spleen 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Spleen,50588,A,N,CHEMBL624043
,BAO_0000218,,,8170,,2106.0,,,1,12866,,Distribution in female dog spleen 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Spleen,50588,A,N,CHEMBL624044
,BAO_0000218,,,8170,,945.0,,,1,12867,,Distribution in female dog stomach 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Stomach,50588,A,N,CHEMBL624045
,BAO_0000218,,,8170,,945.0,,,1,12868,,Distribution in female dog stomach 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Stomach,50588,A,N,CHEMBL624046
,BAO_0000218,,,8170,,2046.0,,,1,12869,,Distribution in female dog thyroid 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Thyroid gland,50588,A,N,CHEMBL624047
,BAO_0000218,,,8170,,2046.0,,,1,12870,,Distribution in female dog thyroid 72 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Thyroid gland,50588,A,N,CHEMBL624048
,BAO_0000218,,,8170,,1088.0,,,1,12871,,Distribution in female dog urine 24 hours after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL874408
,BAO_0000218,,,8170,,1088.0,,,1,12872,,Distribution in female dog urine 72 hr after administration.,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL624049
,BAO_0000218,,,14283,,1969.0,,,0,12873,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL624050
,BAO_0000019,,,5623,,,,,0,12874,,Plasma concentration at 7 hr after intravenous dosing,Autocuration,,1,,,,22224,A,U,CHEMBL624051
,BAO_0000218,,,13477,,,,,1,12875,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623278
,BAO_0000218,,,13477,,,,,1,12876,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623279
,BAO_0000218,,,13477,,,,,1,12877,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623280
,BAO_0000218,,,13477,,,,,1,12878,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623963
,BAO_0000218,,,13477,,,,,1,12879,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623964
,BAO_0000218,,,13477,,,,,1,12880,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623965
,BAO_0000218,,,13477,,,,,1,12881,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623966
,BAO_0000218,,,13477,,,,,1,12882,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874415
,BAO_0000218,,,13477,,,,,1,12883,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623967
,BAO_0000218,,,13477,,,,,1,12884,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623968
,BAO_0000218,,,13477,,,,,1,12885,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623969
,BAO_0000218,,,13477,,,,,1,12886,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628409
,BAO_0000218,,,13477,,,,,1,12887,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628410
,BAO_0000218,,,13477,,,,,1,12888,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628411
,BAO_0000218,,,13477,,,,,1,12889,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628412
,BAO_0000019,,,12553,,,,,0,12890,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,Autocuration,,1,,,,22224,A,U,CHEMBL628413
,BAO_0000019,,,14548,,1969.0,,,0,12891,,The concentration in plasmat; Not determined,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL628414
,BAO_0000218,,,14393,,,,,1,12892,,Tissue level at 10 mg/kg/po in wistar rats in blood,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628415
,BAO_0000218,,,14393,,,,,1,12893,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628416
,BAO_0000218,,,14393,,,,,1,12894,,Tissue level at 10 mg/kg/po in wistar rats in heart,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628417
,BAO_0000218,,,14393,,2107.0,,,1,12895,,Tissue level at 10 mg/kg/po in wistar rats in liver,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL874908
,BAO_0000218,,,14393,,,,,1,12896,,Tissue level at 10 mg/kg/po in wistar rats in plasma,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628418
,BAO_0000218,,,14393,,2385.0,,,1,12897,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL628419
,BAO_0000218,,,14393,,,,,1,12898,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628420
,BAO_0000019,,,1629,,,,,0,12899,,Water solubility at 37 degree C.,Autocuration,,1,,,,22224,A,U,CHEMBL628421
,BAO_0000100,,,8194,,,,,0,12900,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,Autocuration,,1,,,,22229,P,U,CHEMBL626726
,BAO_0000100,,,8194,,,,,0,12901,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,Autocuration,,1,,,,22229,P,U,CHEMBL626727
,BAO_0000218,,,8594,,178.0,,,1,12902,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626728
,BAO_0000218,,,8594,,178.0,,,1,12903,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626729
,BAO_0000218,,,8594,,178.0,,,1,12904,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626730
,BAO_0000218,,,8594,,178.0,,,1,12905,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626731
,BAO_0000218,,,8594,,178.0,,,1,12906,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL626732
,BAO_0000218,,,8594,,948.0,,,1,12907,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626733
,BAO_0000218,,,8594,,948.0,,,1,12908,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626734
,BAO_0000218,,,8594,,948.0,,,1,12909,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626735
,BAO_0000218,,,8594,,948.0,,,1,12910,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL874909
,BAO_0000218,,,8594,,948.0,,,1,12911,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL626736
,BAO_0000218,,,8594,,2113.0,,,1,12912,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL626737
,BAO_0000218,,,8594,,2113.0,,,1,12913,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL630999
,BAO_0000218,,,8594,,2113.0,,,1,12914,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL631000
,BAO_0000218,,,8594,,2113.0,,,1,12915,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL631001
,BAO_0000218,,,8594,,2113.0,,,1,12916,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL631002
,BAO_0000218,,,8594,,2107.0,,,1,12917,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL631003
,BAO_0000218,,,8594,,2107.0,,,1,12918,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL631004
,BAO_0000218,,,8594,,2107.0,,,1,12919,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL631005
,BAO_0000218,,,8594,,2107.0,,,1,12920,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL631006
,BAO_0000218,,,8594,,2107.0,,,1,12921,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL631007
,BAO_0000218,,,8594,,2048.0,,,1,12922,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL631008
,BAO_0000218,,,8594,,2048.0,,,1,12923,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL631009
,BAO_0000218,,,8594,,2048.0,,,1,12924,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL631010
,BAO_0000218,,,8594,,2048.0,,,1,12925,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL631011
,BAO_0000218,,,8594,,2048.0,,,1,12926,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL631012
,BAO_0000218,,,8594,,2046.0,,,1,12927,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL630271
,BAO_0000218,,,8594,,2046.0,,,1,12928,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL630272
,BAO_0000218,,,8594,,2046.0,,,1,12929,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL630273
,BAO_0000218,,,8594,,2046.0,,,1,12930,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL630274
,BAO_0000218,,,8594,,2046.0,,,1,12931,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL630275
,BAO_0000218,,,8594,,,,,1,12932,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875782
,BAO_0000218,,,8594,,,,,1,12933,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630276
,BAO_0000218,,,8594,,,,,1,12934,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630277
,BAO_0000218,,,8594,,,,,1,12935,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630278
,BAO_0000218,,,8594,,,,,1,12936,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630279
,BAO_0000019,,,8151,,,,,0,12937,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,Autocuration,,1,,,,22224,A,U,CHEMBL630280
,BAO_0000019,,,8151,,,,,0,12938,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Autocuration,,1,,,,22224,A,U,CHEMBL630281
,BAO_0000218,,,7132,,,,,1,12939,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL630282
,BAO_0000218,,,7132,,,,,1,12940,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL630283
,BAO_0000019,,,5797,,,,,0,12941,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),Autocuration,,1,,,,22224,A,U,CHEMBL630284
,BAO_0000019,,,7849,,,,,0,12942,,Alkylating activity was determined,Autocuration,,1,,,,22224,A,U,CHEMBL630285
,BAO_0000251,Microsomes,,14220,,,,,0,12943,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),Autocuration,,1,,,,22224,A,U,CHEMBL630286
,BAO_0000218,,,8650,,,,,1,12944,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL630069
,BAO_0000218,,,8650,,,,,1,12945,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL630070
,BAO_0000218,,,8650,,,,,1,12946,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL630071
,BAO_0000218,,,8650,,,,,1,12947,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL630072
,BAO_0000218,,,8650,,,,,1,12948,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL875110
,BAO_0000218,,,7116,,,,,1,12949,,Compound was tested for antidiuretic activity in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630073
,BAO_0000019,,,14131,,,,,0,12950,,Compound was tested for inactivation kinetic values,Autocuration,,1,,,,22224,A,U,CHEMBL630074
,BAO_0000218,,In vivo,7415,,,,,0,12951,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,Autocuration,,1,,,,22224,A,U,CHEMBL630075
,BAO_0000019,,,13178,,,,,0,12952,,Dissociation rate calculated from the first-order equation using the t1/2 value,Autocuration,,1,,,,22224,A,U,CHEMBL630076
,BAO_0000100,,,8815,,,,,0,12953,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,Autocuration,,1,,,,22229,P,U,CHEMBL630077
,BAO_0000100,,,1450,,,,,0,12954,,Aqueous solubility was measured,Autocuration,,1,,,,22229,P,U,CHEMBL630078
,BAO_0000100,,,1450,,,,,0,12955,,Aqueous solubility was measured at a pH 4,Autocuration,,1,,,,22229,P,U,CHEMBL630079
,BAO_0000100,,,1450,,,,,0,12956,,Aqueous solubility (pH 7),Autocuration,,1,,,,22229,P,U,CHEMBL630080
,BAO_0000100,,,1450,,,,,0,12957,,Aqueous solubility was measured at a pH 9,Autocuration,,1,,,,22229,P,U,CHEMBL630081
,BAO_0000019,,,12711,,,,,0,12958,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",Autocuration,,1,,,,22224,A,U,CHEMBL630082
,BAO_0000019,,,12711,,,,,0,12959,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",Autocuration,,1,,,,22224,A,U,CHEMBL630083
,BAO_0000019,,,12711,,,,,0,12960,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",Autocuration,,1,,,,22224,A,U,CHEMBL630084
,BAO_0000100,,,15032,,,,,0,12961,,Aqueous solubility of the compound,Autocuration,,1,,,,22229,P,U,CHEMBL629198
,BAO_0000100,,,9964,,,,,0,12962,,Aqueous solubility at 37 degree Celsius at pH 7.38,Autocuration,,1,,,,22229,P,U,CHEMBL629199
,BAO_0000100,,,14962,,,,,0,12963,,Aqueous solubility in pH 7.4 phosphate buffer,Autocuration,,1,,,,22229,P,U,CHEMBL629200
,BAO_0000218,,,12487,,,,,1,12964,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL629201
,BAO_0000218,,,12487,,,,,1,12965,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL629202
,BAO_0000218,,,10026,,,,,1,12966,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL875111
,BAO_0000218,,,10026,,,,,1,12967,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL629203
,BAO_0000218,,,10026,,,,,1,12968,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL629204
,BAO_0000218,,,10026,,,,,1,12969,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL629205
,BAO_0000218,,,10026,,,,,1,12970,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL629206
,BAO_0000019,,,10026,,,,,0,12971,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,Autocuration,,1,,,,22224,A,U,CHEMBL631185
,BAO_0000218,,,7415,,,,,1,12972,,Compound was evaluated for the average bile flow rat in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631186
,BAO_0000218,,,17025,,,,,1,12973,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL631187
,BAO_0000218,,,17025,,,,,1,12974,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL631188
,BAO_0000019,,,10184,,,,,0,12975,,Average half life period was determined,Autocuration,,1,,,,22224,A,U,CHEMBL876419
,BAO_0000019,,,10184,,,,,0,12976,,Average half life period was determined,Autocuration,,1,,,,22224,A,U,CHEMBL631189
,BAO_0000218,,,8613,,,,,1,12977,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL631190
,BAO_0000218,,,8613,,,,,1,12978,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL631191
,BAO_0000218,,,8613,,,,,1,12979,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL631192
,BAO_0000218,,,8613,,,,,1,12980,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL632400
,BAO_0000218,,,8613,,,,,1,12981,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL630564
,BAO_0000218,,,8613,,,,,1,12982,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL630565
,BAO_0000218,,,8613,,,,,1,12983,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL630566
,BAO_0000218,,,8613,,,,,1,12984,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL631229
,BAO_0000218,,,8613,,,,,1,12985,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL631230
,BAO_0000100,,,6030,,,,,0,12986,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL876428
,BAO_0000100,,,6147,,,,,0,12987,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL631231
,BAO_0000100,,,14556,,,,,0,12988,,Calculated partition coefficient (clogP) (MacLogP),Autocuration,,1,,,,22229,P,U,CHEMBL631232
,BAO_0000019,,,768,,,,,0,12989,,Hydrophilicity was determined,Autocuration,,1,,,,22224,A,U,CHEMBL631233
,BAO_0000100,,,14452,,,,,0,12990,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL631234
,BAO_0000019,,,5237,,,,,0,12991,,Increased absorption was determined,Autocuration,,1,,,,22224,A,U,CHEMBL883126
,BAO_0000100,,,14378,,,,,0,12992,,Lipophilicity value was evaluated,Autocuration,,1,,,,22224,P,U,CHEMBL631235
,BAO_0000100,,,14418,,,,,0,12993,,Log P value of the compound.,Autocuration,,1,,,,22224,P,U,CHEMBL631236
,BAO_0000019,,,5249,,,,,0,12994,,Partition coefficient of compound was determined,Autocuration,,1,,,,22224,A,U,CHEMBL631237
,BAO_0000100,,,14621,,,,,0,12995,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL631238
,BAO_0000100,,,12542,,,,,0,12996,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL876429
,BAO_0000019,,,12542,,,,,0,12997,,Partition coefficient was measured by medchem software; Not calculated,Autocuration,,1,,,,22224,A,U,CHEMBL631414
,BAO_0000100,,,12542,,,,,0,12998,,Partition coefficient was measured by octanol-water using standard shake-flask method,Autocuration,,1,,,,22224,P,U,CHEMBL631415
,BAO_0000100,,,15462,,,,,0,12999,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL631416
,BAO_0000019,,,14884,,,,,0,13000,,Partition coefficient (logP),Autocuration,,1,,,,22224,A,U,CHEMBL631417
,BAO_0000100,,,16526,,,,,0,13001,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL631418
,BAO_0000100,,,13693,,,,,0,13002,,The Octanol/Water partition coefficient CLogP,Autocuration,,1,,,,22229,P,U,CHEMBL631419
,BAO_0000019,,,13693,,,,,0,13003,,The pharmacokinetic parameter C Log p was reported,Autocuration,,1,,,,22224,A,U,CHEMBL631420
,BAO_0000100,,,13779,,,,,0,13004,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL631421
,BAO_0000100,,,14772,,,,,0,13005,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL631422
,BAO_0000100,,,14393,,,,,0,13006,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL631423
,BAO_0000218,,In vivo,14793,,1969.0,,,1,13007,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL876430
,BAO_0000218,,In vivo,14793,,1969.0,,,1,13008,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL631424
,BAO_0000218,,In vivo,13744,,1969.0,,,1,13009,,Compound was administered intravenously in dog to evaluate plasma clearance values,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL631425
,BAO_0000218,,In vivo,13744,,1969.0,,,0,13010,,Compound was administered intravenously in monkey to evaluate plasma clearance values,Autocuration,Simiiformes,1,314293.0,,Plasma,22224,A,U,CHEMBL631426
,BAO_0000218,,In vivo,13744,,1969.0,,,1,13011,,Compound was administered intravenously in mouse to evaluate plasma clearance values,Intermediate,Mus musculus,1,10090.0,,Plasma,50594,A,N,CHEMBL631427
,BAO_0000218,,In vivo,13207,,1969.0,,,1,13012,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL631428
,BAO_0000218,Microsomes,In vitro,5669,,2107.0,,,1,13013,,Intrinsic clearance in Rhesus liver microsome,Intermediate,Macaca mulatta,1,9544.0,,Liver,50797,A,N,CHEMBL631429
,BAO_0000218,Microsomes,In vitro,5669,,2107.0,,,1,13014,,Intrinsic clearance in dog liver microsome,Intermediate,Canis lupus familiaris,1,9615.0,,Liver,50588,A,N,CHEMBL631430
,BAO_0000218,Microsomes,In vitro,5669,,2107.0,,,1,13015,,Intrinsic clearance in rat liver microsome,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL631431
,BAO_0000218,,In vivo,4853,,1969.0,,,1,13016,,Low plasma clearance was calculated in rhesus monkey,Intermediate,Macaca mulatta,1,9544.0,,Plasma,50797,A,N,CHEMBL631432
,BAO_0000218,,In vivo,16452,,,,,1,13017,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631433
,BAO_0000218,,In vivo,11954,,,,,0,13018,,Plasma clearance after intravenous dose of 0.3 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL631434
,BAO_0000218,,In vivo,11954,,,,,0,13019,,Plasma clearance after intravenous dose of 1 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL631435
,BAO_0000218,,In vivo,11954,,,,,0,13020,,Plasma clearance after intravenous dose of 3 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL631436
,BAO_0000218,,In vivo,11954,,,,,0,13021,,Plasma clearance after intravenous dose of 3.87 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL631437
,BAO_0000218,,In vivo,5669,,,,,1,13022,,Plasma clearance after peroral administration at 10 mpk in Rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631438
,BAO_0000218,,In vivo,5669,,,,,1,13023,,Plasma clearance after peroral administration at 10 mpk in Rhesus,Intermediate,Macaca mulatta,1,9544.0,,,50797,A,N,CHEMBL876431
,BAO_0000218,,In vivo,5669,,,,,1,13024,,Plasma clearance after peroral administration at 10 mpk in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631439
,BAO_0000218,,In vivo,13662,,,,,1,13025,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631440
,BAO_0000019,,,8272,,,,,0,13026,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),Autocuration,,1,,,,22224,A,U,CHEMBL631441
,BAO_0000019,,,13410,,,,,0,13027,,Critical Micellar concentration was determined,Autocuration,,1,,,,22224,A,U,CHEMBL631442
,BAO_0000019,,,13410,,,,,0,13028,,Critical Micellar concentration of the compound. was determined,Autocuration,,1,,,,22224,A,U,CHEMBL626525
,BAO_0000019,,,12628,,,,,0,13029,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,Autocuration,,1,,,,22224,A,U,CHEMBL627168
,BAO_0000019,,,9675,,,,,0,13030,,Critical micellar concentration was measured in water by the dye solubilization method,Autocuration,,1,,,,22224,A,U,CHEMBL875618
,BAO_0000019,,,12628,,,,,0,13031,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,Autocuration,,1,,,,22224,B,U,CHEMBL626612
,BAO_0000019,,,12766,,,,,0,13032,,CMR value (relative to BAY K 8644),Autocuration,,1,,,,22224,A,U,CHEMBL626613
,BAO_0000019,,,7849,,,,,0,13033,,Carbamoylating activity was determined,Autocuration,,1,,,,22224,A,U,CHEMBL626614
,BAO_0000218,,,12187,,,,,0,13034,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL626615
,BAO_0000019,,,2040,,,,,0,13035,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,Autocuration,,1,,,,22224,A,U,CHEMBL626616
,BAO_0000019,,,2040,,,,,0,13036,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,Autocuration,,1,,,,22224,A,U,CHEMBL626617
,BAO_0000218,,In vivo,14180,,1969.0,,,1,13037,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626618
,BAO_0000218,,In vivo,14180,,1969.0,,,1,13038,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626619
,BAO_0000218,,In vivo,14474,,,,,1,13039,,"Clearance rate at 0.46 mg/kg, iv, in dogs",Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626620
,BAO_0000218,,In vivo,14474,,,,,1,13040,,"Clearance rate at 5.5 mg/kg, iv, in rat",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626621
,BAO_0000218,,In vivo,14548,,,,,1,13041,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL626622
,BAO_0000218,,In vivo,14548,,,,,1,13042,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL626623
,BAO_0000218,,In vivo,14548,,,,,1,13043,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626624
,BAO_0000218,,In vivo,14548,,,,,1,13044,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626625
,BAO_0000218,,Ex vivo,6125,,2107.0,,,1,13045,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL626626
,BAO_0000218,,In vivo,6874,,,,,0,13046,,Tested for the total clearance of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL626627
,BAO_0000218,,In vivo,15343,,,,,1,13047,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626628
,BAO_0000218,,In vivo,6236,,,,,0,13048,,Total body clearance was determined,Autocuration,,1,,,,22224,A,U,CHEMBL626629
,BAO_0000218,,,11510,,,,,1,13049,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626630
,BAO_0000218,,,11510,,,,,1,13050,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626631
,BAO_0000100,,,8194,,,,,0,13051,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,Autocuration,,1,,,,22229,P,U,CHEMBL626632
,BAO_0000100,,,8194,,,,,0,13052,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,Autocuration,,1,,,,22229,P,U,CHEMBL626633
,BAO_0000100,,,8194,,,,,0,13053,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,Autocuration,,1,,,,22229,P,U,CHEMBL626634
,BAO_0000100,,,8194,,,,,0,13054,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,Autocuration,,1,,,,22229,P,U,CHEMBL626635
,BAO_0000100,,,8194,,,,,0,13055,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,Autocuration,,1,,,,22229,P,U,CHEMBL626636
,BAO_0000100,,,8194,,,,,0,13056,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,Autocuration,,1,,,,22229,P,U,CHEMBL626637
,BAO_0000218,,,13273,,,,,1,13057,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),Intermediate,Pneumocystis carinii,1,4754.0,,,50339,A,N,CHEMBL626638
,BAO_0000218,,,13273,,,,,1,13058,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,Intermediate,Pneumocystis carinii,1,4754.0,,,50339,A,N,CHEMBL626639
,BAO_0000218,,,13273,,,,,1,13059,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,Intermediate,Pneumocystis carinii,1,4754.0,,,50339,A,N,CHEMBL626640
,BAO_0000218,,,13273,,,,,1,13060,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,Intermediate,Pneumocystis carinii,1,4754.0,,,50339,A,N,CHEMBL626641
,BAO_0000218,,,13273,,,,,1,13061,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,Intermediate,Pneumocystis carinii,1,4754.0,,,50339,A,N,CHEMBL627272
,BAO_0000218,,,13273,,,,,1,13062,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,Intermediate,Pneumocystis carinii,1,4754.0,,,50339,A,N,CHEMBL627273
,BAO_0000218,,,13273,,,,,1,13063,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),Intermediate,Pneumocystis carinii,1,4754.0,,,50339,A,N,CHEMBL627441
,BAO_0000218,,,13273,,,,,1,13064,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),Intermediate,Pneumocystis carinii,1,4754.0,,,50339,A,N,CHEMBL628355
,BAO_0000218,,,13273,,,,,1,13065,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),Intermediate,Pneumocystis carinii,1,4754.0,,,50339,A,N,CHEMBL628356
,BAO_0000218,,,13273,,,,,1,13066,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),Intermediate,Pneumocystis carinii,1,4754.0,,,50339,A,N,CHEMBL628357
,BAO_0000218,,,13273,,,,,1,13067,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),Intermediate,Pneumocystis carinii,1,4754.0,,,50339,A,N,CHEMBL628358
,BAO_0000218,,,13273,,,,,1,13068,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),Intermediate,Pneumocystis carinii,1,4754.0,,,50339,A,N,CHEMBL622307
,BAO_0000019,,,13118,,,,,0,13069,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,Autocuration,,1,,,,22224,A,U,CHEMBL622527
,BAO_0000019,,,13118,,,,,0,13070,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,Autocuration,,1,,,,22224,A,U,CHEMBL622528
,BAO_0000019,,,13118,,,,,0,13071,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,Autocuration,,1,,,,22224,A,U,CHEMBL622529
,BAO_0000019,,,13118,,,,,0,13072,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,Autocuration,,1,,,,22224,A,U,CHEMBL622992
,BAO_0000019,,,13118,,,,,0,13073,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,Autocuration,,1,,,,22224,A,U,CHEMBL622993
,BAO_0000019,,,13118,,,,,0,13074,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,Autocuration,,1,,,,22224,A,U,CHEMBL622994
,BAO_0000218,,,10633,,,,,1,13075,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622995
,BAO_0000218,,,10633,,,,,1,13076,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622996
,BAO_0000218,,,10633,,,,,1,13077,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622997
,BAO_0000218,,,10633,,,,,1,13078,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622998
,BAO_0000218,,,5767,,,,,0,13079,,Cp max following ip administration at 1 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL622999
,BAO_0000218,,In vivo,3302,,1969.0,,,0,13080,,Maximum concentration in plasma was reported at 0.5 hour,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL623000
,BAO_0000218,,In vivo,3302,,1969.0,,,0,13081,,Maximum concentration in plasma was reported at 2 hour,Autocuration,,1,,,Plasma,22224,A,U,CHEMBL623001
,BAO_0000218,,,12467,,,,,1,13082,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL623002
,BAO_0000100,,,11778,,,,,0,13083,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),Autocuration,,1,,,,22229,P,U,CHEMBL623003
,BAO_0000019,,,4321,,,,,0,13084,,Steady state concentration was evaluated,Autocuration,,1,,,,22224,A,U,CHEMBL623004
,BAO_0000019,,,14884,,,,,0,13085,,Partition coefficient (logP),Autocuration,,1,,,,22224,A,U,CHEMBL623005
,BAO_0000019,,,15234,,,,,0,13086,,Partition coefficient (logD7.4),Autocuration,,1,,,,22224,A,U,CHEMBL623006
,BAO_0000218,,In vivo,14198,,2107.0,,,1,13087,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL623007
,BAO_0000218,,In vivo,14198,,10000001.0,,,1,13088,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL623008
,BAO_0000218,,In vivo,14198,,2037.0,,,1,13089,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL876654
,BAO_0000218,,In vivo,14198,,,,,1,13090,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623009
,BAO_0000218,,In vivo,14198,,,,,1,13091,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623010
,BAO_0000218,,In vivo,14198,,948.0,,,1,13092,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL623011
,BAO_0000218,,In vivo,14198,,160.0,,,1,13093,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL623012
,BAO_0000019,,,8151,,,,,0,13094,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,Autocuration,,1,,,,22224,A,U,CHEMBL623013
,BAO_0000019,,,8151,,,,,0,13095,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Autocuration,,1,,,,22224,A,U,CHEMBL623014
,BAO_0000019,,,8151,,1088.0,,,0,13096,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,Autocuration,,1,,,Urine,22224,A,U,CHEMBL623015
,BAO_0000019,,,8151,,1088.0,,,0,13097,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Autocuration,,1,,,Urine,22224,A,U,CHEMBL623016
,BAO_0000019,,,8151,,1088.0,,,0,13098,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,Autocuration,,1,,,Urine,22224,A,U,CHEMBL624858
,BAO_0000218,,,8151,,,,,1,13099,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624859
,BAO_0000218,,,8151,,,,,1,13100,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624860
,BAO_0000218,,,8151,,,,,1,13101,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624861
,BAO_0000218,,,8151,,,,,1,13102,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624862
,BAO_0000218,,,8151,,,,,1,13103,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624863
,BAO_0000218,,,8151,,,,,1,13104,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876655
,BAO_0000218,,,6996,,,,,1,13105,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624864
,BAO_0000218,,,6996,,,,,1,13106,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624865
,BAO_0000218,,,6996,,,,,1,13107,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624866
,BAO_0000218,,,6996,,,,,1,13108,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,Expert,Canis lupus familiaris,1,9615.0,,,50588,F,N,CHEMBL624867
,BAO_0000218,,,6996,,,,,1,13109,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL624868
,BAO_0000218,,,6996,,,,,1,13110,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628450
,BAO_0000218,,,6996,,,,,1,13111,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628451
,BAO_0000218,,,6996,,,,,1,13112,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628452
,BAO_0000218,,,6996,,,,,1,13113,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628453
,BAO_0000218,,,6996,,,,,1,13114,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628454
,BAO_0000218,,,6996,,,,,1,13115,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628455
,BAO_0000218,,,6996,,,,,1,13116,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628456
,BAO_0000218,,,6996,,,,,1,13117,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628457
,BAO_0000218,,,6996,,,,,1,13118,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL877505
,BAO_0000218,,,6996,,,,,1,13119,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628458
,BAO_0000218,,,6996,,,,,1,13120,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628459
,BAO_0000218,,,6996,,,,,1,13121,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628460
,BAO_0000218,,,6996,,,,,1,13122,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628461
,BAO_0000218,,,6996,,,,,0,13123,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",Autocuration,,1,,,,22224,B,U,CHEMBL628462
,BAO_0000218,,,6996,,,,,1,13124,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628463
,BAO_0000218,,,6996,,,,,1,13125,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",Expert,Rattus norvegicus,1,10116.0,,,50597,F,N,CHEMBL625666
,BAO_0000218,,,6996,,,,,0,13126,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Autocuration,,1,,,,22224,B,U,CHEMBL625667
,BAO_0000218,,,6996,,,,,1,13127,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Expert,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625668
,BAO_0000218,,,6996,,,,,1,13128,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625669
,BAO_0000019,,,7114,,,,,0,13129,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,Autocuration,,1,,,,22224,A,U,CHEMBL625670
,BAO_0000218,,,7114,,,,,1,13130,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625671
,BAO_0000218,,,8613,,,,,1,13131,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL625672
,BAO_0000218,,,8613,,,,,1,13132,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL625673
,BAO_0000218,,,8613,,,,,1,13133,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL625674
,BAO_0000218,,,8613,,,,,1,13134,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL625675
,BAO_0000218,,,8613,,,,,1,13135,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL627637
,BAO_0000218,,,8613,,,,,1,13136,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL627638
,BAO_0000218,,,8613,,,,,1,13137,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL627639
,BAO_0000218,,,8613,,,,,1,13138,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL627640
,BAO_0000218,,,8613,,,,,1,13139,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL627641
,BAO_0000218,,,8613,,,,,1,13140,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL627642
,BAO_0000218,,,8613,,,,,1,13141,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL877506
,BAO_0000218,,,8613,,,,,1,13142,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627275
,BAO_0000218,,,11219,,,,,1,13143,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",Intermediate,Mustela putorius furo,1,9669.0,,,50506,A,N,CHEMBL627643
,BAO_0000218,,,11219,,,,,1,13144,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Intermediate,Mustela putorius furo,1,9669.0,,,50506,A,N,CHEMBL631246
,BAO_0000218,,,11219,,,,,1,13145,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Intermediate,Mustela putorius furo,1,9669.0,,,50506,A,N,CHEMBL631247
,BAO_0000218,,,11219,,,,,1,13146,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Intermediate,Mustela putorius furo,1,9669.0,,,50506,A,N,CHEMBL629532
,BAO_0000218,,,11219,,,,,1,13147,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,Intermediate,Mustela putorius furo,1,9669.0,,,50506,A,N,CHEMBL629533
,BAO_0000218,,,11219,,,,,1,13148,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Intermediate,Mustela putorius furo,1,9669.0,,,50506,A,N,CHEMBL629534
,BAO_0000218,,,11219,,,,,1,13149,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,Intermediate,Mustela putorius furo,1,9669.0,,,50506,A,N,CHEMBL629535
,BAO_0000019,,,14837,,,,,0,13150,,Pharmacokinetic parameter :drug bound to plasma was reported,Autocuration,,1,,,,22224,A,U,CHEMBL625932
,BAO_0000019,,,14837,,,,,0,13151,,compound was evaluated for drug bound in plasma,Autocuration,,1,,,,22224,A,U,CHEMBL625933
,BAO_0000218,,,15343,,,,,1,13152,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625934
,BAO_0000218,,,13761,,,,,0,13153,,Bioavailability,Autocuration,Eutheria,1,9347.0,,,22224,A,U,CHEMBL625935
,BAO_0000218,,,14810,,,,,1,13154,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625936
,BAO_0000218,,,14810,,,,,1,13155,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625937
,BAO_0000218,,,13249,,,,,1,13156,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625938
,BAO_0000218,,,9267,,1970.0,,,1,13157,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,Intermediate,Rattus norvegicus,1,10116.0,,Bile,50597,A,N,CHEMBL625939
,BAO_0000218,,,9267,,1970.0,,,1,13158,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,Intermediate,Rattus norvegicus,1,10116.0,,Bile,50597,A,N,CHEMBL625940
,BAO_0000218,,,9267,,1970.0,,,1,13159,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,Intermediate,Rattus norvegicus,1,10116.0,,Bile,50597,A,N,CHEMBL874464
,BAO_0000218,,,9267,,1970.0,,,1,13160,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,Intermediate,Rattus norvegicus,1,10116.0,,Bile,50597,A,N,CHEMBL625941
,BAO_0000218,,,9267,,1970.0,,,1,13161,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,Intermediate,Rattus norvegicus,1,10116.0,,Bile,50597,A,N,CHEMBL625942
,BAO_0000218,,,9267,,1970.0,,,1,13162,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,Intermediate,Rattus norvegicus,1,10116.0,,Bile,50597,A,N,CHEMBL625943
,BAO_0000218,,,15549,,1977.0,,,1,13163,,In vitro protein binding in human serum at 5 ug/ml,Intermediate,Homo sapiens,1,9606.0,,Serum,50587,A,N,CHEMBL625944
,BAO_0000019,,,10929,,,,,0,13164,,Serum protein binding ability was measured,Autocuration,,1,,,,22224,A,U,CHEMBL625945
,BAO_0000019,,,15444,,,,,0,13165,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),Autocuration,,1,,,,22224,A,U,CHEMBL625946
,BAO_0000218,,In vivo,12860,,,,,0,13166,,Oral bioavailability in dog,Autocuration,Canis lupus familiaris,1,9615.0,,,22224,A,U,CHEMBL625947
,BAO_0000218,,In vivo,12170,,,,,1,13167,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625948
,BAO_0000218,,In vivo,15173,,,,,0,13168,,Absolute oral bioavailability at an iv dose of 14 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL625949
,BAO_0000218,,In vivo,15173,,,,,0,13169,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL625950
,BAO_0000218,,In vivo,15173,,,,,0,13170,,Oral bioavailability (dose 15 mg/kg i.v.),Autocuration,Eutheria,1,9347.0,,,22224,A,U,CHEMBL625951
,BAO_0000218,,In vivo,15173,,,,,0,13171,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,Autocuration,,1,,,,22224,A,U,CHEMBL625952
,BAO_0000218,,In vivo,15173,,,,,0,13172,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,Autocuration,,1,,,,22224,A,U,CHEMBL625953
,BAO_0000218,,In vivo,15173,,,,,0,13173,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,Autocuration,,1,,,,22224,A,U,CHEMBL625954
,BAO_0000218,,In vivo,15173,,,,,0,13174,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,Autocuration,,1,,,,22224,A,U,CHEMBL882959
,BAO_0000218,,In vivo,11767,,,,,1,13175,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625955
,BAO_0000218,,In vivo,11219,,,,,0,13176,,Bioavailability in ferret,Autocuration,Mustela putorius furo,1,9669.0,,,22224,A,U,CHEMBL625956
,BAO_0000218,,In vivo,12186,,,,,1,13177,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL625957
,BAO_0000218,,,11510,,,,,1,13178,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625958
,BAO_0000218,,,11510,,,,,1,13179,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625959
,BAO_0000218,,,11510,,,,,1,13180,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626642
,BAO_0000218,,,11510,,,,,1,13181,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631330
,BAO_0000218,,,11510,,,,,1,13182,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631331
,BAO_0000218,,,11510,,,,,1,13183,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631332
,BAO_0000218,,,11510,,,,,1,13184,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631333
,BAO_0000218,,,11510,,,,,1,13185,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632018
,BAO_0000218,,,11510,,,,,1,13186,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632019
,BAO_0000218,,,11510,,,,,1,13187,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632020
,BAO_0000218,,,11510,,,,,1,13188,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632021
,BAO_0000218,,,11510,,,,,1,13189,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632022
,BAO_0000218,,,11510,,,,,1,13190,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632023
,BAO_0000218,,,11510,,,,,1,13191,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632024
,BAO_0000218,,,11510,,,,,1,13192,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874472
,BAO_0000218,,,11510,,,,,1,13193,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632025
,BAO_0000218,,,11510,,,,,1,13194,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632026
,BAO_0000218,,,11510,,,,,1,13195,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632027
,BAO_0000218,,,11510,,,,,1,13196,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632028
,BAO_0000218,,,11510,,,,,1,13197,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626430
,BAO_0000218,,,11510,,,,,1,13198,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626431
,BAO_0000218,,,11510,,,,,1,13199,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626432
,BAO_0000218,,,11510,,,,,1,13200,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626433
,BAO_0000218,,,11510,,,,,1,13201,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626434
,BAO_0000218,,,11510,,,,,1,13202,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627280
,BAO_0000218,,,11510,,,,,1,13203,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627281
,BAO_0000218,,,11510,,,,,1,13204,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627282
,BAO_0000019,,,7199,,,,,0,13205,,Total body clearance was measured at given dose,Autocuration,,1,,,,22224,A,U,CHEMBL627283
,BAO_0000218,,,7199,,,,,0,13206,,Total body clearance was measured at given dose.,Autocuration,,1,,,,22224,A,U,CHEMBL627284
,BAO_0000218,,,7095,,,,,1,13207,,Metabolic clearance from the body in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627285
,BAO_0000218,,In vivo,7095,,,,,0,13208,,Renal clearance from the body,Autocuration,,1,,,,22224,A,U,CHEMBL627286
,BAO_0000218,,In vivo,7095,,,,,1,13209,,Renal clearance from the body in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875477
,BAO_0000218,,In vivo,12528,,,,,1,13210,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627287
,BAO_0000218,,In vivo,12528,,,,,1,13211,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL627288
,BAO_0000218,,,7095,,,,,1,13212,,Total clearance from the body in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627289
,BAO_0000218,,In vivo,14223,,1969.0,,,1,13213,,Clearance into cortex from rat plasma or PBS,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627290
,BAO_0000218,,In vivo,13569,,,,,0,13214,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,Autocuration,,1,,,,22224,A,U,CHEMBL627291
,BAO_0000218,,In vivo,13569,,,,,0,13215,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,Autocuration,,1,,,,22224,A,U,CHEMBL627292
,BAO_0000218,,In vivo,13569,,,,,0,13216,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,Autocuration,,1,,,,22224,A,U,CHEMBL627293
,BAO_0000218,,In vivo,13569,,,,,0,13217,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,Autocuration,,1,,,,22224,A,U,CHEMBL627294
,BAO_0000218,,In vivo,13569,,,,,0,13218,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,Autocuration,,1,,,,22224,A,U,CHEMBL875478
,BAO_0000218,,In vivo,13979,,,,,0,13219,,Clearance was determined,Autocuration,,1,,,,22224,A,U,CHEMBL627295
,BAO_0000218,,In vivo,14315,,,,,1,13220,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627296
,BAO_0000218,,In vivo,14315,,,,,1,13221,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,Intermediate,Oryctolagus cuniculus,1,9986.0,,,50592,A,N,CHEMBL626119
,BAO_0000218,,In vivo,14315,,,,,1,13222,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626120
,BAO_0000218,,In vivo,12174,,,,,1,13223,,Clearance in rat after iv dose (100 ug/kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626121
,BAO_0000218,,In vivo,12797,,,,,0,13224,,Clearance in guinea pig,Autocuration,Cavia porcellus,1,10141.0,,,22224,A,U,CHEMBL626122
,BAO_0000218,,In vivo,12797,,,,,1,13225,,Compound was evaluated for clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626123
,BAO_0000218,,In vivo,12797,,,,,1,13226,,Compound was evaluated for the clearance in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL623456
,BAO_0000218,,In vivo,12797,,,,,1,13227,,Compound was evaluated for the clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623457
,BAO_0000218,,In vivo,11500,,,,,1,13228,,Compound was tested in vivo for clearance after iv administration in the rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623458
,BAO_0000218,,In vivo,15173,,,,,0,13229,,IV clearance determined at an iv dose of 14 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL623459
,BAO_0000218,,In vivo,15173,,,,,0,13230,,IV clearance determined at an iv dose of 15.2 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL875484
,BAO_0000218,,In vivo,15173,,,,,0,13231,,IV clearance determined at an iv dose of 15 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL623460
,BAO_0000218,,In vivo,15173,,,,,0,13232,,IV clearance determined at an peroral dose of 30 mg/kg.,Autocuration,,1,,,,22224,A,U,CHEMBL623461
,BAO_0000218,,In vivo,15173,,,,,0,13233,,IV clearance determined at an peroral dose of 30.2 mg/kg.,Autocuration,,1,,,,22224,A,U,CHEMBL623462
,BAO_0000218,,In vivo,15173,,,,,0,13234,,IV clearance determined at an peroral dose of 30.3 mg/kg.,Autocuration,,1,,,,22224,A,U,CHEMBL627386
,BAO_0000218,,In vivo,14198,,2113.0,,,1,13235,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627387
,BAO_0000218,,In vivo,14198,,2107.0,,,1,13236,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627388
,BAO_0000218,,In vivo,14198,,2048.0,,,1,13237,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627389
,BAO_0000218,,In vivo,14198,,2385.0,,,1,13238,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627390
,BAO_0000218,,In vivo,14198,,1969.0,,,1,13239,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627391
,BAO_0000218,,In vivo,14198,,,,,1,13240,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627392
,BAO_0000218,,In vivo,14198,,2106.0,,,1,13241,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL627393
,BAO_0000218,,In vivo,14198,,3126.0,,,1,13242,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Trachea,50597,A,N,CHEMBL627394
,BAO_0000218,,In vivo,14198,,10000001.0,,,1,13243,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL627395
,BAO_0000218,,In vivo,14198,,2037.0,,,1,13244,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL875485
,BAO_0000218,,In vivo,14198,,,,,1,13245,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627396
,BAO_0000218,,In vivo,14198,,,,,1,13246,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627397
,BAO_0000218,,In vivo,14198,,948.0,,,1,13247,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL627398
,BAO_0000218,,In vivo,14198,,10000001.0,,,1,13248,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL627399
,BAO_0000218,,In vivo,14198,,2113.0,,,1,13249,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627400
,BAO_0000218,,In vivo,14198,,2107.0,,,1,13250,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627401
,BAO_0000218,,In vivo,14198,,2048.0,,,1,13251,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627402
,BAO_0000218,,In vivo,14198,,2385.0,,,1,13252,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL627403
,BAO_0000218,,In vivo,14198,,1969.0,,,1,13253,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL627404
,BAO_0000218,,In vivo,14198,,,,,1,13254,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623101
,BAO_0000218,,In vivo,14198,,2106.0,,,1,13255,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL877480
,BAO_0000218,,In vivo,14198,,3126.0,,,1,13256,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Trachea,50597,A,N,CHEMBL623102
,BAO_0000218,,In vivo,14198,,10000001.0,,,1,13257,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL623103
,BAO_0000218,,In vivo,14198,,2037.0,,,1,13258,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL623104
,BAO_0000218,,In vivo,14198,,,,,1,13259,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623105
,BAO_0000218,,In vivo,14198,,,,,1,13260,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623106
,BAO_0000218,,In vivo,14198,,948.0,,,1,13261,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL623107
,BAO_0000218,,In vivo,14198,,160.0,,,1,13262,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL623108
,BAO_0000218,,In vivo,14198,,2113.0,,,1,13263,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL623109
,BAO_0000218,,In vivo,14198,,2107.0,,,1,13264,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL623110
,BAO_0000218,,In vivo,14198,,2048.0,,,1,13265,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL623111
,BAO_0000218,,In vivo,14198,,2385.0,,,1,13266,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL625060
,BAO_0000218,,In vivo,14198,,1969.0,,,1,13267,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625061
,BAO_0000218,,In vivo,14198,,,,,1,13268,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625062
,BAO_0000218,,In vivo,14198,,2106.0,,,1,13269,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625063
,BAO_0000218,,In vivo,14198,,3126.0,,,1,13270,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Trachea,50597,A,N,CHEMBL625064
,BAO_0000218,,In vivo,14198,,10000001.0,,,1,13271,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Bone,50597,A,N,CHEMBL625065
,BAO_0000218,,In vivo,14198,,2037.0,,,1,13272,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL625066
,BAO_0000218,,In vivo,14198,,,,,1,13273,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625067
,BAO_0000218,,In vivo,14198,,,,,1,13274,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625068
,BAO_0000218,,In vivo,14198,,948.0,,,1,13275,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL622159
,BAO_0000218,,In vivo,14198,,160.0,,,1,13276,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Intestine,50597,A,N,CHEMBL622160
,BAO_0000218,,In vivo,14198,,2113.0,,,1,13277,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL622161
,BAO_0000218,,In vivo,14198,,2048.0,,,1,13278,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL622162
,BAO_0000218,,In vivo,14198,,2385.0,,,1,13279,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL622163
,BAO_0000218,,In vivo,14198,,1969.0,,,1,13280,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622313
,BAO_0000218,,In vivo,14198,,,,,1,13281,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622314
,BAO_0000218,,In vivo,14198,,2106.0,,,1,13282,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL622315
,BAO_0000218,,In vivo,14198,,3126.0,,,1,13283,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,Trachea,50597,A,N,CHEMBL622316
,BAO_0000218,,,15599,,,,,1,13284,,Normal diffusion coefficient in water for Escherichia coli,Intermediate,Escherichia coli,1,562.0,,,50212,A,N,CHEMBL877486
,BAO_0000019,,,8204,,,,,0,13285,,Average max percent decrease in RVR (renal vascular resistance) was determined,Autocuration,,1,,,,22224,A,U,CHEMBL622317
,BAO_0000019,,,8204,,,,,0,13286,,Average max percent decrease in RVR (renal vascular resistance) was determined.,Autocuration,,1,,,,22224,A,U,CHEMBL622318
,BAO_0000019,,,6154,,,,,0,13287,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,Autocuration,,1,,,,22224,A,U,CHEMBL622319
,BAO_0000019,,,6154,,,,,0,13288,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,Autocuration,,1,,,,22224,A,U,CHEMBL622320
,BAO_0000019,,,6154,,,,,0,13289,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,Autocuration,,1,,,,22224,A,U,CHEMBL622321
,BAO_0000019,,,6154,,,,,0,13290,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,Autocuration,,1,,,,22224,A,U,CHEMBL622322
,BAO_0000019,,,7114,,,,,0,13291,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,Autocuration,,1,,,,22224,A,U,CHEMBL622323
,BAO_0000218,,,7114,,,,,1,13292,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622324
,BAO_0000218,,,8133,,1088.0,,,1,13293,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622325
,BAO_0000218,,,8133,,1088.0,,,1,13294,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622326
,BAO_0000218,,,8133,,1088.0,,,1,13295,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL877487
,BAO_0000218,,,8133,,1088.0,,,1,13296,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622327
,BAO_0000218,,,8133,,1088.0,,,1,13297,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622328
,BAO_0000218,,,8133,,1088.0,,,1,13298,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622329
,BAO_0000218,,,8133,,1088.0,,,1,13299,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622330
,BAO_0000218,,,8133,,1088.0,,,1,13300,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622331
,BAO_0000218,,,8133,,1088.0,,,1,13301,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622332
,BAO_0000218,,,8133,,1088.0,,,1,13302,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622333
,BAO_0000218,,,8133,,1088.0,,,0,13303,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Autocuration,Simiiformes,1,314293.0,,Urine,22224,A,U,CHEMBL627658
,BAO_0000218,,,8133,,1088.0,,,0,13304,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",Autocuration,Simiiformes,1,314293.0,,Urine,22224,A,U,CHEMBL630428
,BAO_0000218,,,8133,,1088.0,,,0,13305,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Autocuration,Simiiformes,1,314293.0,,Urine,22224,A,U,CHEMBL630429
,BAO_0000218,,,8133,,1088.0,,,0,13306,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",Autocuration,Simiiformes,1,314293.0,,Urine,22224,A,U,CHEMBL630430
,BAO_0000218,,,8133,,1088.0,,,0,13307,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",Autocuration,Simiiformes,1,314293.0,,Urine,22224,A,U,CHEMBL630431
,BAO_0000218,,,8133,,1088.0,,,1,13308,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL630432
,BAO_0000218,,,8133,,1088.0,,,1,13309,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL630433
,BAO_0000218,,,8133,,1088.0,,,1,13310,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL630434
,BAO_0000218,,,8133,,1088.0,,,1,13311,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629372
,BAO_0000218,,,8133,,1088.0,,,1,13312,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629553
,BAO_0000218,,,8133,,1088.0,,,1,13313,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629554
,BAO_0000218,,,8133,,1088.0,,,1,13314,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL874447
,BAO_0000218,,,8133,,1088.0,,,1,13315,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629555
,BAO_0000218,,,8133,,1088.0,,,1,13316,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629556
,BAO_0000218,,,8133,,1088.0,,,1,13317,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629557
,BAO_0000218,,,8133,,1088.0,,,1,13318,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629558
,BAO_0000218,,,8133,,1088.0,,,1,13319,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629559
,BAO_0000218,,,8133,,1088.0,,,1,13320,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629560
,BAO_0000218,,,8133,,1088.0,,,1,13321,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL629561
,BAO_0000218,,,8133,,1088.0,,,1,13322,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL629562
,BAO_0000218,,,8133,,1088.0,,,1,13323,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL629563
,BAO_0000218,,,8133,,1088.0,,,1,13324,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL629564
,BAO_0000218,,,8133,,1088.0,,,1,13325,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL629565
,BAO_0000218,,,8133,,1088.0,,,1,13326,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL629566
,BAO_0000218,,,8133,,1088.0,,,1,13327,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL629567
,BAO_0000218,,,8133,,1088.0,,,1,13328,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL629568
,BAO_0000218,,,8133,,1088.0,,,1,13329,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL629569
,BAO_0000218,,,8133,,1088.0,,,1,13330,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL629570
,BAO_0000218,,,8133,,1088.0,,,0,13331,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Autocuration,Simiiformes,1,314293.0,,Urine,22224,A,U,CHEMBL629571
,BAO_0000218,,In vivo,12170,,,,,0,13332,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL629572
,BAO_0000218,,In vivo,12170,,,,,0,13333,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL629573
,BAO_0000218,,In vivo,4985,,,,,0,13334,,Bioavailability (dose 20 mg/kg),Autocuration,Eutheria,1,9347.0,,,22224,A,U,CHEMBL629574
,BAO_0000218,,In vivo,15145,,,,,0,13335,,Bioavailability in dog,Autocuration,Canis lupus familiaris,1,9615.0,,,22224,A,U,CHEMBL629575
,BAO_0000218,,In vivo,14080,,,,,0,13336,,Bioavailability in rat (Sprague-Dawley) (male),Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL874448
,BAO_0000218,,In vivo,11219,,,,,0,13337,,Bioavailability in monkey (dose 10 mg/kg i.d.),Autocuration,Primates,1,9443.0,,,22224,A,U,CHEMBL629576
,BAO_0000218,,In vivo,15145,,,,,0,13338,,Bioavailability in rat,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL629577
,BAO_0000218,,In vivo,15145,,,,,0,13339,,Bioavailability in rat,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL629578
,BAO_0000218,,In vivo,1202,,,,,0,13340,,Bioavailability in dog (dose 3.0 mg/kg p.o.),Autocuration,Canis lupus familiaris,1,9615.0,,,22224,A,U,CHEMBL629579
,BAO_0000218,,In vivo,1202,,,,,0,13341,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,Autocuration,Canis lupus familiaris,1,9615.0,,,22224,A,U,CHEMBL882958
,BAO_0000218,,In vivo,1202,,,,,1,13342,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,Intermediate,Pan troglodytes,1,9598.0,,,50505,A,N,CHEMBL629580
,BAO_0000218,,In vivo,4026,,,,,0,13343,,Bioavailability,Autocuration,Eutheria,1,9347.0,,,22224,A,U,CHEMBL629581
,BAO_0000218,,In vivo,1492,,,,,0,13344,,Bioavailability in squirrel monkey,Autocuration,Saimiri,1,9520.0,,,22224,A,U,CHEMBL629582
,BAO_0000218,,In vivo,12793,,,,,1,13345,,Bioavailability was evaluated in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628522
,BAO_0000218,,In vivo,12793,,,,,1,13346,,Bioavailability was evaluated in hamster,Intermediate,Cricetinae,1,10026.0,,,100712,A,N,CHEMBL625432
,BAO_0000218,,In vivo,12793,,,,,0,13347,,Bioavailability in rat,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL625433
,BAO_0000218,,In vivo,14793,,1969.0,,,1,13348,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625434
,BAO_0000218,,In vivo,14793,,1969.0,,,1,13349,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL625435
,BAO_0000218,,In vivo,14793,,,,,0,13350,,Bioavailability in rat (dose 10 mg/kg p.o.),Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL625436
,BAO_0000218,,In vivo,14731,,,,,1,13351,,Bioavailability was measured in cynomolgus monkeys.,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL874588
,BAO_0000218,,In vivo,14731,,,,,1,13352,,Bioavailability was measured in nude mice.,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625437
,BAO_0000218,,In vivo,12187,,,,,0,13353,,Bioavailability in ferret (dose 10 mg/kg i.d.),Autocuration,Mustela putorius furo,1,9669.0,,,22224,A,U,CHEMBL625438
,BAO_0000218,,In vivo,12187,,,,,0,13354,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL625439
,BAO_0000218,,In vivo,12187,,,,,0,13355,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL625440
,BAO_0000218,,In vivo,12187,,,,,0,13356,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),Autocuration,Simiiformes,1,314293.0,,,22224,A,U,CHEMBL625441
,BAO_0000218,,In vivo,12187,,,,,0,13357,,Bioavailability in rat (dose 10 mg/kg i.d.),Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL625442
,BAO_0000218,,In vivo,12187,,,,,1,13358,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625443
,BAO_0000218,,In vivo,17431,,,,,0,13359,,Bioavailability was determined; extremely poor,Autocuration,,1,,,,22224,A,U,CHEMBL625444
,BAO_0000218,,In vivo,13318,,,,,1,13360,,% bioavailability in mice after oral administration of prodrug,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625445
,BAO_0000218,,In vivo,9025,,,,,1,13361,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625446
,BAO_0000218,,In vivo,9025,,,,,1,13362,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL882960
,BAO_0000218,,In vivo,9025,,,,,1,13363,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625447
,BAO_0000218,,In vivo,9025,,,,,1,13364,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625448
,BAO_0000218,,In vivo,9025,,,,,1,13365,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625449
,BAO_0000218,,In vivo,9025,,,,,1,13366,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL874589
,BAO_0000218,,In vivo,9025,,,,,1,13367,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625450
,BAO_0000218,,In vivo,9025,,,,,1,13368,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625451
,BAO_0000218,,In vivo,9025,,,,,1,13369,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626584
,BAO_0000218,,In vivo,9025,,,,,1,13370,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626585
,BAO_0000218,,In vivo,9025,,,,,1,13371,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626586
,BAO_0000218,,In vivo,9025,,,,,1,13372,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626587
,BAO_0000218,,In vivo,9025,,,,,1,13373,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626588
,BAO_0000218,,In vivo,9025,,,,,1,13374,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626589
,BAO_0000218,,In vivo,9025,,,,,1,13375,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626590
,BAO_0000218,,In vivo,9025,,,,,1,13376,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626591
,BAO_0000218,,In vivo,9025,,,,,1,13377,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL627181
,BAO_0000218,,In vivo,9025,,,,,1,13378,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628083
,BAO_0000218,,In vivo,15173,,,,,0,13379,,IV clearance determined at an peroral dose of 15 mg/kg.,Autocuration,,1,,,,22224,A,U,CHEMBL628084
,BAO_0000218,,In vivo,7732,,,,,1,13380,,Mouse oral clearance was measured against Hymenolepiasis nana.,Expert,Hymenolepis nana,1,102285.0,,,50064,F,N,CHEMBL628085
,BAO_0000218,,In vivo,7732,,,,,1,13381,,Mouse oral clearance was measured against Nematospiroides dubius,Expert,Heligmosomoides polygyrus,1,6339.0,,,50545,F,N,CHEMBL628086
,BAO_0000218,,In vivo,7732,,,,,0,13382,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,Autocuration,,1,,,,22224,F,U,CHEMBL628087
,BAO_0000218,,In vivo,7732,,,,,1,13383,,Mouse oral clearance was measured against N. nana; NT is Not Tested,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL628088
,BAO_0000218,,In vivo,7732,,,,,0,13384,,Mouse oral clearance was measured against N. nana; NT is Not Tested,Autocuration,,1,,,,22224,B,U,CHEMBL628089
,BAO_0000218,,In vivo,8328,,,,,0,13385,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,Autocuration,,1,,,,22224,A,U,CHEMBL628090
,BAO_0000218,,In vivo,8328,,,,,0,13386,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,Autocuration,,1,,,,22224,A,U,CHEMBL628091
,BAO_0000218,,In vivo,8328,,,,,0,13387,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,Autocuration,,1,,,,22224,A,U,CHEMBL628092
,BAO_0000218,,In vivo,8328,,,,,0,13388,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,Autocuration,,1,,,,22224,A,U,CHEMBL628093
,BAO_0000218,,In vivo,8328,,,,,0,13389,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,Autocuration,,1,,,,22224,A,U,CHEMBL875607
,BAO_0000218,,In vivo,8328,,,,,0,13390,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,Autocuration,,1,,,,22224,A,U,CHEMBL625710
,BAO_0000218,,In vivo,8328,,,,,0,13391,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,Autocuration,,1,,,,22224,A,U,CHEMBL625711
,BAO_0000218,,In vivo,8328,,,,,0,13392,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,Autocuration,,1,,,,22224,A,U,CHEMBL625712
,BAO_0000218,,In vivo,8328,,,,,0,13393,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,Autocuration,,1,,,,22224,A,U,CHEMBL625713
,BAO_0000218,,In vivo,13376,,,,,1,13394,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625714
,BAO_0000218,,In vivo,13477,,,,,1,13395,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,Intermediate,Macaca mulatta,1,9544.0,,,50797,A,N,CHEMBL625715
,BAO_0000218,,In vivo,13477,,,,,1,13396,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625716
,BAO_0000218,,In vivo,13477,,,,,1,13397,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625717
,BAO_0000218,,In vivo,13313,,,,,1,13398,,Plasma clearance was determined for the compound in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625718
,BAO_0000218,,In vivo,12504,,,,,1,13399,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625719
,BAO_0000218,,In vivo,12504,,,,,1,13400,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625720
,BAO_0000218,,In vivo,12504,,,,,1,13401,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625721
,BAO_0000218,,In vivo,12504,,,,,1,13402,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625722
,BAO_0000218,,In vivo,13129,,,,,1,13403,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625723
,BAO_0000218,,In vivo,7732,,,,,1,13404,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,Intermediate,Heligmosomoides polygyrus,1,6339.0,,,50545,A,N,CHEMBL625724
,BAO_0000218,,In vivo,7732,,,,,1,13405,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,Intermediate,Heligmosomoides polygyrus,1,6339.0,,,50545,A,N,CHEMBL625725
,BAO_0000218,,In vivo,7732,,,,,1,13406,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,Intermediate,Heligmosomoides polygyrus,1,6339.0,,,50545,A,N,CHEMBL625726
,BAO_0000218,,In vivo,7732,,,,,1,13407,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,Intermediate,Heligmosomoides polygyrus,1,6339.0,,,50545,A,N,CHEMBL875608
,BAO_0000218,,In vivo,7732,,,,,1,13408,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,Intermediate,Heligmosomoides polygyrus,1,6339.0,,,50545,A,N,CHEMBL625727
,BAO_0000218,,In vivo,9278,,1088.0,,,0,13409,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,Autocuration,Rattus norvegicus,1,10116.0,,Urine,22224,A,U,CHEMBL625728
,BAO_0000218,,In vivo,9278,,,,,0,13410,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL625729
,BAO_0000218,,In vivo,9278,,,,,0,13411,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL625730
,BAO_0000218,,In vivo,9278,,1088.0,,,0,13412,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Autocuration,Rattus norvegicus,1,10116.0,,Urine,22224,A,U,CHEMBL625731
,BAO_0000218,,In vivo,9278,,1088.0,,,0,13413,,Urinary clearance was determined in rat at 25 mg/kg os dosage,Autocuration,Rattus norvegicus,1,10116.0,,Urine,22224,A,U,CHEMBL626417
,BAO_0000218,,In vivo,9278,,1088.0,,,1,13414,,Urinary clearance was determined at 100 mg/kg oral dosage in human,Intermediate,Homo sapiens,1,9606.0,,Urine,50587,A,N,CHEMBL626418
,BAO_0000218,,In vivo,9278,,1088.0,,,1,13415,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL626419
,BAO_0000218,,In vivo,5932,,1969.0,,,1,13416,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626592
,BAO_0000218,,In vivo,5932,,1969.0,,,1,13417,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626593
,BAO_0000218,,In vivo,5182,,,,,1,13418,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626594
,BAO_0000218,,In vivo,10499,,,,,1,13419,,Clearance rate in dogs,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625035
,BAO_0000019,,In vitro,6051,,,,,0,13420,,Compound was measured for intrinsic clearance,Autocuration,,1,,,,22224,A,U,CHEMBL625036
,BAO_0000100,,,17508,,,,,0,13421,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625037
,BAO_0000100,,,6228,,,,,0,13422,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625038
,BAO_0000100,,,6231,,,,,0,13423,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625039
,BAO_0000100,,,17740,,,,,0,13424,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625040
,BAO_0000100,,,6495,,,,,0,13425,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625041
,BAO_0000100,,,2171,,,,,0,13426,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625042
,BAO_0000019,,,3255,,,,,0,13427,,Partition coefficient of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL874411
,BAO_0000019,,,6821,,,,,0,13428,,Permeability,Autocuration,,1,,,,22224,A,U,CHEMBL625043
,BAO_0000100,,,2685,,,,,0,13429,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625044
,BAO_0000019,,,17584,,,,,0,13430,,Partition coefficient (logD),Autocuration,,1,,,,22224,A,U,CHEMBL625045
,BAO_0000100,,,13824,,,,,0,13431,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),Autocuration,,1,,,,22229,P,U,CHEMBL625046
,BAO_0000100,,,13824,,,,,0,13432,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),Autocuration,,1,,,,22229,P,U,CHEMBL625047
,BAO_0000100,,,16479,,,,,0,13433,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625048
,BAO_0000100,,,11997,,,,,0,13434,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625049
,BAO_0000100,,,2988,,,,,0,13435,,Calculated logarithm of partition coefficient (P) was determined,Autocuration,,1,,,,22229,P,U,CHEMBL625050
,BAO_0000100,,,931,,,,,0,13436,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625051
,BAO_0000100,,,4381,,,,,0,13437,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL874412
,BAO_0000100,,,4397,,,,,0,13438,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625052
,BAO_0000100,,,5889,,,,,0,13439,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL625053
,BAO_0000019,,,6154,,,,,0,13440,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,Autocuration,,1,,,,22224,A,U,CHEMBL623250
,BAO_0000019,,,6154,,,,,0,13441,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,Autocuration,,1,,,,22224,A,U,CHEMBL623251
,BAO_0000019,,,6154,,,,,0,13442,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,Autocuration,,1,,,,22224,A,U,CHEMBL623252
,BAO_0000019,,,6154,,,,,0,13443,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,Autocuration,,1,,,,22224,A,U,CHEMBL623253
,BAO_0000019,,,6154,,,,,0,13444,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,Autocuration,,1,,,,22224,A,U,CHEMBL623254
,BAO_0000019,,,6154,,,,,0,13445,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,Autocuration,,1,,,,22224,A,U,CHEMBL623255
,BAO_0000019,,,6887,,,,,0,13446,,Percent degradation of compound at a pH of 1 over a 18 hr period,Autocuration,,1,,,,22224,A,U,CHEMBL626831
,BAO_0000019,,,6887,,,,,0,13447,,Percent degradation of compound at pH of 1 over an 18 hr period,Autocuration,,1,,,,22224,A,U,CHEMBL877494
,BAO_0000019,,,14116,,,,,0,13448,,Delta Logarithm of Partition Coefficient value was determined.,Autocuration,,1,,,,22224,A,U,CHEMBL626832
,BAO_0000019,,,11137,,,,,0,13449,,Delta logPoct-cyc,Autocuration,,1,,,,22224,A,U,CHEMBL626833
,BAO_0000100,,,7230,,,,,0,13450,,Lipophilicity estimated on reversed phase TLC,Autocuration,,1,,,,22224,P,U,CHEMBL626834
,BAO_0000019,,,15741,,,,,0,13451,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,Autocuration,,1,,,,22224,A,U,CHEMBL626835
,BAO_0000019,,,9663,,,,,0,13452,,Delta logPoct-cyc,Autocuration,,1,,,,22224,A,U,CHEMBL626836
,BAO_0000100,,,9663,,,,,0,13453,,Change in logarithm of partition coefficient of the compound,Autocuration,,1,,,,22229,P,U,CHEMBL626837
,BAO_0000019,,,13807,,,,,0,13454,,Delta logD (pH 6.5),Autocuration,,1,,,,22224,A,U,CHEMBL626838
,BAO_0000100,,,13807,,,,,0,13455,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",Autocuration,,1,,,,22224,P,U,CHEMBL626839
,BAO_0000019,,,17425,,,,,0,13456,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,Autocuration,,1,,,,22224,A,U,CHEMBL626840
,BAO_0000019,,,12143,,,,,0,13457,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),Autocuration,,1,,,,22224,A,U,CHEMBL626841
,BAO_0000219,,,12608,,,,,0,13458,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,Autocuration,,1,,,,22224,A,U,CHEMBL626842
,BAO_0000219,,,12608,,,,,0,13459,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,Autocuration,,1,,,,22224,A,U,CHEMBL626843
,BAO_0000218,,,8649,,,,,1,13460,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626844
,BAO_0000218,,,8649,,,,,1,13461,,Amount of deuterium retained was reported after normal workup in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL877495
,BAO_0000218,,,8649,,,,,1,13462,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626845
,BAO_0000218,,,8649,,,,,1,13463,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626846
,BAO_0000218,,,8649,,,,,1,13464,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626847
,BAO_0000218,,,8649,,,,,1,13465,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628677
,BAO_0000218,,,8649,,,,,1,13466,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628678
,BAO_0000019,,,9659,,,,,0,13467,,Compound was subjected to electrochemical oxidation,Autocuration,,1,,,,22224,A,U,CHEMBL628679
,BAO_0000019,,,9659,,,,,0,13468,,Compound was subjected to photochemical oxidation,Autocuration,,1,,,,22224,A,U,CHEMBL628680
,BAO_0000019,,,9659,,,,,0,13469,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,Autocuration,,1,,,,22224,A,U,CHEMBL628681
,BAO_0000019,,,9659,,,,,0,13470,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,Autocuration,,1,,,,22224,A,U,CHEMBL628682
,BAO_0000019,,,9659,,,,,0,13471,,Oxidation of compound by methemoglobin in presence of hydroperoxide,Autocuration,,1,,,,22224,A,U,CHEMBL628683
,BAO_0000218,,,9607,,,,,1,13472,,Percent diffusion through fuzzy rat skin after 48 h of incubation,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628684
,BAO_0000100,,,7057,,,,,0,13473,,Dissociation constant (pKa),Autocuration,,1,,,,22229,P,U,CHEMBL877501
,BAO_0000100,,,7057,,,,,0,13474,,Dissociation constant value of the compound; ND means not determined.,Autocuration,,1,,,,22224,P,U,CHEMBL628685
,BAO_0000218,,,7911,,178.0,,,1,13475,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628686
,BAO_0000218,,,7911,,178.0,,,1,13476,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL628687
,BAO_0000218,,,7911,,,,,1,13477,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628688
,BAO_0000218,,,7911,,,,,1,13478,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628689
,BAO_0000218,,,7911,,2107.0,,,1,13479,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628690
,BAO_0000218,,,7911,,2107.0,,,1,13480,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL629363
,BAO_0000218,,,7911,,2106.0,,,1,13481,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL629364
,BAO_0000218,,,7911,,2106.0,,,1,13482,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL629365
,BAO_0000218,,,7911,,,,,1,13483,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629366
,BAO_0000218,,,7911,,1088.0,,,1,13484,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629367
,BAO_0000218,,,7911,,1988.0,,,1,13485,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,Rattus norvegicus,1,10116.0,,Feces,50597,A,N,CHEMBL629368
,BAO_0000218,,,7911,,1088.0,,,1,13486,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL877502
,BAO_0000218,,,13792,,2037.0,,,1,13487,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,Intermediate,Mus musculus,1,10090.0,,Cerebellum,50594,A,N,CHEMBL629369
,BAO_0000218,,,13792,,955.0,,,1,13488,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL629370
,BAO_0000218,,,8133,,1088.0,,,0,13489,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",Autocuration,Simiiformes,1,314293.0,,Urine,22224,A,U,CHEMBL629371
,BAO_0000218,,,8133,,1088.0,,,0,13490,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Autocuration,Simiiformes,1,314293.0,,Urine,22224,A,U,CHEMBL626276
,BAO_0000218,,,8133,,1088.0,,,0,13491,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Autocuration,Simiiformes,1,314293.0,,Urine,22224,A,U,CHEMBL626277
,BAO_0000218,,,8133,,1088.0,,,0,13492,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Autocuration,Simiiformes,1,314293.0,,Urine,22224,A,U,CHEMBL631250
,BAO_0000218,,,8133,,1088.0,,,1,13493,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631251
,BAO_0000218,,,8133,,1088.0,,,1,13494,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631252
,BAO_0000218,,,8133,,1088.0,,,1,13495,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631253
,BAO_0000218,,,8133,,1088.0,,,1,13496,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631254
,BAO_0000218,,,8133,,1088.0,,,1,13497,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631255
,BAO_0000218,,,8133,,1088.0,,,1,13498,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631256
,BAO_0000218,,,8133,,1088.0,,,1,13499,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631257
,BAO_0000218,,,8133,,1088.0,,,1,13500,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628009
,BAO_0000218,,,8133,,1088.0,,,1,13501,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628010
,BAO_0000218,,,8133,,1088.0,,,1,13502,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628011
,BAO_0000218,,,8133,,1088.0,,,1,13503,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628012
,BAO_0000218,,,8133,,1088.0,,,1,13504,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628013
,BAO_0000218,,,8133,,1088.0,,,1,13505,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628014
,BAO_0000218,,,8133,,1088.0,,,1,13506,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL628015
,BAO_0000218,,,8133,,1088.0,,,1,13507,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL628016
,BAO_0000218,,,8133,,1088.0,,,1,13508,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL874461
,BAO_0000218,,,8133,,1088.0,,,1,13509,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL628017
,BAO_0000218,,,8133,,1088.0,,,1,13510,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL628018
,BAO_0000218,,,8133,,1088.0,,,1,13511,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL628019
,BAO_0000218,,,8133,,1088.0,,,1,13512,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL628020
,BAO_0000218,,,8133,,1088.0,,,1,13513,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL628021
,BAO_0000218,,,8133,,1088.0,,,1,13514,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL628022
,BAO_0000218,,,8133,,1088.0,,,1,13515,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL628023
,BAO_0000218,,,8133,,1088.0,,,0,13516,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Autocuration,Simiiformes,1,314293.0,,Urine,22224,A,U,CHEMBL628024
,BAO_0000218,,,8133,,1088.0,,,0,13517,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",Autocuration,Simiiformes,1,314293.0,,Urine,22224,A,U,CHEMBL628025
,BAO_0000218,,,8133,,1088.0,,,0,13518,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Autocuration,Simiiformes,1,314293.0,,Urine,22224,A,U,CHEMBL628026
,BAO_0000218,,,8133,,1088.0,,,0,13519,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Autocuration,Simiiformes,1,314293.0,,Urine,22224,A,U,CHEMBL628027
,BAO_0000218,,,8133,,1088.0,,,0,13520,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Autocuration,Simiiformes,1,314293.0,,Urine,22224,A,U,CHEMBL628028
,BAO_0000218,,,8133,,1088.0,,,1,13521,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628029
,BAO_0000218,,,8133,,1088.0,,,1,13522,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628030
,BAO_0000218,,,8133,,1088.0,,,1,13523,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628031
,BAO_0000218,,,8133,,1088.0,,,1,13524,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628032
,BAO_0000218,,,8133,,1088.0,,,1,13525,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628033
,BAO_0000218,,,8133,,1088.0,,,1,13526,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628034
,BAO_0000218,,,8133,,1088.0,,,1,13527,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628035
,BAO_0000218,,,8133,,1088.0,,,1,13528,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628036
,BAO_0000218,,,8133,,1088.0,,,1,13529,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL874462
,BAO_0000218,,In vivo,9025,,,,,1,13530,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628037
,BAO_0000218,,In vivo,9025,,,,,1,13531,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628123
,BAO_0000218,,In vivo,9025,,,,,1,13532,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628124
,BAO_0000218,,In vivo,9025,,,,,1,13533,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628125
,BAO_0000218,,In vivo,9025,,,,,1,13534,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628126
,BAO_0000218,,In vivo,9025,,,,,1,13535,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628127
,BAO_0000218,,In vivo,9025,,,,,1,13536,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628128
,BAO_0000218,,In vivo,9025,,,,,1,13537,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628129
,BAO_0000218,,In vivo,9025,,,,,1,13538,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628130
,BAO_0000218,,In vivo,9025,,,,,1,13539,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628131
,BAO_0000218,,In vivo,9025,,,,,1,13540,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628132
,BAO_0000218,,In vivo,9025,,,,,1,13541,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628133
,BAO_0000218,,In vivo,9025,,,,,1,13542,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628134
,BAO_0000218,,In vivo,9025,,,,,1,13543,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628135
,BAO_0000218,,In vivo,9025,,,,,1,13544,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628136
,BAO_0000218,,In vivo,9025,,,,,1,13545,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628137
,BAO_0000218,,In vivo,9025,,,,,1,13546,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628138
,BAO_0000218,,In vivo,9025,,,,,1,13547,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628139
,BAO_0000218,,In vivo,9025,,,,,1,13548,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628140
,BAO_0000218,,In vivo,9025,,,,,1,13549,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628141
,BAO_0000218,,In vivo,9025,,,,,1,13550,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628142
,BAO_0000218,,In vivo,9025,,,,,1,13551,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628143
,BAO_0000218,,In vivo,9025,,,,,1,13552,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628144
,BAO_0000218,,In vivo,9025,,,,,1,13553,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628145
,BAO_0000218,,In vivo,9025,,,,,1,13554,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL628146
,BAO_0000218,,In vivo,9025,,,,,1,13555,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625355
,BAO_0000218,,In vivo,9025,,,,,1,13556,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625356
,BAO_0000218,,In vivo,9025,,,,,1,13557,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625357
,BAO_0000218,,In vivo,9025,,,,,1,13558,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625527
,BAO_0000218,,In vivo,9025,,,,,1,13559,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL875473
,BAO_0000218,,In vivo,9025,,,,,1,13560,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL625528
,BAO_0000218,,In vivo,9025,,,,,1,13561,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626304
,BAO_0000218,,In vivo,9025,,1637.0,,,1,13562,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,Intermediate,Canis lupus familiaris,1,9615.0,,Artery,50588,A,N,CHEMBL624138
,BAO_0000100,,,6448,,,,,0,13563,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL624139
,BAO_0000100,,,17221,,,,,0,13564,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL624140
,BAO_0000100,,,6545,,,,,0,13565,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL624141
,BAO_0000100,,,577,,,,,0,13566,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL624142
,BAO_0000100,,,6285,,,,,0,13567,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL624143
,BAO_0000100,,,6500,,,,,0,13568,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL624144
,BAO_0000100,,,6716,,,,,0,13569,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL624145
,BAO_0000100,,,13658,,,,,0,13570,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL624146
,BAO_0000100,,,6549,,,,,0,13571,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL624147
,BAO_0000100,,,14685,,,,,0,13572,,Calculated partition coefficient (clogP) (MacLogP),Autocuration,,1,,,,22229,P,U,CHEMBL883123
,BAO_0000019,,,6893,,,,,0,13573,,Partition coefficient (logP),Autocuration,,1,,,,22224,A,U,CHEMBL624148
,BAO_0000019,,,3687,,,,,0,13574,,Kinetic parameter was determined,Autocuration,,1,,,,22224,A,U,CHEMBL874416
,BAO_0000100,,,4207,,,,,0,13575,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL624149
,BAO_0000100,,,4626,,,,,0,13576,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL624150
,BAO_0000100,,,1021,,,,,0,13577,,Lipophilicity was determined,Autocuration,,1,,,,22224,P,U,CHEMBL624151
,BAO_0000100,,,3777,,,,,0,13578,,Lipophilicity was determined,Autocuration,,1,,,,22224,P,U,CHEMBL624152
,BAO_0000100,,,17533,,,,,0,13579,,Lipophilicity was determined,Autocuration,,1,,,,22224,P,U,CHEMBL622139
,BAO_0000100,,,6524,,,,,0,13580,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL622140
,BAO_0000100,,,17533,,,,,0,13581,,Lipophilicity was determined,Autocuration,,1,,,,22224,P,U,CHEMBL622141
,BAO_0000100,,,6480,,,,,0,13582,,Lipophilicity in octanol-water,Autocuration,,1,,,,22224,P,U,CHEMBL622142
,BAO_0000100,,,17606,,,,,0,13583,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL622143
,BAO_0000100,,,6863,,,,,0,13584,,Octanol-water partition coefficient was determined,Autocuration,,1,,,,22229,P,U,CHEMBL622144
,BAO_0000019,,,1356,,,,,0,13585,,Partition coefficient (logP),Autocuration,,1,,,,22224,A,U,CHEMBL877473
,BAO_0000100,,,3326,,,,,0,13586,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL622145
,BAO_0000019,,,1356,,,,,0,13587,,Partition coefficient was determined; ND means not determined,Autocuration,,1,,,,22224,A,U,CHEMBL622146
,BAO_0000100,,,12984,,,,,0,13588,,Calculated partition coefficient (clogP),Autocuration,,1,,,,22229,P,U,CHEMBL622147
,BAO_0000019,,,17363,,,,,0,13589,,Partition coefficient of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL622148
,BAO_0000019,,,6827,,,,,0,13590,,Permeability was determined,Autocuration,,1,,,,22224,A,U,CHEMBL883124
,BAO_0000100,,,261,,,,,0,13591,,The compound was evaluated for the partition coefficient,Autocuration,,1,,,,22229,P,U,CHEMBL622149
,BAO_0000019,,,2685,,,,,0,13592,,Partition coefficient (logP),Autocuration,,1,,,,22224,A,U,CHEMBL622150
,BAO_0000100,,,414,,,,,0,13593,,The lipophilicity was reported,Autocuration,,1,,,,22224,P,U,CHEMBL622151
,BAO_0000100,,,15769,,,,,0,13594,,logarithm of the octanol-water partition coefficient for the compound,Autocuration,,1,,,,22229,P,U,CHEMBL622152
,BAO_0000019,,,17248,,,,,0,13595,,Clogp value was determined,Autocuration,,1,,,,22224,A,U,CHEMBL622153
,BAO_0000218,,In vivo,16935,,,,,0,13596,,Clp at a dose of 1.5 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL877474
,BAO_0000218,,In vivo,16935,,,,,0,13597,,Clp at a dose of 2.0 mg/kg,Autocuration,,1,,,,22224,A,U,CHEMBL622154
,BAO_0000218,,In vivo,14832,,1969.0,,,0,13598,,"Clp, plasma clearance at a dose of 10 mg/kg",Autocuration,,1,,,Plasma,22224,A,U,CHEMBL622155
,BAO_0000218,,In vivo,14832,,1969.0,,,0,13599,,"Clp, plasma clearance at a dose of 50 mg/kg",Autocuration,,1,,,Plasma,22224,A,U,CHEMBL622156
,BAO_0000218,,In vivo,2399,,1969.0,,,1,13600,,Compound was tested for plasma clearance in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622157
,BAO_0000218,,In vivo,2399,,1969.0,,,1,13601,,Compound was tested for plasma clearance in rat; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622158
,BAO_0000218,,In vivo,6227,,,,,1,13602,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622807
,BAO_0000218,,In vivo,6227,,,,,1,13603,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,Intermediate,Macaca mulatta,1,9544.0,,,50797,A,N,CHEMBL622808
,BAO_0000218,,In vivo,5623,,,,,0,13604,,Plasma clearance by iv administration at a dose 0.003 ug/mL,Autocuration,,1,,,,22224,A,U,CHEMBL622809
,BAO_0000218,,In vivo,4854,,,,,0,13605,,Plasma clearance determined,Autocuration,,1,,,,22224,A,U,CHEMBL622810
,BAO_0000218,,In vivo,4493,,,,,1,13606,,Plasma clearance after iv administration at 3 mg/kg in hamster,Intermediate,Cricetinae,1,10026.0,,,100712,A,N,CHEMBL876653
,BAO_0000218,,In vivo,4493,,,,,1,13607,,Plasma clearance after iv administration at 4 mg/kg in hamster,Intermediate,Cricetinae,1,10026.0,,,100712,A,N,CHEMBL622811
,BAO_0000218,,In vivo,14956,,,,,1,13608,,Rate of clearance in rat was determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622986
,BAO_0000218,,In vivo,15372,,1969.0,,,1,13609,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622987
,BAO_0000218,,In vivo,15372,,1969.0,,,1,13610,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622988
,BAO_0000218,,In vivo,15372,,1969.0,,,1,13611,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622989
,BAO_0000218,,In vivo,15372,,1969.0,,,1,13612,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622990
,BAO_0000218,,In vivo,15604,,1969.0,,,0,13613,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Autocuration,Simiiformes,1,314293.0,,Plasma,22224,A,U,CHEMBL622991
,BAO_0000218,,In vivo,15604,,1969.0,,,1,13614,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL622227
,BAO_0000218,,In vivo,15604,,1969.0,,,1,13615,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL622228
,BAO_0000218,,In vivo,14964,,,,,1,13616,,Clpl value in rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622229
,BAO_0000218,,In vivo,15240,,,,,1,13617,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,Intermediate,Cavia porcellus,1,10141.0,,,50512,A,N,CHEMBL622230
,BAO_0000218,,In vivo,16449,,,,,1,13618,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL622231
,BAO_0000218,,In vivo,16449,,,,,1,13619,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,Intermediate,Macaca fascicularis,1,9541.0,,,100710,A,N,CHEMBL622232
,BAO_0000218,,In vivo,12902,,,,,0,13620,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,Autocuration,,1,,,,22224,A,U,CHEMBL622233
,BAO_0000218,,In vivo,12902,,,,,0,13621,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,Autocuration,,1,,,,22224,A,U,CHEMBL622234
,BAO_0000218,,In vivo,12902,,,,,0,13622,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,Autocuration,,1,,,,22224,A,U,CHEMBL622235
,BAO_0000218,,In vivo,12902,,,,,0,13623,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,Autocuration,,1,,,,22224,A,U,CHEMBL622236
,BAO_0000218,,In vivo,12902,,,,,0,13624,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,Autocuration,,1,,,,22224,A,U,CHEMBL622237
,BAO_0000218,,In vivo,12902,,,,,0,13625,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,Autocuration,,1,,,,22224,A,U,CHEMBL877482
,BAO_0000218,,In vivo,12902,,,,,0,13626,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,Autocuration,,1,,,,22224,A,U,CHEMBL622238
,BAO_0000218,,In vivo,12902,,,,,0,13627,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,Autocuration,,1,,,,22224,A,U,CHEMBL622239
,BAO_0000218,,In vivo,11149,,178.0,,,0,13628,,Cmax was calculated as maximum concentration reached in the blood,Autocuration,,1,,,Blood,22224,A,U,CHEMBL622240
,BAO_0000218,,In vivo,11149,,178.0,,,0,13629,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,Autocuration,,1,,,Blood,22224,A,U,CHEMBL622241
,BAO_0000218,,In vivo,5669,,,,,1,13630,,Cmax was determine after peroral administration at 10 mpk in Rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631013
,BAO_0000218,,In vivo,5669,,,,,1,13631,,Cmax was determine after peroral administration at 10 mpk in Rhesus,Intermediate,Macaca mulatta,1,9544.0,,,50797,A,N,CHEMBL631014
,BAO_0000218,,In vivo,5669,,,,,1,13632,,Cmax was determine after peroral administration at 10 mpk in dog,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631015
,BAO_0000218,,In vivo,5669,,,,,1,13633,,Cmax was determine after peroral administration at 160 mpk in Rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631016
,BAO_0000218,,In vivo,5669,,,,,1,13634,,Cmax was determine after peroral administration at 20 mpk in Rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631017
,BAO_0000218,,In vivo,5669,,,,,1,13635,,Cmax was determine after peroral administration at 50 mpk in Rat,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631018
,BAO_0000218,,In vivo,4236,,,,,0,13636,,Cmax was determined,Autocuration,,1,,,,22224,A,U,CHEMBL631019
,BAO_0000218,,,13792,,955.0,,,1,13637,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL875761
,BAO_0000218,,,13792,,955.0,,,1,13638,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL631020
,BAO_0000218,,,13792,,955.0,,,1,13639,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL631669
,BAO_0000218,,,13792,,955.0,,,1,13640,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL631670
,BAO_0000218,,,13792,,2435.0,,,1,13641,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,Intermediate,Mus musculus,1,10090.0,,Striatum,50594,A,N,CHEMBL631671
,BAO_0000218,,,8418,,178.0,,,1,13642,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631672
,BAO_0000218,,,8418,,178.0,,,1,13643,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631673
,BAO_0000218,,,8418,,178.0,,,1,13644,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631856
,BAO_0000218,,,8418,,178.0,,,1,13645,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631857
,BAO_0000218,,,8418,,178.0,,,1,13646,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631858
,BAO_0000218,,,8418,,178.0,,,1,13647,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631859
,BAO_0000218,,,8418,,178.0,,,1,13648,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631860
,BAO_0000218,,,8418,,178.0,,,1,13649,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631861
,BAO_0000218,,,8418,,178.0,,,1,13650,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631862
,BAO_0000218,,,8418,,178.0,,,1,13651,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631863
,BAO_0000218,,,8418,,178.0,,,1,13652,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631864
,BAO_0000218,,,8418,,178.0,,,1,13653,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631865
,BAO_0000218,,,8418,,178.0,,,1,13654,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631866
,BAO_0000218,,,8418,,178.0,,,1,13655,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL629360
,BAO_0000218,,,8418,,178.0,,,1,13656,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL629361
,BAO_0000218,,,8418,,178.0,,,1,13657,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL629362
,BAO_0000218,,,8418,,178.0,,,1,13658,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL630740
,BAO_0000218,,,8418,,178.0,,,1,13659,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL630741
,BAO_0000218,,,8418,,178.0,,,1,13660,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL630742
,BAO_0000218,,,8418,,,,,1,13661,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630743
,BAO_0000218,,,8418,,,,,1,13662,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630744
,BAO_0000218,,,8418,,,,,1,13663,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630745
,BAO_0000218,,,8418,,,,,1,13664,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630746
,BAO_0000218,,,8418,,,,,1,13665,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630747
,BAO_0000218,,,8418,,,,,1,13666,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630748
,BAO_0000218,,,8418,,,,,1,13667,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632056
,BAO_0000218,,,8418,,,,,1,13668,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632057
,BAO_0000218,,,8418,,,,,1,13669,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632058
,BAO_0000218,,,8418,,,,,1,13670,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632059
,BAO_0000218,,,8418,,,,,1,13671,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632060
,BAO_0000218,,,8418,,,,,1,13672,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632061
,BAO_0000218,,,8418,,,,,1,13673,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629207
,BAO_0000218,,,8418,,,,,1,13674,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629208
,BAO_0000218,,,8418,,,,,1,13675,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629209
,BAO_0000218,,,8418,,,,,1,13676,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629210
,BAO_0000218,,,8418,,,,,1,13677,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629211
,BAO_0000218,,,8418,,,,,1,13678,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629212
,BAO_0000218,,,8418,,,,,1,13679,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629213
,BAO_0000218,,,8133,,1088.0,,,1,13680,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629214
,BAO_0000218,,,8133,,1088.0,,,1,13681,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629215
,BAO_0000218,,,8133,,1088.0,,,1,13682,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL635154
,BAO_0000218,,,6996,,,,,1,13683,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629216
,BAO_0000218,,,6996,,,,,1,13684,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629217
,BAO_0000218,,,6996,,,,,1,13685,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629218
,BAO_0000218,,,6996,,,,,1,13686,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629219
,BAO_0000218,,,6996,,,,,1,13687,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629220
,BAO_0000218,,,6996,,,,,1,13688,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629221
,BAO_0000218,,,6996,,,,,1,13689,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631127
,BAO_0000218,,,6996,,,,,1,13690,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631128
,BAO_0000218,,,6996,,,,,1,13691,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631129
,BAO_0000218,,,6996,,,,,1,13692,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631130
,BAO_0000218,,,6996,,,,,1,13693,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631131
,BAO_0000218,,,6996,,,,,1,13694,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631132
,BAO_0000218,,,6996,,,,,1,13695,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631133
,BAO_0000218,,,6996,,,,,1,13696,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631134
,BAO_0000218,,,6996,,,,,1,13697,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875120
,BAO_0000218,,,6996,,,,,1,13698,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631135
,BAO_0000218,,,6996,,,,,1,13699,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631136
,BAO_0000218,,,6996,,,,,1,13700,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631137
,BAO_0000218,,,6996,,,,,1,13701,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631138
,BAO_0000218,,,6996,,,,,1,13702,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631139
,BAO_0000218,,,6996,,,,,1,13703,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631140
,BAO_0000218,,,6996,,,,,1,13704,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631141
,BAO_0000218,,,6996,,,,,1,13705,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631142
,BAO_0000218,,,6996,,,,,1,13706,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631143
,BAO_0000218,,,6996,,,,,1,13707,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631144
,BAO_0000218,,,6996,,,,,1,13708,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631145
,BAO_0000218,,,6996,,,,,1,13709,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631146
,BAO_0000218,,,6996,,,,,1,13710,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631147
,BAO_0000218,,,6996,,,,,1,13711,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631148
,BAO_0000218,,,6996,,,,,1,13712,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631149
,BAO_0000218,,,6996,,,,,1,13713,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631150
,BAO_0000218,,,6996,,,,,1,13714,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631151
,BAO_0000218,,,6996,,,,,1,13715,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631152
,BAO_0000218,,,6996,,,,,1,13716,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631443
,BAO_0000218,,,6996,,,,,1,13717,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631444
,BAO_0000218,,,6996,,,,,1,13718,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631445
,BAO_0000218,,,6996,,,,,1,13719,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631446
,BAO_0000218,,,6996,,,,,1,13720,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631447
,BAO_0000218,,,6996,,,,,1,13721,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631448
,BAO_0000218,,,6996,,,,,1,13722,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631449
,BAO_0000218,,,6996,,,,,1,13723,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL631450
,BAO_0000218,,,6996,,,,,1,13724,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL629724
,BAO_0000218,,In vivo,9716,,14.0,,,1,13725,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,Mus musculus,1,10090.0,,Zone of skin,50594,A,N,CHEMBL629725
,BAO_0000218,,In vivo,9716,,14.0,,,1,13726,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,Mus musculus,1,10090.0,,Zone of skin,50594,A,N,CHEMBL629726
,BAO_0000218,,In vivo,9716,,2106.0,,,1,13727,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL629727
,BAO_0000218,,In vivo,9716,,2106.0,,,1,13728,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL630404
,BAO_0000218,,In vivo,9716,,2106.0,,,1,13729,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL630405
,BAO_0000218,,In vivo,9716,,2106.0,,,1,13730,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL630406
,BAO_0000218,,In vivo,9716,,945.0,,,1,13731,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,Mus musculus,1,10090.0,,Stomach,50594,A,N,CHEMBL630407
,BAO_0000218,,In vivo,9716,,945.0,,,1,13732,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,Mus musculus,1,10090.0,,Stomach,50594,A,N,CHEMBL630573
,BAO_0000218,,In vivo,9716,,945.0,,,1,13733,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,Mus musculus,1,10090.0,,Stomach,50594,A,N,CHEMBL630574
,BAO_0000218,,In vivo,9716,,945.0,,,1,13734,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,Mus musculus,1,10090.0,,Stomach,50594,A,N,CHEMBL630575
,BAO_0000218,,In vivo,9716,,,,,1,13735,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL630576
,BAO_0000218,,In vivo,9716,,,,,1,13736,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL630577
,BAO_0000218,,In vivo,9716,,,,,1,13737,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL630578
,BAO_0000218,,In vivo,9716,,,,,1,13738,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL630579
,BAO_0000218,,,12192,,2113.0,,,1,13739,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL630580
,BAO_0000218,,,12192,,2113.0,,,1,13740,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL630581
,BAO_0000218,,,12192,,2113.0,,,1,13741,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL630582
,BAO_0000218,,,12192,,,,,1,13742,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL630583
,BAO_0000218,,,12192,,,,,1,13743,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL630584
,BAO_0000218,,,12192,,,,,1,13744,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL630585
,BAO_0000218,,,12192,,,,,1,13745,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL630586
,BAO_0000218,,,12192,,,,,1,13746,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL630587
,BAO_0000218,,,12192,,,,,1,13747,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL630588
,BAO_0000218,,,12192,,,,,1,13748,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL630589
,BAO_0000218,,,12192,,,,,1,13749,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL630590
,BAO_0000019,,,12192,,1988.0,,,0,13750,,Removal of 238-Plutonium(IV) in feces at 24 h,Autocuration,,1,,,Feces,22224,A,U,CHEMBL630591
,BAO_0000019,,,12192,,1988.0,,,0,13751,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),Autocuration,,1,,,Feces,22224,A,U,CHEMBL630592
,BAO_0000019,,,12192,,,,,0,13752,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,Autocuration,,1,,,,22224,A,U,CHEMBL630593
,BAO_0000019,,,12192,,,,,0,13753,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),Autocuration,,1,,,,22224,A,U,CHEMBL630594
,BAO_0000019,,,12192,,1088.0,,,0,13754,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),Autocuration,,1,,,Urine,22224,A,U,CHEMBL630595
,BAO_0000019,,,12192,,1088.0,,,0,13755,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),Autocuration,,1,,,Urine,22224,A,U,CHEMBL630596
,BAO_0000019,,,12192,,1088.0,,,0,13756,,Removal of 238-Plutonium(IV) in urine after 0-24 h,Autocuration,,1,,,Urine,22224,A,U,CHEMBL630597
,BAO_0000019,,,12192,,1088.0,,,0,13757,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),Autocuration,,1,,,Urine,22224,A,U,CHEMBL630598
,BAO_0000019,,,12192,,1088.0,,,0,13758,,Removal of 238-Plutonium(IV) in urine after 0-4 h,Autocuration,,1,,,Urine,22224,A,U,CHEMBL630599
,BAO_0000019,,,12192,,1088.0,,,0,13759,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),Autocuration,,1,,,Urine,22224,A,U,CHEMBL630600
,BAO_0000019,,,12192,,1088.0,,,0,13760,,Removal of 238-Plutonium(IV) in urine after 4-24 h,Autocuration,,1,,,Urine,22224,A,U,CHEMBL630601
,BAO_0000019,,,12192,,1088.0,,,0,13761,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),Autocuration,,1,,,Urine,22224,A,U,CHEMBL630602
,BAO_0000019,,,12192,,1088.0,,,0,13762,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),Autocuration,,1,,,Urine,22224,A,U,CHEMBL630603
,BAO_0000019,,,12192,,1088.0,,,0,13763,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),Autocuration,,1,,,Urine,22224,A,U,CHEMBL630604
,BAO_0000218,,In vivo,12017,,178.0,,,1,13764,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624869
,BAO_0000218,,In vivo,12017,,178.0,,,1,13765,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL624870
,BAO_0000218,,In vivo,12017,,178.0,,,1,13766,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL623189
,BAO_0000218,,In vivo,12017,,178.0,,,1,13767,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL623190
,BAO_0000218,,In vivo,12017,,178.0,,,1,13768,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL623191
,BAO_0000218,,In vivo,12017,,,,,1,13769,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623192
,BAO_0000218,,In vivo,12017,,,,,1,13770,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623193
,BAO_0000218,,In vivo,12017,,,,,1,13771,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623194
,BAO_0000218,,In vivo,12017,,,,,1,13772,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623195
,BAO_0000218,,In vivo,12017,,,,,1,13773,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623196
,BAO_0000218,,,11836,,,,,1,13774,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623197
,BAO_0000218,,,11836,,,,,1,13775,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623198
,BAO_0000218,,,11836,,,,,1,13776,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623199
,BAO_0000218,,,11836,,2385.0,,,1,13777,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623200
,BAO_0000218,,,11836,,2385.0,,,1,13778,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623201
,BAO_0000218,,,11836,,2385.0,,,1,13779,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623202
,BAO_0000218,,,11836,,2385.0,,,1,13780,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623203
,BAO_0000218,,,11836,,2385.0,,,1,13781,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623204
,BAO_0000218,,,11836,,2385.0,,,1,13782,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623205
,BAO_0000218,,,11836,,2385.0,,,1,13783,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623206
,BAO_0000218,,,11836,,2385.0,,,1,13784,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623207
,BAO_0000218,,,11836,,2385.0,,,1,13785,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623208
,BAO_0000218,,,11836,,2385.0,,,1,13786,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623209
,BAO_0000218,,,11836,,2385.0,,,1,13787,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL623210
,BAO_0000218,,,11836,,,,,1,13788,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623211
,BAO_0000218,,,11836,,995.0,,,1,13789,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL623212
,BAO_0000019,,,12640,,,,,0,13790,,Tested in vitro for intrinsic activity relative to quinpirole,Autocuration,,1,,,,22224,A,U,CHEMBL623213
,BAO_0000019,,,14218,,,,,0,13791,,"Relative ion enhancement, determined in pulsed ultrafiltration",Autocuration,,1,,,,22224,A,U,CHEMBL623214
,BAO_0000019,,,11296,,,,,0,13792,,% ionization at the pH 7.4 at 37 degree Centigrade,Autocuration,,1,,,,22224,A,U,CHEMBL623215
,BAO_0000019,,,10929,,,,,0,13793,,Percentage ionization was measured,Autocuration,,1,,,,22224,A,U,CHEMBL623216
,BAO_0000218,,,13841,,,,,1,13794,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,Intermediate,Bos taurus,1,9913.0,,,50591,A,N,CHEMBL623217
,BAO_0000019,,,10431,,,,,0,13795,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,Autocuration,,1,,,,22224,A,U,CHEMBL623218
,BAO_0000019,,,10431,,,,,0,13796,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,Autocuration,,1,,,,22224,A,U,CHEMBL623913
,BAO_0000019,,,10431,,,,,0,13797,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,Autocuration,,1,,,,22224,A,U,CHEMBL623914
,BAO_0000100,,,8826,,,,,0,13798,,Compound was evaluated for the partition coefficient in octanol/water,Autocuration,,1,,,,22229,P,U,CHEMBL623915
,BAO_0000100,,,8826,,,,,0,13799,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),Autocuration,,1,,,,22229,P,U,CHEMBL624080
,BAO_0000019,,,9884,,,,,0,13800,,Equilibrium constant measured by the pulse radiolysis at pH 7,Autocuration,,1,,,,22224,A,U,CHEMBL624081
,BAO_0000218,,,9827,,,,,1,13801,,In vitro hydrolytic rate constant determined in human blood,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL624082
,BAO_0000218,,,10009,,,,,1,13802,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL625054
,BAO_0000019,,,10009,,,,,0,13803,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,Autocuration,,1,,,,22224,A,U,CHEMBL877485
,BAO_0000218,,,10009,,,,,1,13804,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625055
,BAO_0000218,,,10009,,,,,1,13805,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625056
,BAO_0000218,,,10009,,,,,1,13806,,In vitro oxidation of compound in presence of human plasma,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL625057
,BAO_0000019,,,10009,,,,,0,13807,,In vitro oxidation of compound in presence of hydrogen peroxide,Autocuration,,1,,,,22224,A,U,CHEMBL625058
,BAO_0000218,,,10009,,,,,1,13808,,In vitro oxidation of compound in presence of mouse brain homogenate,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625059
,BAO_0000218,,,10009,,,,,1,13809,,In vitro oxidation of compound in presence of mouse liver homogenate,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629536
,BAO_0000218,,,11510,,,,,1,13810,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629537
,BAO_0000218,,,11510,,,,,1,13811,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629538
,BAO_0000218,,,11510,,,,,1,13812,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629539
,BAO_0000218,,,11510,,,,,1,13813,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL874445
,BAO_0000218,,,11510,,,,,1,13814,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629540
,BAO_0000218,,,11510,,,,,1,13815,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629541
,BAO_0000218,,,11510,,,,,1,13816,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629542
,BAO_0000218,,,11510,,,,,1,13817,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630243
,BAO_0000218,,,11510,,,,,1,13818,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630244
,BAO_0000218,,,11510,,,,,1,13819,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630245
,BAO_0000218,,,11510,,,,,1,13820,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630246
,BAO_0000218,,,11510,,,,,1,13821,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630247
,BAO_0000218,,,11510,,,,,1,13822,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630248
,BAO_0000218,,In vivo,13100,,178.0,,,1,13823,,Biodistribution in rat blood at 240 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL630249
,BAO_0000218,,In vivo,13100,,178.0,,,1,13824,,Biodistribution in rat blood at 30 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL630250
,BAO_0000218,,In vivo,13100,,178.0,,,1,13825,,Biodistribution in rat blood at 360 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL630251
,BAO_0000218,,In vivo,13100,,178.0,,,1,13826,,Biodistribution in rat blood at 3 hr after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL630252
,BAO_0000218,,In vivo,13100,,178.0,,,1,13827,,Biodistribution in rat blood at 60 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL630408
,BAO_0000218,,In vivo,13100,,2037.0,,,1,13828,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL630409
,BAO_0000218,,In vivo,13100,,2037.0,,,1,13829,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL874446
,BAO_0000218,,In vivo,13100,,2037.0,,,1,13830,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL630410
,BAO_0000218,,In vivo,13100,,2037.0,,,1,13831,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL630411
,BAO_0000218,,In vivo,13100,,2037.0,,,1,13832,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL630412
,BAO_0000218,,In vivo,13100,,2037.0,,,1,13833,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL630413
,BAO_0000218,,In vivo,13100,,2037.0,,,1,13834,,Biodistribution in rat cerebellum at 3 hr after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL630414
,BAO_0000218,,In vivo,13100,,2037.0,,,1,13835,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL630415
,BAO_0000218,,In vivo,13100,,,,,1,13836,,Biodistribution in rat cortex at 120 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630416
,BAO_0000218,,In vivo,13100,,,,,1,13837,,Biodistribution in rat cortex at 1440 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630417
,BAO_0000218,,In vivo,13100,,,,,1,13838,,Biodistribution in rat cortex at 15 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630418
,BAO_0000218,,In vivo,13100,,,,,1,13839,,Biodistribution in rat cortex at 240 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630419
,BAO_0000218,,In vivo,13100,,,,,1,13840,,Biodistribution in rat cortex at 30 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630420
,BAO_0000218,,In vivo,13100,,,,,1,13841,,Biodistribution in rat cortex at 360 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630421
,BAO_0000218,,In vivo,13100,,,,,1,13842,,Biodistribution in rat cortex at 3 hr after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630422
,BAO_0000218,,In vivo,13100,,,,,1,13843,,Biodistribution in rat cortex at 60 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630423
,BAO_0000218,,In vivo,13100,,948.0,,,1,13844,,Biodistribution in rat heart at 120 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL630424
,BAO_0000218,,In vivo,13100,,948.0,,,1,13845,,Biodistribution in rat heart at 15 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL630425
,BAO_0000218,,In vivo,13100,,948.0,,,1,13846,,Biodistribution in rat heart at 240 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL629462
,BAO_0000218,,In vivo,13100,,948.0,,,1,13847,,Biodistribution in rat heart at 30 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL630426
,BAO_0000218,,In vivo,13100,,948.0,,,1,13848,,Biodistribution in rat heart at 360 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL630427
,BAO_0000218,,In vivo,13100,,948.0,,,1,13849,,Biodistribution in rat heart at 3 hr after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL625877
,BAO_0000218,,In vivo,13100,,948.0,,,1,13850,,Biodistribution in rat heart at 60 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL625878
,BAO_0000218,,In vivo,13100,,10000000.0,,,1,13851,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL625879
,BAO_0000218,,In vivo,13100,,10000000.0,,,1,13852,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL625880
,BAO_0000218,,In vivo,13100,,10000000.0,,,1,13853,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL625881
,BAO_0000218,,In vivo,13100,,10000000.0,,,1,13854,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL625882
,BAO_0000218,,In vivo,13100,,10000000.0,,,1,13855,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL625883
,BAO_0000218,,In vivo,13100,,2113.0,,,1,13856,,Biodistribution in rat kidney at 120 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625884
,BAO_0000218,,In vivo,13100,,2113.0,,,1,13857,,Biodistribution in rat kidney at 1440 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625885
,BAO_0000218,,In vivo,13100,,2113.0,,,1,13858,,Biodistribution in rat kidney at 15 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL628649
,BAO_0000218,,In vivo,13100,,2113.0,,,1,13859,,Biodistribution in rat kidney at 240 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL628650
,BAO_0000218,,In vivo,13100,,2113.0,,,1,13860,,Biodistribution in rat kidney at 30 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL628651
,BAO_0000218,,In vivo,13100,,2113.0,,,1,13861,,Biodistribution in rat kidney at 360 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL628652
,BAO_0000218,,In vivo,13100,,2113.0,,,1,13862,,Biodistribution in rat kidney at 60 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL628653
,BAO_0000218,,In vivo,13100,,2107.0,,,1,13863,,Biodistribution in rat liver at 120 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628654
,BAO_0000218,,In vivo,13100,,2107.0,,,1,13864,,Biodistribution in rat liver at 1440 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL628655
,BAO_0000218,,In vivo,13100,,2107.0,,,1,13865,,Biodistribution in rat liver at 15 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625238
,BAO_0000218,,In vivo,13100,,2107.0,,,1,13866,,Biodistribution in rat liver at 240 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625239
,BAO_0000218,,In vivo,13100,,2107.0,,,1,13867,,Biodistribution in rat liver at 30 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625240
,BAO_0000218,,In vivo,13100,,2107.0,,,1,13868,,Biodistribution in rat liver at 360 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625241
,BAO_0000218,,In vivo,13100,,2107.0,,,1,13869,,Biodistribution in rat liver at 60 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625242
,BAO_0000218,,In vivo,13100,,2048.0,,,1,13870,,Biodistribution in rat lung at 120 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL874587
,BAO_0000218,,In vivo,13100,,2048.0,,,1,13871,,Biodistribution in rat lung at 1440 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625405
,BAO_0000218,,In vivo,13100,,2048.0,,,1,13872,,Biodistribution in rat lung at 15 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625406
,BAO_0000218,,In vivo,13100,,2048.0,,,1,13873,,Biodistribution in rat lung at 240 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625407
,BAO_0000218,,In vivo,13100,,2048.0,,,1,13874,,Biodistribution in rat lung at 30 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625408
,BAO_0000218,,In vivo,13100,,2048.0,,,1,13875,,Biodistribution in rat lung at 360 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625409
,BAO_0000218,,,12361,,1515.0,,,1,13876,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,Intermediate,Rattus norvegicus,1,10116.0,,Thoracic aorta,50597,A,N,CHEMBL625410
,BAO_0000218,,,12361,,1515.0,,,1,13877,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,Intermediate,Rattus norvegicus,1,10116.0,,Thoracic aorta,50597,A,N,CHEMBL625411
,BAO_0000218,,,12361,,1515.0,,,1,13878,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,Intermediate,Rattus norvegicus,1,10116.0,,Thoracic aorta,50597,A,N,CHEMBL625412
,BAO_0000218,,,12361,,1515.0,,,1,13879,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,Intermediate,Rattus norvegicus,1,10116.0,,Thoracic aorta,50597,A,N,CHEMBL625413
,BAO_0000218,,,12361,,1515.0,,,1,13880,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,Intermediate,Rattus norvegicus,1,10116.0,,Thoracic aorta,50597,A,N,CHEMBL625414
,BAO_0000218,,,12361,,1515.0,,,1,13881,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,Intermediate,Rattus norvegicus,1,10116.0,,Thoracic aorta,50597,A,N,CHEMBL625415
,BAO_0000218,,,12361,,1515.0,,,1,13882,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,Intermediate,Rattus norvegicus,1,10116.0,,Thoracic aorta,50597,A,N,CHEMBL625416
,BAO_0000218,,,12712,,1088.0,,,1,13883,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625417
,BAO_0000218,,,7415,,1988.0,,,1,13884,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,Intermediate,Rattus norvegicus,1,10116.0,,Feces,50597,A,N,CHEMBL625418
,BAO_0000218,,,7415,,1088.0,,,1,13885,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625419
,BAO_0000218,,,7415,,,,,1,13886,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625420
,BAO_0000218,,,7415,,,,,1,13887,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626996
,BAO_0000218,,,7415,,1988.0,,,1,13888,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",Intermediate,Rattus norvegicus,1,10116.0,,Feces,50597,A,N,CHEMBL626997
,BAO_0000218,,,7415,,1088.0,,,1,13889,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626998
,BAO_0000218,,,7415,,,,,1,13890,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626999
,BAO_0000218,,,8050,,,,,1,13891,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627000
,BAO_0000218,,,8050,,,,,1,13892,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627001
,BAO_0000218,,,8050,,,,,1,13893,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627002
,BAO_0000218,,,8050,,,,,1,13894,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627003
,BAO_0000218,,,8050,,1088.0,,,1,13895,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,Intermediate,Mus musculus,1,10090.0,,Urine,50594,A,N,CHEMBL627004
,BAO_0000218,,,8050,,1088.0,,,1,13896,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,Intermediate,Mus musculus,1,10090.0,,Urine,50594,A,N,CHEMBL627005
,BAO_0000218,,,8050,,1088.0,,,1,13897,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,Intermediate,Mus musculus,1,10090.0,,Urine,50594,A,N,CHEMBL874594
,BAO_0000218,,,8050,,1088.0,,,1,13898,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,Intermediate,Mus musculus,1,10090.0,,Urine,50594,A,N,CHEMBL627006
,BAO_0000218,,,8050,,1088.0,,,1,13899,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,Intermediate,Mus musculus,1,10090.0,,Urine,50594,A,N,CHEMBL627007
,BAO_0000218,,,8050,,1088.0,,,1,13900,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,Intermediate,Mus musculus,1,10090.0,,Urine,50594,A,N,CHEMBL627884
,BAO_0000218,,,8050,,1088.0,,,1,13901,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,Intermediate,Mus musculus,1,10090.0,,Urine,50594,A,N,CHEMBL627885
,BAO_0000218,,,8050,,1088.0,,,1,13902,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,Intermediate,Mus musculus,1,10090.0,,Urine,50594,A,N,CHEMBL627886
,BAO_0000218,,,8050,,1088.0,,,1,13903,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,Intermediate,Mus musculus,1,10090.0,,Urine,50594,A,N,CHEMBL627887
,BAO_0000218,,,8050,,1088.0,,,1,13904,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,Intermediate,Mus musculus,1,10090.0,,Urine,50594,A,N,CHEMBL627888
,BAO_0000218,,,8050,,1088.0,,,1,13905,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,Intermediate,Mus musculus,1,10090.0,,Urine,50594,A,N,CHEMBL628057
,BAO_0000218,,,8050,,1088.0,,,1,13906,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,Intermediate,Mus musculus,1,10090.0,,Urine,50594,A,N,CHEMBL627405
,BAO_0000218,,,12582,,1088.0,,,1,13907,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627406
,BAO_0000218,,,12582,,1088.0,,,1,13908,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627407
,BAO_0000218,,,12582,,1088.0,,,1,13909,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627408
,BAO_0000218,,,12582,,1088.0,,,1,13910,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627409
,BAO_0000218,,,12582,,1088.0,,,1,13911,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL875486
,BAO_0000218,,,12582,,1088.0,,,1,13912,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627410
,BAO_0000218,,,12582,,1088.0,,,1,13913,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627411
,BAO_0000218,,,12582,,1088.0,,,1,13914,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627412
,BAO_0000218,,,12582,,1088.0,,,1,13915,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627413
,BAO_0000218,,,12582,,1088.0,,,1,13916,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627414
,BAO_0000218,,,12582,,1088.0,,,1,13917,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627415
,BAO_0000218,,,12582,,1088.0,,,1,13918,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627416
,BAO_0000218,,,12582,,1088.0,,,1,13919,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627417
,BAO_0000218,,,12582,,1088.0,,,1,13920,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627418
,BAO_0000218,,,12582,,1088.0,,,1,13921,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627419
,BAO_0000218,,,12582,,1088.0,,,1,13922,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627320
,BAO_0000218,,,12582,,1088.0,,,1,13923,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627321
,BAO_0000218,,In vivo,12017,,2113.0,,,1,13924,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627322
,BAO_0000218,,In vivo,12017,,2113.0,,,1,13925,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627323
,BAO_0000218,,In vivo,12017,,2113.0,,,1,13926,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627491
,BAO_0000218,,In vivo,12017,,2113.0,,,1,13927,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627492
,BAO_0000218,,In vivo,12017,,2113.0,,,1,13928,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL627493
,BAO_0000218,,In vivo,12017,,2107.0,,,1,13929,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627494
,BAO_0000218,,In vivo,12017,,2107.0,,,1,13930,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627495
,BAO_0000218,,In vivo,12017,,2107.0,,,1,13931,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627496
,BAO_0000218,,In vivo,12017,,2107.0,,,1,13932,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627497
,BAO_0000218,,In vivo,12017,,2107.0,,,1,13933,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL627498
,BAO_0000218,,In vivo,12017,,2048.0,,,1,13934,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627499
,BAO_0000218,,In vivo,12017,,2048.0,,,1,13935,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627500
,BAO_0000218,,In vivo,12017,,2048.0,,,1,13936,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627501
,BAO_0000218,,In vivo,12017,,2048.0,,,1,13937,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625616
,BAO_0000218,,In vivo,12017,,2048.0,,,1,13938,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625617
,BAO_0000218,,In vivo,12017,,2385.0,,,1,13939,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL625618
,BAO_0000218,,In vivo,12017,,2385.0,,,1,13940,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL625619
,BAO_0000218,,In vivo,12017,,2385.0,,,1,13941,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL625620
,BAO_0000218,,In vivo,12017,,2385.0,,,1,13942,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL625621
,BAO_0000218,,In vivo,12017,,2385.0,,,1,13943,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL625622
,BAO_0000218,,In vivo,12017,,2106.0,,,1,13944,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625788
,BAO_0000218,,In vivo,12017,,2106.0,,,1,13945,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625789
,BAO_0000218,,In vivo,12017,,2106.0,,,1,13946,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625790
,BAO_0000218,,In vivo,12017,,2106.0,,,1,13947,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625791
,BAO_0000218,,In vivo,12017,,2106.0,,,1,13948,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL622334
,BAO_0000218,,In vivo,12017,,2046.0,,,1,13949,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622335
,BAO_0000218,,In vivo,12017,,2046.0,,,1,13950,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622336
,BAO_0000218,,In vivo,12017,,2046.0,,,1,13951,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622337
,BAO_0000218,,In vivo,12017,,2046.0,,,1,13952,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622338
,BAO_0000218,,In vivo,12017,,2046.0,,,1,13953,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL622339
,BAO_0000218,,In vivo,12017,,,,,1,13954,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL624153
,BAO_0000218,,In vivo,12017,,,,,1,13955,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628430
,BAO_0000218,,In vivo,12017,,,,,1,13956,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628431
,BAO_0000218,,In vivo,12017,,,,,1,13957,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628432
,BAO_0000218,,In vivo,12017,,,,,1,13958,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628433
,BAO_0000218,,In vivo,12017,,2106.0,,,1,13959,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL628434
,BAO_0000218,,In vivo,12017,,2106.0,,,1,13960,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL626789
,BAO_0000218,,In vivo,12017,,2106.0,,,1,13961,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL626790
,BAO_0000218,,In vivo,12017,,2106.0,,,1,13962,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL626791
,BAO_0000218,,In vivo,12017,,2106.0,,,1,13963,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL626792
,BAO_0000218,,In vivo,12017,,2106.0,,,1,13964,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL626793
,BAO_0000218,,,11510,,,,,1,13965,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627436
,BAO_0000218,,,11510,,,,,1,13966,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627437
,BAO_0000218,,,11510,,,,,1,13967,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627438
,BAO_0000218,,,11510,,,,,1,13968,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627439
,BAO_0000218,,,11510,,,,,1,13969,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627440
,BAO_0000218,,,11510,,,,,1,13970,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627602
,BAO_0000218,,,11510,,,,,1,13971,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627603
,BAO_0000218,,,11510,,,,,1,13972,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627604
,BAO_0000218,,,11510,,,,,1,13973,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627605
,BAO_0000218,,,11510,,,,,1,13974,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627606
,BAO_0000218,,,11510,,,,,1,13975,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627607
,BAO_0000218,,,11510,,,,,1,13976,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627608
,BAO_0000218,,,11510,,,,,1,13977,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627609
,BAO_0000218,,,11510,,,,,1,13978,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627610
,BAO_0000218,,,11510,,,,,1,13979,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627611
,BAO_0000218,,,11510,,,,,1,13980,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627612
,BAO_0000100,,,8362,,,,,0,13981,,Octanol:water partition coefficient is evaluated,Autocuration,,1,,,,22229,P,U,CHEMBL627613
,BAO_0000100,,,8257,,,,,0,13982,,Partition coefficient in 1-octanol/water system,Autocuration,,1,,,,22224,P,U,CHEMBL627614
,BAO_0000100,,,8257,,,,,0,13983,,Partition coefficient in 1-octanol/water system measured using radio active compounds,Autocuration,,1,,,,22224,P,U,CHEMBL627615
,BAO_0000100,,,9468,,,,,0,13984,,Partition coefficient in octanol/water system was determined,Autocuration,,1,,,,22224,P,U,CHEMBL627616
,BAO_0000100,,,9468,,,,,0,13985,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,Autocuration,,1,,,,22224,P,U,CHEMBL627617
,BAO_0000019,,,10568,,,,,0,13986,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,Autocuration,,1,,,,22224,A,U,CHEMBL627618
,BAO_0000019,,,10568,,,,,0,13987,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",Autocuration,,1,,,,22224,A,U,CHEMBL627619
,BAO_0000019,,,15359,,,,,0,13988,,Pseudo-first-order rate constant of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL627620
,BAO_0000019,,,15359,,,,,0,13989,,Pseudo-first-order rate constant with 1-min time point,Autocuration,,1,,,,22224,A,U,CHEMBL627621
,BAO_0000019,,,15359,,,,,0,13990,,Pseudo-first-order rate constant without 1-min time point,Autocuration,,1,,,,22224,A,U,CHEMBL627622
,BAO_0000019,,,10431,,,,,0,13991,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,Autocuration,,1,,,,22224,A,U,CHEMBL627623
,BAO_0000019,,,10431,,,,,0,13992,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,Autocuration,,1,,,,22224,A,U,CHEMBL627624
,BAO_0000019,,,10431,,,,,0,13993,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,Autocuration,,1,,,,22224,A,U,CHEMBL627625
,BAO_0000019,,,15704,,,,,0,13994,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,Autocuration,,1,,,,22224,A,U,CHEMBL628523
,BAO_0000019,,,15287,,,,,0,13995,,The alkaline hydrolysis second order rate constant(K OH) of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL628524
,BAO_0000019,,,7516,,,,,0,13996,,The efflux rate constant of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL628525
,BAO_0000019,,,12973,,,,,0,13997,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,Autocuration,,1,,,,22224,A,U,CHEMBL625732
,BAO_0000019,,,12973,,,,,0,13998,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,Autocuration,,1,,,,22224,A,U,CHEMBL625733
,BAO_0000019,,,12973,,,,,0,13999,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,Autocuration,,1,,,,22224,F,U,CHEMBL625734
,BAO_0000019,,,12973,,,,,0,14000,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,Autocuration,,1,,,,22224,A,U,CHEMBL625913
,BAO_0000019,,,8696,,,,,0,14001,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,Autocuration,,1,,,,22224,A,U,CHEMBL625914
,BAO_0000019,,,15052,,,,,0,14002,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,Autocuration,,1,,,,22224,A,U,CHEMBL625915
,BAO_0000019,,,15052,,,,,0,14003,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,Autocuration,,1,,,,22224,A,U,CHEMBL625916
,BAO_0000019,,,10503,,,,,0,14004,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),Autocuration,,1,,,,22224,A,U,CHEMBL625917
,BAO_0000019,,,8354,,,,,0,14005,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL625918
,BAO_0000019,,,8354,,,,,0,14006,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL625919
,BAO_0000019,,,8354,,,,,0,14007,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL625920
,BAO_0000019,,,8354,,,,,0,14008,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL874453
,BAO_0000019,,,8354,,,,,0,14009,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL625921
,BAO_0000019,,,10503,,,,,0,14010,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,Autocuration,,1,,,,22224,A,U,CHEMBL625922
,BAO_0000019,,,8354,,,,,0,14011,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL625923
,BAO_0000019,,,8354,,,,,0,14012,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL625924
,BAO_0000019,,,8354,,,,,0,14013,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL625925
,BAO_0000019,,,8354,,,,,0,14014,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL625926
,BAO_0000218,,In vivo,13100,,2048.0,,,1,14015,,Biodistribution in rat lung at 60 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL627704
,BAO_0000218,,In vivo,13100,,,,,1,14016,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627705
,BAO_0000218,,In vivo,13100,,,,,1,14017,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627706
,BAO_0000218,,In vivo,13100,,,,,1,14018,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627707
,BAO_0000218,,In vivo,13100,,,,,1,14019,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627708
,BAO_0000218,,In vivo,13100,,,,,1,14020,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628361
,BAO_0000218,,In vivo,13100,,,,,1,14021,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628362
,BAO_0000218,,In vivo,13100,,2435.0,,,1,14022,,Biodistribution in rat striatum at 120 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL628363
,BAO_0000218,,In vivo,13100,,2435.0,,,1,14023,,Biodistribution in rat striatum at 1440 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL628364
,BAO_0000218,,In vivo,13100,,2435.0,,,1,14024,,Biodistribution in rat striatum at 15 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL628365
,BAO_0000218,,In vivo,13100,,2435.0,,,1,14025,,Biodistribution in rat striatum at 240 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL874454
,BAO_0000218,,In vivo,13100,,2435.0,,,1,14026,,Biodistribution in rat striatum at 30 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL628531
,BAO_0000218,,In vivo,13100,,2435.0,,,1,14027,,Biodistribution in rat striatum at 360 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL628532
,BAO_0000218,,In vivo,13100,,2435.0,,,1,14028,,Biodistribution in rat striatum at 3 hr after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL628533
,BAO_0000218,,In vivo,13100,,2435.0,,,1,14029,,Biodistribution in rat striatum at 60 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Striatum,50597,A,N,CHEMBL628534
,BAO_0000218,,In vivo,13100,,2046.0,,,1,14030,,Biodistribution in rat thyroid at 120 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL628535
,BAO_0000218,,In vivo,13100,,2046.0,,,1,14031,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL628536
,BAO_0000218,,In vivo,13100,,2046.0,,,1,14032,,Biodistribution in rat thyroid at 15 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL628537
,BAO_0000218,,In vivo,13100,,2046.0,,,1,14033,,Biodistribution in rat thyroid at 240 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL628538
,BAO_0000218,,In vivo,13100,,2046.0,,,1,14034,,Biodistribution in rat thyroid at 30 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL628539
,BAO_0000218,,In vivo,13100,,2046.0,,,1,14035,,Biodistribution in rat thyroid at 360 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL630297
,BAO_0000218,,In vivo,13100,,2046.0,,,1,14036,,Biodistribution in rat thyroid at 60 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL630298
,BAO_0000218,,In vivo,13100,,955.0,,,1,14037,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL630299
,BAO_0000218,,In vivo,13100,,955.0,,,1,14038,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL628094
,BAO_0000218,,In vivo,13100,,955.0,,,1,14039,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL628095
,BAO_0000218,,In vivo,13100,,955.0,,,1,14040,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL874648
,BAO_0000218,,In vivo,13100,,955.0,,,1,14041,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL628096
,BAO_0000218,,In vivo,13100,,955.0,,,1,14042,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL628097
,BAO_0000218,,In vivo,13100,,955.0,,,1,14043,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL628098
,BAO_0000019,,,13331,,,,,0,14044,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",Autocuration,,1,,,,22224,A,U,CHEMBL628099
,BAO_0000019,,,13331,,,,,0,14045,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",Autocuration,,1,,,,22224,A,U,CHEMBL628100
,BAO_0000019,,,13331,,,,,0,14046,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),Autocuration,,1,,,,22224,A,U,CHEMBL628101
,BAO_0000019,,,13331,,,,,0,14047,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",Autocuration,,1,,,,22224,A,U,CHEMBL628102
,BAO_0000019,,,13331,,,,,0,14048,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",Autocuration,,1,,,,22224,A,U,CHEMBL628103
,BAO_0000019,,,13331,,,,,0,14049,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",Autocuration,,1,,,,22224,A,U,CHEMBL628104
,BAO_0000019,,,13331,,,,,0,14050,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",Autocuration,,1,,,,22224,A,U,CHEMBL628105
,BAO_0000019,,,13331,,,,,0,14051,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",Autocuration,,1,,,,22224,A,U,CHEMBL628106
,BAO_0000218,,,10086,,1088.0,,,1,14052,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628107
,BAO_0000218,,,10086,,1088.0,,,0,14053,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Autocuration,,1,,,Urine,22224,F,U,CHEMBL628108
,BAO_0000218,,,10086,,1088.0,,,1,14054,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628109
,BAO_0000218,,,10086,,1088.0,,,0,14055,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Autocuration,,1,,,Urine,22224,F,U,CHEMBL625299
,BAO_0000218,,,10086,,1088.0,,,1,14056,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625300
,BAO_0000218,,,10086,,1088.0,,,1,14057,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625301
,BAO_0000218,,,10086,,1088.0,,,1,14058,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625302
,BAO_0000218,,,10086,,1088.0,,,1,14059,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL874649
,BAO_0000218,,,13248,,,,,1,14060,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625303
,BAO_0000218,,,13248,,,,,1,14061,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625463
,BAO_0000218,,,14527,,2107.0,,,1,14062,,In vitro metabolism in human liver microsomes,Intermediate,Homo sapiens,1,9606.0,,Liver,50587,A,N,CHEMBL625464
,BAO_0000218,,,3008,,,,,1,14063,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL625465
,BAO_0000218,,,12582,,1088.0,,,1,14064,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL625466
,BAO_0000218,,,12582,,1088.0,,,1,14065,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL625467
,BAO_0000218,,,12582,,1088.0,,,1,14066,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625468
,BAO_0000218,,,12582,,1088.0,,,1,14067,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625469
,BAO_0000218,,,12582,,1088.0,,,1,14068,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625470
,BAO_0000218,,,12582,,1088.0,,,1,14069,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL632418
,BAO_0000218,,,12582,,1088.0,,,1,14070,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL627250
,BAO_0000218,,,12582,,1088.0,,,1,14071,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL627251
,BAO_0000218,,,12582,,1088.0,,,1,14072,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL627252
,BAO_0000218,,,12582,,1088.0,,,1,14073,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL627253
,BAO_0000218,,,12582,,1088.0,,,1,14074,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL627254
,BAO_0000218,,,12582,,1088.0,,,1,14075,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL875471
,BAO_0000218,,,12582,,1088.0,,,1,14076,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL627255
,BAO_0000218,,,12582,,1088.0,,,1,14077,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL627256
,BAO_0000218,,,12582,,1088.0,,,1,14078,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL627257
,BAO_0000218,,,12582,,1088.0,,,1,14079,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL627258
,BAO_0000218,,,12582,,1088.0,,,1,14080,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL627259
,BAO_0000218,,,12582,,1088.0,,,1,14081,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL627260
,BAO_0000218,,,12582,,1088.0,,,1,14082,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623256
,BAO_0000218,,,12582,,1088.0,,,1,14083,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL874413
,BAO_0000218,,,12582,,1088.0,,,1,14084,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623257
,BAO_0000218,,,12582,,1088.0,,,1,14085,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623258
,BAO_0000218,,,12582,,1088.0,,,1,14086,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623259
,BAO_0000218,,,12582,,1088.0,,,1,14087,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623260
,BAO_0000218,,,12582,,1088.0,,,1,14088,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623261
,BAO_0000218,,,12582,,1088.0,,,1,14089,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623262
,BAO_0000218,,,12582,,1088.0,,,1,14090,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623263
,BAO_0000218,,,12582,,1088.0,,,1,14091,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623264
,BAO_0000218,,,12582,,1088.0,,,1,14092,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623265
,BAO_0000218,,,12582,,1088.0,,,1,14093,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623266
,BAO_0000218,,,12582,,1088.0,,,1,14094,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623267
,BAO_0000218,,,12582,,1088.0,,,1,14095,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623268
,BAO_0000218,,,12582,,1088.0,,,1,14096,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623269
,BAO_0000218,,,12582,,1088.0,,,1,14097,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623270
,BAO_0000218,,,12582,,1088.0,,,1,14098,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623271
,BAO_0000218,,,12582,,1088.0,,,1,14099,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623272
,BAO_0000218,,,12582,,1088.0,,,1,14100,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623273
,BAO_0000218,,,12582,,1088.0,,,1,14101,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623274
,BAO_0000218,,,12582,,1088.0,,,1,14102,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL874414
,BAO_0000218,,,12582,,1088.0,,,1,14103,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623275
,BAO_0000218,,,12582,,1088.0,,,1,14104,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629150
,BAO_0000218,,,12582,,1088.0,,,1,14105,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623276
,BAO_0000218,,,12582,,1088.0,,,1,14106,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623277
,BAO_0000218,,,12582,,1088.0,,,1,14107,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623112
,BAO_0000218,,,12582,,1088.0,,,1,14108,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623113
,BAO_0000218,,,12582,,1088.0,,,1,14109,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623800
,BAO_0000218,,,12582,,1088.0,,,1,14110,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623801
,BAO_0000218,,In vivo,12017,,2106.0,,,1,14111,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL623802
,BAO_0000218,,In vivo,12017,,995.0,,,1,14112,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL623803
,BAO_0000218,,In vivo,12017,,995.0,,,1,14113,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL623970
,BAO_0000218,,In vivo,12017,,995.0,,,1,14114,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Uterus,50597,A,N,CHEMBL623971
,BAO_0000218,,In vivo,14045,,178.0,,,1,14115,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL623972
,BAO_0000218,,In vivo,14045,,178.0,,,1,14116,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL623973
,BAO_0000218,,In vivo,14045,,178.0,,,1,14117,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL623974
,BAO_0000218,,In vivo,14045,,178.0,,,1,14118,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL623975
,BAO_0000218,,In vivo,14045,,955.0,,,1,14119,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL623976
,BAO_0000218,,In vivo,14045,,955.0,,,1,14120,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL623977
,BAO_0000218,,In vivo,14045,,955.0,,,1,14121,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL623978
,BAO_0000218,,In vivo,14045,,955.0,,,1,14122,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL623979
,BAO_0000218,,In vivo,14045,,,,,1,14123,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623980
,BAO_0000218,,In vivo,14045,,,,,1,14124,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL623981
,BAO_0000218,,In vivo,14045,,,,,1,14125,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626278
,BAO_0000218,,In vivo,14045,,,,,1,14126,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626279
,BAO_0000218,,In vivo,14045,,,,,1,14127,,Biodistribution in mice bladder plus excreted urine was determined,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626280
,BAO_0000218,,,14045,,,,,1,14128,,"Percentage biodistribution in mouse blood, 10 minutes post injection",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626281
,BAO_0000218,,,14045,,,,,1,14129,,"Percentage biodistribution in mouse blood, 30 minutes post injection",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626282
,BAO_0000218,,,14045,,,,,1,14130,,"Percentage biodistribution in mouse blood, 5 minutes post injection",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626283
,BAO_0000218,,,14045,,,,,1,14131,,"Percentage biodistribution in mouse blood, 60 minutes post injection",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626284
,BAO_0000218,,,14045,,955.0,,,1,14132,,"Percentage biodistribution in mouse brain, 10 minutes post injection",Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL626285
,BAO_0000218,,,14045,,955.0,,,1,14133,,"Percentage biodistribution in mouse brain, 30 minutes post injection",Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL626286
,BAO_0000218,,,14045,,955.0,,,1,14134,,"Percentage biodistribution in mouse brain, 5 minutes post injection",Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL626287
,BAO_0000218,,,14045,,955.0,,,1,14135,,"Percentage biodistribution in mouse brain, 60 minutes post injection",Intermediate,Mus musculus,1,10090.0,,Brain,50594,A,N,CHEMBL626288
,BAO_0000218,,,14045,,,,,1,14136,,"Percentage biodistribution in mouse heart, 10 minutes post injection",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626289
,BAO_0000218,,,14045,,,,,1,14137,,"Percentage biodistribution in mouse heart, 30 minutes post injection",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626290
,BAO_0000218,,,14045,,,,,1,14138,,"Percentage biodistribution in mouse heart, 5 minutes post injection",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL626291
,BAO_0000218,,,14045,,,,,1,14139,,"Percentage biodistribution in mouse heart, 60 minutes post injection",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL839888
,BAO_0000218,,,14045,,160.0,,,1,14140,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",Intermediate,Mus musculus,1,10090.0,,Intestine,50594,A,N,CHEMBL626292
,BAO_0000218,,,14045,,160.0,,,1,14141,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",Intermediate,Mus musculus,1,10090.0,,Intestine,50594,A,N,CHEMBL626293
,BAO_0000218,,,14045,,160.0,,,1,14142,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",Intermediate,Mus musculus,1,10090.0,,Intestine,50594,A,N,CHEMBL626294
,BAO_0000218,,,14045,,160.0,,,1,14143,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",Intermediate,Mus musculus,1,10090.0,,Intestine,50594,A,N,CHEMBL626295
,BAO_0000218,,,14045,,2107.0,,,1,14144,,"Percentage biodistribution in mouse liver, 10 minutes post injection",Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL627659
,BAO_0000218,,,14045,,2107.0,,,1,14145,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL627660
,BAO_0000218,,,14045,,2107.0,,,1,14146,,"Percentage biodistribution in mouse liver, 5 minutes post injection",Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL627661
,BAO_0000218,,In vivo,14045,,2107.0,,,1,14147,,Biodistribution in mice liver at 60 minutes of post injection,Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL627662
,BAO_0000218,,In vivo,14045,,2048.0,,,1,14148,,Biodistribution in mice lungs at 10 min of post injection,Intermediate,Mus musculus,1,10090.0,,Lung,50594,A,N,CHEMBL627663
,BAO_0000218,,,14045,,,,,1,14149,,"Percentage biodistribution in mouse lung, 30 minutes post injection",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627664
,BAO_0000218,,,14045,,,,,1,14150,,"Percentage biodistribution in mousee lung, 5 minutes post injection",Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL627665
,BAO_0000218,,In vivo,14045,,2048.0,,,1,14151,,Biodistribution in mice lungs at 60 min of post injection,Intermediate,Mus musculus,1,10090.0,,Lung,50594,A,N,CHEMBL627666
,BAO_0000218,,,14045,,2106.0,,,1,14152,,Percentage biodistribution in mouse spleen,Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL627667
,BAO_0000218,,,14045,,945.0,,,1,14153,,Percentage biodistribution in mouse stomach,Intermediate,Mus musculus,1,10090.0,,Stomach,50594,A,N,CHEMBL627668
,BAO_0000218,,,11745,,1088.0,,,1,14154,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,Intermediate,Mus musculus,1,10090.0,,Urine,50594,A,N,CHEMBL627669
,BAO_0000218,,In vivo,13257,,1255.0,,,0,14155,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,Autocuration,,1,,,Urinary bladder,22224,A,U,CHEMBL627670
,BAO_0000218,,In vivo,13257,,178.0,,,0,14156,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,Autocuration,,1,,,Blood,22224,A,U,CHEMBL627671
,BAO_0000218,,In vivo,13257,,1474.0,,,0,14157,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,Autocuration,,1,,,Bone element,22224,A,U,CHEMBL627672
,BAO_0000218,,In vivo,13257,,,,,0,14158,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,Autocuration,,1,,,,22224,A,U,CHEMBL627673
,BAO_0000218,,In vivo,13257,,2113.0,,,0,14159,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,Autocuration,,1,,,Kidney,22224,A,U,CHEMBL627674
,BAO_0000218,,In vivo,13257,,2107.0,,,0,14160,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,Autocuration,,1,,,Liver,22224,A,U,CHEMBL627675
,BAO_0000218,,In vivo,13257,,2048.0,,,0,14161,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,Autocuration,,1,,,Lung,22224,A,U,CHEMBL627676
,BAO_0000218,,In vivo,13257,,2385.0,,,0,14162,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL627677
,BAO_0000019,,,8354,,,,,0,14163,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL627678
,BAO_0000218,,,7095,,1977.0,,,1,14164,,Affinity for protein binding expressed as association constant in fresh rat serum,Intermediate,Rattus norvegicus,1,10116.0,,Serum,50597,A,N,CHEMBL627679
,BAO_0000019,,,12185,,,,,0,14165,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,Autocuration,,1,,,,22224,A,U,CHEMBL627680
,BAO_0000019,,,12185,,,,,0,14166,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,Autocuration,,1,,,,22224,A,U,CHEMBL627681
,BAO_0000019,,,12185,,,,,0,14167,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,Autocuration,,1,,,,22224,A,U,CHEMBL627682
,BAO_0000019,,,12185,,,,,0,14168,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,Autocuration,,1,,,,22224,A,U,CHEMBL627683
,BAO_0000019,,,12686,,,,,0,14169,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,Autocuration,,1,,,,22224,A,U,CHEMBL627684
,BAO_0000019,,,12686,,,,,0,14170,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",Autocuration,,1,,,,22224,A,U,CHEMBL874441
,BAO_0000019,,,12686,,,,,0,14171,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,Autocuration,,1,,,,22224,A,U,CHEMBL627685
,BAO_0000019,,,12686,,,,,0,14172,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",Autocuration,,1,,,,22224,A,U,CHEMBL627686
,BAO_0000019,,,8057,,,,,0,14173,,Apparent rate constant Koff for inactivation of dTMP synthase.,Autocuration,,1,,,,22224,A,U,CHEMBL627687
,BAO_0000019,,,15778,,,,,0,14174,,The irreversible inhibitor activity by second order rate equation.,Autocuration,,1,,,,22224,A,U,CHEMBL627688
,BAO_0000218,,,12375,,,,,1,14175,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628038
,BAO_0000218,,,12375,,,,,1,14176,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628039
,BAO_0000218,,,12375,,,,,1,14177,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628040
,BAO_0000019,,,13588,,,,,0,14178,,Dissociation rate calculated from the first-order equation using t1/2 value,Autocuration,,1,,,,22224,A,U,CHEMBL628041
,BAO_0000019,,,15039,,,,,0,14179,,The compound was tested for Binding constant against DNA,Autocuration,,1,,,,22224,A,U,CHEMBL630226
,BAO_0000019,,,9500,,,,,0,14180,,First order rate constant for cyclization of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL628042
,BAO_0000019,,,10014,,,,,0,14181,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,Autocuration,,1,,,,22224,A,U,CHEMBL625232
,BAO_0000019,,,10014,,,,,0,14182,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,Autocuration,,1,,,,22224,A,U,CHEMBL625233
,BAO_0000019,,,568,,,,,0,14183,,Hydrolysis rate constant was determined,Autocuration,,1,,,,22224,A,U,CHEMBL625979
,BAO_0000019,,,10026,,,,,0,14184,,Observed first order rate constant,Autocuration,,1,,,,22224,A,U,CHEMBL625980
,BAO_0000019,,,10281,,,,,0,14185,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,Autocuration,,1,,,,22224,A,U,CHEMBL625981
,BAO_0000019,,,10281,,,,,0,14186,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,Autocuration,,1,,,,22224,A,U,CHEMBL625982
,BAO_0000019,,,9680,,,,,0,14187,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,Autocuration,,1,,,,22224,A,U,CHEMBL625983
,BAO_0000019,,,13028,,,,,0,14188,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL625984
,BAO_0000019,,,13028,,,,,0,14189,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL625985
,BAO_0000019,,,13028,,,,,0,14190,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL625986
,BAO_0000019,,,13028,,,,,0,14191,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL625987
,BAO_0000019,,,13028,,,,,0,14192,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL625988
,BAO_0000019,,,13028,,,,,0,14193,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL625989
,BAO_0000019,,,13028,,,,,0,14194,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL625990
,BAO_0000019,,,13028,,,,,0,14195,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL625991
,BAO_0000019,,,13028,,,,,0,14196,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL625992
,BAO_0000019,,,13028,,,,,0,14197,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL625993
,BAO_0000019,,,13028,,,,,0,14198,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL631973
,BAO_0000019,,,13028,,,,,0,14199,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL632143
,BAO_0000019,,,13028,,,,,0,14200,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL632144
,BAO_0000019,,,13028,,,,,0,14201,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL632145
,BAO_0000019,,,13028,,,,,0,14202,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL632146
,BAO_0000019,,,13028,,,,,0,14203,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL632147
,BAO_0000019,,,13028,,,,,0,14204,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL632148
,BAO_0000019,,,13028,,,,,0,14205,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL632149
,BAO_0000019,,,13028,,,,,0,14206,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL632150
,BAO_0000019,,,13028,,,,,0,14207,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL632151
,BAO_0000218,,,3008,,,,,1,14208,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL632152
,BAO_0000218,,,4509,,,,,1,14209,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL632153
,BAO_0000218,,,4509,,,,,1,14210,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL632154
,BAO_0000218,,,8613,,,,,1,14211,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL632155
,BAO_0000218,,,8613,,,,,1,14212,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL632156
,BAO_0000218,,,8613,,,,,1,14213,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL632157
,BAO_0000218,,,8613,,,,,1,14214,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL632158
,BAO_0000218,,,8613,,,,,1,14215,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL632159
,BAO_0000218,,,8613,,,,,1,14216,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL626305
,BAO_0000218,,,8613,,,,,1,14217,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL626306
,BAO_0000218,,,8613,,,,,1,14218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL626307
,BAO_0000218,,,8613,,,,,1,14219,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL626308
,BAO_0000218,,,8613,,,,,1,14220,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL626479
,BAO_0000218,,,8613,,,,,1,14221,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,Intermediate,Human herpesvirus 1,1,10298.0,,,50602,A,N,CHEMBL626480
,BAO_0000100,,,6021,,,,,0,14222,,Calculated partition coefficient (clogP) (MlogP),Autocuration,,1,,,,22229,P,U,CHEMBL626481
,BAO_0000019,,,9348,,,,,0,14223,,Equipotent potent ratio relative to carbachol (nicotinic activity),Autocuration,,1,,,,22224,A,U,CHEMBL626482
,BAO_0000218,,,15592,,,,,1,14224,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626483
,BAO_0000218,,,15592,,,,,1,14225,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL626484
,BAO_0000100,,,15592,,,,,0,14226,,Solubility at pH 7.4 in micro g/mL;NA denotes available,Autocuration,,1,,,,22229,P,U,CHEMBL626485
,BAO_0000100,,,15592,,,,,0,14227,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,Autocuration,,1,,,,22229,P,U,CHEMBL626486
,BAO_0000100,,,15592,,,,,0,14228,,Solubility at pH 7.4 in ug/mL;NA denotes not available,Autocuration,,1,,,,22229,P,U,CHEMBL626487
,BAO_0000218,,In vivo,15592,,1969.0,,,1,14229,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Intermediate,Canis lupus familiaris,1,9615.0,,Plasma,50588,A,N,CHEMBL626488
,BAO_0000218,,,7095,,1977.0,,,1,14230,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,Intermediate,Rattus norvegicus,1,10116.0,,Serum,50597,A,N,CHEMBL626489
,BAO_0000019,,,16618,,,,,0,14231,,Area under the MAP curve measured over 5 min; ND means Not determined,Autocuration,,1,,,,22224,A,U,CHEMBL626490
,BAO_0000100,,,16835,,,,,0,14232,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,Autocuration,,1,,,,22224,P,U,CHEMBL626491
,BAO_0000100,,,15284,,,,,0,14233,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,Autocuration,,1,,,,22229,P,U,CHEMBL626492
,BAO_0000019,,,15750,,,,,0,14234,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,Autocuration,,1,,,,22224,A,U,CHEMBL626493
,BAO_0000218,,In vivo,16618,,,,,1,14235,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626494
,BAO_0000218,,In vivo,16618,,,,,0,14236,,Half life after oral tested,Autocuration,,1,,,,22224,A,U,CHEMBL626495
,BAO_0000218,,,15812,,1969.0,,,1,14237,,Half life was determined in plasma of rat; NT indicates not tested,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626496
,BAO_0000218,,In vivo,16618,,,,,1,14238,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626497
,BAO_0000218,,In vivo,16618,,,,,0,14239,,Oral bioavailability after oral tested,Autocuration,,1,,,,22224,A,U,CHEMBL626498
,BAO_0000218,,,13098,,,,,1,14240,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626499
,BAO_0000218,,,13098,,,,,1,14241,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626500
,BAO_0000218,,,15812,,1969.0,,,1,14242,,half life was determined in plasma of rat; NT indicates not tested,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626501
,BAO_0000218,,,15812,,1969.0,,,1,14243,,half life was determined in plasma of rat; NT means not tested,Intermediate,Rattus norvegicus,1,10116.0,,Plasma,50597,A,N,CHEMBL626502
,BAO_0000218,,,11510,,,,,1,14244,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626503
,BAO_0000218,,,11510,,,,,1,14245,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626504
,BAO_0000218,,,11510,,,,,1,14246,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626505
,BAO_0000218,,,11510,,,,,1,14247,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626506
,BAO_0000218,,,11510,,,,,1,14248,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626507
,BAO_0000218,,,11510,,,,,1,14249,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626508
,BAO_0000218,,,11510,,,,,1,14250,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626509
,BAO_0000218,,,11510,,,,,1,14251,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875480
,BAO_0000218,,,11510,,,,,1,14252,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626510
,BAO_0000218,,,11510,,,,,1,14253,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626511
,BAO_0000218,,,11510,,,,,1,14254,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL626512
,BAO_0000218,,,11510,,,,,1,14255,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628208
,BAO_0000218,,,11510,,,,,1,14256,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628209
,BAO_0000218,,,11510,,,,,1,14257,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628210
,BAO_0000218,,,11510,,,,,1,14258,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628211
,BAO_0000218,,,11510,,,,,1,14259,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628212
,BAO_0000218,,,11510,,,,,1,14260,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628213
,BAO_0000218,,,12582,,1088.0,,,1,14261,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628214
,BAO_0000218,,,12582,,1088.0,,,1,14262,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628215
,BAO_0000218,,,12582,,1088.0,,,1,14263,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628216
,BAO_0000218,,,12582,,1088.0,,,1,14264,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626595
,BAO_0000218,,,12582,,1088.0,,,1,14265,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626596
,BAO_0000218,,,12582,,1088.0,,,1,14266,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626597
,BAO_0000218,,,12582,,1088.0,,,1,14267,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626598
,BAO_0000218,,,12582,,1088.0,,,1,14268,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL622242
,BAO_0000218,,,12582,,1088.0,,,1,14269,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL622243
,BAO_0000218,,,12582,,1088.0,,,1,14270,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL622244
,BAO_0000218,,,12582,,1088.0,,,1,14271,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL622245
,BAO_0000218,,,12582,,1088.0,,,1,14272,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL622246
,BAO_0000218,,,12582,,1088.0,,,1,14273,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL622247
,BAO_0000218,,,12582,,1088.0,,,1,14274,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL622248
,BAO_0000218,,,12582,,1088.0,,,1,14275,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL877483
,BAO_0000218,,,12582,,1088.0,,,1,14276,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL622249
,BAO_0000218,,,12582,,1088.0,,,1,14277,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622250
,BAO_0000218,,,12582,,1088.0,,,1,14278,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622251
,BAO_0000218,,,12582,,1088.0,,,1,14279,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622252
,BAO_0000218,,,12582,,1088.0,,,1,14280,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622253
,BAO_0000218,,,12582,,1088.0,,,1,14281,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622254
,BAO_0000218,,,12582,,1088.0,,,1,14282,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622255
,BAO_0000218,,,12582,,1088.0,,,1,14283,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622256
,BAO_0000218,,,12582,,1088.0,,,1,14284,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622257
,BAO_0000218,,,12582,,1088.0,,,1,14285,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622258
,BAO_0000218,,,12582,,1088.0,,,1,14286,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622259
,BAO_0000218,,,12582,,1088.0,,,1,14287,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622927
,BAO_0000218,,,12582,,1088.0,,,1,14288,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622928
,BAO_0000218,,,12582,,1088.0,,,1,14289,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL622929
,BAO_0000218,,,12582,,1088.0,,,1,14290,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL623182
,BAO_0000218,,,12582,,1088.0,,,1,14291,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL623183
,BAO_0000218,,,12582,,1088.0,,,1,14292,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623184
,BAO_0000218,,,12582,,1088.0,,,1,14293,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623185
,BAO_0000218,,,12582,,1088.0,,,1,14294,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL877484
,BAO_0000218,,,12582,,1088.0,,,1,14295,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL627274
,BAO_0000218,,,12582,,1088.0,,,1,14296,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623186
,BAO_0000218,,,12582,,1088.0,,,1,14297,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623187
,BAO_0000218,,,12582,,1088.0,,,1,14298,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL623188
,BAO_0000218,,,12582,,1088.0,,,1,14299,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628055
,BAO_0000218,,,12582,,1088.0,,,1,14300,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628056
,BAO_0000218,,,12582,,1088.0,,,1,14301,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628200
,BAO_0000218,,,12582,,1088.0,,,1,14302,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628201
,BAO_0000218,,,12582,,1088.0,,,1,14303,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628202
,BAO_0000218,,,12582,,1088.0,,,1,14304,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628203
,BAO_0000218,,,12582,,1088.0,,,1,14305,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628204
,BAO_0000218,,,12582,,1088.0,,,1,14306,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628205
,BAO_0000218,,,12582,,1088.0,,,1,14307,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628206
,BAO_0000218,,In vivo,13257,,2367.0,,,0,14308,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),Autocuration,,1,,,Prostate gland,22224,A,U,CHEMBL628207
,BAO_0000218,,In vivo,13257,,2367.0,,,0,14309,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,Autocuration,,1,,,Prostate gland,22224,A,U,CHEMBL627220
,BAO_0000218,,In vivo,13257,,2385.0,,,0,14310,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL627221
,BAO_0000218,,In vivo,13257,,2367.0,,,0,14311,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),Autocuration,,1,,,Prostate gland,22224,A,U,CHEMBL627222
,BAO_0000218,,In vivo,13257,,,,,0,14312,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,Autocuration,,1,,,,22224,A,U,CHEMBL627223
,BAO_0000218,,In vivo,13257,,2385.0,,,0,14313,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL632062
,BAO_0000218,,In vivo,13257,,2106.0,,,0,14314,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,Autocuration,,1,,,Spleen,22224,A,U,CHEMBL632063
,BAO_0000218,,In vivo,13257,,1255.0,,,0,14315,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,Autocuration,,1,,,Urinary bladder,22224,A,U,CHEMBL632064
,BAO_0000218,,In vivo,13257,,178.0,,,0,14316,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,Autocuration,,1,,,Blood,22224,A,U,CHEMBL632065
,BAO_0000218,,In vivo,13257,,1474.0,,,0,14317,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,Autocuration,,1,,,Bone element,22224,A,U,CHEMBL632066
,BAO_0000218,,In vivo,13257,,,,,0,14318,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,Autocuration,,1,,,,22224,A,U,CHEMBL632067
,BAO_0000218,,In vivo,13257,,2113.0,,,0,14319,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,Autocuration,,1,,,Kidney,22224,A,U,CHEMBL629188
,BAO_0000218,,In vivo,13257,,2107.0,,,0,14320,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,Autocuration,,1,,,Liver,22224,A,U,CHEMBL629189
,BAO_0000218,,In vivo,13257,,2048.0,,,0,14321,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,Autocuration,,1,,,Lung,22224,A,U,CHEMBL629190
,BAO_0000218,,In vivo,13257,,2385.0,,,0,14322,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL629191
,BAO_0000218,,In vivo,13257,,2367.0,,,0,14323,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),Autocuration,,1,,,Prostate gland,22224,A,U,CHEMBL629192
,BAO_0000218,,In vivo,13257,,2385.0,,,0,14324,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL629193
,BAO_0000218,,In vivo,13257,,2367.0,,,0,14325,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),Autocuration,,1,,,Prostate gland,22224,A,U,CHEMBL629194
,BAO_0000218,,In vivo,13257,,,,,0,14326,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,Autocuration,,1,,,,22224,A,U,CHEMBL629195
,BAO_0000218,,In vivo,13257,,2385.0,,,0,14327,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL629373
,BAO_0000218,,In vivo,13257,,2106.0,,,0,14328,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,Autocuration,,1,,,Spleen,22224,A,U,CHEMBL629374
,BAO_0000218,,In vivo,13257,,2367.0,,,0,14329,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,Autocuration,,1,,,Prostate gland,22224,A,U,CHEMBL629375
,BAO_0000218,,In vivo,13257,,1255.0,,,0,14330,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,Autocuration,,1,,,Urinary bladder,22224,A,U,CHEMBL629376
,BAO_0000218,,In vivo,13257,,178.0,,,0,14331,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,Autocuration,,1,,,Blood,22224,A,U,CHEMBL629377
,BAO_0000218,,In vivo,13257,,1474.0,,,0,14332,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,Autocuration,,1,,,Bone element,22224,A,U,CHEMBL629378
,BAO_0000218,,In vivo,13257,,,,,0,14333,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,Autocuration,,1,,,,22224,A,U,CHEMBL629379
,BAO_0000218,,In vivo,13257,,2113.0,,,0,14334,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,Autocuration,,1,,,Kidney,22224,A,U,CHEMBL629151
,BAO_0000218,,In vivo,13257,,2107.0,,,0,14335,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,Autocuration,,1,,,Liver,22224,A,U,CHEMBL629152
,BAO_0000218,,In vivo,13257,,2048.0,,,0,14336,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,Autocuration,,1,,,Lung,22224,A,U,CHEMBL629153
,BAO_0000218,,In vivo,13257,,2385.0,,,0,14337,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL629154
,BAO_0000218,,In vivo,13257,,2367.0,,,0,14338,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),Autocuration,,1,,,Prostate gland,22224,A,U,CHEMBL629155
,BAO_0000218,,In vivo,13257,,2367.0,,,0,14339,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,Autocuration,,1,,,Prostate gland,22224,A,U,CHEMBL629156
,BAO_0000218,,In vivo,13257,,2385.0,,,0,14340,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL629157
,BAO_0000218,,In vivo,13257,,2367.0,,,0,14341,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),Autocuration,,1,,,Prostate gland,22224,A,U,CHEMBL629158
,BAO_0000218,,In vivo,13257,,,,,0,14342,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,Autocuration,,1,,,,22224,A,U,CHEMBL629159
,BAO_0000218,,In vivo,13257,,2385.0,,,0,14343,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL629160
,BAO_0000218,,In vivo,13257,,2106.0,,,0,14344,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,Autocuration,,1,,,Spleen,22224,A,U,CHEMBL629161
,BAO_0000218,,In vivo,13257,,1255.0,,,0,14345,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,Autocuration,,1,,,Urinary bladder,22224,A,U,CHEMBL629162
,BAO_0000218,,In vivo,13257,,178.0,,,0,14346,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,Autocuration,,1,,,Blood,22224,A,U,CHEMBL629163
,BAO_0000218,,In vivo,13257,,1474.0,,,0,14347,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,Autocuration,,1,,,Bone element,22224,A,U,CHEMBL629164
,BAO_0000218,,In vivo,13257,,,,,0,14348,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,Autocuration,,1,,,,22224,A,U,CHEMBL629165
,BAO_0000218,,In vivo,13257,,2107.0,,,0,14349,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,Autocuration,,1,,,Liver,22224,A,U,CHEMBL629166
,BAO_0000218,,In vivo,13257,,2048.0,,,0,14350,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,Autocuration,,1,,,Lung,22224,A,U,CHEMBL629167
,BAO_0000218,,In vivo,13257,,2385.0,,,0,14351,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL629168
,BAO_0000019,,,2193,,,,,0,14352,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,Autocuration,,1,,,,22224,A,U,CHEMBL629169
,BAO_0000019,,,2193,,,,,0,14353,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,Autocuration,,1,,,,22224,A,U,CHEMBL629170
,BAO_0000019,,,2193,,,,,0,14354,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,Autocuration,,1,,,,22224,A,U,CHEMBL631153
,BAO_0000019,,,2193,,,,,0,14355,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,Autocuration,,1,,,,22224,A,U,CHEMBL875121
,BAO_0000019,,,2193,,,,,0,14356,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,Autocuration,,1,,,,22224,A,U,CHEMBL631154
,BAO_0000019,,,2193,,,,,0,14357,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,Autocuration,,1,,,,22224,A,U,CHEMBL631155
,BAO_0000019,,,568,,,,,0,14358,,Hydrolysis rate constant was determined,Autocuration,,1,,,,22224,A,U,CHEMBL631156
,BAO_0000019,,,9680,,,,,0,14359,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",Autocuration,,1,,,,22224,A,U,CHEMBL631157
,BAO_0000019,,,9680,,,,,0,14360,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",Autocuration,,1,,,,22224,A,U,CHEMBL631158
,BAO_0000019,,,9680,,,,,0,14361,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",Autocuration,,1,,,,22224,A,U,CHEMBL631159
,BAO_0000019,,,10026,,,,,0,14362,,Observed second order rate constant,Autocuration,,1,,,,22224,A,U,CHEMBL631160
,BAO_0000019,,,10281,,,,,0,14363,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,Autocuration,,1,,,,22224,A,U,CHEMBL631161
,BAO_0000019,,,10014,,,,,0,14364,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,Autocuration,,1,,,,22224,A,U,CHEMBL631162
,BAO_0000019,,,10014,,,,,0,14365,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,Autocuration,,1,,,,22224,A,U,CHEMBL630313
,BAO_0000019,,,9680,,,,,0,14366,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",Autocuration,,1,,,,22224,A,U,CHEMBL630314
,BAO_0000019,,,9680,,,,,0,14367,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",Autocuration,,1,,,,22224,A,U,CHEMBL630315
,BAO_0000019,,,13028,,,,,0,14368,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL630316
,BAO_0000019,,,13028,,,,,0,14369,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL630986
,BAO_0000019,,,13028,,,,,0,14370,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL630987
,BAO_0000019,,,13028,,,,,0,14371,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL630988
,BAO_0000019,,,13028,,,,,0,14372,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL630989
,BAO_0000019,,,13028,,,,,0,14373,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL630990
,BAO_0000019,,,13028,,,,,0,14374,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL630991
,BAO_0000019,,,13028,,,,,0,14375,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL630992
,BAO_0000019,,,13028,,,,,0,14376,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL630993
,BAO_0000019,,,13028,,,,,0,14377,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,1,,,,22224,A,U,CHEMBL630994
,BAO_0000218,,,10014,,,,,1,14378,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630995
,BAO_0000019,,,9962,,,,,0,14379,,Association constant for compound at 31 degree C was determined,Autocuration,,1,,,,22224,A,U,CHEMBL629252
,BAO_0000019,,,12029,,,,,0,14380,,Calculated antagonist equilibrium dissociation constant of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL629253
,BAO_0000019,,,12029,,,,,0,14381,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,Autocuration,,1,,,,22224,A,U,CHEMBL629944
,BAO_0000218,,,10583,,3126.0,,,1,14382,,Dissociation constants vs LTE4 on guinea pig trachea,Intermediate,Cavia porcellus,1,10141.0,,Trachea,50512,A,N,CHEMBL629945
,BAO_0000019,,,568,,,,,0,14383,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",Autocuration,,1,,,,22224,A,U,CHEMBL629946
,BAO_0000019,,,568,,,,,0,14384,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",Autocuration,,1,,,,22224,A,U,CHEMBL629947
,BAO_0000019,,,568,,,,,0,14385,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",Autocuration,,1,,,,22224,A,U,CHEMBL629948
,BAO_0000019,,,568,,,,,0,14386,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",Autocuration,,1,,,,22224,A,U,CHEMBL856024
,BAO_0000019,,,7493,,,,,0,14387,,Affinity constant KD value was derived from TMP,Autocuration,,1,,,,22224,A,U,CHEMBL629949
,BAO_0000019,,,8371,,,,,0,14388,,Apparent dissociation (binding) rate constant was evaluated,Autocuration,,1,,,,22224,A,U,CHEMBL629950
,BAO_0000100,,,13114,,,,,0,14389,,Dissociation constant (KD) of the compound,Autocuration,,1,,,,22224,P,U,CHEMBL630127
,BAO_0000100,,,15515,,,,,0,14390,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,Autocuration,,1,,,,22224,P,U,CHEMBL630128
,BAO_0000100,,,522,,,,,0,14391,,Dissociation constant from ESR titration experiments,Autocuration,,1,,,,22224,P,U,CHEMBL630129
,BAO_0000019,,,13888,,,,,0,14392,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),Autocuration,,1,,,,22224,,U,CHEMBL630130
,BAO_0000100,,,2616,,,,,0,14393,,Dissociation constant was evaluated.,Autocuration,,1,,,,22224,P,U,CHEMBL875234
,BAO_0000100,,,3798,,,,,0,14394,,Dissociation constant was reported,Autocuration,,1,,,,22224,P,U,CHEMBL630131
,BAO_0000218,,,8731,,,,,1,14395,,Dissociation constant was determined in rat pituitary cells.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630132
,BAO_0000019,,,11892,,,,,0,14396,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,Autocuration,,1,,,,22224,A,U,CHEMBL630133
,BAO_0000019,,,11892,,,,,0,14397,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,Autocuration,,1,,,,22224,A,U,CHEMBL630134
,BAO_0000019,,,2582,,,,,0,14398,,Equilibrium dissociation constant of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL630135
,BAO_0000019,,,11892,,,,,0,14399,,Equilibrium dissociation constant was determined,Autocuration,,1,,,,22224,A,U,CHEMBL630136
,BAO_0000019,,,13396,,,,,0,14400,,Kinetic constant KD was evaluated,Autocuration,,1,,,,22224,A,U,CHEMBL630137
,BAO_0000019,,,603,,,,,0,14401,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,Autocuration,,1,,,,22224,A,U,CHEMBL630138
,BAO_0000019,,,15673,,,,,0,14402,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,Autocuration,,1,,,,22224,A,U,CHEMBL630139
,BAO_0000019,,,10368,,,,,0,14403,,Rate constant for hydrolysis in aqueous acetone.,Autocuration,,1,,,,22224,A,U,CHEMBL630140
,BAO_0000019,,,14228,,,,,0,14404,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,Autocuration,,1,,,,22224,A,U,CHEMBL875235
,BAO_0000218,,,11510,,,,,1,14405,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876439
,BAO_0000218,,,11510,,,,,1,14406,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630605
,BAO_0000218,,,11510,,,,,1,14407,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630606
,BAO_0000218,,,11510,,,,,1,14408,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630607
,BAO_0000218,,,11510,,,,,1,14409,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630608
,BAO_0000218,,,11510,,,,,1,14410,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630609
,BAO_0000218,,,11510,,,,,1,14411,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630610
,BAO_0000218,,,11510,,,,,1,14412,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630611
,BAO_0000218,,,11510,,,,,1,14413,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629552
,BAO_0000218,,,11510,,,,,1,14414,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629733
,BAO_0000218,,,11510,,,,,1,14415,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629734
,BAO_0000218,,,11510,,,,,1,14416,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629735
,BAO_0000218,,,11510,,,,,1,14417,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629736
,BAO_0000218,,,11510,,,,,1,14418,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629737
,BAO_0000218,,,11510,,,,,1,14419,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629738
,BAO_0000218,,,11510,,,,,1,14420,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629739
,BAO_0000218,,,11510,,,,,1,14421,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629740
,BAO_0000218,,,11510,,,,,1,14422,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629741
,BAO_0000218,,,11510,,,,,1,14423,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629742
,BAO_0000218,,,11510,,,,,1,14424,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629743
,BAO_0000218,,,11510,,,,,1,14425,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629744
,BAO_0000218,,,11510,,,,,1,14426,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629745
,BAO_0000218,,,11510,,,,,1,14427,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629746
,BAO_0000218,,,11510,,,,,1,14428,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629747
,BAO_0000218,,,11510,,,,,1,14429,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629748
,BAO_0000218,,,11510,,,,,1,14430,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629749
,BAO_0000218,,,11510,,,,,1,14431,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629750
,BAO_0000218,,,11510,,,,,1,14432,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629751
,BAO_0000218,,,11510,,,,,1,14433,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629752
,BAO_0000218,,,11510,,,,,1,14434,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629753
,BAO_0000218,,,11510,,,,,1,14435,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629754
,BAO_0000218,,,11510,,,,,1,14436,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629755
,BAO_0000218,,,11510,,,,,1,14437,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629756
,BAO_0000218,,,11510,,,,,1,14438,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629757
,BAO_0000218,,,11510,,,,,1,14439,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629758
,BAO_0000218,,,11510,,,,,1,14440,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629759
,BAO_0000218,,,11510,,,,,1,14441,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL629760
,BAO_0000218,,,11510,,,,,1,14442,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876443
,BAO_0000218,,,8310,,,,,1,14443,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL629761
,BAO_0000218,,,8310,,,,,1,14444,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL629762
,BAO_0000218,,,8310,,,,,1,14445,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629763
,BAO_0000218,,,8310,,,,,1,14446,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629764
,BAO_0000218,,,8310,,,,,1,14447,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629765
,BAO_0000218,,,8310,,,,,1,14448,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629766
,BAO_0000218,,,8310,,,,,1,14449,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629767
,BAO_0000218,,,8310,,,,,1,14450,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL629768
,BAO_0000218,,,8310,,,,,1,14451,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629769
,BAO_0000218,,,8310,,,,,1,14452,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL629770
,BAO_0000218,,,8310,,,,,1,14453,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,Intermediate,Canis lupus familiaris,1,9615.0,,,50588,A,N,CHEMBL629771
,BAO_0000218,,,8310,,,,,1,14454,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629772
,BAO_0000218,,,8310,,,,,1,14455,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL629773
,BAO_0000218,,,8310,,,,,1,14456,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625455
,BAO_0000218,,,8310,,,,,1,14457,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625456
,BAO_0000218,,,8310,,,,,1,14458,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL625457
,BAO_0000218,,,12582,,1088.0,,,1,14459,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625458
,BAO_0000218,,,12582,,1088.0,,,1,14460,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625459
,BAO_0000218,,,12582,,1088.0,,,1,14461,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL875483
,BAO_0000218,,,12582,,1088.0,,,1,14462,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL634779
,BAO_0000218,,,12582,,1088.0,,,1,14463,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625460
,BAO_0000218,,,12582,,1088.0,,,1,14464,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626117
,BAO_0000218,,,12582,,1088.0,,,1,14465,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626118
,BAO_0000218,,,12582,,1088.0,,,1,14466,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628342
,BAO_0000218,,,12582,,1088.0,,,1,14467,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628343
,BAO_0000218,,,12582,,1088.0,,,1,14468,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628344
,BAO_0000218,,,12582,,1088.0,,,1,14469,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628345
,BAO_0000218,,,12582,,1088.0,,,1,14470,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628346
,BAO_0000218,,,12582,,1088.0,,,1,14471,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628347
,BAO_0000218,,,12582,,1088.0,,,1,14472,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628348
,BAO_0000218,,,12582,,1088.0,,,1,14473,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628349
,BAO_0000218,,,12582,,1088.0,,,1,14474,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL875611
,BAO_0000218,,,12582,,1088.0,,,1,14475,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628350
,BAO_0000218,,,12582,,1088.0,,,1,14476,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628351
,BAO_0000218,,,12582,,1088.0,,,1,14477,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628352
,BAO_0000218,,,12582,,1088.0,,,1,14478,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628353
,BAO_0000218,,,12582,,1088.0,,,1,14479,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628354
,BAO_0000218,,,12582,,1088.0,,,1,14480,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626667
,BAO_0000218,,,12582,,1088.0,,,1,14481,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626668
,BAO_0000218,,,12582,,1088.0,,,1,14482,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626669
,BAO_0000218,,,12582,,1088.0,,,1,14483,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626670
,BAO_0000218,,,12582,,1088.0,,,1,14484,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626671
,BAO_0000218,,,12582,,1088.0,,,1,14485,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626672
,BAO_0000218,,,12582,,1088.0,,,1,14486,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626673
,BAO_0000218,,,12582,,1088.0,,,1,14487,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626674
,BAO_0000218,,,12582,,1088.0,,,1,14488,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626675
,BAO_0000218,,,12582,,1088.0,,,1,14489,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626676
,BAO_0000218,,,12582,,1088.0,,,1,14490,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626677
,BAO_0000218,,,12582,,1088.0,,,1,14491,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626678
,BAO_0000218,,,12582,,1088.0,,,1,14492,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626679
,BAO_0000218,,,12582,,1088.0,,,1,14493,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL875612
,BAO_0000218,,,12582,,1088.0,,,1,14494,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626680
,BAO_0000218,,,12582,,1088.0,,,1,14495,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626681
,BAO_0000218,,,12582,,1088.0,,,1,14496,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626682
,BAO_0000218,,,12582,,1088.0,,,1,14497,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626683
,BAO_0000218,,,12582,,1088.0,,,1,14498,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626684
,BAO_0000218,,,12582,,1088.0,,,1,14499,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626685
,BAO_0000218,,,12582,,1088.0,,,1,14500,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626686
,BAO_0000218,,,12582,,1088.0,,,1,14501,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626687
,BAO_0000218,,,12582,,1088.0,,,1,14502,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL624978
,BAO_0000218,,,12582,,1088.0,,,1,14503,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL624979
,BAO_0000218,,,12582,,1088.0,,,1,14504,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL624980
,BAO_0000218,,,12582,,1088.0,,,1,14505,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL624981
,BAO_0000218,,,12582,,1088.0,,,1,14506,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL624982
,BAO_0000218,,In vivo,13257,,2367.0,,,0,14507,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),Autocuration,,1,,,Prostate gland,22224,A,U,CHEMBL627564
,BAO_0000218,,In vivo,13257,,2367.0,,,0,14508,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),Autocuration,,1,,,Prostate gland,22224,A,U,CHEMBL627565
,BAO_0000218,,In vivo,13257,,,,,0,14509,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,Autocuration,,1,,,,22224,A,U,CHEMBL627566
,BAO_0000218,,In vivo,13257,,2385.0,,,0,14510,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL627567
,BAO_0000218,,In vivo,13257,,2106.0,,,0,14511,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,Autocuration,,1,,,Spleen,22224,A,U,CHEMBL627568
,BAO_0000218,,In vivo,13257,,2113.0,,,0,14512,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,Autocuration,,1,,,Kidney,22224,A,U,CHEMBL627569
,BAO_0000218,,In vivo,13257,,1255.0,,,0,14513,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,Autocuration,,1,,,Urinary bladder,22224,A,U,CHEMBL627570
,BAO_0000218,,In vivo,13257,,178.0,,,0,14514,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,Autocuration,,1,,,Blood,22224,A,U,CHEMBL627571
,BAO_0000218,,In vivo,13257,,1474.0,,,0,14515,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,Autocuration,,1,,,Bone element,22224,A,U,CHEMBL627572
,BAO_0000218,,In vivo,13257,,,,,0,14516,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,Autocuration,,1,,,,22224,A,U,CHEMBL627573
,BAO_0000218,,In vivo,13257,,2113.0,,,0,14517,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,Autocuration,,1,,,Kidney,22224,A,U,CHEMBL627574
,BAO_0000218,,In vivo,13257,,2107.0,,,0,14518,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,Autocuration,,1,,,Liver,22224,A,U,CHEMBL627575
,BAO_0000218,,In vivo,13257,,2048.0,,,0,14519,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,Autocuration,,1,,,Lung,22224,A,U,CHEMBL627576
,BAO_0000218,,In vivo,13257,,2385.0,,,0,14520,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL627577
,BAO_0000218,,In vivo,13257,,2367.0,,,0,14521,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),Autocuration,,1,,,Prostate gland,22224,A,U,CHEMBL627578
,BAO_0000218,,In vivo,13257,,2367.0,,,0,14522,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,Autocuration,,1,,,Prostate gland,22224,A,U,CHEMBL627579
,BAO_0000218,,In vivo,13257,,2385.0,,,0,14523,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL627580
,BAO_0000218,,In vivo,13257,,2367.0,,,0,14524,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),Autocuration,,1,,,Prostate gland,22224,A,U,CHEMBL627581
,BAO_0000218,,In vivo,13257,,,,,0,14525,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,Autocuration,,1,,,,22224,A,U,CHEMBL627582
,BAO_0000218,,In vivo,13257,,2385.0,,,0,14526,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL627583
,BAO_0000218,,In vivo,13257,,2106.0,,,0,14527,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,Autocuration,,1,,,Spleen,22224,A,U,CHEMBL627584
,BAO_0000218,,In vivo,13257,,2367.0,,,0,14528,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,Autocuration,,1,,,Prostate gland,22224,A,U,CHEMBL627585
,BAO_0000218,,In vivo,13257,,2385.0,,,0,14529,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,Autocuration,,1,,,Muscle tissue,22224,A,U,CHEMBL627586
,BAO_0000218,,In vivo,15413,,,,,1,14530,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627587
,BAO_0000218,,In vivo,15413,,,,,1,14531,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL627588
,BAO_0000218,,In vivo,15413,,,,,1,14532,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628250
,BAO_0000218,,In vivo,15413,,,,,1,14533,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628251
,BAO_0000218,,In vivo,15413,,10000000.0,,,1,14534,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL628252
,BAO_0000218,,In vivo,15413,,10000000.0,,,1,14535,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL628253
,BAO_0000218,,In vivo,15413,,1898.0,,,1,14536,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,Rattus norvegicus,1,10116.0,,Hypothalamus,50597,A,N,CHEMBL628254
,BAO_0000218,,In vivo,15413,,1898.0,,,1,14537,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,Rattus norvegicus,1,10116.0,,Hypothalamus,50597,A,N,CHEMBL877493
,BAO_0000218,,In vivo,15413,,,,,1,14538,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628255
,BAO_0000218,,In vivo,15413,,,,,1,14539,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628256
,BAO_0000218,,In vivo,15413,,10000000.0,,,1,14540,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL628257
,BAO_0000218,,In vivo,15413,,1898.0,,,1,14541,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,Rattus norvegicus,1,10116.0,,Hypothalamus,50597,A,N,CHEMBL628258
,BAO_0000218,,In vivo,15413,,,,,1,14542,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628259
,BAO_0000218,,In vivo,15413,,,,,1,14543,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628429
,BAO_0000218,,In vivo,15413,,10000000.0,,,1,14544,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL626862
,BAO_0000218,,In vivo,15413,,1898.0,,,1,14545,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,Hypothalamus,50597,A,N,CHEMBL626863
,BAO_0000218,,In vivo,15413,,2037.0,,,1,14546,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL625886
,BAO_0000218,,In vivo,15413,,2037.0,,,1,14547,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL625887
,BAO_0000218,,In vivo,15413,,,,,1,14548,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625888
,BAO_0000218,,In vivo,15413,,,,,1,14549,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625889
,BAO_0000218,,In vivo,15413,,10000000.0,,,1,14550,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL625890
,BAO_0000218,,In vivo,15413,,10000000.0,,,1,14551,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL625891
,BAO_0000218,,In vivo,15413,,1898.0,,,1,14552,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,Intermediate,Rattus norvegicus,1,10116.0,,Hypothalamus,50597,A,N,CHEMBL625892
,BAO_0000218,,In vivo,15413,,1898.0,,,1,14553,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,Intermediate,Rattus norvegicus,1,10116.0,,Hypothalamus,50597,A,N,CHEMBL625893
,BAO_0000218,,In vivo,15413,,2037.0,,,1,14554,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,Intermediate,Rattus norvegicus,1,10116.0,,Cerebellum,50597,A,N,CHEMBL625894
,BAO_0000218,,In vivo,15413,,,,,1,14555,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625895
,BAO_0000019,,,12404,,,,,0,14556,,Reaction rate parameter value for phosphate with transfer with respect to ATP,Autocuration,,1,,,,22224,A,U,CHEMBL625896
,BAO_0000019,,,568,,,,,0,14557,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",Autocuration,,1,,,,22224,A,U,CHEMBL625897
,BAO_0000019,,,568,,,,,0,14558,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",Autocuration,,1,,,,22224,A,U,CHEMBL625898
,BAO_0000019,,,568,,,,,0,14559,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",Autocuration,,1,,,,22224,A,U,CHEMBL625899
,BAO_0000019,,,12404,,,,,0,14560,,Reaction rate parameter value for phosphate with transfer with respect to ATP,Autocuration,,1,,,,22224,A,U,CHEMBL626124
,BAO_0000218,,,7624,,,,,1,14561,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,Intermediate,Escherichia coli,1,562.0,,,50212,A,N,CHEMBL628500
,BAO_0000218,,,7624,,,,,1,14562,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL857856
,BAO_0000218,,,7624,,,,,1,14563,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628501
,BAO_0000019,,,4643,,,,,0,14564,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",Autocuration,,1,,,,22224,A,U,CHEMBL628502
,BAO_0000019,,,11532,,,,,0,14565,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,Autocuration,,1,,,,22224,A,U,CHEMBL628503
,BAO_0000019,,,11018,,,,,0,14566,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,Autocuration,,1,,,,22224,A,U,CHEMBL628504
,BAO_0000019,,,2276,,,,,0,14567,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",Autocuration,,1,,,,22224,A,U,CHEMBL628505
,BAO_0000019,,,2276,,,,,0,14568,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",Autocuration,,1,,,,22224,A,U,CHEMBL874452
,BAO_0000019,,,2276,,,,,0,14569,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",Autocuration,,1,,,,22224,A,U,CHEMBL628506
,BAO_0000019,,,2276,,,,,0,14570,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",Autocuration,,1,,,,22224,A,U,CHEMBL628507
,BAO_0000019,,,2276,,,,,0,14571,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",Autocuration,,1,,,,22224,A,U,CHEMBL628508
,BAO_0000019,,,8949,,,,,0,14572,,Michaelis constant (KM) was evaluated,Autocuration,,1,,,,22224,A,U,CHEMBL628509
,BAO_0000019,,,12404,,,,,0,14573,,Reaction rate parameter value for phosphate with transfer with respect to ATP,Autocuration,,1,,,,22224,A,U,CHEMBL628510
,BAO_0000019,,,7625,,,,,0,14574,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,Autocuration,,1,,,,22224,B,U,CHEMBL628511
,BAO_0000019,,,7625,,,,,0,14575,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,Autocuration,,1,,,,22224,B,U,CHEMBL628512
,BAO_0000019,,,7625,,,,,0,14576,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,Autocuration,,1,,,,22224,B,U,CHEMBL628513
,BAO_0000019,,,7625,,,,,0,14577,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,Autocuration,,1,,,,22224,B,U,CHEMBL628514
,BAO_0000019,,,12908,,,,,0,14578,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,Autocuration,,1,,,,22224,A,U,CHEMBL628515
,BAO_0000019,,,10368,,,,,0,14579,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,Autocuration,,1,,,,22224,A,U,CHEMBL628516
,BAO_0000019,,,13108,,,,,0,14580,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),Autocuration,,1,,,,22224,A,U,CHEMBL628517
,BAO_0000019,,,13108,,,,,0,14581,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),Autocuration,,1,,,,22224,A,U,CHEMBL628518
,BAO_0000019,,,15217,,,,,0,14582,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,Autocuration,,1,,,,22224,A,U,CHEMBL628519
,BAO_0000019,,,15217,,,,,0,14583,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,Autocuration,,1,,,,22224,A,U,CHEMBL628520
,BAO_0000019,,,10933,,,,,0,14584,,Binding constant was determined,Autocuration,,1,,,,22224,A,U,CHEMBL628521
,BAO_0000019,,,2363,,,,,0,14585,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,Autocuration,,1,,,,22224,A,U,CHEMBL630443
,BAO_0000019,,,2363,,,,,0,14586,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,Autocuration,,1,,,,22224,A,U,CHEMBL630444
,BAO_0000019,,,2276,,,,,0,14587,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,Autocuration,,1,,,,22224,A,U,CHEMBL857732
,BAO_0000100,,,14915,,,,,0,14588,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,Autocuration,,1,,,,22224,P,U,CHEMBL630445
,BAO_0000019,,,8847,,,,,0,14589,,Catalytic rate constant of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL630446
,BAO_0000019,,,15357,,,,,0,14590,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,Autocuration,,1,,,,22224,B,U,CHEMBL630447
,BAO_0000019,,,2869,,,,,0,14591,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),Autocuration,,1,,,,22224,A,U,CHEMBL630448
,BAO_0000019,,,3484,,,,,0,14592,,Catalytic rate constant against phospholipase A2 was determined,Autocuration,,1,,,,22224,A,U,CHEMBL630449
,BAO_0000019,,,1373,,,,,0,14593,,"Compound was evaluated for catalytic constant, Kcat",Autocuration,,1,,,,22224,A,U,CHEMBL630450
,BAO_0000019,,,8142,,,,,0,14594,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,Autocuration,,1,,,,22224,A,U,CHEMBL630451
,BAO_0000019,,,14131,,,,,0,14595,,Kcat calculated from 0.693/T1/2,Autocuration,,1,,,,22224,A,U,CHEMBL630452
,BAO_0000019,,,17269,,,,,0,14596,,Kcat was determined,Autocuration,,1,,,,22224,A,U,CHEMBL630453
,BAO_0000019,,,3485,,,,,0,14597,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,Autocuration,,1,,,,22224,A,U,CHEMBL630454
,BAO_0000019,,,3485,,,,,0,14598,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,Autocuration,,1,,,,22224,A,U,CHEMBL630455
,BAO_0000019,,,3485,,,,,0,14599,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,Autocuration,,1,,,,22224,A,U,CHEMBL631487
,BAO_0000019,,,5962,,,,,0,14600,,Kcat value was determined,Autocuration,,1,,,,22224,A,U,CHEMBL631488
,BAO_0000019,,,3133,,,,,0,14601,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,Autocuration,,1,,,,22224,A,U,CHEMBL876440
,BAO_0000019,,,3133,,,,,0,14602,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,Autocuration,,1,,,,22224,A,U,CHEMBL631489
,BAO_0000019,,,2276,,,,,0,14603,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",Autocuration,,1,,,,22224,A,U,CHEMBL857742
,BAO_0000019,,,2276,,,,,0,14604,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",Autocuration,,1,,,,22224,A,U,CHEMBL631490
,BAO_0000019,,,2276,,,,,0,14605,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",Autocuration,,1,,,,22224,A,U,CHEMBL631491
,BAO_0000019,,,2276,,,,,0,14606,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",Autocuration,,1,,,,22224,A,U,CHEMBL631492
,BAO_0000019,,,2276,,,,,0,14607,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",Autocuration,,1,,,,22224,A,U,CHEMBL631493
,BAO_0000019,,,4892,,,,,0,14608,,Kinetic parameter for rate of conversion to PABA was determined,Autocuration,,1,,,,22224,A,U,CHEMBL631494
,BAO_0000019,,,3133,,,,,0,14609,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,Autocuration,,1,,,,22224,A,U,CHEMBL631495
,BAO_0000218,,,11488,,1988.0,,,1,14610,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Intermediate,Rattus norvegicus,1,10116.0,,Feces,50597,A,N,CHEMBL631496
,BAO_0000218,,,11488,,1088.0,,,1,14611,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631497
,BAO_0000218,,,11488,,1088.0,,,1,14612,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631498
,BAO_0000218,,,11488,,1088.0,,,1,14613,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629776
,BAO_0000218,,,11488,,1088.0,,,1,14614,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629777
,BAO_0000218,,,11488,,1088.0,,,1,14615,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL629778
,BAO_0000218,,,11488,,,,,1,14616,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630456
,BAO_0000218,,,11488,,,,,1,14617,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630457
,BAO_0000218,,,11488,,,,,1,14618,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630458
,BAO_0000218,,,11488,,,,,1,14619,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630459
,BAO_0000218,,,11488,,,,,1,14620,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630460
,BAO_0000218,,,11488,,,,,1,14621,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL876550
,BAO_0000218,,,11488,,,,,1,14622,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630461
,BAO_0000218,,,11488,,,,,1,14623,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630462
,BAO_0000218,,,11488,,,,,1,14624,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630463
,BAO_0000218,,,11488,,,,,1,14625,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630464
,BAO_0000218,,,11488,,,,,1,14626,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630465
,BAO_0000218,,,11488,,,,,1,14627,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630466
,BAO_0000218,,,11488,,,,,1,14628,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630467
,BAO_0000218,,,11488,,,,,1,14629,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630633
,BAO_0000218,,,11488,,,,,1,14630,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630634
,BAO_0000218,,,11488,,,,,1,14631,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630635
,BAO_0000218,,,11488,,,,,1,14632,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630636
,BAO_0000218,,,11488,,,,,1,14633,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630637
,BAO_0000218,,,7132,,1988.0,,,1,14634,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL630638
,BAO_0000218,,,7132,,1988.0,,,1,14635,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL630639
,BAO_0000218,,,7132,,1988.0,,,1,14636,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL630640
,BAO_0000218,,,7132,,1988.0,,,1,14637,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL876551
,BAO_0000218,,,7132,,1088.0,,,1,14638,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL630641
,BAO_0000218,,,7132,,1088.0,,,1,14639,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL630642
,BAO_0000218,,,7132,,1088.0,,,1,14640,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL630643
,BAO_0000218,,,7132,,1088.0,,,1,14641,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL630644
,BAO_0000218,,,7132,,1088.0,,,1,14642,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL630645
,BAO_0000218,,,7132,,1988.0,,,1,14643,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL625599
,BAO_0000218,,,7132,,1988.0,,,1,14644,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL625600
,BAO_0000218,,,7132,,1988.0,,,1,14645,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL625601
,BAO_0000218,,,7132,,1988.0,,,1,14646,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Feces,50592,A,N,CHEMBL625602
,BAO_0000218,,,7132,,1088.0,,,1,14647,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL627470
,BAO_0000218,,,7132,,1088.0,,,1,14648,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL627471
,BAO_0000218,,,7132,,1088.0,,,1,14649,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL627472
,BAO_0000218,,,7132,,1088.0,,,1,14650,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL627473
,BAO_0000218,,,7132,,1088.0,,,1,14651,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Intermediate,Oryctolagus cuniculus,1,9986.0,,Urine,50592,A,N,CHEMBL627474
,BAO_0000218,,In vivo,13925,,178.0,,,1,14652,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627475
,BAO_0000218,,In vivo,13925,,178.0,,,1,14653,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL627476
,BAO_0000218,,,12582,,1088.0,,,1,14654,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627477
,BAO_0000218,,,12582,,1088.0,,,1,14655,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627478
,BAO_0000218,,,12582,,1088.0,,,1,14656,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627479
,BAO_0000218,,,12582,,1088.0,,,1,14657,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627480
,BAO_0000218,,,12582,,1088.0,,,1,14658,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627481
,BAO_0000218,,,12582,,1088.0,,,1,14659,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627482
,BAO_0000218,,,12582,,1088.0,,,1,14660,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL627483
,BAO_0000218,,,12582,,1088.0,,,1,14661,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL875636
,BAO_0000218,,,12582,,1088.0,,,1,14662,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL625764
,BAO_0000218,,,12582,,1088.0,,,1,14663,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL625765
,BAO_0000218,,,12582,,1088.0,,,1,14664,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL625766
,BAO_0000218,,,12582,,1088.0,,,1,14665,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL625767
,BAO_0000218,,,12582,,1088.0,,,1,14666,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL625768
,BAO_0000218,,,12582,,1088.0,,,1,14667,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL625769
,BAO_0000218,,,12582,,1088.0,,,1,14668,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL625770
,BAO_0000218,,,12582,,1088.0,,,1,14669,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL625771
,BAO_0000218,,,12582,,1088.0,,,1,14670,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL625772
,BAO_0000218,,,12582,,1088.0,,,1,14671,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Intermediate,Canis lupus familiaris,1,9615.0,,Urine,50588,A,N,CHEMBL625773
,BAO_0000218,,,12582,,1088.0,,,1,14672,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625774
,BAO_0000218,,,12582,,1088.0,,,1,14673,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625775
,BAO_0000218,,,12582,,1088.0,,,1,14674,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625776
,BAO_0000218,,,12582,,1088.0,,,1,14675,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625777
,BAO_0000218,,,12582,,1088.0,,,1,14676,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625778
,BAO_0000218,,,12582,,1088.0,,,1,14677,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625779
,BAO_0000218,,,12582,,1088.0,,,1,14678,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625780
,BAO_0000218,,,12582,,1088.0,,,1,14679,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL625781
,BAO_0000218,,,12582,,1088.0,,,1,14680,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL875637
,BAO_0000218,,,12582,,1088.0,,,1,14681,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626473
,BAO_0000218,,,12582,,1088.0,,,1,14682,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626474
,BAO_0000218,,,12582,,1088.0,,,1,14683,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626475
,BAO_0000218,,,12582,,1088.0,,,1,14684,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626476
,BAO_0000218,,,12582,,1088.0,,,1,14685,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL634397
,BAO_0000218,,,12582,,1088.0,,,1,14686,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL626477
,BAO_0000218,,,12582,,1088.0,,,1,14687,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631069
,BAO_0000218,,,12582,,1088.0,,,1,14688,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631070
,BAO_0000218,,,12582,,1088.0,,,1,14689,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631071
,BAO_0000218,,,12582,,1088.0,,,1,14690,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631072
,BAO_0000218,,,12582,,1088.0,,,1,14691,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631073
,BAO_0000218,,,12582,,1088.0,,,1,14692,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631074
,BAO_0000218,,,12582,,1088.0,,,1,14693,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631075
,BAO_0000218,,,12582,,1088.0,,,1,14694,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631725
,BAO_0000218,,,12582,,1088.0,,,1,14695,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631726
,BAO_0000218,,,12582,,1088.0,,,1,14696,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631727
,BAO_0000218,,,12582,,1088.0,,,1,14697,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631728
,BAO_0000218,,,12582,,1088.0,,,1,14698,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631729
,BAO_0000218,,,12582,,1088.0,,,1,14699,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631730
,BAO_0000218,,,12582,,1088.0,,,1,14700,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631731
,BAO_0000218,,,12582,,1088.0,,,1,14701,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631910
,BAO_0000218,,In vivo,15413,,10000000.0,,,1,14702,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,Intermediate,Rattus norvegicus,1,10116.0,,Hippocampus,50597,A,N,CHEMBL631911
,BAO_0000218,,In vivo,15413,,1898.0,,,1,14703,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,Intermediate,Rattus norvegicus,1,10116.0,,Hypothalamus,50597,A,N,CHEMBL631912
,BAO_0000218,,In vivo,15413,,1898.0,,,1,14704,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,Intermediate,Rattus norvegicus,1,10116.0,,Hypothalamus,50597,A,N,CHEMBL631913
,BAO_0000218,,In vivo,12017,,178.0,,,1,14705,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631914
,BAO_0000218,,In vivo,12017,,178.0,,,1,14706,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631915
,BAO_0000218,,In vivo,12017,,178.0,,,1,14707,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL875778
,BAO_0000218,,In vivo,12017,,178.0,,,1,14708,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631916
,BAO_0000218,,In vivo,12017,,178.0,,,1,14709,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631917
,BAO_0000218,,In vivo,12017,,178.0,,,1,14710,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631918
,BAO_0000218,,In vivo,12017,,178.0,,,1,14711,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631919
,BAO_0000218,,In vivo,12017,,178.0,,,1,14712,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631920
,BAO_0000218,,In vivo,12017,,178.0,,,1,14713,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631921
,BAO_0000218,,In vivo,12017,,178.0,,,1,14714,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631922
,BAO_0000218,,In vivo,12017,,178.0,,,1,14715,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL631923
,BAO_0000218,,In vivo,12017,,,,,1,14716,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631924
,BAO_0000218,,In vivo,12017,,,,,1,14717,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630234
,BAO_0000218,,In vivo,12017,,,,,1,14718,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630235
,BAO_0000218,,In vivo,12017,,,,,1,14719,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630236
,BAO_0000218,,In vivo,12017,,,,,1,14720,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630237
,BAO_0000218,,In vivo,12017,,,,,1,14721,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630238
,BAO_0000218,,In vivo,12017,,,,,1,14722,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630239
,BAO_0000218,,In vivo,12017,,,,,1,14723,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630303
,BAO_0000218,,In vivo,12017,,,,,1,14724,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630304
,BAO_0000218,,In vivo,12017,,,,,1,14725,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630305
,BAO_0000218,,In vivo,12017,,2113.0,,,1,14726,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL630306
,BAO_0000218,,In vivo,12017,,2113.0,,,1,14727,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL630307
,BAO_0000218,,In vivo,12017,,2113.0,,,1,14728,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL630308
,BAO_0000218,,In vivo,12017,,2113.0,,,1,14729,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL630309
,BAO_0000218,,In vivo,12017,,2113.0,,,1,14730,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL629309
,BAO_0000218,,In vivo,12017,,2113.0,,,1,14731,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL629993
,BAO_0000218,,In vivo,12017,,2113.0,,,1,14732,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL629994
,BAO_0000218,,In vivo,12017,,2113.0,,,1,14733,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL629995
,BAO_0000218,,In vivo,12017,,2113.0,,,1,14734,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL631993
,BAO_0000218,,In vivo,12017,,2113.0,,,1,14735,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL631994
,BAO_0000218,,In vivo,12017,,2113.0,,,1,14736,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL631995
,BAO_0000218,,In vivo,12017,,2107.0,,,1,14737,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL631996
,BAO_0000218,,In vivo,12017,,2107.0,,,1,14738,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL631997
,BAO_0000218,,In vivo,12017,,2107.0,,,1,14739,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL631998
,BAO_0000218,,In vivo,12017,,2107.0,,,1,14740,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL631999
,BAO_0000218,,In vivo,12017,,2107.0,,,1,14741,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL632000
,BAO_0000218,,In vivo,12017,,2107.0,,,1,14742,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL632001
,BAO_0000218,,In vivo,12017,,2107.0,,,1,14743,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL874424
,BAO_0000218,,In vivo,12017,,2107.0,,,1,14744,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL632002
,BAO_0000218,,In vivo,12017,,2107.0,,,1,14745,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL632003
,BAO_0000019,,,3133,,,,,0,14746,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,Autocuration,,1,,,,22224,A,U,CHEMBL632004
,BAO_0000019,,,2742,,,,,0,14747,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,Autocuration,,1,,,,22224,A,U,CHEMBL632005
,BAO_0000019,,,2742,,,,,0,14748,,Compound was tested for amidase rate in the presence of N62C screen enzyme,Autocuration,,1,,,,22224,A,U,CHEMBL632006
,BAO_0000019,,,2742,,,,,0,14749,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,Autocuration,,1,,,,22224,A,U,CHEMBL632007
,BAO_0000019,,,2742,,,,,0,14750,,Compound was tested for amidase rate in the presence of S166C screen enzyme,Autocuration,,1,,,,22224,A,U,CHEMBL632008
,BAO_0000019,,,2742,,,,,0,14751,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,Autocuration,,1,,,,22224,A,U,CHEMBL632009
,BAO_0000019,,,2742,,,,,0,14752,,Compound was tested for esterase rate in the presence of N62C screen enzyme,Autocuration,,1,,,,22224,A,U,CHEMBL632010
,BAO_0000019,,,2742,,,,,0,14753,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,Autocuration,,1,,,,22224,A,U,CHEMBL857750
,BAO_0000019,,,2742,,,,,0,14754,,Compound was tested for esterase rate in the presence of S166C screen enzyme,Autocuration,,1,,,,22224,A,U,CHEMBL632011
,BAO_0000019,,,2276,,,,,0,14755,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,,1,,,,22224,A,U,CHEMBL632012
,BAO_0000019,,,2276,,,,,0,14756,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,,1,,,,22224,A,U,CHEMBL632013
,BAO_0000019,,,2276,,,,,0,14757,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",Autocuration,,1,,,,22224,A,U,CHEMBL632014
,BAO_0000019,,,2276,,,,,0,14758,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,,1,,,,22224,A,U,CHEMBL629622
,BAO_0000019,,,2276,,,,,0,14759,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,,1,,,,22224,A,U,CHEMBL629623
,BAO_0000019,,,2276,,,,,0,14760,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",Autocuration,,1,,,,22224,A,U,CHEMBL629624
,BAO_0000019,,,17269,,,,,0,14761,,Ratio of Kcat to that of Km was determined,Autocuration,,1,,,,22224,A,U,CHEMBL629625
,BAO_0000019,,,2276,,,,,0,14762,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",Autocuration,,1,,,,22224,A,U,CHEMBL629626
,BAO_0000019,,,2276,,,,,0,14763,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",Autocuration,,1,,,,22224,A,U,CHEMBL629627
,BAO_0000019,,,15917,,,,,0,14764,,"Compound was evaluated for constant, Kd",Autocuration,,1,,,,22224,A,U,CHEMBL629628
,BAO_0000019,,,10933,,,,,0,14765,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,Autocuration,,1,,,,22224,A,U,CHEMBL629629
,BAO_0000019,,,10933,,,,,0,14766,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,Autocuration,,1,,,,22224,A,U,CHEMBL629630
,BAO_0000019,,,14293,,,,,0,14767,,Dissociation Constant of compound determined,Autocuration,,1,,,,22224,A,U,CHEMBL856030
,BAO_0000019,,,6698,,,,,0,14768,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,Autocuration,,1,,,,22224,B,U,CHEMBL629631
,BAO_0000019,,,6698,,,,,0,14769,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,Autocuration,,1,,,,22224,B,U,CHEMBL629632
,BAO_0000100,,,4318,,,,,0,14770,,Dissociation constant of compound with Fructose was determined,Autocuration,,1,,,,22224,P,U,CHEMBL629633
,BAO_0000100,,,4318,,,,,0,14771,,Dissociation constant of compound with Fructose was determined; Not determined,Autocuration,,1,,,,22224,P,U,CHEMBL629634
,BAO_0000100,,,4318,,,,,0,14772,,Dissociation constant of compound with Lactulose was determined,Autocuration,,1,,,,22224,P,U,CHEMBL629635
,BAO_0000100,,,4318,,,,,0,14773,,Dissociation constant of compound with Lactulose was determined; Not determined,Autocuration,,1,,,,22224,P,U,CHEMBL629636
,BAO_0000100,,,14959,,,,,0,14774,,Dissociation constant of the Compound,Autocuration,,1,,,,22224,P,U,CHEMBL629637
,BAO_0000100,,,5913,,,,,0,14775,,Dissociation constant by non-linear regression analysis,Autocuration,,1,,,,22224,P,U,CHEMBL629638
,BAO_0000100,,,14218,,,,,0,14776,,Dissociation constant was determined,Autocuration,,1,,,,22224,P,U,CHEMBL629639
,BAO_0000100,,,10689,,,,,0,14777,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,Autocuration,,1,,,,22224,P,U,CHEMBL629640
,BAO_0000100,,,13925,,,,,0,14778,,Dissociation constant was determined,Autocuration,,1,,,,22224,P,U,CHEMBL629641
,BAO_0000100,,,16359,,,,,0,14779,,Dissociation constant was determined,Autocuration,,1,,,,22224,P,U,CHEMBL631344
,BAO_0000218,,,10944,,2385.0,,,1,14780,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL631345
,BAO_0000019,,,11080,,,,,0,14781,,The dissociation constant determined by fluorescence displacement assay,Autocuration,,1,,,,22224,A,U,CHEMBL631346
,BAO_0000019,,,17805,,,,,0,14782,,kd value surface plasmon resonance (SPR) method,Autocuration,,1,,,,22224,A,U,CHEMBL631524
,BAO_0000218,,,10944,,2385.0,,,1,14783,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL631525
,BAO_0000019,,,16645,,,,,0,14784,,First dissociation constant of the binding of compound to V30M TTR,Autocuration,,1,,,,22224,F,U,CHEMBL631526
,BAO_0000019,,,16645,,,,,0,14785,,Second dissociation constant of the binding of compound to V30M TTR,Autocuration,,1,,,,22224,F,U,CHEMBL631527
,BAO_0000019,,,7793,,,,,0,14786,,"Compound was evaluated for equilibrium constant, Ke",Autocuration,,1,,,,22224,A,U,CHEMBL631528
,BAO_0000019,,,12199,,1898.0,,,0,14787,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,Autocuration,,1,,,Hypothalamus,22224,A,U,CHEMBL631529
,BAO_0000019,,,12199,,1898.0,,,0,14788,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,Autocuration,,1,,,Hypothalamus,22224,A,U,CHEMBL631530
,BAO_0000019,,,9680,,,,,0,14789,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,Autocuration,,1,,,,22224,A,U,CHEMBL631531
,BAO_0000019,,,9680,,,,,0,14790,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,Autocuration,,1,,,,22224,A,U,CHEMBL631532
,BAO_0000019,,,9680,,,,,0,14791,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,Autocuration,,1,,,,22224,A,U,CHEMBL631533
,BAO_0000218,,,13758,,,,,1,14792,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL876552
,BAO_0000218,,,13758,,,,,1,14793,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL631534
,BAO_0000218,,,13758,,,,,1,14794,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL631535
,BAO_0000218,,,13758,,,,,1,14795,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL631536
,BAO_0000218,,,13758,,,,,1,14796,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL631537
,BAO_0000218,,,13758,,,,,1,14797,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL631538
,BAO_0000218,,,13758,,,,,1,14798,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL631539
,BAO_0000218,,,13758,,,,,1,14799,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL631540
,BAO_0000218,,,14393,,,,,1,14800,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625637
,BAO_0000218,,,14393,,,,,1,14801,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625638
,BAO_0000218,,,15078,,,,,1,14802,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL625639
,BAO_0000218,,In vivo,13925,,955.0,,,1,14803,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625640
,BAO_0000218,,In vivo,13925,,955.0,,,1,14804,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625641
,BAO_0000218,,In vivo,13925,,948.0,,,1,14805,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL625642
,BAO_0000218,,In vivo,13925,,948.0,,,1,14806,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL625643
,BAO_0000218,,In vivo,13925,,2113.0,,,1,14807,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625644
,BAO_0000218,,In vivo,13925,,2113.0,,,1,14808,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Kidney,50597,A,N,CHEMBL625645
,BAO_0000218,,In vivo,13925,,2107.0,,,1,14809,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625646
,BAO_0000218,,In vivo,13925,,2107.0,,,1,14810,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625647
,BAO_0000218,,In vivo,13925,,2048.0,,,1,14811,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625648
,BAO_0000218,,In vivo,13925,,2048.0,,,1,14812,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL625649
,BAO_0000218,,In vivo,13925,,2385.0,,,1,14813,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL625650
,BAO_0000218,,In vivo,13925,,2385.0,,,1,14814,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL625651
,BAO_0000218,,In vivo,13925,,14.0,,,1,14815,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL625652
,BAO_0000218,,In vivo,13925,,14.0,,,1,14816,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Zone of skin,50597,A,N,CHEMBL625653
,BAO_0000218,,In vivo,13925,,2106.0,,,1,14817,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625654
,BAO_0000218,,In vivo,13925,,2106.0,,,1,14818,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL625655
,BAO_0000218,,In vivo,9712,,178.0,,,1,14819,,Biodistribution of Compound in rat blood after 15 minutes of administration,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625656
,BAO_0000218,,In vivo,9712,,178.0,,,1,14820,,Biodistribution of Compound in rat blood after 2 minutes of administration,Intermediate,Rattus norvegicus,1,10116.0,,Blood,50597,A,N,CHEMBL625657
,BAO_0000218,,In vivo,9712,,955.0,,,1,14821,,Biodistribution of Compound in rat brain after 15 minutes of administration,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625658
,BAO_0000218,,In vivo,9712,,955.0,,,1,14822,,Biodistribution of Compound in rat brain after 2 minutes of administration,Intermediate,Rattus norvegicus,1,10116.0,,Brain,50597,A,N,CHEMBL625659
,BAO_0000218,,In vivo,9712,,948.0,,,1,14823,,Biodistribution of Compound in rat heart after 15 minutes of administration,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL625660
,BAO_0000218,,In vivo,9712,,948.0,,,1,14824,,Biodistribution of Compound in rat heart after 2 minutes of administration,Intermediate,Rattus norvegicus,1,10116.0,,Heart,50597,A,N,CHEMBL625661
,BAO_0000218,,In vivo,9712,,2107.0,,,1,14825,,Biodistribution of Compound in rat liver after 15 minutes of administration,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625662
,BAO_0000218,,In vivo,9712,,2107.0,,,1,14826,,Biodistribution of Compound in rat liver after 2 minutes of administration,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL625663
,BAO_0000218,,In vivo,9712,,2048.0,,,1,14827,,Biodistribution of Compound in rat lung after 15 minutes of administration,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL875621
,BAO_0000218,,In vivo,9712,,2048.0,,,1,14828,,Biodistribution of Compound in rat lung after 2 minutes of administration,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL628382
,BAO_0000218,,In vivo,9712,,2385.0,,,1,14829,,Biodistribution of Compound in rat muscle after 15 minutes of administration,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL628383
,BAO_0000218,,In vivo,9712,,2385.0,,,1,14830,,Biodistribution of Compound in rat muscle after 2 minutes of administration,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL628384
,BAO_0000218,,,13925,,,,,1,14831,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628385
,BAO_0000218,,,13925,,,,,1,14832,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875753
,BAO_0000218,,,13925,,,,,1,14833,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628386
,BAO_0000218,,,6941,,,,,1,14834,,Organ distribution in rat blood 2 minutes after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628387
,BAO_0000218,,,6941,,,,,1,14835,,Organ distribution in rat blood 2 hr after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628388
,BAO_0000218,,,6941,,,,,1,14836,,Organ distribution in rat blood 30 minutes after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628389
,BAO_0000218,,,6941,,,,,1,14837,,Organ distribution in rat blood 30 min after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL632756
,BAO_0000218,,,6941,,,,,1,14838,,Organ distribution in rat brain 2 minutes after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628390
,BAO_0000218,,,6941,,,,,1,14839,,Organ distribution in rat brain 2 hr after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631811
,BAO_0000218,,,6941,,,,,1,14840,,Organ distribution in rat brain 30 minutes after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631812
,BAO_0000218,,,6941,,,,,1,14841,,Organ distribution in rat heart 2 minutes after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631813
,BAO_0000218,,,6941,,,,,1,14842,,Organ distribution in rat heart 2 hr after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631814
,BAO_0000218,,,6941,,,,,1,14843,,Organ distribution in rat heart 30 minutes after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631815
,BAO_0000218,,,6941,,,,,1,14844,,Organ distribution in rat kidney 2 minutes after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631816
,BAO_0000218,,,6941,,,,,1,14845,,Organ distribution in rat kidney 2 hr after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL875758
,BAO_0000218,,,6941,,,,,1,14846,,Organ distribution in rat kidney 30 minutes after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631817
,BAO_0000218,,,6941,,2107.0,,,1,14847,,Organ distribution in rat liver 2 minutes after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL631818
,BAO_0000218,,,6941,,2107.0,,,1,14848,,Organ distribution in rat liver 2 hr after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL631819
,BAO_0000218,,,6941,,2107.0,,,1,14849,,Organ distribution in rat liver 30 minutes after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL631820
,BAO_0000218,,,6941,,,,,1,14850,,Organ distribution in rat lung 2 minutes after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631821
,BAO_0000218,,,6941,,,,,1,14851,,Organ distribution in rat lung 2 hr after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631822
,BAO_0000218,,,6941,,,,,1,14852,,Organ distribution in rat lung 30 minutes after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL631823
,BAO_0000218,,,6941,,2385.0,,,1,14853,,Organ distribution in rat muscle 2 minutes after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL631824
,BAO_0000218,,,6941,,2385.0,,,1,14854,,Organ distribution in rat muscle 2 hr after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL631825
,BAO_0000218,,,6941,,2385.0,,,1,14855,,Organ distribution in rat muscle 30 minutes after intravenous injection,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL631826
,BAO_0000218,,In vivo,14439,,,,,1,14856,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL631827
,BAO_0000218,,In vivo,14439,,,,,1,14857,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL631828
,BAO_0000218,,In vivo,14439,,,,,1,14858,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL631829
,BAO_0000218,,,12582,,1088.0,,,1,14859,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL875759
,BAO_0000218,,,12582,,1088.0,,,1,14860,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631830
,BAO_0000218,,,12582,,1088.0,,,1,14861,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631831
,BAO_0000218,,,12582,,1088.0,,,1,14862,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631832
,BAO_0000218,,,12582,,1088.0,,,1,14863,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631833
,BAO_0000218,,,12582,,1088.0,,,1,14864,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631834
,BAO_0000218,,,12582,,1088.0,,,1,14865,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631835
,BAO_0000218,,,12582,,1088.0,,,1,14866,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631836
,BAO_0000218,,,12582,,1088.0,,,1,14867,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631837
,BAO_0000218,,,12582,,1088.0,,,1,14868,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631838
,BAO_0000218,,,12582,,1088.0,,,1,14869,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631839
,BAO_0000218,,,12582,,1088.0,,,1,14870,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631840
,BAO_0000218,,,12582,,1088.0,,,1,14871,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631841
,BAO_0000218,,,12582,,1088.0,,,1,14872,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631842
,BAO_0000218,,,12582,,1088.0,,,1,14873,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631843
,BAO_0000218,,,12582,,1088.0,,,1,14874,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631844
,BAO_0000218,,,12582,,1088.0,,,1,14875,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631845
,BAO_0000218,,,12582,,1088.0,,,1,14876,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631846
,BAO_0000218,,,12582,,1088.0,,,1,14877,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL875760
,BAO_0000218,,,12582,,1088.0,,,1,14878,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL632199
,BAO_0000218,,,12582,,1088.0,,,1,14879,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631847
,BAO_0000218,,,12582,,1088.0,,,1,14880,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL631848
,BAO_0000218,,,12582,,1088.0,,,1,14881,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628707
,BAO_0000218,,,12582,,1088.0,,,1,14882,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628708
,BAO_0000218,,,12582,,1088.0,,,1,14883,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628709
,BAO_0000218,,,12582,,1088.0,,,1,14884,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628710
,BAO_0000218,,,12582,,1088.0,,,1,14885,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628711
,BAO_0000218,,,12582,,1088.0,,,1,14886,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628712
,BAO_0000218,,,12582,,1088.0,,,1,14887,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628713
,BAO_0000218,,,12582,,1088.0,,,1,14888,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Intermediate,Rattus norvegicus,1,10116.0,,Urine,50597,A,N,CHEMBL628714
,BAO_0000218,,,7415,,,,,1,14889,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL628715
,BAO_0000019,,,7313,,,,,0,14890,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,Autocuration,,1,,,,22224,A,U,CHEMBL629179
,BAO_0000019,,,7313,,,,,0,14891,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,Autocuration,,1,,,,22224,A,U,CHEMBL629180
,BAO_0000019,,,7313,,,,,0,14892,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,Autocuration,,1,,,,22224,A,U,CHEMBL875108
,BAO_0000019,,,7570,,1235.0,,,0,14893,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,Autocuration,,1,,,Adrenal cortex,22224,A,U,CHEMBL629181
,BAO_0000019,,,7570,,1235.0,,,0,14894,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,Autocuration,,1,,,Adrenal cortex,22224,A,U,CHEMBL629182
,BAO_0000019,,,7570,,,,,0,14895,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,Autocuration,,1,,,,22224,A,U,CHEMBL629183
,BAO_0000019,,,7570,,,,,0,14896,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,Autocuration,,1,,,,22224,A,U,CHEMBL629184
,BAO_0000019,,,7570,,1235.0,,,0,14897,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,Autocuration,,1,,,Adrenal cortex,22224,A,U,CHEMBL629185
,BAO_0000019,,,7570,,1235.0,,,0,14898,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,Autocuration,,1,,,Adrenal cortex,22224,A,U,CHEMBL629186
,BAO_0000019,,,7570,,,,,0,14899,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,Autocuration,,1,,,,22224,A,U,CHEMBL629187
,BAO_0000019,,,7570,,,,,0,14900,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,Autocuration,,1,,,,22224,A,U,CHEMBL629887
,BAO_0000019,,,7570,,,,,0,14901,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,Autocuration,,1,,,,22224,A,U,CHEMBL629888
,BAO_0000019,,,7570,,,,,0,14902,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,Autocuration,,1,,,,22224,A,U,CHEMBL629889
,BAO_0000019,,,7570,,1235.0,,,0,14903,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,Autocuration,,1,,,Adrenal cortex,22224,A,U,CHEMBL629890
,BAO_0000019,,,7570,,,,,0,14904,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,Autocuration,,1,,,,22224,A,U,CHEMBL629891
,BAO_0000019,,,7570,,,,,0,14905,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,Autocuration,,1,,,,22224,A,U,CHEMBL629892
,BAO_0000019,,,7570,,1235.0,,,0,14906,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,Autocuration,,1,,,Adrenal cortex,22224,A,U,CHEMBL629893
,BAO_0000019,,,7570,,,,,0,14907,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,Autocuration,,1,,,,22224,A,U,CHEMBL629894
,BAO_0000019,,,7570,,,,,0,14908,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,Autocuration,,1,,,,22224,A,U,CHEMBL629895
,BAO_0000218,,In vivo,14122,,,,,0,14909,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",Autocuration,Canis lupus familiaris,1,9615.0,,,22224,A,U,CHEMBL875109
,BAO_0000218,,In vivo,16449,,,,,0,14910,,Absolute bioavailability in male cynomolgus monkeys,Autocuration,Macaca fascicularis,1,9541.0,,,22224,A,U,CHEMBL629896
,BAO_0000218,,In vivo,16449,,,,,0,14911,,Absolute bioavailability in maleSprague-Dawley rats,Autocuration,Rattus norvegicus,1,10116.0,,,22224,A,U,CHEMBL629897
,BAO_0000218,,In vivo,12017,,2107.0,,,1,14912,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL629898
,BAO_0000218,,In vivo,12017,,2107.0,,,1,14913,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL630057
,BAO_0000218,,In vivo,12017,,2107.0,,,1,14914,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Liver,50597,A,N,CHEMBL630058
,BAO_0000218,,In vivo,12017,,2048.0,,,1,14915,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL630059
,BAO_0000218,,In vivo,12017,,2048.0,,,1,14916,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL630060
,BAO_0000218,,In vivo,12017,,2048.0,,,1,14917,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL630061
,BAO_0000218,,In vivo,12017,,2048.0,,,1,14918,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL630062
,BAO_0000218,,In vivo,12017,,2048.0,,,1,14919,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL630063
,BAO_0000218,,In vivo,12017,,2048.0,,,1,14920,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL630064
,BAO_0000218,,In vivo,12017,,2048.0,,,1,14921,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL630065
,BAO_0000218,,In vivo,12017,,2048.0,,,1,14922,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL630066
,BAO_0000218,,In vivo,12017,,2048.0,,,1,14923,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL630067
,BAO_0000218,,In vivo,12017,,2048.0,,,1,14924,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Lung,50597,A,N,CHEMBL630068
,BAO_0000218,,In vivo,12017,,2385.0,,,1,14925,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL631113
,BAO_0000218,,In vivo,12017,,2385.0,,,1,14926,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL631114
,BAO_0000218,,In vivo,12017,,2385.0,,,1,14927,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL631115
,BAO_0000218,,In vivo,12017,,2385.0,,,1,14928,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL631116
,BAO_0000218,,In vivo,12017,,2385.0,,,1,14929,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL630528
,BAO_0000218,,In vivo,12017,,2385.0,,,1,14930,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL630529
,BAO_0000218,,In vivo,12017,,2385.0,,,1,14931,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL630530
,BAO_0000218,,In vivo,12017,,2385.0,,,1,14932,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL630531
,BAO_0000218,,In vivo,12017,,2385.0,,,1,14933,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL630532
,BAO_0000218,,In vivo,12017,,2385.0,,,1,14934,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Muscle tissue,50597,A,N,CHEMBL630533
,BAO_0000218,,In vivo,15045,,178.0,,,1,14935,,Biodistribution in normal mice blood after 120 hr,Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL630534
,BAO_0000218,,In vivo,15045,,178.0,,,1,14936,,Biodistribution in normal mice blood after 24 hr,Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL630535
,BAO_0000218,,In vivo,15045,,178.0,,,1,14937,,Biodistribution in normal mice blood after 4 hr,Intermediate,Mus musculus,1,10090.0,,Blood,50594,A,N,CHEMBL630536
,BAO_0000218,,In vivo,15045,,10000001.0,,,1,14938,,Biodistribution in normal mice bone after 120 hr,Intermediate,Mus musculus,1,10090.0,,Bone,50594,A,N,CHEMBL630537
,BAO_0000218,,In vivo,15045,,10000001.0,,,1,14939,,Biodistribution in normal mice bone after 24 hr,Intermediate,Mus musculus,1,10090.0,,Bone,50594,A,N,CHEMBL630538
,BAO_0000218,,In vivo,15045,,10000001.0,,,1,14940,,Biodistribution in normal mice bone after 4 hr,Intermediate,Mus musculus,1,10090.0,,Bone,50594,A,N,CHEMBL630539
,BAO_0000218,,In vivo,15045,,948.0,,,1,14941,,Biodistribution in normal mice heart after 120 hr,Intermediate,Mus musculus,1,10090.0,,Heart,50594,A,N,CHEMBL630540
,BAO_0000218,,In vivo,15045,,948.0,,,1,14942,,Biodistribution in normal mice heart after 24 hr,Intermediate,Mus musculus,1,10090.0,,Heart,50594,A,N,CHEMBL630541
,BAO_0000218,,In vivo,15045,,948.0,,,1,14943,,Biodistribution in normal mice heart after 4 hr,Intermediate,Mus musculus,1,10090.0,,Heart,50594,A,N,CHEMBL630542
,BAO_0000218,,In vivo,15045,,2113.0,,,1,14944,,Biodistribution in normal mice kidney after 120 hr,Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL630543
,BAO_0000218,,In vivo,15045,,2113.0,,,1,14945,,Biodistribution in normal mice kidney after 24 hr,Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL630544
,BAO_0000218,,In vivo,15045,,2113.0,,,1,14946,,Biodistribution in normal mice kidney after 4 hr,Intermediate,Mus musculus,1,10090.0,,Kidney,50594,A,N,CHEMBL630545
,BAO_0000218,,In vivo,15045,,2107.0,,,1,14947,,Biodistribution in normal mice liver after 120 hr,Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL630546
,BAO_0000218,,In vivo,15045,,2107.0,,,1,14948,,Biodistribution in normal mice liver after 24 hr,Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL630547
,BAO_0000218,,In vivo,15045,,2107.0,,,1,14949,,Biodistribution in normal mice liver after 4 hr,Intermediate,Mus musculus,1,10090.0,,Liver,50594,A,N,CHEMBL630548
,BAO_0000218,,In vivo,15045,,2106.0,,,1,14950,,Biodistribution in normal mice spleen after 120 hr,Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL630549
,BAO_0000218,,In vivo,15045,,2106.0,,,1,14951,,Biodistribution in normal mice spleen after 24 hr,Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL630550
,BAO_0000218,,In vivo,15045,,2106.0,,,1,14952,,Biodistribution in normal mice spleen after 4 hr,Intermediate,Mus musculus,1,10090.0,,Spleen,50594,A,N,CHEMBL876426
,BAO_0000218,,In vivo,12017,,2106.0,,,1,14953,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL630551
,BAO_0000218,,In vivo,12017,,2106.0,,,1,14954,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL630552
,BAO_0000218,,In vivo,12017,,2106.0,,,1,14955,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL630553
,BAO_0000218,,In vivo,12017,,2106.0,,,1,14956,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL630554
,BAO_0000218,,In vivo,12017,,2106.0,,,1,14957,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL630555
,BAO_0000218,,In vivo,12017,,2106.0,,,1,14958,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL630556
,BAO_0000218,,In vivo,12017,,2106.0,,,1,14959,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL630557
,BAO_0000218,,In vivo,12017,,2106.0,,,1,14960,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL630558
,BAO_0000218,,In vivo,12017,,2106.0,,,1,14961,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL630559
,BAO_0000218,,In vivo,12017,,2106.0,,,1,14962,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Spleen,50597,A,N,CHEMBL630560
,BAO_0000218,,In vivo,12017,,2046.0,,,1,14963,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,Rattus norvegicus,1,10116.0,,Thyroid gland,50597,A,N,CHEMBL876427
,BAO_0000218,,,14941,,,,,1,14964,,The Kel values in female wistar rats.,Intermediate,Rattus norvegicus,1,10116.0,,,50597,A,N,CHEMBL630561
,BAO_0000019,,,4646,,,,,0,14965,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,Autocuration,,1,,,,22224,A,U,CHEMBL630562
,BAO_0000019,,,8847,,,,,0,14966,,Hydrolysis rate constant of the compound,Autocuration,,1,,,,22224,A,U,CHEMBL630563
,BAO_0000100,,,11778,,,,,0,14967,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,Autocuration,,1,,,,22229,P,U,CHEMBL629673
,BAO_0000019,,,2363,,,,,0,14968,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",Autocuration,,1,,,,22224,A,U,CHEMBL629674
,BAO_0000019,,,2363,,,,,0,14969,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",Autocuration,,1,,,,22224,A,U,CHEMBL629675
,BAO_0000019,,,2363,,,,,0,14970,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",Autocuration,,1,,,,22224,A,U,CHEMBL629676
,BAO_0000019,,,2363,,,,,0,14971,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",Autocuration,,1,,,,22224,A,U,CHEMBL629677
,BAO_0000019,,,8371,,,,,0,14972,,Apparent inactivation rate constant was evaluated,Autocuration,,1,,,,22224,A,U,CHEMBL629678
,BAO_0000019,,,14883,,,,,0,14973,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,Autocuration,,1,,,,22224,A,U,CHEMBL629679
,BAO_0000019,,,14883,,,,,0,14974,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,Autocuration,,1,,,,22224,A,U,CHEMBL629680
,BAO_0000019,,,4643,,,,,0,14975,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,Autocuration,,1,,,,22224,A,U,CHEMBL629681
,BAO_0000019,,,3519,,,,,0,14976,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,Autocuration,,1,,,,22224,A,U,CHEMBL629682
,BAO_0000019,,,10600,,,,,0,14977,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,Autocuration,,1,,,,22224,A,U,CHEMBL629683
,BAO_0000019,,,8501,,,,,0,14978,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,Autocuration,,1,,,,22224,F,U,CHEMBL629684
,BAO_0000100,,,8505,,,,,0,14979,,Dissociation constant was determined,Autocuration,,1,,,,22224,P,U,CHEMBL629685
,BAO_0000100,,,9778,,,,,0,14980,,Dissociation constant was determined,Autocuration,,1,,,,22224,P,U,CHEMBL629686
,BAO_0000100,,,9778,,,,,0,14981,,Dissociation constant at pH 7.4,Autocuration,,1,,,,22224,P,U,CHEMBL872932
,BAO_0000100,,,9778,,,,,0,14982,,Dissociation constant in presence of 1 mM dithiothreitol,Autocuration,,1,,,,22224,P,U,CHEMBL629687
,BAO_0000019,,,13007,,,,,0,14983,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,Autocuration,,1,,,,22224,A,U,CHEMBL872931
,BAO_0000019,,,13007,,,,,0,14984,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,Autocuration,,1,,,,22224,A,U,CHEMBL628151
,BAO_0000019,,,13007,,,,,0,14985,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,Autocuration,,1,,,,22224,A,U,CHEMBL628152
,BAO_0000019,,,13007,,,,,0,14986,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,Autocuration,,1,,,,22224,A,U,CHEMBL628153
,BAO_0000019,,,11482,,,,,0,14987,,Kinetic constant for aromatization of androstenedione,Autocuration,,1,,,,22224,A,U,CHEMBL628154
,BAO_0000019,,,11482,,,,,0,14988,,Kinetic constant for aromatization of testosterone,Autocuration,,1,,,,22224,A,U,CHEMBL628155
,BAO_0000019,,,2303,,,,,0,14989,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,Autocuration,,1,,,,22224,A,U,CHEMBL628156
,BAO_0000019,,,11964,,,,,0,14990,,Local inhibition constant was determined,Autocuration,,1,,,,22224,A,U,CHEMBL628157
,BAO_0000218,,,3140,,,,,1,14991,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,Intermediate,Saccharomyces cerevisiae,1,4932.0,,,50347,A,N,CHEMBL857533
,BAO_0000100,,,10650,,,,,0,14992,,Dissociation constant value of the compound,Autocuration,,1,,,,22224,P,U,CHEMBL628158
,BAO_0000019,,,4667,,964.0,,,0,14993,,In vitro permeability through cornea without epithelium,Autocuration,,1,,,Cornea,22224,A,U,CHEMBL628159
,BAO_0000019,,,4667,,964.0,,,0,14994,,In vitro permeability through intact cornea,Autocuration,,1,,,Cornea,22224,A,U,CHEMBL875616
,BAO_0000218,,,9199,,964.0,,,1,14995,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,Intermediate,Oryctolagus cuniculus,1,9986.0,,Cornea,50592,A,N,CHEMBL628160
,BAO_0000019,,,11966,,,,,0,14996,,Rate of enzyme inactivation for the compound was determined,Autocuration,,1,,,,22224,A,U,CHEMBL628161
,BAO_0000019,,,4667,,964.0,,,0,14997,,In vitro permeability through cornea without epithelium,Autocuration,,1,,,Cornea,22224,A,U,CHEMBL628162
,BAO_0000019,,,4667,,964.0,,,0,14998,,In vitro permeability through intact cornea,Autocuration,,1,,,Cornea,22224,A,U,CHEMBL628163
,BAO_0000019,,,8354,,,,,0,14999,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL628164
,BAO_0000019,,,8354,,,,,0,15000,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL628165
,BAO_0000019,,,8354,,,,,0,15001,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL628166
,BAO_0000019,,,8354,,,,,0,15002,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL628167
,BAO_0000019,,,8354,,,,,0,15003,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL628168
,BAO_0000019,,,8354,,,,,0,15004,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL628169
,BAO_0000019,,,8354,,,,,0,15005,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL628170
,BAO_0000019,,,8354,,,,,0,15006,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL628171
,BAO_0000019,,,8354,,,,,0,15007,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL627434
,BAO_0000019,,,8354,,,,,0,15008,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL627435
,BAO_0000019,,,8354,,,,,0,15009,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL628110
,BAO_0000019,,,8354,,,,,0,15010,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL628111
,BAO_0000019,,,8354,,,,,0,15011,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL628112
,BAO_0000019,,,8354,,,,,0,15012,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL628260
,BAO_0000019,,,8354,,,,,0,15013,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,1,,,,22224,A,U,CHEMBL628261
,BAO_0000218,,In vivo,14439,,,,,1,15014,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL628262
,BAO_0000218,,In vivo,14439,,,,,1,15015,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,Intermediate,Homo sapiens,1,9606.0,,,50587,A,N,CHEMBL628263
,BAO_0000218,,In vivo,14439,,,,,1,15016,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL628264
,BAO_0000218,,In vivo,14439,,,,,1,15017,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL628265
,BAO_0000218,,In vivo,14439,,,,,1,15018,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL628266
,BAO_0000218,,In vivo,14439,,,,,1,15019,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL628267
,BAO_0000218,,In vivo,14439,,,,,1,15020,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL628268
,BAO_0000218,,In vivo,14439,,,,,1,15021,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL628269
,BAO_0000218,,In vivo,14439,,,,,1,15022,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL628270
,BAO_0000218,,In vivo,14439,,,,,1,15023,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL628271
,BAO_0000218,,In vivo,14439,,,,,1,15024,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),Intermediate,Mus musculus,1,10090.0,,,50594,A,N,CHEMBL628272
